













This thesis has been submitted in fulfilment of the requirements for a postgraduate degree 
(e.g. PhD, MPhil, DClinPsychol) at the University of Edinburgh. Please note the following 
terms and conditions of use: 
 
This work is protected by copyright and other intellectual property rights, which are 
retained by the thesis author, unless otherwise stated. 
A copy can be downloaded for personal non-commercial research or study, without 
prior permission or charge. 
This thesis cannot be reproduced or quoted extensively from without first obtaining 
permission in writing from the author. 
The content must not be changed in any way or sold commercially in any format or 
medium without the formal permission of the author. 
When referring to this work, full bibliographic details including the author, title, 
awarding institution and date of the thesis must be given. 
 
  
Epidemiology of antimicrobial resistance at the 
livestock-human interface in an urban environment: a 
One Health approach 
 











A Thesis submitted for the degree of Doctor of Philosophy 
The University of Edinburgh 
June, 2019 






















































































I declare that this thesis and the analyses described within it are original and my 
own composition, expect where explicitly stated below, and that this work has 
not been submitted for any other degree or professional qualification. Data 
collection described herein was primarily carried out by myself and members of 
the UrbanZoo project. Laboratory based work, including bacterial culture and 
bacterial DNA extraction were conducted by laboratory teams at University of 
Nairobi, Kenya Medical Research Institute, and the International Livestock 
Research Institute. Whole Genome Sequencing (WGS) of E. coli isolates was 
performed at the Wellcome Centre for Human Genetics, Oxford Genomics 
Centre (funded by Wellcome Trust grant reference 203141/Z/16/Z). 
Bioinformatic processing of sequences was conducted by members of the 
Modernizing Medical Microbiology Informatics Group (University of Oxford), 
Dr Melissa Ward, Dr Bryan Wee and myself. Phylogenetic analysis was 
conducted by Dr Bryan Wee and myself.  













Livestock have been implicated as a reservoir for antimicrobial resistant (AMR) 
bacteria that may spread to humans, with the keeping of livestock widely 
postulated as a risk factor for AMR in humans. However, quantitative evidence 
of the role of livestock in the emergence and transmission of AMR bacteria to 
human populations is lacking. This thesis focuses on the role of livestock 
keeping as a potentially high-risk interface for AMR transmission between 
humans and livestock in urban Nairobi. To achieve this, E. coli isolates were 
systematically collected from sympatric human and livestock populations in 99 
households across Nairobi, Kenya. E. coli was characterised both phenotypically 
(through antimicrobial susceptibility testing) and genetically (through whole 
genome sequencing). 
In the first part of this thesis, I conduct a comprehensive systematic review to 
investigate existing evidence that food animals are responsible for transfer of 
resistant E. coli and their AMR determinants to humans. I demonstrate that the 
current evidence regarding transmission of drug resistance between food 
animals and humans is limited and that similarity of AMR bacteria or AMR 
determinants in the two populations does not, by itself, provide information on 
directionality of transfer. I highlight the need to use high resolution genomic 
analysis on human and livestock bacterial samples collected in time and space 
to better understand the direction and frequency of AMR transmission between 
these populations.  
Next, utilising AMR phenotypes and genotypes, I explored the variation in 
carriage of AMR E. coli and investigated the role of livestock ownership as a risk 
factor for AMR carriage in humans. First, I explored the epidemiology of 
clinically relevant AMR phenotypes and AMR genetic markers.  I detected high 
rates of AMR phenotypes, with 47.6% and 21.1% of isolates displaying resistance 
to ≥ 3 and ≥5 antimicrobial classes respectively. Whole-genome sequencing 
revealed 60 acquired genes and 14 point mutations conferring AMR to 9 
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antimicrobial classes. sul2, strA, strB, tetA, and blaTEM-1B were the most 
frequently detected AMR genes conferring resistance to sulfonamides, 
aminoglycosides, tetracyclines, and β-lactams respectively – the most 
commonly found phenotypes. Highest carriage of AMR genes and phenotypes 
was observed in humans, pigs and poultry compared to goats, rabbits and 
bovines. Secondly, I demonstrated that the presence of livestock in the 
household did not influence phenotypic or genotypic AMR carriage in humans, 
but the impact of keeping livestock on human AMR carriage was instead 
influenced by presence of animal manure in the household.  
Utilising high resolution sequencing data, I proceeded to investigate the 
patterns of bacterial relatedness and strain sharing as a proxy for transmission 
potential. I showed that livestock and human isolates are genetically 
heterogeneous, with minimal evidence of clustering by host group, and that E. 
coli genomes in humans did not segregate according to livestock ownership. 
Next, I found evidence of 91 sharing events differing by less than ten base pairs 
(59 involving livestock isolates only 23 human isolates only, and 9 between 
humans and livestock), and that most of the sharing events were confined 
within households with only occasional instances of spread between household. 
I also demonstrate that high-resolution sequence-based analysis of SNPs is more 
discriminatory than MLST – a widely used tool in describing transmission of E. 
coli. 
Next, I described the patterns of antimicrobial sales in humans and livestock, 
and the level of awareness and common behaviours related to antimicrobial 
prescribing amongst human and veterinary pharmacists in urban Nairobi. β-
lactams, fluoroquinolones, first and second generation cephalosporins, and 
metronidazole were the most commonly purchased human antimicrobials while 
tetracyclines, sulphonamides, penicillins, and macrolides were the most 
commonly purchased veterinary antimicrobials. This finding was in line with 
the resistance phenotypes and genotypes described in this thesis. I found that 
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whilst most pharmacists were knowledgeable about antimicrobial use and AMR, 
inappropriate prescribing practices were common and that over the counter sale 
of antimicrobials, without a prescription, was a common occurrence in both 
human and veterinary drug stores. 
In the final section of the thesis, I investigated the co-occurrence patterns of 
acquired AMR genes and the role of conjugative plasmids on the epidemiology 
of AMR spread. I found evidence of co-location of multiple AMR genes in both 
human and livestock isolates, potentially enabling acquisition and 
dissemination of multi-drug resistance phenotypes in a single step. I found a 
diversity of known plasmids and plasmid replicons that were associated with 
the distribution of acquired AMR genes.   
To conclude, I discuss the findings of this thesis in the context of the current 
epidemiology of AMR pathogens at the human-livestock interface and highlight 
future directions for research on AMR transmission, and discuss implications of 
my findings for public health. This thesis demonstrates how fine-scale genomic 
analysis explicitly embedded within an epidemiologically structured sampling 
framework can be utilized to track bacterial sharing and in the surveillance of 
AMR prevalence in a low income urban setting. The connectivity of bacteria and 
their AMR determinants between humans and livestock and the ultimate 
impacts upon human health lends strong support for a holistic ‘One Health’ 









Antimicrobial resistance (AMR) – the ability of bacteria to survive in the 
presence of antimicrobials – is a serious public health concern in all countries 
across the globe. The role of livestock as a source of antimicrobial resistant 
bacterial infections increasingly observed in humans has been the subject of 
much speculation and is poorly understood. This thesis investigates the 
transmission of AMR bacteria between human and livestock populations in a 
developing country urban environment using a One Health approach – defined 
as “an interdisciplinary approach that considers the fundamental connections 
between human, animal, and environmental health”.  
A common bacterium that inhabits the mammalian gut, Escherichia coli 
(hereafter E. coli), was isolated from faecal samples of cohabiting human and 
livestock populations across Nairobi, Kenya. E. coli were cultured and isolates 
were tested for resistance to a range of antimicrobials. The genomic information 
for bacterial isolates from each individual (complete set of DNA, including all of 
their genes) was obtained using a genetic analysis technique known as whole 
genome sequencing.  
In the first part of this thesis, I carried out a systematic review of current 
evidence for the transfer of resistant E. coli between farm animals and people 
across the globe. I found studies suggesting that resistant E. coli bacteria can be 
passed directly to humans by livestock, but limitations in those studies mean 
that the causative role of farm animals in the rise and spread of AMR bacteria 
cannot be unequivocally determined.  
Next, I analysed the occurrence of clinically relevant resistant bacteria in 
livestock and humans in Nairobi and the genes associated with this resistance. 
I observed a high prevalence of bacterial strains resistant to commonly used 
antimicrobials: sulfonamides, aminoglycosides, tetracyclines, and β-lactams. 
Resistant bacteria were most commonly found in humans, pigs and poultry, 
compared to other species such as cattle, goats and rabbits. These livestock 
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species are growing in importance in most developing countries. In addition, 
resistant bacteria were as common in people living in households without 
livestock as those in households with livestock.  Also, disposing of animal 
manure in household compounds made it more likely that people would carry 
AMR bacteria. Further, my analysis suggested that resistance genes were mostly 
located on genetic elements (known as plasmids) that can be transferred both 
from one bacterium to another and between humans and animals, suggesting a 
mechanism for the spread of the causes of resistance. 
Next, examining the bacterial genetic sequences from humans and livestock, 
and comparing them with each other, I found evidence of sharing of bacteria, 
mostly confined within humans, and separately, within livestock, with limited 
evidence of sharing between these groups of potential hosts. I also 
demonstrated that whole genome sequencing is more powerful in tracking 
sharing of bacteria in host populations than standard genetic tests that inspect 
only a handful of genes. 
Finally, investigating the practices and knowledge among antimicrobial retailers 
in Nairobi, I found that, while most pharmacists were knowledgeable about 
antimicrobial use, inappropriate prescribing practices were common and that 
both human and veterinary antimicrobials were sold over the counter, often 
without a prescription. 
This thesis demonstrates how robust data and state-of-the-art genome analysis 
can be used to shed light on how antimicrobial resistant bacteria arise and 
spread in human and animal populations, and my results can help design plans 
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Mr. X. has a sore throat. He buys some penicillin and gives himself, not 
enough to kill the Streptococci but enough to educate them to resist 
penicillin. He then infects his wife. Mrs. X gets pneumonia and is 
treated with penicillin. As the streptococci are now resistant to 
penicillin the treatment fails. Mrs. X dies.  
Who is primarily responsible for Mrs. X’s death? 
                         Alexander Fleming, 1945                                                   
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Chapter 1  Introduction to antimicrobial resistance 
1.1 The global status of antimicrobial resistance 
Antimicrobial resistance (AMR) is a major global public health concern (WHO, 
2015b)  which complicates the treatment of infections and is associated with 
increased morbidity and mortality of common diseases (Bush and Fisher, 2011; 
Davies, 2011). Since the discovery of penicillin in 1928 (Abraham and Chain, 
1940), antimicrobials have played a vital role in reducing morbidity and 
mortality from infectious diseases; however, these healthcare gains are now 
under threat because of the emergence and spread of drug resistant pathogens. 
In particular, the emergence and global dissemination of multidrug resistant 
(MDR, resistant to multiple drug classes) bacteria has enormous implications 
for healthcare delivery and population health (Smith and Coast, 2013).  
A recent synthesis of evidence indicated that an estimated 700,000 deaths 
globally were attributable to infections caused by antimicrobial resistant 
organisms, and this could reach 10 million/year by 2050 (O’Neill, 2016).In 2011, 
the Centers for Disease Control and Prevention (CDC) reported that AMR 
associated infections and complications were responsible for 23,000 deaths in 
the United States of America in 2013 (CDC, 2013). Similarly, in the European 
Union, it is estimated that the number of deaths attributable to AMR bacteria is 
about 25,000 each year (ECDC and EMEA Joint Working Group, 2009). 
Considering the sub-optimal hygiene conditions, high burden of infectious 
diseases, lack of AMR surveillance and the dearth of antimicrobial stewardship 
programs in most developing nations, the burden of AMR may be more evident 
in these settings.  While the general consensus is that AMR burden is high in 
most low- and middle-income countries (LMICs), a lack of standardized and 
comprehensive data prevents an accurate quantification of morbidity, mortality 
and economic cost associated with AMR infections (Laxminarayan, 2014). 
However, there are some country-specific examples; in 2010, a study in Thailand 
suggested that 43% (19,122 of 45,209) of deaths caused by hospital-acquired 
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MDR bacterial infections in Thailand were excess mortality due to MDR (Lim et 
al., 2016), significantly higher than in high income countries (HICs).  
In the last decade, the emergence and rapid global dissemination of resistance 
to antimicrobials considered of last resort has been reported as a serious public 
health concern. For example, emergence and rapid increase in carbapenems-
resistant Enterobacteriaceae (CRE) such as Klebsiella pneumoniae 
carbapenemase (KPC) (Yigit et al., 2001) and New Delhi metallo-β-lactamase 
(NDM1)(Kumarasamy et al., 2010) heralded the advent of what was described as 
a global “antimicrobial apocalypse”. Colistin had long been considered as an 
antimicrobial of last resort in human medicine, usually reserved to treat MDR 
Gram negative bacteria due to the absence of acquired resistance (Falagas and 
Kasiakou, 2006; Cai et al., 2012). However, in 2015, Liu et al reported the 
discovery of a transferrable plasmid mediated colistin resistance gene, mcr-1, in 
E. coli bacteria from pigs, food and humans (Liu et al., 2015). Since then, mcr-1 
(and the associated plasmid(s)) has been identified in different hosts in several 
countries across five continents (Wang et al., 2018).   
In addition to the global public health burden, AMR infections add considerable 
costs to already overburdened health care systems nationally and globally 
(Smith and Coast, 2013). Recent predictions suggest that the economic burden 
of AMR infections could result in a reduction of 2% to 3.5% in global gross 
domestic product in 2050, amounting to between 60 and 100 trillion US dollars, 
globally (Adeyi et al., 2017). Further, according to the same report, AMR is 
projected to have a significant impact on livestock production, with estimates 
predicting a reduction of 2.6%-7.5% in global livestock production by 2050. The 
relative economic costs associated with AMR infections are speculated to be 
higher in LMICs, and are likely to increase as resistance to second- and third-
generation antimicrobials develops, leading to situations where critically ill 
patients need supportive care, and antimicrobials no longer have therapeutic 
efficacy.  
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1.2 Burden of AMR in Kenya  
 
The mortality attributable to Gram negative AMR pathogens, increasingly 
involved in infectious diseases in humans, has been described in healthcare and 
community settings in differing prevalence across numerous developing 
nations. As elsewhere in sub-Saharan Africa, data on antimicrobial resistance 
burden is scant and patchy in Kenya, both from the clinic and community 
(WHO, 2014). There are, however, a small number of cross-sectional surveys 
mostly from tertiary healthcare facilities, typically found in large cities and 
urban areas. A study from a large private hospital in Nairobi suggest that among 
E. coli and Klebsiella pneumoniae, the two most frequent bacteria cultured from 
clinical samples, 8% were extended-spectrum β-lactamase (ESBLs) producers. 
This same study showed that MDR carriage was common, with susceptibility 
limited to carbapenems and nitrofurantoin (Maina et al., 2013). However, 
carbapenem resistance is also emerging, with the first report in Africa of the 
NDM-1 β-lactamase gene identified in K. pneumoniae reported in the same 
hospital (Poirel et al., 2011). Similarly, carbapenem resistance bacterial infections 
have been reported elsewhere in Kenya (Ayoyi et al., 2017; Henson et al., 2017).  
Likewise, in Kenya, the burden of AMR carriage in livestock is yet to be 
evaluated. A study on faecal carriage of MDR E. coli isolates from pigs, chicken 
and cattle meant for slaughter at two abattoirs in Nairobi demonstrated a high 
prevalence of MDR carriage (Kikuvi et al., 2006). The same study demonstrated 
that despite banning chloramphenicol for farm animal use in Kenya, 5% of E. 
coli isolates from pigs were resistant to chloramphenicol. In another study, 
resistance against tetracyclines (76%) and cotrimoxazole (72%), 
chloramphenicol (13%) and ciprofloxacin (19%) were detected in E. coli isolates 
from chicken meant for slaughter in Nairobi (Adelaide et al., 2008).  
Whilst the highlighted studies identified high carriage of AMR in a variety of 
bacterial pathogens, most of these studies focused on either human or livestock 
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populations without making comparisons of resistances between the two 
populations.  
1.3 Antimicrobial resistance in E. coli 
 
Escherichia coli is a facultative anaerobe, Gram negative rod that colonises the 
lower gut of humans and animals (Ingraham and Neidhardt, 1996). Although E. 
coli can be a harmless gut commensal, some pathogenic variants cause life-
threatening bloodstream infections, and other common infections, such as 
urinary tract infections (Dobrindt, 2005). Data from the Global Enteric Multi-
Center Study (GEMS) - a large case-control study investigating the burden of 
paediatric diarrheal disease in sub-Saharan Africa and South Asia – identified 
enterotoxigenic E. coli as a major causative agent of severe diarrhoea among 
children in these areas (Kotloff et al., 2013). Phylogenetic analysis suggests that 
E. coli can be grouped into seven major phylogenetic groups (A, B1, B2, C, D, E 
and F) known as phylogroups (Clermont et al., 2000). Human and animal 
commensal strains belong mostly to groups A and B1 respectively, suggesting an 
association between phylogenetic groups and host species. Conversely, human 
pathogenic strains belong to categories B2 and to a lesser extent D (Escobar-
Paramo et al., 2006).  
The β-lactam class of antimicrobials, particularly cephalosporins, are the main 
drug class used to treat E. coli infections. However, in the last decade, the 
incidence of E. coli infections resistant to new generation cephalosporins has 
increased worldwide (Coque et al., 2008a). The emergence and global spread of 
resistance to fluoroquinolones, carbapenems and colistin is also a threat 
(Collignon, 2009; Liu et al., 2015). Typically, MDR bacteria are associated with 
nosocomial infections. However, MDR E. coli, including ESBL-producing 
strains, have increasingly been associated with community-acquired infections. 
In setting such as Nairobi, where animals and humans co-habit, these AMR E. 
coli are capable of colonizing humans and animals and of flowing between them. 
However, the relative roles of humans and livestock in the emergence and 
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dissemination of AMR bacteria and their AMR determinants remain poorly 
understood.  
1.4 Development and spread of AMR bacteria and AMR determinants  
 
AMR itself may arise de novo by via mutations in chromosomal genes and spread 
clonally with the bacteria, or be encoded on mobile genetic elements such as 
plasmids that are transferred horizontally between bacterial strains or species 
(Blair et al., 2015).   
1.4.1 Innate mechanisms of resistance 
Innate resistance refers to the de novo development of resistance from 
spontaneous mutation in the bacteria thus generating a resistant phenotype. 
Point mutations under selection pressure within bacterial genomes have an 
important role in the development and evolution of antimicrobial resistance in 
particular pathogens (Davies and Davies, 2010). In general, such mutations 
resulting in AMR alter the antimicrobial action via one of the following 
mechanisms: (i) altering the antimicrobial target thus decreasing the affinity for 
the drug, (ii) a decrease in the drug uptake, (iii) activation of efflux mechanisms 
to expel the drug from the cell, or iv) upregulating the production of enzymes 
that inactivate the antimicrobial agent (e.g. erythromycin ribosomal methylase 
in staphylococci) (Figure 1.1) (Mcmanus, 1997; Piddock, 2006; Sandegren and 
Andersson, 2009). In E coli, mutational alterations in the Quinolone Resistance 
Determining Regions (QRDR) in the gyrA and parC genes of bacteria are 
recognized to be the major mechanisms through which resistance to 
fluoroquinolones develops (Waters and Davies, 1997).  
 
 









Figure 1.1 An overview of innate resistance mechanisms of β-lactam antimicrobials 
targeting a penicillin-binding protein (PBP). While antimicrobial A and B can enter the 
cell via a membrane-spanning porin protein, antimicrobial C cannot cross the outer 
membrane and so is unable to access the target PBP. Adapted from 
https://www.nature.com/articles/nrmicro3380#f1 (Blair et al., 2014). 
 
1.4.2 Mechanisms of horizontal gene transfer 
Bacteria also develop resistance to antimicrobials through the acquisition of 
new genetic material from other resistant organisms (Tenover, 2006; Bennett, 
2008; Boerlin and Reid-Smith, 2008). This is termed horizontal gene transfer 
(HGT) or lateral gene transfer (Danchin, 2016), and may occur between bacterial 
strains of the same or different species and/or genera and include transduction, 
conjugation and transformation (Mcmanus, 1997). The uptake of ready-made 
genes from the ‘mobile gene pool’ enables rapid evolutionary adaptation to 
novel ecological niches, such as new hosts, without the reliance upon rare 
beneficial mutations arising from spontaneous mutation in the bacteria in the 
population (Jain et al., 2003).  
 Transformation is regarded as a parasexual process that is defined as the 
internalization of exogenous DNA and subsequent integration into the recipient 
bacterial chromosome by homologous recombination (Tenover, 2006). Unlike 
transduction and conjugation, transformation is entirely directed by the 
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recipient cell and all required proteins are encoded in the core genome 
(Johnston et al., 2014).  
During conjugation, plasmid borne resistance genes are transferred from one 
bacterium to another via the pilus, an elongated proteinaceous appendage 
found on the surface of bacteria. In transduction, bacteriophage vectors transfer 
AMR genes between two bacteria. Both transduction and conjugation are 
mediated by semi-autonomous vectors: bacteriophages and conjugative 
elements such as conjugative plasmids, or chromosomally integrated 
conjugative elements (ICEs) and conjugative transposons respectively. Of the 
above-mentioned mobile genetic elements (MGEs), conjugative plasmids are 
the most significant.  
 
Plasmids are extra chromosomal, self-replicating circular or linear fragments of 
DNA found in bacteria (Leplae et al., 2004). Conjugative (that is they encode the 
functions necessary to promote cell-to-cell DNA transfer, particularly their own 
transfer) or mobilisable plasmids can horizontally disseminate resistance genes 
among bacterial pathogens. Based on the relatively conserved regions in the 
plasmid genome, molecular characterisation reveals that certain plasmid 
incompatibility types are more clinically relevant in disseminating antimicrobial 
resistance genes (e.g. Incl1, IncA/C, IncF and IncH12) than others (Carattoli, 
2011). Studies from numerous parts of the world have revealed the distribution 
of plasmids harbouring ESBL genes such as blaCTX, blaSHV, blaCMY, and blaTEM and 
plasmid-mediated quinolone resistance (PMQR) genes (qnrA, qnrB, and qnrS) 
in E. coli (Huddleston, 2014; von Wintersdorff et al., 2016). Of particular concern 
is the increasingly reported spread of plasmids harbouring resistance 
determinants to critically important antimicrobials such as carbapenems 
(Carattoli, 2013). As evident in the Liu et al study (Liu et al., 2015) , the mcr1 gene, 
encoding colistin resistance, was initially located on a Incl2 plasmid, but in 
subsequent isolates was located on IncHl2 and IncX4 plasmid family types, 
suggesting multiple pathways for horizontal dissemination (Hasman et al., 
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2015). Furthermore, multiple AMR genes are often co-localized on the same 
plasmid, which allows for the relatively easy spread of MDR (von Wintersdorff 
et al., 2016). 
1.5 Global and local patterns of antimicrobial usage in humans and 
animals  
The use of antimicrobials in clinical and veterinary medicine has led to a 
decrease in the burden of infectious diseases in both humans and animals, and 
facilitated complex medical interventions such as organ transplantation (Smith 
and Coast, 2013). However, antimicrobial use, misuse or overuse in human and 
animal health exerts selective pressures on bacterial pathogens leading to 
development of AMR.   
1.5.1 Antimicrobial usage in humans  
Global consumption of human antimicrobials increased by 36% between 2000 
and 2010 with India having the world’s highest consumption of antimicrobials 
closely followed by China and the USA (Van Boeckel et al., 2014). Further, the 
same study noted significant increases in the consumption of monobactams, 
glycopeptides, cephalosporins, and fluoroquinolones. This increase was more 
evident amongst the BRICS countries (Brazil, Russia, India, China and South 
Africa) that accounted for 76% of the global increase (Figure 1. 2). 
 












In agreement with Van Boeckel et al 2014, results from a recent analysis of global 
antimicrobial sales data, indicate that antimicrobial consumption rates in 
humans increased between 2000 and 2015 (Klein et al., 2018). Further, the same 
study noted that while the antimicrobial consumption rates in most LMICs were 
lower when compared to HICs, despite higher bacterial disease burden, 
consumption in LMICs was rapidly converging to rates similar to HICs (Figure 
1.3). This increase, the authors postulate, may partly be a result of improved 





Figure 1.2 Global human consumption of antibiotics in 2010. Expressed in standard 
units i.e. pills, capsules per person. Source: Van Boeckel et al 2014. 











While there are been only handful formal data in Kenya regarding antimicrobial 
consumption at a national level, there have been attempts to understand 
prescribing and practice locally (Mitema and Kikuvi, 2004; Omulo et al., 2017; 
Opanga et al., 2018). One of these studies, based on antimicrobial import data, 
estimate that, from 1997-2001, consumption of antimicrobials in clinical 
medicine increased by 4%, with penicillins and fluoroquinolones being the most 
widely used antimicrobials (Mitema and Kikuvi, 2004). A point prevalence study 
in a referral hospital in Western Kenya reported that third generation 
cephalosporins (55%), imidazole derivatives like metronidazole (41.8%) and 
broad spectrum penicillins (41.8%) were the most common prescribed 
antimicrobials (Opanga et al., 2018).  
 
Figure 1.3. Graph showing how the global antibiotic consumption rate (DDDs per 
1,000 inhabitants per day) has rapidly increased for LMICs, while remaining nearly 
constant for HICs. Source (Klein et al., 2018). 
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1.5.2 Antimicrobial usage in livestock  
Antimicrobials are also widely used in livestock for treatment of infections, 
prophylaxis and metaphylaxis (Marshall and Levy, 2011). In 2006, use of sub-
therapeutic doses of antimicrobials for growth-promotion was discontinued in 
the European Union (Phillips, 2007), and indications are, for example in the 
pork and poultry sectors in Denmark, that the prevalence of AMR has decreased 
since then (Aarestrup et al., 2001). Livestock husbandry systems in most LMICs 
have a higher dependency on antimicrobials because of a more disease-prone 
environments and lower levels of biosecurity than in HICs (Grace, 2015; 
Ayukekbong et al., 2017). However, although antimicrobial overuse in intensive 
production is emerging in these settings, lack of access to antimicrobials among 
smallholders in LMICs hinders optimal livestock production (Robinson et al., 
2016b).  
In 2010, a study estimated the global consumption of antimicrobials in food 
animals at 63,151 tons and is projected to rise by 67% (105,596 tons) by 2030 (Van 
Boeckel et al., 2015), with the majority of that increase occurring in emerging 
economies where the demand for livestock products, particularly poultry and 
pigs, is growing rapidly (Figure 1.4).  
For instance, the same study projects that, in China – the largest producer and 
user of antimicrobials in the world – the livestock sector could consume a third 
of the antimicrobials produced worldwide by 2030. These estimates suggest that 
















1.5.3 Surveillance of antimicrobial usage in LMICs 
Monitoring antimicrobial usage – particularly for WHO-classified highest 
priority critically important antimicrobials – in both human and animal 
populations allows identification of areas in which targeted interventions hold 
promise of reducing drivers of resistance (Morgan et al., 2011). 
Currently, most LMICs lack structures capable of quantifying consumption of 
antimicrobials at sufficient resolution to provide usage data by antimicrobial 
class, population type, purpose of usage, and route of administration, which are 
necessary to facilitate effective interventions to optimize use (WHO, 2018). 
Similarly, in these settings, the ecosystem in which human and livestock 
antimicrobials are produced, distributed, and consumed including the 
numerous possible data sources is complex and variable, and therefore makes 
data collection on antimicrobial use challenging. A variety of approaches are 
available for assessing patterns of antimicrobial use in humans and animals and 
include:  (i) total national imports, (ii) drug sales volume from local 
Figure 1.4. Graph showing the global antibiotic consumption rate in livestock 
(milligrams per 10 km2 pixels (Top) and average SD of estimates of milligrams per 
PCU (bottom)). Source Van Boeckel et al., 2015.  
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manufacturers and wholesalers, (iii) point prevalence data on antimicrobial 
consumption collected at health care or farm level (Queenan et al., 2017) (Figure 
1.5). The multiplicity of methods for quantifying usage hinders comparability of 
antimicrobial consumption across countries, and importantly between human 












Figure 1.5. A schematic diagram indicating possible sources that can be used to 
obtain information on antibiotic consumption in humans and animals. 
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1.5.4 Antimicrobial use in food animals: risk to AMR in humans  
Currently, there is no consensus regarding the interplay between antimicrobial 
use in food-producing animals and subsequent development of AMR in human 
population. In the recent past, a plethora of studies have suggested that 
widespread antimicrobial use in food animals might contribute to the 
development of resistance to antimicrobials commonly used in human 
medicine, especially given the overlap of antimicrobials used for these different 
purposes (Marshall and Levy, 2011; Landers et al., 2012). Collectively, these 
studies highlight the complexities in understanding the burden and 
transmission of AMR among populations (Woolhouse et al., 2015). A recent 
systematic review indicated that interventions that limit antimicrobial use in 
food animals reduced AMR bacteria in these animals by up to 39%, and a similar 
association in the studied human populations (Tang et al., 2017). Conversely, a 
modelling study indicated that interventions curtailing antimicrobial 
consumption in animals have, as a stand-alone measure, little impact on the 
carriage of AMR in humans (van Bunnik and Woolhouse, 2017). Evidence 
relating to the potential for transfer of AMR from food animals to humans will 
be discussed in chapter two. However, briefly, three key pathways of transfer of 
AMR bacteria and their AMR determinants from food animals to humans have 
been postulated: (i) direct acquisition of resistant pathogen from livestock, (ii) 
clonal transfer of a resistant pathogen to humans, followed by transmission in 
the human population, and (iii) horizontal transmission of AMR genes from 
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1.6 Characterisation of E. coli and AMR  
1.6.1 Antimicrobial Susceptibility Testing 
Antimicrobial susceptibility testing (AST) methods are used to confirm 
susceptibility to chosen empirical antimicrobial agents, or to detect resistance 
in individual bacterial isolates (Jorgensen and Ferraro, 1998). Further, ASTs can 
help to identify isolates with defined resistance mechanisms of major interest to 
public health (for example, ESBL producers) (Pereckaite et al., 2018). Several 
different AST methods are available for use by clinical microbiology 
laboratories: broth dilution tests, antimicrobial gradient method, and disk 
diffusion test. Of the three methods, disk diffusion test is the widely used in the 
vast majority of clinical laboratories in LMICs, because it is simple and 
standardized (Bauer et al., 1966). In this method, the zones of growth inhibition 
around each of the antimicrobial disks (dispensed onto bacteria-containing agar 
plates) are measured to the nearest millimetre. The diameter of the zone is 
related to the susceptibility of an isolate and those values translated to 
categories of susceptible, intermediate, or resistant using the latest tables 
published by the Clinical and Laboratory Standards Institute (CLSI) (CLSI, 2016) 
or European Committee on Antimicrobial Susceptibility Testing (EUCAST) 
(Matuschek et al., 2014).  
For most antimicrobials, there is good correlation between inhibition zone 
diameters and minimum inhibitory concentration (MIC) (Ericsson and Sherris, 
1971) which is considered the 'gold standard' against which all other 
susceptibility testing methods, and breakpoints are assessed and set respectively 
(Matuschek et al., 2014). Although ASTs are an integral part of microbiology 
laboratory, they are time consuming (turnaround times are usually between 12 h 
and 48 h), as they involve regrowth of the organism in the absence and presence 
of the relevant antimicrobials. As such, genotypic methods are increasingly 
being used to identify specific AMR genes or genetic mutations using molecular 
or genomic (usually DNA-based, amplification-based or sequencing-based) 
methods. Whereas various genotypic methods are available for generating 
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antimicrobial susceptibility profiles in bacterial pathogens (e.g. PCR or 
microarrays) (Sabat et al., 2013), whole genome sequencing (WGS) yields far 
more information and does not require a priori knowledge of the resistance 
phenotype of the isolate (Ellington et al., 2017).  
1.6.2 The impact of whole genome sequencing on microbiology 
In recent decades, whole genome sequencing has become an increasingly 
important technology for understanding pathogen evolution, AMR surveillance, 
and genomic epidemiology in most modern clinical laboratories (Didelot et al., 
2012). As WGS allows comparison of the genetic differences between organisms 
down to the resolution of a single base pair, this method has several advantages 
in terms of:  (i) providing unprecedented level of strain discrimination including 
insight into the evolutionary context of the strain, (ii) identifying potential 
epidemiological linkages, including when other metadata that could be used to 
infer epidemiological links is not available, (iii) inferring geographical origins of 
an outbreak strains from the phylogenetic signal, and (iv) identifying of genetic 
elements that may result in pathogenicity (e.g. virulence factors) or AMR  (e.g. 
AMR genes and point mutations associated with reduced susceptibility ) (Baker 
et al., 2018b; Jenkins et al., 2019).  
The advent of high throughput next-generation sequencing (NGS) technologies, 
including 454 pyrosequencing, Illumina and Ion Torrent sequencing, has led to 
large scale analyses of pathogen genomes and the costs of bacterial WGS 
continue to decline. Currently, the sequencing cost of a bacterial genome using 
NGS can be as little as $100, including sample preparation, library quality 
control, and sequencing (Motro and Moran-Gilad, 2017). This reflects a 400-fold 
reduction in costs as compared with only 8 years ago. As a result, comparative 
analysis of WGS is now the reference typing method used in outbreak studies in 
some countries; for instance, in 2015, Public Health England (PHE) adopted 
WGS as the molecular typing method of choice for investigating food-borne 
outbreaks of STEC O157:H7 in England (Dallman et al., 2015).  
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WGS provides the current ‘gold standard’ resolution for studying genetic 
relatedness and determining the evolutionary origins of pathogen lineages – a 
key element in understanding the transmission of AMR bacteria and AMR 
determinants between hosts. The genetic relatedness of isolates can be 
determined by the phylogenetic analysis of the single‐nucleotide 
polymorphisms (SNPs), or with core genome multilocus sequence (cgMLST) 
(Kluytmans-van den Bergh et al., 2016). The major advantage of SNP analysis or 
cgMLST lies in the increased resolution than traditional molecular tools such as 
multilocus sequence typing (MLST) or fingerprint-based methods, like pulsed-
field gel electrophoresis (PFGE) and amplified fragment length polymorphism 
(AFLP) (Schürch and van Schaik, 2017). Of the aforementioned methods, MLST, 
based on 7 housekeeping genes, is the most widely used method for determining 
bacterial population structures, and assigning isolates to lineages, as it is a 
relatively fast, accurate, and reproducible tool (Maiden et al., 1998).  
A study based on genetic markers (MLST) revealed a broad genetic similarity 
between chicken and human E. coli strains, suggesting clonal transfer 
(Leverstein-van Hall et al., 2011); however, subsequent WGS revealed that the 
isolates were actually separated by 1,263 core genome SNPs (de Been et al., 2014) 
highlighting the potential ‘added value’ of WGS. When combined with 
phylogeographic methods, WGS yields the potential for quantitative hypothesis 
testing for inferring pathogen movement between host populations (Ward et 
al., 2014; Richardson et al., 2018). For example, a recent study, combining WGS 
and discrete state phylogeographic analysis, identified successful host-
switching events of Staphylococcus aureus clones between humans and 
livestock hosts (Richardson et al., 2018).  
In the last decade, through WGS analysis of bacterial pathogens, we have a 
better understanding of the range of different genes associated with AMR. 
Identification of these genes is important to understand how and where AMR 
develops and spreads across different host populations and ecological niches. 
Several AMR gene databases and bioinformatic tools that enable the 
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identification of AMR genes from whole- or partial-genome sequence data, 
including unannotated raw sequence assembly contigs, already exist. These 
AMR databases are either downloadable for use locally (for example using 
ARIBA (Hunt et al., 2017) or SRST2 (Inouye et al., 2014)) or are web-based 
solutions and include: ARG-ANNOT (Gupta et al., 2014), ResFinder (Zankari et 
al., 2012a), and Comprehensive Antimicrobial Research Database, CARD 
(McArthur et al., 2013). While these tools are invaluable for understanding 
resistance in bacteria, their success is hinged on comprehensiveness and quality 
of the AMR gene databases used – most of which are heavily biased towards 
human pathogens, and commonly studied bacteria (Boolchandani et al., 2019). 
In addition, complex resistance mechanism, such as those associated with 
overexpression of AMR genes (Shigemura et al., 2015) or epistatic relationships 
between multiple genes (Baroud et al., 2013), are challenging to identify in AMR 
gene databases.  
While in silico analysis of bacterial genomes for the presence of AMR genes or 
point mutations known to confer resistance data is now widely accepted for 
public health investigations, the use of WGS to predict antimicrobial 
susceptibility phenotype (genotype-to-phenotype) is still an area of active 
development (Ellington et al., 2017).  A small number of studies have assessed 
the feasibility of using WGS to infer AMR in E. coli (Stoesser et al., 2013) (Ingle 
et al., 2018). These studies are mostly based on screening for known AMR genes 
or point mutations known to confer resistance (e.g. AMR mutations associated 
with ciprofloxacin resistance). In one study, Stoesser et al. reported the overall 
sensitivity and specificity of the genotypic prediction when compared with 
standard phenotypic test for five antimicrobials (amoxicillin, co-amoxiclav, 
gentamycin, ciprofloxacin, ceftriaxone, ceftazidime and meropenem) as 0.99 
and 0.96 respectively.  
Further, WGS is central to the development of a culture-independent method 
of bacterial identification – metagenomics. Although yet to be implemented in 
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routine diagnostics, metagenomic analysis is an important tool to characterise 
the genomic composition, including diversity and abundance of bacterial 
communities thus bypassing the bottleneck imposed by single colony selection 
(Pehrsson et al., 2016; Munk et al., 2017). The use of metagenomic analyses in 
monitoring AMR in host populations has been undertaken; for example, a 
recent study reported that AMR resistomes in pig and poultry isolates obtained 
across Europe were different in abundance and composition (Munk et al., 2018).  
In order to translate genomic data into actionable knowledge that can be used 
to improve surveillance and control of AMR, a recent review highlights the need 
for combining the high resolution offered by WGS with high-fidelity 
epidemiological metadata (EFSA, 2013). At the very least, AMR surveillance 
studies should identify high-risk populations (human and animal) for AMR 
transmission, and provide specific guidance for reducing AMR carriage. 
While this technological advancement is unfolding, the uptake and utilization 
of the genome sequencing technologies in most LMICs is limited mainly due to 
the high cost of establishing and maintaining a sequencing facility and lack of 
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1.7 Research background  
As elsewhere in sub-Saharan Africa, a combination of growth and rural-urban 
migration has led to substantial increase in the population of urban and peri-
urban Nairobi, the capital city of Kenya, rising from 2m in 1999 to 3.5m in 2013 
(KNBS, 2014). In urban Nairobi, people live in a continuum of urban spaces with 
varying population densities, with the vast majority of people living in slums, 
often characterised by small household areas and high population density 
(estimated as 28,200 people per km2) (Joshi et al., 2011; Bird et al., 2017). This 
rapid population shift is associated with social disparity, poor sanitation, poor 
living conditions, and poses a risk to human health through the emergence and 
spread of infectious diseases (Yang et al., 2012). Given the high infectious disease 
burden in both human and animal populations, antimicrobial usage is a crutch 
that is used as a low-cost alternative to comprehensive hygiene and biosafety 
measures (in animal production) – a significant driver of AMR. To date, few 
studies have investigated the burden of AMR studies in LMICs, highlighting the 
need for further research is in such settings (Dar et al., 2016).  
Livestock have been implicated as a reservoir for AMR bacteria that may spread 
to humans, with the keeping of livestock widely thought to be a risk factor for 
AMR in humans (Bélanger et al., 2011; O’Neill, 2015). However, quantitative 
evidence regarding the role of livestock in the emergence and transmission of 
AMR bacteria and their resistance determinants are lacking. Studies 
investigating the epidemiology of AMR have tended to focus on either human 
or livestock populations without making comparisons of resistances between 
the two populations. In particular, few studies have included urban livestock, 
which are increasingly important, particularly in LMIC settings (Satterthwaite 
et al., 2010) and may contribute to the maintenance of zoonotic bacteria and 
AMR in the complex urban environment.  
Urban Nairobi is an ideal place to analyse the complex interaction of pathogens 
between and within human and livestock populations: the wealthy live 
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alongside the poor, livestock live alongside people, human and livestock waste 
is poorly disposed, and largely unregulated food systems take place in connected 
networks (Roesel and Grace, 2014; Alarcon et al., 2017). The close degree of 
mixing and contact between livestock and humans creates diverse ecological 
niches (or ‘interfaces’) (Hassell et al., 2017), which present broad opportunities 
for either population to act as a reservoir from which AMR bacteria or their AMR 
determinants could be transmitted in either direction. 
This thesis focuses on the role of livestock keeping as a potentially high-risk 
interface for AMR transmission between humans and livestock in urban Nairobi 
using E. coli a proxy for transmission. E. coli is an ideal organism to study the 
spread of AMR in this complex environment since it is a commensal in both 
human and food animal populations, shares the same niche as enteric 
pathogens and is genetically diverse (Jaureguy et al., 2008; Tenaillon et al., 2010). 
The hypothesis underpinning this study is that there is an epidemiologically 
significant spillover of AMR bacteria and AMR determinants from livestock to 
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1.8 Research objectives 
In this thesis, I use a combination of genomics, epidemiological and ecological 
methods to investigate patterns of bacterial strain sharing and AMR in E. coli in 
sympatric human and livestock populations in Nairobi, Kenya. In this respect, 
my thesis can be split into four broad themes:  
(i) Review of existing evidence (and the nature of evidence used to 
support, or not support) that food animals are responsible for transfer 
of resistant E. coli and their AMR determinants to humans.  
(ii) Characterising the patterns and epidemiology of AMR-E. coli carriage 
from co-habiting human and livestock populations.  
(iii) Analysis of AMR gene co-occurrence patterns and the role of 
conjugative plasmids on the epidemiology of AMR spread.  
(iv) Genetic analysis of E. coli isolates to elucidate patterns of bacterial 
relatedness and strain sharing as a proxy for transmission potential.  
(v) A cross-sectional study to investigate the patterns of antimicrobial 
use in humans and livestock in urban Nairobi and importantly, and 
help in explaining the phenotypic and genotypic AMR patterns 
identified in human and livestock populations in this thesis.  
 








































The term epidemiology is often preceded by an adjective, making reference 
to the topic of its application. One of the most iconic and dramatic of these 
adjectival descriptors is shoe-leather, raising the image of an on-the-ground 
investigation racing to find a solution to a deadly epidemic. 
Jonathan M. Samet, 2010  
(Quoting Alexander D. Langmuir, 1910–1993) 




Chapter 2 Materials and methods 
2.1 Introduction  
This chapter provides a detailed overview of methodological elements that are 
common to chapters throughout the thesis, including study design, data 
collection in the field, laboratory procedures, certain analytical approaches, and 
the statistical frameworks that underpin them. Additional methods relating to 
analysis of data that are unique to particular analyses, are outlined in detail in 
the relevant chapters. 
2.2 Ethics statement  
The collection of data adhered to the legal requirements of the International 
Livestock Research Institute (ILRI). Ethical approval for human sampling and 
data collection was obtained from the ILRI Institutional Research Ethics 
Committee (ILRI IREC) ILRI-IACUC2015/09.  ILRI IREC is registered and 
accredited by the National Commission for Science, Technology and Innovation 
(NACOSTI) in Kenya, and approved by the Federal wide Assurance (FWA) for 
the Protection of Human Subjects in the United States of America.  Livestock 
samples were obtained under the approval of the ILRI Institutional Animal Care 
and Use Committee (reference ILR-IACUC2015/18).  The antimicrobial usage 
survey was conducted under approval of project reference ILRI-IREC2017-35. 
2.3 Study design  
This thesis research is part the UrbanZoo project (http://www.zoonotic-
diseases.org/project/urban-zoo-project/) a Medical Research Council-funded 
project that aimed to utilise a landscape genetics approach to understand the 
movement and sharing of pathogens in a major developing city. A significant 
component of the UrbanZoo project was the ’99 household project’ which 
focused on sampling of households across socio-economic strata of Nairobi to 
investigate the role of informal livestock keeping practices as a route of zoonotic 
disease emergence in humans.  




As such, a cross-sectional study targeting sympatric human and livestock 
populations in Nairobi, Kenya was carried out from August 2015 to October 2016 
with the aim of maximising the spatial distribution and diversity of livestock 
keeping practices across the city while capturing socio-economic diversity and 
population distribution. Geospatial mapping data produced by Institut Français 
de Recherche en Afrique (IFRA) was used to identify 17 classes of residential 
neighbourhood in Nairobi based on different land-use patterns (e.g. residential, 
industrial, institutional) and physical landscape attributes (such as tree cover, 
plot size, amount of gated space, roofing type, presence of agriculture) (Ledant 
et al., 2011). The choice of the 17 different classes of residential neighbourhoods 
was premised on the assumption that neighbourhoods with similar physical 
characteristics are also similar in terms of other qualities, such as socio-
economic status, and service provision. The classification was validated with 817 
household questionnaires across the city.  
Subsequently, the 17 classes of neighbourhoods were ranked by average income 
and merged into seven wealth groups (Table 2.1). Administrative boundaries 
were overlaid on maps of each wealth group, which yielded 70 sub-locations. To 
maximise geographical spread across the city, while ensuring equal 
representation across the different wealth categories, a population-weighted 
approach was used to decide how many sub-locations should be chosen from 
each wealth group (Table 2.1). Thereafter, thirty three households were chosen 
based on: a) selection of slum and peripheral rural areas with high livestock 
densities, in which previous project activities had been carried out (8 sub-
locations); b) selection of one sub-location to represent each remaining 
neighbourhood class (15 sub-locations); c) selection of 10 further sub-locations 
to make up the target number for each wealth group, attempting to maximise 
both spatial distribution,   socio-economic diversity, and proportion of 
population belonging to the dominant class (Figure 2.1). 




Table 2.1. Distribution of the seven wealth groups used by the Urban Zoo Project, and the number of sub-locations with a dominant wealth group 
identified and selected across the city. Reprinted with permission  (Bettridge et al., 2017). 
 

















A > 13.5% Detached housing with 
intense tree cover 
Detached housing on very large plots (>3000 m²)  39890 1 8 3 
B Detached housing on large plots (400 - 3000 m²)  22462 2 8 4 
C > 13.5% Attached and semi-
detached housing 
Attached housing on medium plots (<400 m²) with important tree 
cover 
22084 2 
D 3-13.5% Apartment building Apartment buildings with gated space 22084 2 
E 3-13.5% Attached and semi-
detached housing 
Higher standing row houses (plot size > 190 m²) 13352 3 5 3 
F Lower standing row houses (plot size < 190 m²) 6153 4 3 3 
G <3% Roof cover  
>50% tiles 
Lower standing apartment buildings 6153 4 
H New areas of dense single housing development 3855 5 9 5 
J <3% Roof cover  
> 40% concrete 
High density multi-storey buildings 3855 5 
K 3- 13.5% Apartment building Apartment buildings with open access 3855 5 
L 3- 13.5% Peripheral areas Peripheral areas (mainly residential) 3855 5 
M Peripheral areas with rural component (presence of agriculture) 2165 6 24 11 
N 3- 13.5% Collective housing Community housing with gated space 2165 6 
P Community housing with open access 2165 6 
Q <3% Roof cover  
>85% corrugated iron sheets 
New areas of low quality housing (built-up area <37%) 2165 6 
R High density planned low quality housing                                                   
(built-up area <37% AND public space >20%) 
2165 6 
S High density unplanned low quality housing (slums)                                     
(built-up area <37% AND public space <20%) 
1301 7 13 4 





For each sublocation, three geographical points were selected at random within 
the dominant housing type, comprising of:  two livestock keeping and one non-
livestock keeping household. A total of 99 households, 66 of which kept 
livestock were visited. Livestock keeping households had to meet strict 
inclusion criteria of: (i) keeping small livestock only (small ruminants - 
goats/sheep, small monogastrics - poultry/rabbits), and (ii) large livestock (large 
ruminants (cattle), large monogastrics (pigs), with or without small livestock 
(Table 2.2). To ensure an equal sample of both cattle and pig-keeping 
households, the combination of livestock keeping households represented in 
each sublocation was randomised, and had to consist of either large ruminant 
and small monogastric, or large monogastric and small ruminant species. For 
sublocations in which households keeping large ruminant or large monogastric 
species were absent, a replacement household keeping either small monogastic 
or small ruminant species was recruited. 
Figure 2.1. Map of the 99 households (black dots) and 33 sublocations (coloured by 
wealth category; 1 – wealthy, 7 – poor) in Nairobi city selected for inclusion in the 
study. 
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rabbits 








Exclusion None None Cattle Pigs 
 
Within the sublocations, local administrative leaders assisted in recruitment, 
which was carried out a few days before the sampling date. The three pre-
selected geographical points were identified on the ground, and the nearest 
three households that met the inclusion criteria identified.  
In a household, human members were defined as those who either slept on the 
premises or (for staff) spend at least 8 hours a day on the household, and 
interacted regularly with the main household members in way to facilitate 
exchange of bacterial pathogens. Such interactions included; sharing food 
prepared on the premises, regularly handling food, animals, animal manure or 
contact with human excrement (for example nannies looking after young 
children). Conversely, humans who lived on the household (e.g. tenants) but 
who had had separate cooking facilities and did not contact or share livestock 









2.4 Data Collection 
In each household, the household head/owner (or a nominated member) 
completed a questionnaire, detailing livestock ownership (e.g. abundance of 
livestock species), management practices (e.g. manure disposal practices), 
household composition (e.g. number of occupants), and socio-economic 
variables.  
Thereafter, following a written informed consent, every human member of the 
household was invited to contribute a faecal sample and answer questionnaires 
on: their age and gender, food consumption and medical history. Rectal swabs 
were obtained from (up to 20) livestock species present in the household 
(ensuring that all species were represented). Project clinicians, and 
veterinarians collected human and livestock faecal samples respectively. 
Questionnaires and data associated with samples was recorded using Open Data 
Kit (ODK) Collect software, on electronic tablets, and uploaded to databases 
held on servers at ILRI. Human and animal faecal samples were collected and 
transported on ice to one of two laboratories (University of Nairobi or Kenya 
Medical Research Institute) within 5 hours of collection. For details of 
questionnaire data, see appendix Tables A1-4.  
2.5 Laboratory work  
Samples were enriched in buffered peptone water for 24 hours, and thereafter 
plated onto eosin methylene blue agar (EMBA) and incubated for 24 hours at 
37°c. One colony from each plate was selected and sub-cultured for a further 24 
hours on a second round of EMBA. Consequently, one purified colony from each 
plate was selected at random (hereafter referred to as an ‘isolate’), and 
confirmed as E. coli by biochemical testing, using triple sugar iron agar (TSI), 
Simmon’s citrate agar, and motility-indole-lysine media. E. coli isolates 
preserved by freezing (-20°c then -80°c) in 15% (v/v) Glycerol. Between the two 
laboratories, laboratory protocols were standardised and a project 




microbiologist was responsible for ensuring that these standards were 
maintained.  
2.5.1 DNA extraction and whole genome sequencing  
Bacterial genomic DNA was extracted using the PureLink Genomic DNA Mini 
Kit (Life Technologies) according to the manufacturer's instructions. The DNA 
concentration and purity was measured using NanoDrop 2000c 
spectrophotometer and the Qubit double-stranded DNA HS Assay Kits (Thermo 
Fisher Scientific, Waltham, MA, USA). Library preparation was conducted 
according to the Illumina protocol and sequenced on an Illumina HiSeq2500 
(Illumina, San Diego, CA, USA) at the Wellcome Trust Centre for Human 
Genetics.  
2.5.2 Sequencing quality control 
For quality control purposes and to check for any variation arising at the 
laboratory or sequencing stage (Robasky et al., 2014), a validated reference 
[CFT073 strain; GenBank: AE014075.1; NCBI RefSeq NC_004431] and a duplicate 
of a randomly chosen sample from each DNA plate were included at specified 
locations on each sequencing plate.  Furthermore, cross-plate sequencing 
replicates were also performed across sequencing batches.  
2.6 Bioinformatic analysis  
Whole genome sequencing (WGS) was carried out at the Wellcome Trust 
Centre for Human Genetics on the Illumina HiSeq 2500 platform. 150 base-pair 
paired-end reads were generated and short-read WGS data were pre-processed 
using an automated protocol developed by the Modernising Medical 
Microbiology Oxford (MMM) Group to: (i) perform standard quality control 
checks using fastQC (Andrews, 2010) with default settings; (ii) trim reads to 
remove remnant adaptor sequences using bbduk, part of the BBTools package 
(Bushnell, 2014), (parameters: minoverlap=12, k=19, mink=12, hdist=1, ktrim=r) 
and (iii) perform a Kraken (Wood and Salzberg, 2014)  speciation analysis 




against an in-house database downloaded from the NCBI sequence read archive 
(www.ncbi.nlm.nih.gov/sra/), with an automated step for removal of 
contaminant (non-bacterial) reads. De novo assembly of E. coli isolates was 
performed using SPAdes v3.64 (Bankevich et al., 2012) (parameters: --careful, -t 
1, --phred-offset 33). Samples deemed as non-E. coli on the basis of the 
speciation analysis were excluded from further analysis. Potentially mixed E. coli 
samples were identified as those with an unusually large assembly size (greater 
than 6 megabases (Mb)) and were removed from the dataset. 
Further downstream processing of E. coli isolates including antimicrobial 
susceptibility testing, in silico MLST analysis, identification of antimicrobial 
resistance determinants and further genetic analysis are explained in the 
relevant chapters.  
2.7 Statistical Analysis  
This section provides, in brief, an overview of the statistical analyses that were 
carried out in this thesis. Other methods with specific details, where used, are 
described in the relevant chapters. Throughout this thesis, a priori hypotheses, 
in which biological understanding of the underlying system was taken into 
consideration, were used to guide the statistical analysis.  
2.7.1 Data exploration  
Following recommendations by (Zuur et al., 2010), in this thesis I routinely 
investigated: (i) collinearity between explanatory variables, (ii) influence of 
outliers in the response or explanatory variables, and (iii) zero inflation (excess 
number of zeros). Outlier detection is based on the assumption of an underlying 
known distribution of the data, which is assumed to be identically and 
independently distributed. Box plots were used to visualise the median and the 
spread of the data. Where outliers in explanatory variables were present (e.g. 
count of livestock), log base 10 transformations were applied to the variable in 
question.  




To test for collinearity between explanatory covariates, for each model, 
relationships between all sets of explanatory covariates were assessed using 
multi-panel pairwise scatterplots, Pearson correlation coefficients, and variance 
inflation factors. Where an excess frequency of zeros (zero inflation) was 
present in the response variables, zero inflated generalised linear mixed effects 
models (GLMMs) were used.  
2.7.2 Parametric and non-parametric tests 
Parametric tests assume underlying statistical distributions (e.g. normal 
distribution) in the data and hypothesis testing is based on the assumptions 
made. Conversely, nonparametric tests do not rely on any distribution (Fay and 
Proschan, 2010).  
The following parametric techniques were used for exploratory data analysis 
and to test for associations:  
(i) Descriptive statistics, to provide summaries about the means and 
variability (standard deviations: SD and standard errors: SE) of the 
variables of interest.  
(ii)  The Pearson’s correlation coefficient (r), to estimate the strength of 
association between pairs of continuous variables.  
The non-parametric statistics used included:  
(i) The Mann-Whitney U Test, used to test the null hypothesis that two 
samples come from the same population (i.e. have the same median) 
(ii) The Chi-square (χ2) test, used to test for associations between 
independent categorical variables and the Fisher’s exact test, used for 
small sample size test for associations between categorical variables.  
Post-hoc comparisons were performed on categorical variables to identify which 
sub-groups differed significantly between each other. Throughout the thesis, 




where stated, a Bonferroni's test was used to adjust for multiple pairwise 
comparisons.  
2.7.3 Generalised Linear Mixed Models 
Generalized linear mixed models (GLMMs) are an extension of linear mixed 
models to allow response variables from different distributions, such as binary 
responses, and to include both fixed and random effects (Zuur et al., 2009). 
GLMMs are used throughout this thesis to investigate the presence of a 
relationship between variables of interest, while accounting for potential non-
independence introduced by a hierarchical sampling design.  
The simplest form of a GLMM model (in matrix notation) may be written as: 
𝒚 = 𝑿𝜷 + 𝒁𝜸 + ε 
where y is the n x 1 vector of the response variable, β is a p x 1 vector of the fixed-
effects regression coefficients, Z is the N×q design matrix for the q random 
effects (the random complement to the fixed X), γ is a q×1 vector of the random 
effects (the random complement to the fixed β), and ε is a N×1 column vector of 
the residuals. 
Deciding the model structure for GLMMs was based on knowledge about the 
relation between Y and X. Where the response variable was a dataset of counts 
(e.g. number of AMR genes), Poisson GLMMs were used. For binary outcomes 
(e.g. presence or absence of an AMR gene), binomial GLMMs were employed.  
When modelling count data with an excess of zero counts, zero inflated Poisson 
GLMMs were used. Zero inflated Poisson GLMMs model count data that exhibit 
a bimodal distribution due to both excess zeros and positive counts, thus 
allowing for a large number of zero cases (e.g. a large number of pan-susceptible 
isolates) without compromising the model. 




Random effects were included in models throughout this thesis, unless 
otherwise stated, to account for the three tiers of nestedness of our sampling 
design; isolates nested within households (n=99), household-level data grouped 
into triplets by sublocation (n=33), and sublocations nested in wealth categories 









Model building was based on biologically plausible hypotheses. Best fitting 
models were estimated by backward exclusion of non-significant terms 
(p=0.05), using Akaike information criteria (AIC), and log-likelihood ratio tests. 
From global models, backward selection procedure for model selection was used 
to sequentially drop variables that give the highest AIC values and largest p-
value. Model fit was checked by plotting the residuals versus fitted values and 
normal probability plots. GLMMs were implemented in the R packages ‘lme4’ 
(Bates et al., 2014) and ‘glmmTMB’ (Magnusson et al., 2017) (for zero inflated 
models). 
Figure 2.2. Hierarchical sampling design of the 99 households project. 
Samples are nested within households, whilst triplets of households are 
nested within sublocations. 
Household 1 Household 2 Household 3 
 Sample 1 Sample 2 Sample 3 
Sub location  




2.7.4 Multivariate statistics  
Multivariate statistical analyses are often used in community ecology to 
summarise high-dimensional data, test hypotheses involving multiple response 
variables, and examine relationships between large sets of variables (Härdle and 
Simar, 2007). In this thesis, two multivariate analytic methods were used; non-
metric multidimensional scaling (NMDS) and principle component analysis 
(PCA).   
NMDS was used to evaluated whether AMR gene communities in human and 
livestock (and the different livestock groups) populations had different 
compositions (beta‐diversity). Compositional dissimilarity of AMR gene 
assemblages between isolates was estimated with the Bray–Curtis dissimilarity 
index (Bray and Curtis, 1957), and pair-wise dissimilarities between isolates were 
analysed by a non-metric multidimensional scaling (NMDS) plot. NMDS was 
performed with the metaMDS function of the R vegan package (Oksanen et al., 
2015). Kruskal's Stress, defined as goodness of fit between similarity rankings 
and ordination distance rankings, was calculated and visualized in a Shepard 
plot (a plot showing the relationship between the actual dissimilarities between 
objects (from the original dissimilarity matrix) and the ordination distances).  
PCA is a reduction method that transforms high-dimensional data (mostly 
highly correlated) into fewer dimensions ‘principal components’ that explain 
much of the variance and represent unobserved characteristics of the 
population (Lever et al., 2017). In this thesis (chapter 7), PCA was used to 
generate a knowledge index as a composite measure of respondent’s knowledge 
about antimicrobial resistance. The first principal component explains the 
largest proportion of the total variance and was used as the knowledge index. 
As such, results of the first principal component were used as inputs to 
regression analyses to  investigate the possible influence of type of drug store 
(human or veterinary), clinical training (present or absent), education level 




(high or low), and range of antimicrobials sold in the drug store (proxy for store 
size) on the knowledge index.  
2.8 Production of maps  
Maps of Nairobi were generated in QGIS Development Team (2018). QGIS 
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 When you can measure what you are speaking about and express 
it in numbers, you know something about it; but when you 
cannot express it in numbers your knowledge about it is of a 
meagre and unsatisfactory kind 
Lord Kevin, 1883 
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Chapter 3  Are food animals responsible for transfer 
of antimicrobial-resistant Escherichia coli or their 
resistance determinants to human populations? A 
systematic review 
3.1 Abstract  
The role of farm animals in the emergence and dissemination of both AMR 
bacteria and their resistance determinants to humans is poorly understood and 
controversial. Here I systematically reviewed the current evidence that food 
animals are responsible for transfer of AMR to humans. 
I searched PubMed, Web of Science and EMBASE for literature published 
between 1940 and 2016. My results show that eight studies (18%) suggested 
evidence of transmission of AMR from food animals to humans, 25 studies (56%) 
suggested transmission between animals and humans with no direction 
specified and 12 studies (26%) did not support transmission. Quality of evidence 
was variable among the included studies; one study (2%) used high resolution 
typing tools, 36 (80%) used intermediate resolution typing tools, 6 (13%) relied 
on low resolution typing tools, and 2 (5%) based conclusions on co-occurrence 
of resistance. Whilst some studies suggested to provide evidence that 
transmission of AMR from food animals to humans may occur, robust 
conclusions on the directionality of transmission cannot be drawn due to 
limitations in study methodologies. My findings highlight the need to combine 
high resolution genomic data analysis with systematically collected 
epidemiological evidence to reconstruct patterns of AMR transmission between 
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3.2 Introduction  
At present, the role of farm animals in the emergence and dissemination of both 
AMR bacteria and their resistance determinants to humans is poorly understood 
and controversial (Marshall and Levy, 2011; Woolhouse et al., 2015). Various 
studies have suggested that AMR bacteria and their AMR determinants can be 
transmitted from food animals to humans via direct contact and/or through 
animal products (Howells and Joynson, 1975; Aminov and Mackie, 2007; 
Jakobsen et al., 2010; Overdevest et al., 2011; Kluytmans et al., 2013; Voets et al., 
2013). However, most of these studies have relied heavily on traditional 
microbiology and molecular tools, such as PFGE and MLST. These tools may not 
have sufficient discriminatory power to provide evidence of the transmission (or 
not) of resistant bacteria and their AMR determinants and, importantly, to infer 
the direction of the transmission (de Been et al., 2014; Woolhouse et al., 2015). 
Evidence from a recent systematic review suggests that a proportion of human 
cephalosporin resistant E. coli clones, often associated with human disease, 
originate from food animals through food products (Lazarus et al., 2015) (though 
these products could have been contaminated elsewhere in the production 
chain (Wooldridge, 2012)). 
Evidence either supporting or refuting the claim that dissemination of AMR 
bacteria or their resistance determinants from food animals to humans is 
occurring will be key to the development of effective policies on antimicrobial 
stewardship and infection control for both human and animal health. To 
address this knowledge gap, I performed a systematic review to i) explore the 
current evidence that food animals are of the source of resistant E. coli and their 
AMR determinants in humans, ii) examine and summarise the kinds of evidence 
used to support, or not support, transfer of resistant E. coli and their AMR 
determinants to humans and iii) make recommendations for future studies to 
address this question. E. coli is found in both human and food animal 
populations (Neidhardt et al., 1996), and has recently been categorised as one of 
the priority pathogens that pose the greatest threat to human health due to 
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widespread AMR (WHO, 2017b). It is for these reasons that, when considering 
transmission between hosts, I chose to focus on E. coli. 
3.3 Methods  
3.3.1 Data sources and search strategy  
A systematic literature search according to the PRISMA (Preferred Reporting 
Items for Systematic reviews and Meta-Analyses) guidelines (Liberati et al., 
2009) was performed. Searches were carried out in multiple electronic 
databases: PubMed, Web of Science and EMBASE for research articles published 
between 1940 and 2016; and Scopus for research articles published between 1960 
and 2016 without geographical and language restriction. An initial and 
subsequent keyword searches with various combinations of search terms: 
Escherichia coli, AMR terminologies, human, and food animal descriptors was 
performed (see Table A2 in Appendix A).  
3.3.2  Selection criteria and data extraction  
Articles were included if they comprised an original research published in a peer 
reviewed journal, and investigated transmission of resistant E. coli and/or AMR 
determinants between humans and food animals. Articles were excluded if: (i) 
they reported only agents other than E. coli; (ii) they studied non-food animals; 
(iii) they focused exclusively on food animals or humans without any overlap 
between the two populations and/or (iv) they focused exclusively on food of 
animal origin. Article searches and screening were performed by considering 
article titles and abstracts for inclusion according to the search criteria. Data 
extraction from studies was performed by one author (DMM) and 
independently checked by another author (BvB) using a customised checklist.  
3.3.3 Data analysis  
For all included studies I categorised the direction of AMR transmission 
according to the authors’ conclusions: i) studies suggesting to provide evidence 
of transmission from food animals to humans with direction specified; ii) 
studies suggesting to provide evidence of transmission from humans to food 
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animals with direction specified; iii) studies suggesting overlap indicating the 
possibility of between-host AMR transmission, with no direction specified; and 
iv) studies suggesting no evidence of transmission in either direction.  
The quality of evidence was assessed using a customised Grading of 
Recommendations Assessment, Development and Evaluation (GRADE) system 
(Godfray et al., 2013). Each paper was matched to the following categories: i) 
high resolution typing: studies using whole genome sequencing (WGS) and 
phylogenetic analysis; ii) intermediate resolution typing: studies carrying out 
genetic characterisation through molecular tools such as MLST; iii) low 
resolution typing: studies using tools such as PFGE; or iv) co-occurrence of 
resistances: studies comparing AMR phenotypes between the two populations.  
Additionally, I assessed the methodological quality of the papers included in the 
review by adapting a standardised quality assessment (Centre for Reviews 
Dissemination, 2009). Each paper was evaluated based on two items aimed at 
assessing potential biases including: study design (active, passive) and 
spatiotemporal matching (no matching, temporal matching only, spatial 
matching only, and both temporal and spatial matching).  
Because of heterogeneity of the studies (regarding typing tools, antimicrobials 
investigated and quality of evidence) I did not perform a meta-analysis. 
However, I used Fisher's exact tests using R package ‘stats’ (R Core Team, 2013) 
to describe associations between direction of transmission, selection bias 
variables and nature of transmission (clonal, determinant or both). I considered 
p<0.05 to be statistically significant. 
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3.4 Results  
3.4.1 Description of included studies  
Of the 5662 distinct articles retrieved, 256 studies were reviewed (Figure 3.1); 
















20947 records identified from 
database search 
5662 records screened 
15285 duplicate records excluded 
256 full articles assessed for 
eligibility 
5406 records excluded as not 
relevant 
45 articles selected for 
systematic review 
211 Articles excluded 
- Exclusively focused on human isolates (n=43) 
- Exclusively focused on food animal isolates 
(n=47) 
- Exclusively focused on food products (n=22) 
- Other bacterial pathogens (n=11) 
- No original data (n=74) 
- Non-food animals (n=5) 
- Focused on environmental isolates (n=9) 
 
Figure 3.1. Flow diagram showing the selection of the studies for inclusion. 









Although the studies span five decades, there has been an increasing number of 
studies on this subject in recent years; with 56% of the studies published since 
2010 (Table A1 in Appendix A). 22 studies (49%) had both temporal and spatial 
matching for human and food animal sampling, while seven (16%) had temporal 
matching only, and 16 (35%) were not temporally or spatially matched. There 
were no statistical associations between whether direction of transmission was 
inferred and study design or spatiotemporal matching.  
Studies in this review reported different livestock species, either alone or in 
combination with other species. Of the eight studies that suggested transfer of 
AMR from food animals to humans, seven studies were based on poultry isolates 
and one study on pig isolates (Table A2 in Appendix A). Amongst the studies, 13 
antimicrobial classes were reported, either alone or in combination with other 
classes (Table A3 in Appendix A). 
Overall, eight studies (18%) suggested to have data to support transfer of AMR 
bacteria and/or their AMR determinants from food animals to humans (Levy, 
Figure 3.2. Geographic distribution of included studies. Different colours show the 
number of papers from each country. The map was created using several R packages 
(ggplot2 (Wickham et al., 2013), mapdata (Becker and Wilks, 2016), maps (Becker and 
Wilks, 2017), and ggmap (Kahle and Wickham, 2013)) in R version 3.4.1. The shapefile 
with borders of countries is freely available from the Natural Earth data set 
(http://www.naturalearthdata.com/). 
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1978; Al-Ghamdi et al., 1999; van den Bogaard et al., 2001; Hammerum et al., 
2006; Johnson et al., 2006; Leverstein-van Hall et al., 2011; Giufre et al., 2012; 
Dierikx et al., 2013), while 25 studies (56%) presented data showing overlap of 
AMR bacteria and AMR determinants between food animals and humans, 
indicating the possibility of between-host AMR transmission but with no 
direction specified (Jorgensen, 1983; Oppegaard et al., 2001; Winokur et al., 2001; 
Ho et al., 2009; Moodley and Guardabassi, 2009; Mulvey et al., 2009; Smet et al., 
2009; Zhang et al., 2009; Ho et al., 2010; Jakobsen et al., 2010; Zhao et al., 2010; 
Deng et al., 2011; Jakobsen et al., 2011; Vieira et al., 2011; Stokes et al., 2012; 
Ciccozzi et al., 2013; Hu et al., 2013; de Been et al., 2014; Hammerum et al., 2014; 
Valentin et al., 2014; Dahms et al., 2015; Dohmen et al., 2015; Huijbers et al., 
2015b; Lupindu et al., 2015; Tseng et al., 2015), and 12 studies (26%) did not 
suggest to find evidence supporting transmission between food animals and 
humans (Kariuki et al., 1997; Kariuki et al., 1999; Maynard et al., 2004; Kang et 
al., 2005; Phongpaichit et al., 2007; Graziani et al., 2009; Schwaiger et al., 2010; 
Xia et al., 2010; Johnson et al., 2012; Riccobono et al., 2012; Jakobsen et al., 2015; 
Ueda et al., 2015). No study in this review suggested to provide evidence for AMR 





















Only one study (2%) based its conclusion regarding transmission on high 
resolution typing tools, 36 studies (80%) on intermediate resolution typing 
tools, six (13%) on low resolution typing tools, and two (5%) on co-occurrence 
of resistances (Figure 3.3). Overall, 18 (40%) studies based their conclusion on 
transmission of AMR determinants, nine (20%) on transmission of AMR 
bacteria and 18 (40%) transmission of AMR bacteria together with AMR 
determinants (Table A4 in Appendix A). There were no statistical association 
between whether direction of transmission was inferred and the nature of 
transmission (p=0.33).  
 
 
Figure 3.3. Nature of evidence 
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3.4.2 Studies suggesting to provide evidence of transmission of AMR 
from food animals to humans with direction specified 
Three studies suggested to find evidence for transfer of AMR bacteria from food 
animals to humans, two of which concluded there is transfer of resistant clones 
from poultry to humans (Al-Ghamdi et al., 1999; van den Bogaard et al., 2001). 
In addition to overlapping clonal patterns, one study reported that human and 
chicken isolates were resistant to spectinomycin, an antimicrobial mostly used 
in veterinary medicine (Al-Ghamdi et al., 1999). Similarly, one study (van den 
Bogaard et al., 2001) reported a higher prevalence of ciprofloxacin resistance 
among food animal isolates compared to human isolates.  
One study found identical ciprofloxacin resistant isolates in chickens and 
humans, which they concluded was suggestive of food animal to human AMR 
transmission (Johnson et al., 2006). Two studies suggested to find evidence for 
horizontal transfer of AMR determinants from food animals to humans 
(Hammerum et al., 2006; Dierikx et al., 2013). One study found that clonally 
unrelated poultry and human isolates shared ESBL/AmpC genes located on 
identical plasmid families (Dierikx et al., 2013). Another study found that 
sulphonamide resistant isolates from pigs and healthy humans shared sul1 and 
sul2 genes (Hammerum et al., 2006).  
Three studies suggested to support transmission of both AMR bacteria and their 
AMR determinants from food animals to humans. Two studies found similar 
sequence types, plasmid families and ESBL genes in E. coli isolates sourced from 
poultry and human patients (Leverstein-van Hall et al., 2011; Giufre et al., 2012). 
A further study reported an increase in tetracycline resistant E. coli in humans 
in contact with tetracycline fed chickens and, therefore, suggested that chickens 
were a reservoir of AMR bacteria and plasmids for humans (Levy, 1978).  
I found that studies suggesting to provide evidence of transmission of AMR from 
food animals to humans did not have distinct features compared to those 
suggesting overlap of resistance, with regard to study methodologies, food 
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animal species, typing tools or antimicrobials tested. For most of these it is 
unclear why they suggested evidence of directional transmission when 25 
broadly similar studies suggested only overlap of resistance.  
3.4.3 Studies suggesting overlap indicating the possibility of between-
host AMR transmission, with no direction specified  
Four studies suggested there was evidence of overlap of resistant E. coli between 
humans and food animals. One of these studies found human and avian 
sequence types associated with MDR clustered together in a Bayesian 
phylogenetic tree (Ciccozzi et al., 2013). Another study found indistinguishable 
PFGE patterns of ampicillin and tetracycline resistant isolates in cattle and 
humans (Lupindu et al., 2015). A cluster analysis of E. coli phylogroups found 
that human, pig and chicken isolates clustered together (Jakobsen et al., 2010). 
One extensive ecological study reported a significant correlation between the 
prevalence of AMR in human and livestock isolates, for both cephalosporins and 
fluoroquinolones(Vieira et al., 2011).  
Thirteen studies suggested there was evidence of overlap of AMR determinants 
in human and food animal isolates. Of the 13 studies, one study using WGS and 
plasmid reconstruction found that clonally unrelated human and poultry 
isolates carried ESBL genes encoded on genetically identical plasmids (de Been 
et al., 2014). Eleven studies found that unrelated human and food animal isolates 
shared identical AMR genes, integrons and plasmids (Oppegaard et al., 2001; 
Winokur et al., 2001; Ho et al., 2009; Moodley and Guardabassi, 2009; Mulvey et 
al., 2009; Smet et al., 2009; Zhang et al., 2009; Ho et al., 2010; Stokes et al., 2012; 
Huijbers et al., 2015b; Tseng et al., 2015). One study identified identical plasmids 
encoding chloramphenicol resistance in unrelated human and food animal 
isolates (Jorgensen, 1983).  
Eight studies suggested there was evidence of overlap of resistant E. coli and 
AMR determinants, with five of these finding that clonally related human and 
food animal isolates harboured similar ESBL gene types and plasmid types (Hu 
et al., 2013; Hammerum et al., 2014; Valentin et al., 2014; Dahms et al., 2015; 
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Dohmen et al., 2015). Likewise, two studies found that clonally related human 
and food animal isolates carried similar fluoroquinolone AMR genes (Zhao et 
al., 2010; Deng et al., 2011). In one study, cluster analysis of AMR gene profiles 
and E. coli pathotypes showed that human and food animal isolates clustered 
together (Jakobsen et al., 2011).  
3.4.4 Studies suggesting no evidence of transmission of AMR between 
humans and food animals 
Two studies found no evidence for transfer of resistant clones, with one of these 
studies finding that human and avian ciprofloxacin resistant  E. coli strains had 
distinct phylogenetic compositions (Graziani et al., 2009). Likewise, a PFGE 
analysis of MDR E. coli isolates from sympatric children and chickens found that 
the isolates were source specific (Kariuki et al., 1999).  
Three studies reported no evidence for transfer of AMR determinants between 
food animals and humans with one of these studies reporting that human and 
porcine isolates had different distribution patterns of sulfonamide and 
tetracycline resistance genes (Schwaiger et al., 2010). Two studies (Kariuki et al., 
1997; Phongpaichit et al., 2007) reported that human and food animal MDR 
isolates had distinct plasmids and integrons.  
Seven studies reported no evidence for transmission of bacterial clones together 
with AMR determinants between food animals and humans. These studies 
showed that human and food animal isolates belonged to different phylogenetic 
groups, and had different AMR genes and plasmid profiles (Maynard et al., 2004; 
Kang et al., 2005; Xia et al., 2010; Johnson et al., 2012; Riccobono et al., 2012; 
Jakobsen et al., 2015; Ueda et al., 2015).  
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3.5  Discussion  
I performed a systematic review to explore the evidence that food animals are 
responsible for the transfer of AMR E. coli and their AMR determinants to 
humans. Some studies in this review suggested to provide evidence for the 
transfer of AMR from and between food animals and humans, while a larger 
number did not suggest to provide evidence of transmission in either direction. 
In addition to the differing nature of methods used to infer direction, studies in 
this review differed in sampling methodologies and antimicrobials tested. These 
differences may have affected the conclusions made regarding the 
epidemiological connection between food animals and humans.  
Much of the evidence regarding transfer of AMR was based on the 
demonstration that AMR E. coli clones and AMR determinants were 
indistinguishable in both food animal and human isolates. However, the 
demonstration of overlapping patterns should be interpreted with care as the 
direction of transmission is difficult to infer, and co-colonisation from a shared 
source is also possible. Demonstrating the direction of transmission and thus 
the  epidemiological history of pathogens and their determinants requires a 
quantitative description of relatedness, including phylogenetic analysis (Grad 
and Lipsitch, 2014). 
Molecular techniques, such as MLST and PCR, used in most studies in this 
review, are limited in resolution (Didelot et al., 2014). In one study, E. coli 
isolates were considered genetically indistinguishable based on MLST 
suggesting clonal transfer (Leverstein-van Hall et al., 2011); however, subsequent 
WGS revealed that the isolates were genetically distinct (de Been et al., 2014), 
highlighting the need for sequencing the entire genome, rather than only a few 
loci. WGS provides the current ‘gold standard’ resolution for studying genetic 
relatedness, but as it is a technology that has only recently become routinely 
available it was used in just one study in this review. Future studies in this area 
could benefit from combining phylogeographic methods with WGS, which 
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yields the potential for quantitative hypothesis testing for inferring pathogen 
movement between host populations (De Maio et al., 2015; Woolhouse et al., 
2015).  
Just over half of the studies in this review did not consider spatiotemporal 
relationships between human and food animal isolates, a fundamental 
requirement for investigating transmission (Singer et al., 2006). Future research 
on the directionality of transmission will benefit from designing studies in 
which epidemiologically linked human and food animal populations are 
systematically sampled, preferably longitudinally (Woolhouse et al., 2015). 
Moreover, there is considerable diversity within both human populations (i.e. 
healthy individuals vs. hospitalised patients) and food animals (i.e. free range 
vs. intensive farming) and the specific population considered may impact their 
exposure to diverse groups of bacteria, thus I recommend that future studies 
investigating transmission of AMR between humans and food animals clearly 
clarify the sub-populations studied. In addition, inclusion of detailed data on 
antimicrobial usage in these populations should be considered. 
None of the included studies provided a detailed overview of antimicrobial 
usage in either human or food animal populations, or association between 
antimicrobial usage and subsequent development of AMR. A recent systematic 
review has indicated that interventions that limit antimicrobial use in food 
animals are associated with a reduction of AMR development in humans (Tang 
et al., 2017), and therefore further research is warranted to explore this complex 
association. 
Although transfer of AMR from humans to food animals is likely (Barber, 2001; 
Wooldridge, 2012), none of the studies in this review suggested to find evidence 
to support transmission from humans to animals. In many instances, 
responsibility for the burden of AMR has been placed on food animals (Barber, 
2001; Woolhouse et al., 2015; Mendelson et al., 2017), and thus study bias may 
exist in terms of source attribution. Therefore, more research is needed to 
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provide evidence for this potential route of transfer and, importantly, the 
relative magnitude of that spread. 
Akin to the studies in this review, most AMR studies focus on a single bacterial 
type; however rapid dissemination of AMR determinants frequently occurs 
between bacterial species, making it hard to track infection source (Sheppard et 
al., 2016). Tracking these determinants, frequently located on plasmids, using 
traditional molecular techniques may be limited. Using long read sequencing 
technologies such as Pacbio can overcome this by accurately generating plasmid 
structures (Orlek et al., 2017). 
This systematic review excluded studies focusing on transmission of resistant 
bacteria and/or their AMR determinants through food animal-sourced food 
products. However, I acknowledge the potentially significant role played by food 
products of food animal origin in dissemination of AMR as reported in a recent 
systematic review (Lazarus et al., 2015). 
I have highlighted studies which suggest to provide evidence for transfer of 
resistant E. coli and their AMR determinants from food animals to humans. 
However, differences in study methodologies, such as lack of spatiotemporal 
overlap in sample collection, and the quality of typing tools used, suggest that 
whereas transmission may occur, the evidence used to support the hypothesis 
is rarely compelling. The underlying problem is that demonstrating similarity 
or identity of AMR bacteria and/or AMR resistance determinants does not, by 
itself, provide information on directionality of transfer; this could be in either 
direction, or both, or neither but from a different source. Information on 
differential prevalence of resistance, and consumption of antimicrobials, in the 
two populations may make stronger inference possible, but these data are rarely 
available.  
Taken together, by combining genomic data analysis and epidemiological 
approaches it may be possible to reconstruct the complex transmission 
        Chapter 3. Role of food animals on human AMR: A systematic review 
55 
dynamics of resistant bacteria and their AMR determinants between human and 
food animal populations. Although we still have some way to go before a truly 
comprehensive integration of data – differential antimicrobial usage data, 
detailed denominator data, information about the origin of the samples, human 
- food animal contact data, and pathogen sequence data – is available, 
disentangling and quantifying transmission of resistant bacteria and their AMR 
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In microbiology the roles of mutation and selection in 
evolution are coming to be better understood through the use 
of bacterial cultures of mutant strains. 
        Edward Lawrie Tatum, 1909-1975 
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Chapter 4 Epidemiology of antimicrobial resistant 
Escherichia coli carriage in sympatric humans and 
livestock in a rapidly urbanising city 
4.1 Abstract  
There are substantial limitations in our understanding of the distribution of 
AMR in humans and livestock in LMICs. Here, I present the results of an 
epidemiological study examining patterns of AMR in E. coli isolates circulating 
in sympatric human (n=321) and livestock (n=633) samples from 99 households 
across Nairobi, Kenya. E. coli isolates were tested for susceptibility to 13 
antimicrobial drugs representing 9 antimicrobial classes.  
Overall, 47.6% and 21.1% of isolates displayed resistance to ≥ 3 and ≥5 
antimicrobial classes respectively. Human isolates showed significantly higher 
proportions of resistance to sulfonamides, trimethoprim, aminoglycosides and 
penicillins compared to livestock (p<0.01), while poultry isolates were more 
commonly resistant to tetracyclines (p=0.01) compared to humans. The most 
common co-resistant phenotype observed was to tetracyclines, streptomycin 
and trimethoprim (30.5%). At the household level, AMR carriage in humans was 
associated with human density (p<0.01) and the presence of livestock manure 
(p=0.03), but livestock keeping on its own had no influence on human AMR 
carriage (p>0.05).  
My findings revealed a high prevalence of AMR E. coli circulating in healthy 
humans and livestock in Nairobi, with no evidence to suggest that keeping 
livestock as a sole risk factor significantly contributed to the burden of AMR in 
humans, although the presence of livestock waste was significant. These results 
provide an understanding of the broader epidemiology of AMR in complex, and 
interconnected urban environments.   
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4.2 Introduction  
Livestock have been implicated as a reservoir for AMR bacteria that may spread 
to humans, with the keeping of livestock widely believed to be a risk factor for 
AMR in humans (Bélanger et al., 2011; O’Neill, 2015). However, quantitative 
evidence describing the role of livestock in the emergence and transmission of 
AMR bacteria to human populations is lacking (Muloi et al., 2018), particularly 
in low- and middle-income countries (LMICs) (Dar et al., 2016). In the absence 
of routine surveillance of AMR in most LMICs, understanding the epidemiology 
of AMR is key to developing effective strategies targeting a reduction in the 
emergence and spread of resistance in the future. 
To date, studies investigating the epidemiology of AMR have tended to focus on 
either human or livestock populations without making comparisons of 
resistances between the two populations. A recent systematic review (Muloi et 
al., 2018) of studies investigating the link of AMR E. coli between humans and 
livestock found only 22 studies of spatiotemporally-related isolates from human 
and livestock populations, just six of which were conducted in LMICs. Notably, 
none of these studies considered urban livestock, which are increasingly 
important, particularly in LMIC settings (Satterthwaite et al., 2010) and may 
contribute to the maintenance of zoonotic bacteria and AMR in the complex 
urban environment (Hassell et al., 2017).   
This study focuses on the role of livestock keeping as a potentially high-risk 
urban interface for AMR transmission between humans and livestock in urban 
Nairobi. Nairobi is a rapidly growing city where livestock are commonly kept 
within household compounds, bringing them into close contact with people. E. 
coli is an ideal organism to study the spread of AMR in this complex 
environment since it is a ubiquitous commensal in both livestock and humans, 
but with a wide range of resistance phenotypes.   
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Here, I report the first study characterising the patterns and epidemiology of 
antimicrobial resistant E. coli from co-habiting human and livestock 
populations in a low resource urban setting.  At the scale of individual 
households, I explore the role of livestock as risk factors for AMR carriage in 
humans, hence providing insight into the pathways of AMR transfer. 
4.3 Methods 
Details on study design, sample collection and bacterial isolation are presented 
in chapter 2.  
4.3.1 Antimicrobial susceptibility testing (AST) 
Antimicrobial susceptibility testing for 13 antimicrobials – ampicillin  (10 g/ml), 
amoxicillin-clavulanic acid (30 g/ml), cefepime (30 g/ml), cefotaxime (30 
g/ml), ceftazidime (30g/ml), chloramphenicol (30 g/ml), ciprofloxacin (5 
g/ml), gentamicin (10 g/ml), nalidixic acid (30 g/ml), streptomycin (25 
g/ml), sulfamethoxazole (30 g/ml), tetracycline (30 g/ml), and trimethoprim 
(2.5 g/ml) – that are frequently used in either/both veterinary and/or human 
medicine in Kenya was carried out using the Kirby-Bauer disc diffusion method 
(Oxoid Ltd., Basingstoke, United Kingdom). Standardised protocols were used, 
in which antimicrobial discs were dispensed onto bacteria-containing agar 
plates and incubated for a maximum of 18 hours at 35oC. E. coli ATCC 25922 was 
used as a quality control of the susceptibility tests.  
Clinical and Laboratory Standards Institute interpretive criteria for 
Enterobacteriaceae (CLSI, 2016) were used to determine breakpoints for 
classifying isolates as either susceptible (‘susceptible’ or ‘intermediate’) or non-
susceptible (‘resistant’) for eleven of the 13 drugs. For tetracycline and 
trimethoprim, isolates were classified into resistant or susceptible because 
examination of the distributions of the zones of inhibition showed populations 
of isolates with distinct phenotypic resistance patterns (Table B1 in Appendix 
B). To describe MDR patterns, the overall resistance profile was calculated by 
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combining the resistance phenotype to each individual class, hereafter referred 
to as AMR carriage (defined as the total number of antimicrobial classes to 
which an isolate was phenotypically resistant).   
4.3.2 Statistical analysis  
The distribution of resistance phenotypes between hosts was calculated using 
Chi-squared tests (humans and livestock), and an one way ANOVA (human vs 
different livestock groups). Tukey's multiple-comparison test was performed 
post-hoc for pairwise comparisons between groups, and P values of <0.05 were 
considered significant. 
GLMMs implemented in R package ‘lme4’ (Bates et al., 2014), with count of 
resistances per isolate as the dependent variable were used to test whether AMR 
carriage differed between host groups. To investigate the co-occurrence of AMR 
phenotypes, a pairwise co-occurrence matrix (presence and absence) of the 
phenotypes was constructed using polycor package (Fox, 2016) in R and the co-
occurrence relationships visualized using corrplot (Wei et al., 2017) in R. A 
correlation between two AMR phenotypes was considered statistically 
significant if the P-value (adjusted for multiple testing using Bonferroni 
correction) was <0.05.  
To investigate finer scale household-level risk factors for AMR carriage in 
humans, I fitted a Poisson-distributed GLMM, with the counts of resistance 
phenotypes as the response variable. Model explanatory variables were human 
density (count of people in a household as a function of household area) and 
types of livestock kept in the household (small livestock only, large livestock 
with or without small livestock, and no livestock).  Additionally, for households 
that kept livestock, a separate Poisson-distributed GLMM was fitted to 
investigate the effect of human density and manure disposal practises (manure 
disposed in the household compound or outside) on human AMR carriage. 
Separate models were fitted for the most prevalent AMR phenotypes 
(tetracyclines, aminoglycosides, sulfonamides, penicillins, and trimethoprim).  
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To account for the nested (or hierarchical) nature of the sampling design 
household site (n=99), sublocation (n=33) and wealth category (n=7) were 
included as random factors.   
 
4.4 Results  
A total of 954 isolates composed of 321 human and 633 livestock E. coli isolates 
in Nairobi, Kenya, were analysed. The number of isolates obtained from each 
source is presented in Table 4.1. 
Table 4.1. Number of human and livestock isolates collected from the 99 
households from Nairobi, Kenya (2015-2016). Livestock isolates are broken 





4.4.1 Patterns of antimicrobial resistance in humans and livestock 
The most common resistance phenotypes (>40% of resistant isolates) were 
those against sulfonamides, trimethoprim, tetracyclines, and aminoglycosides. 
A smaller percentage of isolates (<10%) were resistant to amoxicillin/clavulanic 
acid, cephalosporins, phenicols, and fluoroquinolones (Table 4.2 and Figure 4.1). 
The distribution of resistance to the individual drugs tested is given in Table s2. 
When analysed by host, proportions of AMR-E. coli against each of the 
individual antimicrobial classes, except against cephalosporins, were higher in 
human isolates than those of animal origin. Of 321 human isolates, >40% were 
resistant to sulfonamides, trimethoprim, aminoglycosides, and tetracyclines. Of 
633 livestock isolates, >40% of isolates were resistant to sulfonamides, 
tetracyclines and trimethoprim. For both human and livestock isolates, <10% of 
Source  Number of isolates  % of isolates  
Human 321 33.7 
Livestock:   
Poultry 345 36.2 
Bovine 64 6.7 
Goat 132 13.8 
Pig 51 5.3 
Rabbit 41 4.3 
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isolates were resistant to phenicols, fluoroquinolones, cephalosporins and β-
lactams. Resistance to penicillins, aminoglycosides, sulfonamides and 
trimethoprim was significantly more common in humans than in livestock 
(p<0.01, Chi-squared test; Table 4.2, Figure 4.1a). 
The prevalence of resistance to penicillins, tetracycline, aminoglycoside, 
sulfonamides and trimethoprim varied significantly between humans and 
livestock stratified by taxonomic groups (poultry, pigs, rabbits, bovines and 
goats; Tukey’s post hoc test). Humans were more likely to carry E. coli resistant 
to penicillins, aminoglycoside, sulfonamides and trimethoprim than all species 
of livestock (p<0.05, one-way ANOVA with Tukey's multiple-comparison test). 
Conversely, poultry were more likely to carry isolates resistant to tetracyclines 
than humans (Figure 4.1b, Figure B1 in Appendix B).   
Table 4.2. Percentages of E. coli isolates resistant to different antimicrobial 
classes classified by host type (human or livestock). Numbers show percentages 
of isolates classified as resistant based on the zone of inhibition. Categorical 
interpretation is based on breakpoints used as described in the methods section. 










Sulfonamides 58.2 66 54.2 0.005 
Aminoglycosides 37.1 47.7 31.8 <0.001 
Trimethoprim 47.3 56.1 42.8 0.001 
Tetracyclines 45.7 45.5 45.8 NS 
Penicillins 30.2 40.8 24.8 <0.001 
β-lactam (co-amoxiclav) 1.5 2.5 0.95 NS 
Phenicols 4.0 6.5 2.69 NS 
Cephalosporins 3.8 2.8 4.27 NS 
Fluoroquinolones 6.8 9.7 5.37 NS 




Overall, 284 (29.7%) isolates were susceptible to all 13 antimicrobials tested 
(nine antimicrobial classes). The proportion of pan-susceptible isolates was 
significantly higher among livestock isolates (n=217/633, 34.3%) than in human 
isolates (n=67/321, 20.9%) (p<0.01, Chi-squared test). Of the 217 pan-susceptible 
livestock isolates, 22% of poultry isolates (n=76), 51.6% of bovine isolates (n=33), 
33.3% of pig isolates (n=17), 54.6% of goat isolates (n=72), and 46.3% of rabbit 
isolates (n=19) were pan-susceptible. Across both human and livestock isolates, 
404 (47.6%) and 201 (21.1%) isolates were resistant to ≥ three and five 
antimicrobial classes respectively. Eight isolates (0.8%) showed resistance to ≥7 
antimicrobial classes tested; five (1.6%) from humans and three (0.9%) from 
poultry (Figure 4.2). 
Figure 4.1 Radar charts showing percentages of E. coli isolates resistant to 9 
antibiotic classes. a) human (n=321) and livestock (n=633), and b) human and the 
different livestock species’ (poultry, pig, bovine, goat, rabbit). (Asterisks denote 
significant differences between carriage of this particular resistance phenotype in 
livestock and humans). 













AMR carriage (i.e. the total number of antimicrobial classes an isolate is 
resistant to) was significantly higher in humans than in livestock (OR=1.14, 
p<0.01, GLMM). However when studied in more detail, AMR carriage patterns 
in human isolates was similar to those from pigs and poultry (p>0.05) but 
significantly higher than those from bovines, goats and rabbits (p<0.05) (Table 




Figure 4.2 Distribution of MDR patterns among E.coli isolates obtained from 
humans (n=321), poultry (n=345), pigs (n=51), bovines (n=64), goats (n=132), 
and rabbits (n=41), in Nairobi, Kenya. 
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Table 4.3. Results of a Poisson generalise linear mixed model examining the 
likelihood of AMR carriage within different host groups. Human is used as the 
reference level. NS =Not significant.  





Human  321 Reference Reference Reference 
Livestock  633 -0.13 0.16 <0.01 
    Bovine 64 -0.28 0.14 0.03 
    Poultry 345 -0.08 0.05 NS 
    Pigs 51 0.08 0.11 NS 
    Rabbits 41 -0.37 0.16 0.02 
    Goats 132 -0.48 0.11 <0.01 
   
Examination of the similarity of E. coli antibiograms from human and livestock 
isolates revealed 84 distinct profiles: 30 in livestock, 19 in humans and 35 
common to both (Table B4 in Appendix B). Using a co-occurrence analysis 
based on a statistically significant (p<0.05) correlation coefficient (ρ>0.5) I 
identified a tetracycline-sulfonamide-trimethoprim cluster (Figure 4.3). This co-
resistance was identified in 340 isolates (30.5%): 115 (35.8%) humans and 225 
(35.5%) livestock – 156 (45.2%) poultry, 24 (47.1%) pigs, 9 (22.0%) rabbits, 14 
(21.9%) bovines, and 22 (16.7%) goats. There were no significant differences in 
the distribution of this profile between human and the other host groups (Chi-
squared test; p > 0.05). Further, denoting multi-resistance, this cluster was 





















4.4.2 Antimicrobial resistance exchange between humans and 
livestock at the household level 
In any given household, I found no evidence that the presence of livestock 
increased risk of human AMR carriage (p>0.05, GLMM) (Table 4.4). However, 
human AMR carriage increased with human density (OR=1.26, p=0.003, 95% CI 
[1.08-1.47], GLMM) (Figure 4.4). The impact of livestock keeping on human AMR 
carriage was potentially influenced by disposal practices of animal manure: 
keeping manure inside the household perimeter, compared to disposing of it 
externally, was associated with greater human AMR carriage (OR=1.29, p=0.03, 
Figure 4.3 Heat map representing correlations among AMR phenotypes across 
human (n=321) and livestock (n=633) E. coli isolates. The boldness of the colour 
represents the strength of the relationship between phenotypes, with stronger 
correlations having bolder colours. Numbers within boxes represent correlation 
coefficient (r) values. * indicates statistically significant correlations (p<0.05). 
The scale bar at the bottom indicates whether the correlation between 
phenotypes is positive (closer to 1, dark blue) or negative (closer to −1, dark red). 
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95% CI [1.02-1.63], GLMM) (Table 4.4). My results were consistent when separate 
analyses for the individual resistances was performed (Table B3 in Appendix B).   
Table 4.4. Results of two generalized Poisson Mixed Models investigating 
household risk factors for AMR carriage in humans at the household level. 
Households not keeping livestock used as the reference level in Model 1. 






Human density 0.23 0.08 0.003 
Large livestock (with or without small 
livestock) -0.14 0.12 0.24 
Small livestock only 0.0075 0.11 0.94 
Model 2: AMR carriage, humans in 
livestock keeping household only    
Human density 0.24 0.09 0.009 












Figure 4.4 Fit of a Poisson generalised linear mixed effects model showing how 
increasing human density in a household influences AMR carriage in humans.  All 
other covariates in the models are kept constant. Shading on either side of each line 
represents 95% confidence intervals. Points have been jittered for clarity.  
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4.5 Discussion  
In this study I applied ecological and epidemiological approaches to characterise 
the epidemiology of AMR E. coli isolates systematically collected from sympatric 
human and livestock populations in the rapidly developing urban landscape of 
Nairobi, Kenya.  
Resistance to aminoglycosides, sulfonamides, tetracyclines, trimethoprim and 
penicillins was high in both humans and livestock, while resistance to 
cephalosporins and fluoroquinolones was low. These results are consistent with 
previous studies (Kariuki et al., 2003; Bii et al., 2005; Adelaide et al., 2008; Oundo 
et al., 2008) and may in part be a reflection of the patterns of antimicrobial use 
in human and animal health. However, background data on antimicrobial use 
in these populations is limited. My results indicating a high prevalence of AMR 
carriage are based on non-clinical isolates from humans and livestock.  
When analysed by host, human isolates appeared to have a higher prevalence of 
AMR carriage when compared to livestock isolates, with the exception of 
tetracyclines. In particular, the observed prevalence was significantly higher in 
four clinically relevant antimicrobial classes (penicillins, sulfonamides and 
trimethoprim and aminoglycosides). A possible explanation for this variation in 
AMR carriage is that it relates to variation in antimicrobial use between these 
populations. Although antimicrobials are used extensively in both human and 
livestock populations, previous studies have shown that frequency of  use of 
antimicrobials is higher in human medicine than in livestock, especially in 
resource-poor settings (Kariuki and Dougan, 2014). Similarly, in community 
settings where over-the-counter access to drugs is common, it is likely that 
humans have access to a broader range of antimicrobials, either through self-
medication or inappropriate prescribing; common practices in many low and 
middle-income countries (LMICs) (Omulo et al., 2015; Omulo et al., 2017). 
Likewise, in such settings, infections are commonly treated empirically (often 
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using antimicrobials) with limited microbiological investigations to ascertain 
the causal organism(s). 
Although chloramphenicol use in food animals has been banned in Kenya 
(Group, 2011), I noted 3% resistance to this antimicrobial in livestock. This may 
be explained by the use of florfenicol, a fluorinated derivative of 
chloramphenicol, which shows some cross-resistance with chloramphenicol 
(White et al., 2000). Similarly, the observed proportions of resistance against 
ciprofloxacin (a quinolone antimicrobial not licensed for veterinary use) among 
livestock isolates is probably explained by cross-resistance with other 
quinolones used in veterinary medicine, such as enrofloxacin and norfloxacin.  
At the household level, there is evidence of an intricate interplay between 
humans and livestock in relation to the development and transmission of AMR. 
This analysis revealed that human AMR carriage increased with number of 
occupants in a household, and that keeping manure inside the household 
compound was also significantly associated with AMR carriage in humans. In 
urban Nairobi, people live in a continuum of urban spaces with varying human 
and animal population densities, with the majority (>60%) of people living in 
slums (Joshi et al., 2011; Bird et al., 2017), environments characterised by small 
household areas and high population densities. Population density is an 
important factor in the population prevalence of AMR in populations (Bruinsma 
et al., 2003), and may in part be due to the significant correlation between 
overcrowding and high infectious diseases burden more broadly(Yang et al., 
2012); an important driver of antimicrobial use in resource poor settings such as 
Nairobi. Similarly, high human populations within a household result in a 
greater epidemiological connectivity; thus facilitating exchange of AMR bacteria 
and their AMR determinants. The number of urban dwellers in the majority of 
LMIC cities, including Nairobi, is projected to grow significantly in the near 
future (UNPD, 2014a). While this urban demographic change is unfolding, 
disease burden is expected to burgeon, precipitating high antimicrobial use. For 
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this reason, measures to curb infectious diseases burden by the public health 
policy makers, in part to reduce drug pressure on micro-organisms, are needed.  
This results suggest that at the household level, livestock ownership in and of 
itself does not add to the risk of acquisition or carriage of AMR bacteria in 
humans. However, given the multiple pathways of AMR exchange between 
humans and livestock (Woolhouse et al., 2015), via the food chain or due to 
environmental pollution, it is possible that the direct effect of livestock keeping 
on proportions of AMR in humans could be confounded by other factors not 
captured in this study. This study does, however, suggest that, whilst AMR 
carriage was not directly associated with the presence of livestock in the 
household, the impact of keeping livestock on human AMR carriage was 
mediated by some practices associated with livestock keeping, namely the 
presence or absence of animal manure in the household. These results support 
other studies that have identified animal manure as a reservoir of AMR bacteria 
and AMR determinants (Udikovic-Kolic et al., 2014; Graham et al., 2016). 
Importantly, amplification and persistence of AMR determinants such as AMR 
plasmids can take place in manure and be further disseminated to humans via 
cross-contamination pathways such as through exposed water and food 
(Pornsukarom and Thakur, 2017), or via peri-domestic wildlife. Although there 
is still a lack of knowledge concerning the exact mechanism, particularly the 
genetic basis of transmission (Heuer et al., 2011), strategies that limit AMR gene 
flow to and from manure (to humans) should be adopted. Such measures 
include safe disposal of manure from households, and manure pre-treatment 
prior to application onto crop farms where possible.  
It is important to note that, while this analysis was not designed to address 
transmission of AMR bacteria and their AMR determinants, it is also plausible 
that clonal expansion could have played a role in the observed AMR patterns. 
The finding of 35 common AMR profiles in both human and livestock bacterial 
populations may, in part, reflect overlapping antimicrobial usage patterns, 
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acquisition of AMR from a shared source or clonal expansion. I hypothesise that 
the finding that 30.5% (340/954) of all isolates contain a tetracycline-
sulfonamide-trimethoprim cluster phenotype and that the pairwise correlations 
between these three antimicrobial classes were very high is suggestive of a 
conjugative MDR plasmid circulating within the E. coli population in both 
human and livestock populations. AMR genes conferring resistance to 
tetracycline, sulfonamide and trimethoprim antimicrobial classes are 
commonly associated with mobile genetic elements (Harmer and Hall, 2015), 
and these elements play a pivotal role in dissemination of MDR in E. coli isolates. 
Genetic data is required to validate the existence of mobile genetic elements, 
and determine whether AMR genes are being transferred across them.  
Distinguishing molecular transmission of AMR, from selection for AMR due to 
antimicrobial use, is challenging (Muloi et al., 2018). In particular, in an urban 
environment such as Nairobi, where human habitation, livestock keeping, and 
food supply chains are interconnected (Alarcon et al., 2017) the relative 
contributions of the aforementioned drivers are difficult to quantify. At a finer 
scale, any study investigating the transmission of AMR between humans and 
livestock in these low resource settings needs to consider indirect transmission, 
rather than just direct animal to human and/or human to animal transmission. 
Whilst direct host-to-host transmission of AMR bacteria and AMR 
determinants may occur, in these intricate ecosystems, the role played by the 
wider environment (e.g. wildlife, soil and, in particular, hospital and farm 
effluents) in relation to acquisition of AMR from a common source may be vital.  
4.6 Conclusion  
Taken together, using a rigorously-structured epidemiological study design, I 
report a high prevalence of AMR E. coli carriage in livestock and humans outside 
the clinical setting across a developing-country urban landscape, with no 
evidence that direct contact with livestock contributes to the burden of human 
AMR, but that indirect contact between livestock and humans does play a role. 
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In LMIC urban ecosystems, the elevated prevalence of AMR in both human and 
livestock populations could be attributed to unregulated access to 
antimicrobials, poor hygiene and sanitation, and waste management, which 
encourage the evolution and spread of AMR bacteria. These findings highlight 
a need for targeted surveillance strategies across various sectors, and for actors 
to address and design effective measures to curb AMR in these populations, 
both in Nairobi and in other similar urban landscapes. Further work is required 
to understand the ecology of genetic determinants of resistance, in particular 
the extent of the role plasmids play in the dissemination and evolution of 
resistance traits in these human and livestock populations.  
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People and gorillas, horses and duikers and pigs, monkeys 
and chimps and bats and viruses: We’re all in this together. 
David Quammen, 2012 
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Chapter 5 One Health genomic epidemiology of 
antimicrobial resistant Escherichia coli carriage in co-
habiting human and livestock populations 
5.1 Abstract  
Livestock have been proposed as a reservoir for AMR bacteria and AMR genetic 
determinants that may infect humans, yet quantitative evidence regarding their 
epidemiological role remains lacking. I used a combination of genomics, 
epidemiology and ecology to investigate patterns of AMR carriage in E. coli, 
regarded as a sentinel organism. I conducted a structured epidemiological 
survey of 99 households across Nairobi, Kenya and whole genome sequenced 
one E. coli isolate from 315 human and 594 livestock faecal samples.  
I detected high rates of AMR gene carriage, 60 different acquired genes and 14 
point mutations, and found that 10/74 of the genes were significantly more 
common in human than in livestock isolates. Highest AMR gene carriage was 
observed in humans, pigs and poultry compared to rabbits, goats and bovines. 
AMR gene community composition was not associated with host type or 
household location.  I found that, whilst AMR gene carriage in humans was not 
directly associated with the presence of livestock in the household, the impact 
of keeping livestock on human AMR gene carriage was instead influenced by 
livestock-keeping practices, in particular the presence or absence of animal 
manure in the household.  
In conclusion, I did not find any evidence to support the hypothesis that the 
keeping of livestock is a risk factor for emergence and dissemination of AMR 
genes to humans in this setting. The characterisation of AMR patterns in which 
co-habiting human and livestock populations were systematically sampled 
provides new insight into the broader epidemiology of AMR in complex and 
interconnected urban environments.  
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5.2 Introduction  
Humans and livestock are linked in many ways including direct contact via close 
proximity, and shared environments receiving human and animal waste. The 
close contact that people have with livestock could provide an opportunity for 
either population to act as a reservoir from which AMR bacteria or their AMR 
determinants could be transmitted in either direction, (Planta, 2007; Hassell et 
al., 2017). The tangled interplay of AMR transmission between people and 
livestock is likely to be most acute in LMICs making investigations of AMR 
transfer in these settings a public health priority. Livestock have been proposed 
as a source for AMR bacteria in humans, with the keeping of livestock widely 
believed to be a risk factor for AMR in humans (Bélanger et al., 2011; O’Neill, 
2015). However, quantitative evidence describing the role of livestock in the 
emergence and transmission of AMR bacteria and their resistance determinants 
to human populations is lacking (Muloi et al., 2018; Hanage, 2019).  
Current surveillance of AMR E. coli tends to focus on tracking specific AMR 
genes (mostly of clinical importance such as ESBLs) in either human or livestock 
populations without making comparisons of resistances between the two 
populations (Muloi et al., 2018). Whole genome sequencing of spatiotemporally-
related isolates from human and livestock populations overcomes both of these 
limitations and may help us to improve our understanding of how and where 
AMR develops and spreads across different host populations or niches.  
In this study, using whole genome sequence analysis of E. coli isolates obtained 
from cohabiting human and livestock populations; I determined the prevalence 
and mechanisms of resistance, and characterised AMR gene diversity and 
structure of AMR genes in the different host populations.  At a finer scale, 
epidemiological models were used to investigate risk factors for exchange of 
AMR genes between sympatric humans and livestock, thus shedding light on 
pathways of AMR transfer at household interfaces.  
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5.3 Material and methods 
Details on study design, sample collection, bacterial isolation, whole genome 
sequencing and bioinformatic analysis are presented in chapter 2. 
5.3.1 Detection of antimicrobial resistance genes  
Acquired genes encoding antimicrobial resistance were identified through the 
ResFinder tool (Zankari et al., 2012a) via the Center for Genomic Epidemiology 
batch upload platform (https://cge.cbs.dtu.dk/services/cge/). The threshold of 
AMR gene detection was set to 90% identity and 60% coverage, as this is shown 
to be the optimal threshold for this method (Zankari et al., 2012b). The 60% 
coverage threshold was to ensure that AMR genes spread over two contigs, 
and/or located on the edge of the contig were not missed. As resistance to some 
of the antimicrobial agents, in particular fluoroquinolones, can be caused by 
point mutations (Single Nucleotide Polymorphisms (SNPs)), PointFinder 
(Zankari et al., 2017) was used to detect point mutations known to confer 
antimicrobial resistance.  
5.3.2 Distribution of AMR genes by host types 
Differences in the distribution of AMR genes between hosts were calculated 
using Chi-squared tests (humans and livestock), and one way ANOVA (human 
vs different livestock groups) using R package stats (R Core Team, 2013). Tukey's 
multiple-comparison test was performed post-hoc for pairwise comparisons 
between groups, and P values of <0.05 were considered significant. 
 
5.3.3 Alpha diversity  
Comparisons of alpha diversity between host groups were conducted using 
richness (defined as the number of unique AMR genes in an isolate), Simpson 
diversity index (1-D), and Shannon’s index using the diversity function in the 
vegan package (Oksanen et al., 2015). Mann–Whitney U test was used for 
comparisons between human and livestock. For comparisons of more than two 
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groups, Kruskal–Wallis test was applied, and statistical differences were 
corrected for a multiple comparison test using the Bonferroni correction. 
5.3.4 Rarefaction analysis  
To estimate whether or not differential sampling bias could be, in part, 
responsible for the observed diversity of resistance determinants in the isolates 
I performed a rarefaction analysis (Hughes et al., 2001) using the R package 
iNEXT. Sample-based curves evaluated the number of AMR genes in a sample 
by plotting diversity estimates in relation to the number of sampling units. All 
extrapolation curves were plotted using a doubling in sample size, and 999 
bootstrap replicates were used to estimate 95% confidence intervals. Ninety‐five 
percent confidence intervals were used to determine if differences between 
methods were statistically significant. 
 
5.3.5 Beta diversity  
To complement alpha-diversity analyses, I evaluated whether AMR gene 
communities in human and livestock (and the different livestock groups) 
populations had different structures (beta-diversity). AMR gene counts for each 
antimicrobial class were computed and Hellinger transformed to avoid 
overweighting of rare AMR genes. Bray-Curtis abundance-based dissimilarity 
matrix (by antimicrobial classes) was highly correlated with Jaccard incidence-
based matrix (AMR gene presence and absence) (r = 0.81, P < 0.001; Mantel test), 
so I used a Bray-Curtis abundance-based dissimilarity matrix.  
Bray-Curtis dissimilarity between all samples was calculated using the R 
package vegan. Average-linkage clustering was used for all hierarchical sample 
clustering. A circular Bray-Curtis AMR gene community dendrogram was 
constructed by exporting the dendrogram in Newick format using the ape 
package (Paradis et al., 2004) and displayed using Interactive Tree of Life tool 
(Letunic and Bork, 2016).  
Further, Non-Metric Multidimensional Scaling (NMDS) was used to ordinate 
and visualize the Bray-Curtis distance matrix. Confidence ellipses were drawn 
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around samples from each host group, using a 95% confidence interval. 
Ordination was performed separately for humans compared to livestock, and 
humans compared to the different livestock groups. 
 
5.3.6  Genetic differentiation and structure of AMR genes by 
household location  
Here I investigated genetic differentiation and structure of AMR genes within 
and between host groups from the same household and those from different 
households. I hypothesise that within the same household (across different 
hosts) AMR gene dispersal is widespread and driven by continuous immigration 
of mobile genetic elements and AMR bacteria. Specifically I ask, what is the level 
of AMR gene variation within and between hosts in the same household and 
those from different households? I.e. are AMR gene communities from one 
household genetically more similar than two individuals chosen from two 
different populations? To empirically and quantitatively test the relative 
contribution of geographical location (i.e. within the same household and 
different households) in structuring AMR gene assemblage, intra and inter-
household Bray-Curtis dissimilarities were compared using permutation tests. 
Permutation tests were calculated for, i) human samples only, ii) livestock 
samples only, iii) human and livestock samples, and iv) human and the various 
livestock groups i.e. human and poultry. The statistical significance was tested 
using 106 permutations.  
 
5.3.7 Modelling AMR gene sharing between humans and livestock at 
the household level 
To investigate the potential drivers of AMR gene carriage in humans at the 
household level I used a zero inflated General Linear Mixed Model (GLMM) with 
counts of the individual AMR genes (also referred to as AMR gene length) in 
each of the isolated aggregated at the antimicrobial class level as the dependent 
variable. Risk factors analysed included: human density (persons in a household 
as a function of household area) and kinds of livestock kept in the household 
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(small livestock only, large livestock +/- small livestock, and no livestock). 
Moreover, for households that kept livestock, a separate zero inflated poison 
GLMM was fitted to investigate the influence of human density and manure 
disposal practises (manure disposed in the household compound or outside) on 
AMR gene length. Separate models were fitted for the most prevalent AMR 
genes.  
I first looked for collinearity among our covariates using bivariate correlations. 
Covariates had correlation coefficients 0.3 or less indicating collinearity was not 
a serious concern. Analysis were performed using the glmmTMB package 
(Magnusson et al., 2017) in R. I plotted the diagnostic plots of the zero inflated 
Poisson mixed model, including random effects, to check that the model 
assumptions were not violated using the R package sjPlot (Lüdecke, 2017). To 
account for the nested (or hierarchical) nature of our sampling design 
household site (n=99), sublocation (n=33) and wealth category (n=7) were 
included as random effects.  To estimate the variance due to differences in 
carriage between antimicrobial classes, antimicrobial class was included as a 
random effect. To account for variation due to genome assembly and AMR gene 
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5.4 Results  
5.4.1 Antimicrobial resistance genes characterisation  
 A total of 909 isolates composed of 315 human and 594 livestock isolates (Table 
5.1) were whole genome sequenced and screened for known genetic 
determinants of AMR, including acquired AMR genes and point mutations in 
chromosomal genes associated with AMR.  
Table 5.1 Number of human and livestock isolates collected from the 99 






I detected 60 acquired genes and 14 point mutations (7 in parC region, four gyrA, 
two parE, and one ampC) known to confer resistance to 9 antimicrobial classes. 
Across all isolates, the most common AMR genes were, sul2 (46%), strA (41.1%), 
strB (41.1%), tetA (38.3%), and blaTEM-1B (25%) conferring resistance to 
sulphonamides, aminoglycosides, tetracyclines and β-lactams respectively 
(Figure 5.1). Three hundred and one (41.4%) E. coli isolates analysed were pan-
susceptible. A significantly larger proportion of livestock isolates (45.7%) 
compared to human isolates 102 (31.9%) did not contain a single AMR gene (or 
point mutation) (p<0.001, Fisher’s Exact test). Of the 289 pan-susceptible 
livestock isolates, 31.6% of poultry isolates (n=106), 65.1% of bovine isolates 
(n=41), 34% of pig isolates (n=17), 70.6% of goat isolates (n=96), and 70.7% of 
rabbit isolates (n=29) were pan-susceptible. 
For the majority of the predicted genes the distribution did not significantly 
differ between human and livestock isolates. However, the abundance of 10/74 
Source  Number of isolates  % of isolates  
Human 315 34.7 
Livestock: 594 65.3 
Poultry 314 34.5 
Bovine 61 6.7 
Goat 128 14.1 
Pig 50 5.5 
Rabbit 41 4.5 
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genes (sul1, sul2, strA, strB, blaTEM-1B , mphA, dfrA7, dfrA8, gyrA_S83L, and catA1 
genes was higher in human isolates as compared to livestock isolates (p<0.05, 
Bonferroni correction).  
 
 
Figure 5.1 Prevalence of 74 AMR genes and point mutations associated with 
reduced antimicrobial susceptibility in 315 human and 594 livestock E. coli 
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Considering the heterogeneous nature of “livestock” as a group, I further 
investigated differences in the distribution of AMR genes between human and 
the different livestock groups. Significant differences in the proportion of AMR 
genes were noted in 10 of the 60 acquired genes. These included tetA, sul1, sul2, 
strA, strB, blaTEM-1B, dfraA1, dfrA7, dfrA14 and catA1. Tukey’s post hoc test 
revealed significant differences in the proportion of resistance between different 
pairs of host groups for the ten AMR genes (Figure 5.2, Table C1 in Appendix C). 
Overall, for all AMR genes expect dfrA14, humans had a significantly higher 
proportion when compared to bovines, pigs or rabbits. Conversely, pigs and 
poultry had a significantly higher proportion of strA, and tetA and dfrA14 genes 
respectively when compared to humans.  




Figure 5.2 A subset of genes that differed significantly in abundance between at least two host 
groups.  * P < 0.05, Kruskal test, Bonferroni correction 
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5.4.2 AMR gene abundance and diversity 
Overall, AMR genes were more common in human when compared to livestock isolates 
(median 5 vs. 1; p<0.001, Man-Whitney U test) (Figure 5.3). When compared to the 
different livestock groups, human carriage of AMR genes was not significantly different 
from poultry and pigs (p>0.05, Kruskal Wallis, Bonferroni correction). However, human 
isolates had higher carriage when compared to bovine, goat and rabbit isolates (p < 0.05, 






Figure 5.3 Number of AMR genes per isolate in a) humans and livestock, b) humans 
and the different livestock groups P values were calculated using the Wilcoxon test and 
Kruskal Wallis. Numbers indicate AMR gene numbers within each group. 
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This pattern was consistent with Shannon and Simpson, diversity indices, which assess 








Figure 5.4 Box plot of A) Shannon’s’ diversity, and B) Simpson diversity (1-D) at the AMR 
gene level of the various hots groups. The horizontal line is the median value, the middle 
box indicates the inter-quantile range (IQR), whiskers represent values within 1.5 IQR of 
the lower and upper quartiles, and individual points show outlier values. 
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5.4.3 Rarefaction analysis to evaluate effect of sampling effort on diversity  
Rarefaction analyses were used to evaluate if the sampling effort was sufficient to fully 
capture the diversity of AMR genes in both human and livestock E. coli. Overall, it 
showed that AMR gene diversities were slightly higher in human isolates compared to 
livestock, when sampled at comparable depths. However, despite the depth of our 
sampling, diversities estimates still represent the lower bounds of the “true AMR gene 
diversity”.  Asymptotic estimates of AMR diversity, according to the rarefaction 
analyses, for human and livestock was approximately 4000 and 5000 samples 













Figure 5.5 Sample-based rarefaction curve to assess saturation and estimate the total 
richness (number of AMR genes) predicted in our dataset. Solid black line is the 
rarefaction curve. Dotted line indicates Chao2 estimation of asymptotic richness by 
number of samples, and shading indicates 95% confidence intervals. 
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5.4.4 AMR gene community assemblage  
First, I calculated the Bray Curtis dissimilarities between the gene-level AMR gene 
compositions for all isolates and visualised it in a dendrogram. There was no obvious 









Next, I assessed differences in overall AMR gene community composition in human and 
livestock (and the different livestock groups). I used techniques that are based on the 
relative abundance of AMR genes within communities and the extent of genetic 
divergence between AMR genes. The NMDS ordination in two dimensions adequately 
represented data on the AMR gene community structure, as evidenced by low stress 
values (0.08). The 95% confidence ellipses for the centroids of human and livestock 
overlapped indicating that AMR gene assemblages in both human and livestock were 
similar to each other (Figure 5.7a). Similarly, when compared to the different livestock 
groups, ordination analysis showed that AMR gene community assemblage was not 
significantly different between humans and the different host groups (Figure 5.7b). 
Figure 5.6 A dendrogram showing the AMR gene assemblage for human, poultry, 
pig, bovine, goat, and rabbit AMR gene communities using average linkage of Bray 
Curtis dissimilarities. 
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Figure 5.7 Non-metric multi-dimensional scaling (NMDS) of a Bray-Curtis distance matrix describing AMR gene communities in a) 
human and livestock isolates, and b) human and different livestock groups. Each point symbolizes an isolate’s AMR community, 
some points may overlap completely.  Ellipses represent 95% confidence estimates for mean NMDS scores. Non-overlapping 
centroids are considered significantly different at a = 0.05 




5.4.5 AMR gene assemblage at the household level  
Multivariate permutation tests indicated that AMR gene community in human 
and livestock isolates from the same household and those from different 
households didn’t not differ (p > 0.5, permutation test) (Figure 5.8a). Similar 
pattern was observed when analysing human and the specific livestock groups. 
Livestock isolates from the same households tended to have similar AMR gene 
composition (p<0.01); however this was not evident in human only isolates (p 
>0.05) (Figure 5.8b-c).  
 
Figure 5.8 Comparison of the observed values (red line) with the null 
distribution of the differences in dissimilarity in AMR gene communities within 
and among households for a) both human and livestock, b) human only, c) 
livestock only isolates. 




5.4.6 Role of livestock keeping in AMR gene carriage in humans at the 
household level  
Having established that AMR gene communities were similar in humans and 
livestock, I next aimed to assess whether livestock keeping, and livestock 
keeping practices, influenced AMR gene carriage in humans. The AMR gene 
assemblage in humans was analysed with respect to livestock keeping status 
using nonmetric multidimensional scaling (nMDS) and analysis of similarity. 
The 95% confidence ellipse for the centroid of humans keeping livestock 
overlapped with that of humans not keeping livestock (Figure 5.9). Likewise, 
Permutational Multivariate Analysis of Variance (PERMANOVA) showed that 
the AMR gene composition of humans keeping livestock did not differ from 












Figure 5.9 Non-metric multi-dimensional scaling (NMDS) of a Bray-Curtis 
distance matrix describing AMR gene assemblage in humans with respect to 
the livestock keeping status. Each point symbolizes an isolate’s AMR 
community, some points may overlap completely.  Ellipses represent 95% 
confidence estimates for mean NMDS scores. 




Considering the variation in the different livestock groups kept across the 
households, I analysed the AMR gene assemblage in humans with respect to 
the kind of livestock kept in the household (poultry, bovines, pigs, rabbits and 
goats). Consistently, the AMR gene composition of humans did not vary 
depending on the kind of livestock kept in the household (Adonis R2 <0.01, p= 
1).  
In agreement with the NMDS and PERMANOVA analysis, using zero inflated 
generalised linear mixed models, the results suggest there was little evidence 
(if any) that the presence of livestock (small or large+/-small) influences the 
risk of human AMR gene carriage (p>0.05) (Model1,Table 5.2; Figure 5.10a). The 
impact of livestock was influenced by the use of manure: the risk was 
significantly higher if manure was kept inside the household perimeter 
compared to disposing of externally (OR=2.13, p=0.008, 95% CI [1.22-3.71]) 
(Model 2, Table 5.2; Figure 5.10b), however this was rarely significant when I 
performed separate analyses for the individual AMR genes (Table C1 in 
Appendix C).  
Table 5.2. Results of a zero inflated generalised linear mixed models 
investigating household risk factors for AMR gene carriage in humans at the 
household level. Households not keeping livestock used as the reference level in 
Model 1. 
Model 1: AMR gene length, 
humans in all households 
Estimate Standard error P value 
Human density 0.08 0.21 0.72 
Large livestock (+/- small 
livestock) -0.08 0.3 0.78 
Small livestock only -0.19 0.27 0.47 
Model 2: AMR gene length, 
humans in livestock keeping 
households only    
Human density 0.3 0.25 0.2 
Manure in household 0.75 0.28 0.007 
 














Figure 5.10 Fit of the zero inflated generalised linear mixed models. a) Model 1: 
AMR gene length, humans in all households, b) Model 2: AMR gene length, 
humans in livestock keeping households only. 




5.5 Discussion  
In this study I investigated the epidemiology of AMR gene carriage in E. coli 
isolates systematically collected from sympatric human and livestock populations 
in the rapidly developing urban landscape of Nairobi, Kenya, using a “One 
Health” approach.  
I detected 74 AMR genes (60 acquired and 14 point mutations associated with 
reduced antimicrobial susceptibility) known to confer resistance to nine 
antimicrobial classes. The most common AMR genes were sul2, strA, strA, tetA 
and blaTEM-1B conferring resistance to sulphonamides, aminoglycosides, 
tetracyclines and β-lactams antimicrobial classes all of which are commonly used 
in both livestock and humans. This observed prevalence of AMR genes carriage 
in non-clinical human and livestock isolates highlights the need for continued 
monitoring of the prevalence of ARGs through the continuum of ecosystems, in 
line with the One Health initiative. When analysed by source, most (64/74, 
86.5%) of the genes were found in similar proportions in both humans and 
livestock, highlighting their ubiquitous distribution in both reservoirs, while the 
remainder (10/74, 13.5%) were significantly more common in human than in 
livestock isolates. The greater abundance and diversity of AMR genes in humans, 
chickens and pigs than in bovines, goats and rabbits can be explained by; (i) the 
high antimicrobial usage in humans and in intensively farmed pigs and poultry 
and less so in extensively farmed cattle and goats (Kariuki and Dougan, 2014; 
Woolhouse et al., 2015) – although such data are lacking; and ii) frequent contact 
between humans, chickens and pigs than for humans and goats, rabbits and 
cattle.   
Further evidence for AMR gene similarity between humans and livestock was 
provided by comparisons of human and livestock AMR gene communities, 
findings which demonstrated that human and livestock isolates have overlapping 
AMR gene communities. In complex urban interfaces such as Nairobi where 




humans and livestock are linked in many ways, including direct contact, 
consumption of livestock products by humans, horizontal gene transfer of AMR 
genes and vertical AMR transmission could explain this phenomenon. Further, 
given the shared environments receiving human sewage and manure from 
livestock, it is possible that acquisition of AMR from a common AMR gene ‘pool’ 
can also play a role in the observed overlap. It might also be speculated that 
selection for AMR due to overlapping patterns of antimicrobial use in both 
human and livestock populations might explain the similarity in AMR gene 
communities. It was not possible to distinguish between hypotheses using the 
data in this study.   
The results of this study also indicate that AMR gene communities in livestock 
hosts are structured by the household scale whereas humans shared similar AMR 
genes outside the household confines quite frequently. In addition to the highly 
complex and interconnected food supply chains, humans often move between 
the sublocations enabling dispersal of AMR bacteria and AMR determinants 
across the fragmented urban landscapes. Conversely, livestock are more 
stationary, moving only very rarely between households themselves hence 
reducing the probability of AMR gene dispersal.  
I found that the AMR gene communities of humans keeping livestock were not 
different from those of people not keeping livestock. This contradicts previous 
investigations where animals that live with humans are seen as reservoirs of AMR 
(Jakobsen et al., 2010; Leverstein-van Hall et al., 2011; Lazarus et al., 2015) but in 
agreement with other studies that have found limited contribution of livestock to 
acquisition of AMR bacteria and AMR genes in humans (Ludden et al., 2019b; 
Nguyen et al., 2019). The finding that livestock keeping had no direct effect on 
levels or communities of AMR genes confirms the observed ubiquitous 
distribution of AMR genes in humans and livestock but does not provide evidence 
of transmission of AMR bacteria or genes between the two reservoirs. To 




investigate this further, I hypothesized that sharing would be associated with 
transmission via the same or highly related mobile genetic elements (MGEs) 
(discussed in detail in chapter 8).  
Conversely, my analysis suggest that AMR carriage in humans was instead 
influenced by livestock-keeping practices, in particular the presence animal 
manure in the household. The deposition of manure generated in livestock 
production systems into the environment is identified as a potential pathway for 
amplification and persistence of AMR determinants (Udikovic-Kolic et al., 2014; 
Graham et al., 2016). These genes often located on MGEs such as broad-host-
range plasmids have the potential to survive in soil, and thus potentially 
transferred to humans via cross-contamination pathways such as through 
exposed water and food (Binh et al., 2008; Huijbers et al., 2015a). However, the 
relative role of manured soils in the dissemination of AMR determinants to 
humans remains unknown and may still be highly underestimated (Baker et al., 
2016). This could have important implications for urban public health.  
By only sequencing a single E. coli isolate from each host, the within-host genetic 
diversity of E. coli was not considered in this study. Recent studies have revealed 
that in some bacteria is there is considerable within-host diversity and AMR 
mechanism diversity (Stoesser et al., 2015). In this study, the decision to sequence 
a single isolates from each host was made as a cost-based trade-off between the 
depth of sampling E. coli genetic diversity within each individual and the number 
of unique individuals from which samples could be included. It is possible this 
sampling bottleneck could have led to a signal being missed, but not changes to 
the outcome reported in this study. Assuming that each organism within a sample 
has equal chances of being isolated and cultured, arguably, by-isolate prevalence 
of AMR genes could reflect the AMR carriage in the sample most reliably. Future 
research could benefit from the recent development and use of metagenomics to 




characterise the abundance, diversity and structure of the acquired resistomes 
(Pehrsson et al., 2016; Munk et al., 2017; Munk et al., 2018).  
In this study not all possible sources of AMR E. coli or AMR determinants for 
humans were included (for example, wildlife, environment and importantly food 
of animal origin). Additional studies are required to determine the relative 
contribution of these possible sources of AMR E. coli or AMR determinants for 
humans. Crucially, the role of wildlife populations which are closely associated 
with human and livestock populations and might act as long-distance dispersers 
of AMR should be investigated further. Further studies are required to 
understand whether our findings will be reproduced in other geographical areas, 
and to investigate whether the noticed AMR carriage in both populations is 
transient or a more permanent colonization. 
Currently, AMR phenotypes are monitored routinely in most clinical settings; 
however, this study indicates that it also will be vital to perform active 
surveillance for AMR determinants in the community. Importantly, this study 
shows that genomic analysis of specific resistance markers can augment 
surveillance efforts of AMR bacteria and AMR genes circulating in different 
ecosystems and help to implement timely control strategies designed to mitigate 
risks to public health (Baker et al., 2018b).  
Most low-income settings in which humans and livestock live in close proximity 
are likely to present heightened, but to date poorly studied, risks for the evolution 
and transmission of AMR. By stepping outside of the ‘blame game’ of livestock, 
and medical systems, this study applying a ‘One Health’ approach demonstrates 
that AMR genes conferring AMR to critically important antimicrobials for both 
human and veterinary medicine are widespread in humans and livestock. Second, 
whilst I identified a high prevalence of shared AMR genes between livestock and 
humans and that human and livestock AMR gene communities were similar, I 
did not detect an association between livestock keeping and AMR gene numbers 




or composition in humans. Instead, the impact of keeping livestock on human 
AMR carriage was mediated by practices associated with livestock keeping, 
namely the presence or absence of animal manure in the household. Although 
this study demonstrated AMR gene similarity between human and livestock 
isolates, a combination of strong epidemiological designs, involving longitudinal 
studies with repeated sampling on the same individual or animal, and high-
resolution phylogeographic methods are still required to understand the exact 
direction of transmission. Taken together, this study serves as a model for the 
targeted sampling to harness the power of WGS for understanding the 
epidemiology of AMR across developing urban landscapes, a key in developing 
effective strategies to reduce the development and spread of such resistance in 
the future. 














Chapter 6  
Escherichia coli genetic diversity and 
sharing in co-habiting human and 





Is evolution a theory, a system, or a hypothesis? It is much more 
– it is a general postulate to which all theories, all hypotheses, 
all systems must henceforward bow and which they must satisfy 
in order to be thinkable and true. Evolution is a light which 
illuminates all facts, a trajectory which all lines of thought must 
follow – this is what evolution is 
Teilhard de Chardin, 1955 
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Chapter 6 Escherichia coli genetic diversity and 
sharing in co-habiting human and livestock 
populations in Nairobi, Kenya 
6.1 Abstract  
Livestock have been proposed as an important reservoir for bacterial infections 
that may spread to humans, but previous studies defining relatedness of E. coli 
isolates from livestock and humans have largely been based on typing 
methodology with poor discriminatory power. Here, I use high-resolution 
molecular epidemiology to explore the dynamics of bacterial sharing within and 
between co-habiting human and livestock populations sampled across 99 
households in Nairobi, Kenya, in an epidemiologically structured manner. A 
single E. coli isolate from 301 humans and 568 livestock was sequenced and 
epidemiological data recorded. 
Phylogenetic analysis demonstrated that human and livestock E. coli are highly 
genetically heterogeneous with minimal evidence of clustering by host group. 
Genetic comparison revealed 91 sharing events differing by less than ten base 
pairs, mostly confined within households with instances of spread between 
households. Of these, 59 involved livestock isolates only (mostly in poultry), 23 
human isolates only, and 9 between humans and livestock.  
The genetic analysis reveals evidence of bacterial sharing in human and livestock 
populations, including identification of putative human/livestock transmission. 
Using a ‘One Health’ approach this study provides an integrated evaluation of the 
molecular relatedness of bacteria from co-habiting human and livestock 
populations in a low resource urban settings. These results have significance for 
understanding the spread of bacteria (including AMR bacteria) as well as 
implications for the design of surveillance studies to capture their emergence. 
Future research should analyse the direction of bacterial transmission between 
human and livestock populations.  
 





Humans and livestock are linked in many ways including direct contact via close 
proximity, and shared environments receiving human and animal waste. This 
close degree of mixing and contact between livestock and humans creates 
epidemiological interfaces across which bacteria (including AMR bacteria) can 
pass in either direction (Hassell et al., 2017). However, there is little empirical 
evidence that directly links livestock ownership and the spread of bacteria to 
humans. Understanding the dynamics and processes of bacterial transmission 
between human and livestock populations can inform potential emergence of 
pathogens in urban environments.  
Current understanding of transmission of E. coli is complicated by the fact that 
surveillance studies have used different molecular typing approaches (Schürch 
and van Schaik, 2017). Of the these methods, MLST, based on 7 housekeeping 
genes, is the most widely used method as it is a relatively fast, accurate, and 
reproducible tool, which has enabled the creation of an unambiguous 
nomenclature for bacterial clones. However, sequence conservation in 
housekeeping genes limits its discriminatory power. Recent advances in 
sequencing technology, such as WGS, provide an unprecedented level of 
resolution to infer phylogenetic relatedness, thus identifying, possible or unlikely 
cases of epidemiological linkages of isolates (Baker et al., 2018b). Secondly, 
genomic studies of bacterial spread between humans and livestock have largely 
focused on developed countries with industrial agricultural systems (Gouliouris 
et al., 2018; Ludden et al., 2019b) and have often been subject to the limitations of 
opportunistic sampling with little spatiotemporal overlap between humans and 
livestock (Muloi et al., 2018).  
In this study, I utilise WGS of bacterial isolates obtained from co-habiting 
humans and livestock to elucidate patterns of bacterial strain sharing as a proxy 
for transmission potential. Specifically, the aims of the current study were to 
                 Chapter 6. Tracking bacterial sharing in an urban environment 
103 
investigate: (i) the genetic diversity of commensal E. coli strains, (ii) genomic 
relatedness of E. coli strains from humans and livestock, (iii) the contribution of 
livestock keeping to acquisition of new or more diverse E. coli strains. E. coli is 
found in both human and food animal populations, shares the same niche as 
enteric pathogens and is genetically diverse (Jaureguy et al., 2008; Tenaillon et 
al., 2010), hence in this study, E. coli was considered as an ideal organism to study 
the sharing of pathogens between human and livestock populations. I 
hypothesized that the close proximity and overlap between human and livestock 
populations in Nairobi, aided by the sharing of common environments, would 
result in similar E. coli profiles.  
6.2 Materials and methods 
Details on study design, sample collection, bacterial isolation, whole genome 
sequencing and bioinformatic analysis are presented in chapter 2. 
6.2.1 In silico phylogroup and MLST analysis  
In silico PCR was used to assign isolates to E. coli phylogroups A, B1, B2, C, D, E 
and F using the Clermont method (Clermont et al., 2013).  
In silico MLST was performed using the batch upload mode of the Centre for 
Genetic Epidemiology web interface hosted by the Technical University of 
Denmark (https://cge.cbs.dtu.dk/services/cge/) for multi-locus sequence typing 
(MLST) typing. MLST results were compared to results from ARIBA (Hunt et al., 
2017) using the PubMLST database (http://mlst.warwick.ac.uk/mlst/dbs/Ecoli) 
on the short reads to help resolve the novel sequence types in the data. 
Global optimal eBURST (goeBURST) algorithm (Francisco et al., 2009), as 
implemented in PHYLOViZ (http://goeBURST.phyloviz.net), was performed to 
characterise genetic relatedness of the isolates based on their allelic profiles (with 
respect to their number of locus variants), and to further infer simple patterns of 
evolutionary descent by constructing a minimum spanning tree (MST) from the 
eBURST data. Unknown STs were assigned unique temporary ST numbers, to 
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distinguish them from the STs in the database. Clonal complexes were defined as 
groups of closely related STs differing by no more than one allele from another 
member of the ST.  
6.2.2 SNP analysis  
Of 909 isolates, 40 were excluded from further analysis because of poor quality. 
For analysis of SNPs, the paired-end reads were mapped to the EC958 reference 
genome (GCA_000285655.3) and SNPs identified in the core gene alignment 
using Snippy v4.0, resulting in a final set of 184786 SNPs.  
6.2.3 Maximum-likelihood phylogenetic analysis 
Maximum likelihood (ML) core genome phylogenetic trees were built from the 
184786-SNP alignment of all 869 isolates using FastTree v2.1.10 (Price et al., 2010). 
In the absence of an obvious outgroup, phylogenies were rooted at the midpoint 
between the two most divergent taxa in the trees. All ML trees and associated 
metadata, such as sequence types (STs), host type, and phylogroups, were 
visualized in iToLv4.3 (Letunic and Bork, 2016). 
 
6.2.4 Identification of putative bacterial sharing 
A genetic distance matrix was calculated from all pairwise allelic profile 
comparisons and SNPs respectively, using the library “ape” in R (Paradis et al., 
2004). 
Epidemiological links between each pair of E. coli isolate were established 
through a systematic comparison. Household level sharing was categorised as: 
within household, if a sharing event involved isolates/hosts from the same 
household; between household, if a sharing event involved isolates in different 
household.  Selecting a SNP cutoff to define E. coli transmission clusters was 
informed by two criteria. First, examination of the distribution of genetic 
similarity between individual isolates, expressed as pairwise distances, revealed 
that 88% (74/84) of within-household sharing events with less than 100 pairwise 
SNPs differed by less of equal to 10 SNPs (Figure 6.1, Figure D1 in Appendix D). 
Second, given that the estimated mutation rate for E. coli is one SNP/core 
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genome/year (Stoesser et al., 2016), 10 SNPs were considered to represent possible 















Figure 6.1 Histogram of SNP pairwise distances between isolates with 
differences of 0-100 core genome SNPs. Isolates from the same household 
indicated in blue and those of different households isolates in grey. 
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6.3 Results  
A total of 869 genomes composed of 301 human and 568 livestock E. coli isolates 
in Nairobi, Kenya, were analysed. The number of isolates obtained from each 
source is presented in Table 6.1. 
Table 6.1. Number of human and livestock isolates collected from the 99 






6.3.1 Phylogroup distribution  
Most isolates were assigned to phylogroups B1 (n = 388, 45%) and A (n = 355, 41%). 
The remainder were distributed among phylogroups B2 (n = 50, 5.8%), D (29, 3.3 
%), E (n = 20, 2.3%), C (n = 11, 1.3%), and F (n = 16, 1.8%). When analysed by host, 
the distribution of phylogroups A, C, E and F did not significantly differ between 
human and livestock isolates. Phylogroups B2 and D were significantly more 
common among human isolates versus livestock isolates and phylogroup B1 was 
significantly more common in livestock (Figure 6.2a) (p<0.01, Bonferroni 
correction). The identified phylogroups were present in variable proportions 
across the different livestock groups (Figure 6.2b).  
 
 
Source  Frequency  % of isolates  
Human  301 34.7 
Livestock  568 65.3 
Poultry 295 34 
Goats 127 14.6 
Cattle 59  6.8 
Pigs 49  5.6 
Rabbits 38  4.4 
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6.3.2 MLST distribution 
The results from MLST indicated that the 301 human and 568 livestock isolates 
belonged to 296 different STs (Figure 6.3). No sequence type was assigned to 54 
isolates that carried at least one novel allele not included in the database. Of these 
54 isolates, 8.1% of poultry isolates (n=24), 6.1% of pig (n=3), 7.1% of goats (n=9), 
4.6% of human (n=14), 5.1% of bovine (n=3) and 2.6% of rabbits (n=1) had no 
assigned STs.  
Figure 6.2 Prevalence of 7 phylogroups in a) humans and livestock, b) humans 
and the different livestock groups. 
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Of the 296 identified STs, 78 (26%) were unique to humans, 163 (55%) to 
livestock, and 55 (18%) were found in both human and livestock isolates. The 
three most common STs associated with human isolates were ST10, ST155 and 
ST58, while the three most common STs associated with livestock were ST48, 
ST10 and ST297, although the distribution of STs varied depending on the 
livestock host. The greatest overlap in STs (absolute counts) between human and 
livestock isolates occurred in ST10 (12.2% and 7.2% of humans and livestock 
isolates, respectively), ST48 (2.4% and 8.3% of humans and livestock isolates, 
respectively) and ST155 (4.5% and 3.8% of humans and livestock isolates, 
respectively). Across all sequence types the distributions did not significantly 
differ between human and livestock isolates (p value >0.05 Fisher’s Exact test, 
adjusted for multiple testing). Notably, I identified 5 human isolates belonging to 
ST 131, a clinically relevant clonal group often associated with dissemination of 
CTX-M-15 class of ESBL gene.  
Figure 6.3 Distribution of multi locus sequence types by host group 
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As determined using goeBURST and a minimum spanning tree analysis (Figure 
6.4), the STs were grouped into 37 clonal complexes (CC), and 165 singletons 
(sequence types that did not cluster with any other published ST), indicating that 
eBURST might be unreliable in estimating relatedness in this largely diverse E. 
coli population. Two main subpopulations were identified, CC1 and CC2, 
predominantly associated with ST 48 and ST155 respectively. The two clonal 
complexes were mostly comprised of human and poultry isolates and accounted 




Figure 6.4 Minimum spanning tree reflecting clonal relationships of allelic profiles 
of a) 869 E.coli isolates and the two most common clonal complexes (CC1 and CC2) 
constructed using goeBURST. STs are symbolized by dots; the size of a dot 
corresponds to the number of isolates belonging to an ST (major clusters labelled). 
The colour of each circle represents the source of the strains belonging to that ST. 
Single locus variants (SLVs) are linked by solid lines. A clonal complex was defined 
as a group of STs that had ≥ 6 identical alleles. 
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6.3.3 Genetic differentiation of E. coli isolates from humans and 
livestock  
The key study objective was to determine the extent of genetic diversity of 
commensal bacteria from humans and livestock isolates. To do so, a maximum 
likelihood tree of the 301 human and 568 livestock genomes, based on 184,786 
SNPs in the core gene alignment, was constructed. This analysis revealed a 
diverse population of E. coli population (Figure 6.5) and that genomes from the 
two categories were intermixed and distributed across the phylogeny, with no 
evidence of clustering by host group. However, there was evidence of a highly 
related cluster of goat samples, perhaps denoting a specific goat clone/lineage 
(Figure 6.5). Isolates involved in this cluster were found in 12 different households 
and belonged to ST 297. 
Next, to gain insight into the allelic diversity among isolates within a sequence 
type (a commonly used method to infer relatedness), I analysed all pairwise SNP 
differences between isolates that belonged to sequence type 10 (found in 12.2% 
and 7.2% of humans and livestock isolates, respectively). Figure D2 in Appendix 
D shows a histogram of the 2628 pairwise allelic profile comparisons. This 
analysis revealed that just five pairs (<1% of comparisons) differed by less than 10 
SNPs and that the median pairwise distance was 2415 SNPs (range of 1 to 6686 
allelic differences), highlighting that most of these isolates were genetically 
diverse and genetically distant from each other. A visual comparison of isolates 
belonging to ST10 (Figure 6.5, outer ring, black colour) indicated that the some 
isolates were separated by long branches indicating deep evolutionary 














Figure 6.5 Maximum likelihood tree based on SNPs in the core genes of 869 E. coli isolates 
cultured from humans (n=301) and livestock (n=568). Coloured rings indicate, from the 
centre out, the host of each isolate and the most common sequence type. 
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6.3.4 Analysis of bacterial sharing of E. coli isolates within and between 
human and livestock species 
Pairwise SNP analysis identified 91 isolate pairs that differed by less than or equal 
to 10 SNPs. The estimated mutation rate for E. coli is one SNP/core genome/year 
(Stoesser et al., 2016), and so the 91 pairs were associated with recent transmission 
(up to 10 years) within or between human and livestock populations.  
To analyse and visualise the relatedness of E. coli strains within and between 
human and livestock populations, a network was developed for isolates classified 
as genetically related (less than or equal to 10 SNPs different, equivalent to 
approximately 10 years of evolution). Of the 91 isolate pairs that were closely 
related, 23 were within humans, 59 within livestock and 9 between humans and 
livestock. Evidence of E. coli relatedness between different livestock species, with 











Figure 6.6 Network analysis of E. coli isolates from humans and the different 
livestock populations. Lines are drawn between host groups sharing isolates 
less than ten SNPs, with arbitrary line lengths. Thickness of lines denotes 
number of sharing events. Numbers in nodes designate number of sharing 
within the host group. 
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Across the 99 study sites, I identified 42 (42.4%) households with at least one 
sharing event. Of the 42 households, 22 (52.4% of 42) households were involved 
in livestock-livestock transmission only, 8 (19%) human-human only, 5 (11%) both 
human-human and livestock-livestock, 4 (9.5%) human-livestock only, 2 (4.8%) 
both human-livestock and livestock-livestock, and 1 (2.3%) with both within hosts 
and between hosts sharing.  
Next I analysed whether the number of sharing events in a households was 
dependent on the number of samples collected. Two households (HAR011 and 
KYL027) had a sharing rate of more than 50% (number of sharing events as a 
function of number of samples collected). In HARO11, of 20 livestock samples 
collected, 12 (60% - 6 in poultry and 6 in rabbits) isolates were involved in a 
sharing event, and could be resolved into 2 clusters. Similarly, in KYL027, of 7 
human samples collected, 4 (57%) were involved in sharing and belonged to one 
cluster.   
6.3.4.1 Human-livestock sharing events  
The nine sharing events between humans and livestock could be resolved into 
eight transmission clusters, each involving between 2 and 4 isolates. Of the nine 
events, six involved poultry, one bovine, rabbit and goat respectively. No isolates 
from pigs were closely related to human isolates. Isolates in the 9 pairs belonged 
to seven different STs (ST10, ST48, ST6178, ST58, ST538 ST23 and ST206) and one 
unknown sequence type. Males were significantly more likely to be involved in 
human-livestock sharing that females (p=0.003, Fisher’s Exact test). Further, 6/9 
of persons involved in human-livestock sharing had direct contact with livestock 
through collecting eggs, slaughter, milking or handling manure, although not 
significantly significant (p=0.1, Fisher’s Exact test) (Table D1 in Appendix D). 
The sharing events occurred in 10 household, representing 10% of the sampled 
households. Of the 10 households with a sharing event, eight had livestock while 
two did not, hence the two transmission events happened with livestock from 
neighbouring households. Further, of the two between-household sharing events, 
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one human-poultry transmission occurred in households located in opposite 








6.3.4.2 Human-human sharing  
Overall, of 23 human-human sharing events with 0-10 SNPs identified in this 
dataset, three had 0 SNPs different, six had 1-3 SNPs, and 14 had 4-10 SNPs 
different. Further, the 23 sharing events could be resolved into 15 transmission 
clusters. Twenty-two sharing events involved ten different sequence types. No ST 
was assigned to isolates in one sharing event.  
ST678 was identified as the most common sequence involved in sharing (6 of 23 
pairs, 26.1%), followed by ST2531 and ST10 (both identified in 4 pairs, 17%). Two 
sharing events belonged to ST131. Other infrequent sequence types (found in one 
pair) identified included: ST1136, ST155, ST1611, ST210, ST216, and ST-69 (Figure 
6.8).  
 
Figure 6.7 Spatial distribution of the 10 households involved in human-
livestock clonal sharing. Arrows denote sharing events involving two separate 
households 





















Figure 6.8 Circular maximum-likelihood core-gene phylogenetic tree 
of E. coli isolates from humans only. Inner ring designates the human-
human sharing clusters. Phylogenetic tree was reconstructed based on 
153352 SNPs in the core genome. Outer ring designates the most 
common sequence types. 
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Across the 99 households, 15 households were involved in sharing with most of 
sharing (18 of the 23 related pairs, 78.2%) happening within households compared 









6.3.4.3 Livestock-livestock sharing  
Overall, of 59 livestock-livestock sharing events, three had 0 SNPs different, 19 
had 1-3 SNPs, and 137 had 4-10 SNPs different. In 52/59 (88%) of the related pairs, 
sharing happened within the same livestock species: poultry-poultry (22), goat-
goat (16), rabbit-rabbit (9), bovine-bovine (3) and pig-pig (2). The remaining 
seven pairs happened between different livestock species: poultry-goat (2), 
poultry-rabbit (3), goat-rabbit (1), and rabbit-bovine (1). 
Further, the sharing pairs involved 28 different sequence types, while isolates in 
two sharing events the sequence type could not be explicitly defined in silico. The 
most common STs involved in sharing were ST297 (7 of 59 pairs, 12%), ST 1196 
and ST 4568 (both identified in 6 pairs, 10% respectively) (Figure 6.10, Table D2 
in Appendix D).  
Figure 6.9 Spatial distribution of the 15 households involved in human-
human sharing. Arrows denote sharing events involving two separate 
households. 

















Figure 6.10 Circular maximum-likelihood core-gene phylogenetic 
tree of E. coli isolates from livestock. Inner ring designates the 
livestock-livestock sharing clusters. Phylogenetic tree was 
reconstructed based on 358449 SNPs in the core genome. Outer ring 
designates the most common sequence types. 
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In 50 (85%) of the 59 related pairs, sharing occurred within households while in 

















Figure 6.11 Spatial distribution of the 15 households involved in livestock - 
livestock sharing. Arrows denote sharing events involving two separate 
households. 
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6.3.5 Contribution of livestock keeping on diversity of E. coli in humans  
Here I compared the phylogeny of human isolates with respect to livestock 
keeping status. This demonstrated that genomes from the two categories were 
intermixed and distributed across the phylogeny, with no evidence of clustering 





Figure 6.12 Circular maximum-likelihood core-gene phylogenetic tree of E. 
coli isolates from humans. Phylogenetic tree was reconstructed based on 
153352 SNPs in the core genome. Inner ring designates the livestock keeping 
status. Outer ring designates the transmission clusters (<10 core SNPs).  
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6.4 Discussion 
This analysis demonstrates how bacterial whole genome sequencing analysis 
explicitly embedded within an epidemiologically structured sampling framework 
can be utilized to investigate the genetic relatedness of E. coli from sympatric 
livestock and humans in a low resource urban setting.  
The diversity of E. coli in this study was consistent with previous studies (Musicha 
et al., 2017; Richter et al., 2018; Ludden et al., 2019b) and that, ST10, ST155 and 
ST48 were the predominant STs. STs 10 and 48 are also the most widespread and 
diverse within MLST, suggesting long periods of carriage. Five human isolates 
were found to carry the globally significant clone ST131 with plasmid mediated 
AMR mechanisms including blaCTX-M-15 and aac(6')Ib-cr conferring an ESBL and 
fluoroquinolone resistance phenotype respectively (Coque et al., 2008b). This ST 
is classed as “high-risk” owing to accumulated AMR and proven transmission 
potential (Johnston et al., 2010).   
It is interesting to note that 18% of STs were found in both human and livestock, 
with the greatest overlap happening in the most common STs. Previous studies 
that compared isolates from human and livestock sources using MLST indicated 
that there was evidence of clonal sharing (Leverstein-van Hall et al., 2011; 
Willemsen et al., 2012; Hu et al., 2013). Analysis of ST10 but using the more 
discriminatory sequence based analysis indicated that isolates from the two 
reservoirs were genetically distinct (median pairwise SNPs 2415). Similarly, 
analysis of the population structure of E. coli using goeBURST and phylogroups 
revealed that the same clonal complex or phylogroup could be found in both 
human and livestock isolates. These routinely used methods offer advantages in 
the characterization of acute outbreaks, but their application is limited in non-
epidemic situations, in which population structure is more diffuse (Turrientes et 
al., 2014).  
With respect to population structure, there was no evidence of phylogenetic 
clustering between human and livestock isolates, suggesting that specific 
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commensal E. coli lineages are, in general, not restricted to either human or 
livestock hosts. This distribution of isolates across both population groups 
contrast recent studies that indicate that human and livestock isolates are 
genetically distinct (Ludden et al., 2019b; Nguyen et al., 2019). Conversely, this 
results indicate a closely related lineage of goat E. coli isolates belonging to ST297 
and found in 12 households suggesting that the lineage is highly mobile between 
households, a finding of note for veterinary agencies. It is unclear what factors 
contribute to the epidemiological success of this clone as the households 
belonged to independent farmers and not co-located. I speculate that the 
different farms bought goats from a common source or that the goats shared a 
great-great-grandmother, with the potential for vertical transmission. 
Across the analysed isolates, I detected 91 pairs of E. coli isolates that differed by 
less than 10 pairwise SNP distance based on core gene alignment suggesting 
sharing within approximately the last ten years within/between these reservoirs. 
Of the 91 pairs, 82 were within hosts (human-human and livestock-livestock) and 
nine between human and livestock. Although most (8/9) of the human-livestock 
sharing events happened in households keeping livestock and that increased 
contact with livestock was a “risk factor” for sharing, one sharing event happened 
between livestock and a human not keeping livestock nor with livestock contact. 
I cannot make direct comparison between the sharing events as this analysis did 
not incorporate the differential sampling effort which has a direct impact on 
detection of bacterial sharing. Whilst the frequency of bacterial sharing between 
humans and livestock was low compared to within host sharing, given the high 
number of livestock keeping farms in Urban Nairobi (Alarcon et al., 2017), the 
cumulative burden of bacterial exchange between humans and livestock in the 
community should not be underestimated. 
Within-household sharing was high when compared to between-households and 
may in part be a result of the greater epidemiological connectivity of human and 
livestock populations at the household level thus facilitating exchange of 
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bacteria. Despite the evidence for transmission of E. coli between households, the 
exact mechanism of cross-transmission remains to be established. I speculate that 
the between-households transmission is probably explained by human/livestock 
movement, interconnected food supply chains across the city or dispersal of 
bacterial by peri-domestic wildlife particularly wild birds.  
I found that the bacterial community assemblage did not, generally, vary between 
humans who kept livestock and those who did not. Given the extent of diversity 
identified in human and livestock populations and that isolates from both 
populations were intermixed across the phylogeny I hypothesise that there would 
be minimal evidence of clustering by livestock ownership. Analysis within specific 
lineages or clonal complexes would be required to disentangle the complex 
relationship of livestock ownership and acquisition of bacterial clones in humans. 
Considering the extent of within-host diversity in commensal E. coli by only 
sequencing a single isolate from each host, it is possible this sampling bottleneck 
could have underestimated the sharing events hence inadequate to rule out 
transmission (Stoesser et al., 2015). The decision to sequence a single isolates from 
each host was made as a cost-based trade-off between the depth of sampling E. 
coli genetic diversity within each individual and the number of unique individuals 
from which samples could be included. This situation may be less pronounced in 
clinical settings where endemic circulation of one “outbreak” clone may be more 
likely.  
I underscore the potential role played by other ecological compartments in 
driving sharing of bacterial strains within and between human and livestock 
populations. For instance, peri-domestic wildlife and food of animal origin could 
play a pivotal role in dispersing bacteria across the fragment urban landscapes. In 
addition, the cross-sectional study design precludes any inferences on the 
dynamics of bacterial sharing between humans and livestock across Nairobi, 
hence longitudinal studies are required to understand whether bacterial sharing 
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within and between host populations is transient or a more permanent 
colonization.  
In conclusion, the combination of whole genome sequencing and detailed 
epidemiological analysis has revealed an extensive diversity of commensal E. coli 
and evidence of recent sharing of E. coli lineages between and within sympatric 
human and livestock populations. Detection of dissemination of AMR genes 
independently of host strain rather than sharing of the strain together with the 
plasmid highlights the need to incorporate plasmid transmission analysis in 
studies of antimicrobial resistance epidemiology. This study does not, and is not 
intended to, address the question of directionality of bacterial sharing, in 
particular human/livestock sharing. To achieve this, future research should 
consider the synergy between longitudinal sampling of human and animal 
populations (over time and space), and phylogeographic inferences to investigate 
host-switching events between humans and livestock hosts (Richardson et al., 
2018).  
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The time may come when penicillin can be bought by anyone in 
the shops. Then there is the danger that the ignorant man may 
easily underdose himself and by exposing his microbes to non-
lethal quantities of the drug make them resistant 
Alexander Fleming, 1945 




Chapter 7 A cross-sectional survey of practices and 
knowledge among antimicrobial retailers in Nairobi, 
Kenya 
7.1 Abstract  
AMR driven by antimicrobial consumption is a growing global health threat. 
However, data on antimicrobial consumption patterns in LMICs is sparse. Here, 
I investigate the patterns of antimicrobial sales in humans and livestock in urban 
Nairobi, Kenya, and evaluate the level of awareness and common behaviours 
related to antimicrobial use and AMR amongst human and veterinary 
pharmacists.  
A total of 40 human and 19 veterinary drug store pharmacists were interviewed 
in Nairobi in 2018 using a standard questionnaire. Data recorded included 
demographic variables, types of antimicrobials sold, antimicrobial customers, 
antimicrobial prescribing practices and knowledge of antimicrobial use and 
AMR.  
This study shows that at the retail level, there is a considerable overlap between 
antimicrobial classes (10/15) sold for use in both human and veterinary medicine.  
Whilst in this study, clinical training significantly influenced knowledge on issues 
related to antimicrobial use and AMR and respondents had a relatively adequate 
level of knowledge about AMR, several inappropriate prescribing practices were 
identified. For example, most veterinary and human drug stores (100% and 52% 
respectively) sold antimicrobials without a prescription and noted that customer 
preference was an important factor when prescribing antimicrobials in half of the 
drug stores.  
Although more research is needed to understand the drivers of antimicrobial 
consumption in both human and animal populations, these findings highlight the 
need for immediate strategies to improve prescribing practices across the 
pharmacists in Nairobi and by extension other LMIC country settings.  




7.2 Introduction  
As in most cities in LMICs, in urban Nairobi the high incidence of bacterial 
diseases and antimicrobial resistance in clinical medicine is a major public health 
challenge (Makobe et al., 2012). In both human and animal populations, 
antimicrobials are used for both prophylaxis and treatment of infectious diseases 
and many of the antimicrobials used to treat these infectious diseases are 
pharmacologically similar. It is estimated that more than half of all antimicrobials 
(for use in both humans and animals) are purchased without a prescription and 
used over-the-counter (Brent et al., 2006). There is a paucity of data in Kenya 
regarding antimicrobial usage at both the national and the regional level, but 
there have been attempts to assess the consumption of antimicrobials in food 
producing animals and human health using sales data (Okeke et al., 2005). These 
studies, based on antimicrobial import data, estimate that, from 1997-2001, 
consumption of antimicrobials in clinical medicine increased by 4%, with 
penicillins and fluoroquinolones being the most widely used antimicrobials. 
Collecting data on antimicrobial use simultaneously in both animals and humans 
could provide essential data to help disentangle the primary drivers for the 
development of antimicrobial resistance. Here, I carried out a survey to 
investigate the patterns of antimicrobial sales in humans and animals in urban 
Nairobi.  
Pharmacists (both human and veterinary) play a pivotal role in enhancing 
antimicrobial stewardship initiatives, not just by highlighting the AMR problem, 
but also by influencing crucial prescribing decisions (Broom et al., 2015; Sakeena 
et al., 2018). To further improve antimicrobial use and antimicrobial stewardship 
programmes it is important to have an understanding of the knowledge and 
attitudes towards antimicrobials within different populations such as 
pharmacists. At present, there has been limited research in understanding 
pharmacists’ knowledge of antimicrobial resistance. Here, I aimed to assess the 




level of awareness and common behaviours related to antimicrobial prescribing 
amongst human and veterinary pharmacists.  
7.3 Materials and methods  
7.3.1 Study design and setting  
Within each of the pre-selected 33 sub-locations described in chapter 2 two 
community drug stores – one veterinary drug store and one human drug store – 
were randomly selected and visited. The final distribution of sampled human and 









Community human drug stores are mostly operated by pharmaceutical 
technicians who are responsible for dispensing antimicrobials, while only a few, 
mostly large, drug stores have a registered pharmacist (holding a bachelor’s 
degree in pharmacy). Both pharmaceutical technicians and pharmacists are able 
to sell, but not prescribe antimicrobials in Kenya (Aywak et al., 2017). Veterinary 
drugs stores are mostly operated by animal health technicians (also referred to as 
para-veterinarians) with just a few operated by veterinarians. Animal health 
Figure 7.1. Map of Nairobi county indicating locations of study sites. 




technicians are also not allowed to prescribe antimicrobials. All of the above-
mentioned groups will have obtained clinical/veterinary training at varying 
levels. In this study, ‘pharmacist’ was defined as someone selling antimicrobials 
in a veterinary or a human drug store irrespective of the level of clinical training.  
A draft of the questionnaire was pre-tested with five drug stores (three human 
and two veterinary), and refined on basis of the feedback from the pre-testing 
sessions before final dissemination. In each drug store a detailed questionnaire 
was used to collect data on socio-demographic variables, training on 
antimicrobial use, types of antimicrobials sold (by class), the four antimicrobial 
classes most commonly sold, variation in antimicrobial sales, antimicrobial 
sources, antimicrobial customer characteristics, and antimicrobial prescribing 
practices. A summary of the collected data is presented in Table E1 in Appendix 
E. To assess the knowledge of antimicrobial use and AMR amongst the human 
and veterinary pharmacists a standard questionnaire prepared and used by the 
World Health Organization was adapted (WHO, 2015a). First, I assessed 
respondents’ knowledge on a number of terms routinely used to describe the 
problem of antimicrobial resistance. These terms included:  antibiotic resistance, 
superbugs, antimicrobial resistance, AMR, drug resistance and antibiotic-
resistant bacteria. Next, respondents were asked about their level of agreement 
with ten statements describing their knowledge on AMR and potential solutions 
to antimicrobial resistance. The statements were written on a 5 point Likert scale 








7.3.2 Data analysis 
Descriptive statistics were prepared for all data including frequencies and 
percentages for categorical variables (e.g., gender and education level) and 
means, medians, standard deviations (SDs), quartiles, and ranges for quantitative 
variables (e.g., number of customers) depending on the distribution of the data. 
A chi-square or Fisher's exact test using R package stats (Team, 2013) was used to 
describe differences between proportions of clinical training (present or absent) 
by type of drug store (human or veterinary) and Mann-Whitney U test to compare 
range of antimicrobials (number of different antimicrobial classes) in the two 
types of drug stores.  
7.3.3 Prescribing practices 
Next, I aimed to describe practices and evaluate the factors associated with drug 
prescribing amongst human and veterinary pharmacists. To achieve this, I 
collected data on information provided to customers after purchasing 
antimicrobials as an indicator of good prescribing practices. This included: 
whether pharmacists provided customers with information on dosage, directions 
for use (i.e. completing the prescribed dose), storage instructions, side effects, 
expiry date and contra-indications (De Vries et al., 1994). The data were then 
assessed for multicollinearity using the corrplot package (Wei and Simko, 2013) 
in R to determine if answers to any two or more questions were correlated. There 
did not appear to be a sufficiently strong correlation between any two questions 
for any of them to be excluded. To derive a measure of prescribing practices 
amongst the respondents a composite score (sum of the binary variables, 0/1) 
from individual indicators of good prescribing practices was developed. I fitted a 
generalized linear model (GLM) using R package lme4 (Bates et al., 2014) to assess 
possible influence of type of drug store (human/veterinary), clinical/veterinary 
training (present or absent), education level (high or low) and range of 
antimicrobials sold (number of different antimicrobial classes) in the drug store 
(proxy for store size) on the composite prescribing practices score.  Clinical/vet 




training (defined as having a degree or diploma in clinical or veterinary medicine) 
and education level were analysed separately as some pharmacists had received 
training in disciplines not related to medicine or veterinary studies. P<0·05 was 
considered statistically significant. 
7.3.4 Knowledge on antimicrobial resistance  
In order to assess the internal consistency of the ten statements evaluating the 
level of knowledge on AMR, Cronbach’s alpha coefficients were calculated for 
each statement. Internal consistency is a measure of item-total correlations and 
reliability of the scale, thus describing the extent to which all items in a test 
measure the same concept or construct (Tavakol and Dennick, 2011). An 
unstandardized Cronbach’s alpha coefficient of 0.7 or above was considered to 
demonstrate adequate reliability. 
Principal Component Analysis using polychoric correlation (Holgado–Tello et al., 
2008) was used to generate a composite index for knowledge score and to 
investigate clustering of the knowledge statements (Krishnan, 2010). Analyses 
were performed using the psych package (Revelle, 2017) to conduct PCA (using 
the principal function) without rotation of axes. Scree plot inspection (Cattell, 
1966) and parallel analysis (Cota et al., 1993) were used to choose the optimal 
model in terms of number of components to retain (Figure E1 in Appendix E, 
Table E2 in Appendix E).  
The scores of the first PCA component were used as measure of knowledge of 
AMR, and the higher the knowledge score, the higher the implied knowledge of 
AMR of that respondent. A generalised linear model was used to investigate the 
possible influence of type of drug store (human or veterinary), clinical training 
(present or absent), education level (high or low), and range of antimicrobials 
sold in the drug store (proxy for store size) on the level of knowledge of AMR.  
 




7.4   Results  
7.4.1 Demographic data about the respondents  
A total of 59 participants were interviewed – 40 from human drug stores and 19 
from veterinary drug stores (Table 7.1). Some sub-locations did not have a 
veterinary drug store as these tend to be located in zones of the city where 
animals are kept. The median age of participants in both human and veterinary 
stores was 30 years (range; human, 21-51; livestock, 19-67 years). More than two 
thirds of participants interviewed in both stores were employees (human, 73% 
and veterinary, 74%), and the remainder were store owners. Significantly more 
human pharmacists (90%) than veterinary pharmacists (57%) had undergone 
some form of clinical training (P=0.01, Fisher’s exact test). Additionally, for 
participants who underwent clinical training, professional development 
programmes/trainings aimed at continuing education in AMR were an important 
source of information on antimicrobial stewardship (human pharmacists, 50%; 
and veterinary pharmacists, 41%).  
Table 7.1. Participant demographics and baseline clinical characteristics. 
Variable  Human drug stores 
Veterinary drug 
stores 
Number individuals   40 (67%) 19 (33%) 
Gender Female  21 (52.5%) 9 (47.4%) 
 Male 19 (47.5%) 10 (52.6%) 
Highest education level Primary  0 1 (5.2%) 
 Secondary  4 (10%) 5 (26.3%) 
 Certificate  4 (10%) 5 (26.3%) 
 Diploma  24 (60%) 7 (36.8%) 
 Degree  8 (20%) 1 (5.3%) 
Role  Owner  11 (27.5%) 5 (26.3%) 
 Worker 29 (72.5%) 14 (73.7) 
Age (Median)  30 30 
Clinical/veterinary 
training 
Present  36 (90%) 11 (57%) 
 None  4 (10%) 8 (42.1%) 
Source of training on 
antimicrobial 
stewardship and AMR 
Clinical training 
only  
16 (40%) 3 (15.8%) 
 CPD* 20 (50%) 8 (41.1%) 
 None  4 (10%) 8 (42.1%) 
                                              * Continuing professional development  




7.4.2 Antimicrobials available for sale  
A total of 15 antimicrobial classes were available for sale in either or both human 
and veterinary drug stores (Figure 7.2). Two thirds of the antimicrobial classes 
(10/15) were available in both human and veterinary drug stores while five classes 
(metronidazole, amphenicols, lincosamides, glycopeptides and carbapenems) 
were only available in human drug stores. Of the ten overlapping antimicrobial 
classes, β-lactam/penicillin, tetracycline, sulfonamide, and macrolide 
antimicrobial classes were found in more than 78% of both types of drug stores. 
Of note, carbapenems, third and fourth generation-cephalosporins and 
glycopeptides – antimicrobials restricted to clinical use – were available in 15%, 
4% and 3% of human drug stores respectively. Overall, human drug stores had a 
broader range of antimicrobials available for sale when compared to veterinary 



























Penicillins, metronidazole, fluoroquinolones, and first and second-generation 
cephalosporins were reported as being amongst the four most commonly sold 
antimicrobial classes by the human drug stores in 93%, 65%, 63%, and 43% of the 
stores respectively. However, among the veterinary drug stores, tetracyclines, 
sulfonamides, penicillins and macrolides were reported to be amongst the four 
most commonly sold antimicrobial classes in 79%, 74%, 58%, and 47% of the 
stores respectively. Tetracyclines and sulfonamides were reported to be amongst 
the four most commonly purchased antimicrobial classes by poultry farmers in 
79% and 90% of the veterinary drug stores respectively. The antimicrobial colistin 
Figure 7.2. Proportion of the 15 antibiotic classes reported in human (n=40) 
and/or veterinary drug stores (n=19). Data arranged in order of the average 
proportion of antibiotic classes. 
 




was described as being commonly purchased by poultry farmers in 16% of the 
drugs stores. Sulfonamides, tetracyclines and penicillins were reported to be 
amongst the four most commonly purchased antimicrobial classes by dairy 
farmers in 63%, 47% and 52% of drug stores respectively. In 11% of the veterinary 
drug stores, dairy farmers reportedly purchased first and second-generation 
cephalosporin intra-mammary tubes to treat mastitis cases. The antimicrobials 
reported to be amongst the four most commonly purchased antimicrobial classes 
by pig farmers were penicillins, macrolides and sulphonamides in 37%, 16% and 












Figure 7.3. Proportion of drug stores reporting the most commonly purchased 
antibiotics by different types of farmers based on the primary animal on the 
farm.  




Fifty eight percent of human and 42% of veterinary drug stores reported a rise in 
antimicrobial sales compared to the same period a year earlier. Increased 
customer demand for antimicrobials was the main driver by 80% and 60% of 
human and veterinary pharmacists respectively. Wholesale operations (defined 
as companies that buy drugs in bulk and sell them in smaller quantities to drug 
stores) were reported as the main provider of antimicrobials to human drug 
stores (78%). Conversely, distribution companies (defined as corporations that 
purchase drugs from pharmaceutical companies, store and subsequently 
distribute to drug stores) were reported as the main provider of antimicrobials to 
veterinary drug stores (58%).  
7.4.3 Antimicrobial customer characteristics 
The average daily number of customers purchasing antimicrobials was not 
significantly different (p=0.2; Mann-Whitney U test) between human drug stores 
(25 customers, range 2 - 130) and veterinary drug stores (14 customers, range 2 - 
113).  
Antimicrobials were reportedly prescribed frequently for respiratory tract 
infections, gastro-intestinal infections, and sore throat in 83%, 65% and 58% of 
human drug stores respectively. Additional prescriptions were linked to fever, 
body aches, and skin wounds in 38%, 35% and 13% of human drug stores 
respectively.  
Poultry farmers and veterinary para-professionals were the most frequent buyers 
of antimicrobials, being reported as customers in 95% and 74% of the veterinary 
drug stores respectively. Other customers for antimicrobials included: dairy 
farmers, veterinarians, pig farmers, rabbit famers, and beef farmers in 63%, 58%, 
47%, 37%, and 11% of stores.   




7.4.4 Knowledge of antimicrobial resistance  
More than two-thirds of the respondents in both stores types were aware of the 
terms ‘antibiotic resistance’ and ‘drug resistance’. By contrast, fewer than half of 












More than three quarters of the respondents in both store types agreed that the 
prevalence of drug resistant infections was increasing, and if left unchecked 
routine medical and surgical procedures would become a much riskier 
proposition. Likewise, more than 79% in both types of stores recognised that 
AMR is a problem, and has the potential to affect any country and anyone, 
including them and/or their families. However, most respondents (>80%) 
believed that AMR occurs when their body becomes resistant to antimicrobials 
rather than the bacteria themselves that develop resistance. Similarly, 40% and 
Figure 7.4. Terms used to describe antimicrobial resistance 




53% of human and veterinary respondents respectively suggested that AMR is 
only a problem for regular consumers of antimicrobials. More than half (52%) of 
the respondents interviewed responded neutrally or disagreed with the statement 
that antimicrobial resistant bacteria could be spread from person to person 
(Table E3 and Figure E2 in Appendix E).  
7.4.5 Association between sociodemographic factors and knowledge on 
AMR 
Cronbach’s alpha coefficient for the ten “knowledge statements” was 0.74, 
suggesting an acceptable level of internal consistency and a potential underlying 
latent construct (Table S2 and Figure S1 in the Online Supplementary Document). 
The knowledge score (knowledge about AMR) of the respondents had significant 
positive association with medical/veterinary training (P=0.02), meaning 
respondents with clinical training had a higher knowledge about AMR than those 
who had not undergone such training. The level of knowledge about AMR did 
not differ by store type, education level or range of antimicrobials available in the 
store (p > 0.05) (Table 7.2).   
Table 7.2. Results of a multivariable regression examining the influence of 
sociodemographic factors on knowledge about AMR in a sample of 40 and 19 
human and veterinary drug stores respectively. 
Variable  Estimate Standard 
error  
X2 df p-value 
Veterinary drug store 0.07 0.02 0.3 1 0.59 
Range of 
antimicrobials 
-0.01 0.02 0.31 1 0.58 
Clinical/veterinary 
training  
0.3 0.14 4.86 1 0.02 
High education level  0.04 0.12 0.13 1 0.72 
 
 




7.4.6 Knowledge and views on potential solutions to AMR 
More than 80% of respondents in both store types agreed that people should use 
antimicrobials only when prescribed by a medical practitioner. Also, more than 
two thirds of respondents in both store types agreed that reducing antimicrobial 
use in food animals could help address the problem of antimicrobial resistance. 
In both store types, respondents agreed on the need for governments and 
pharmaceutical companies to invest in research and development of new 
antimicrobials. More than 84% of all respondents agreed that everyone should 
use antimicrobials prudently, but more than 73% of respondents thought that 
medical experts would solve the problem of antimicrobial resistance. Hand 
washing and vaccination of children against infections were supported by more 
than 94% of respondents in both store types. However, 38% and 26% of 
respondents in human and veterinary drug stores agreed that there was not much 
they could do to stop antimicrobial resistance (Table E4 and Figure E3 in 
Appendix E).  
7.4.7 Antimicrobial prescribing practices 
Fifty-two per-cent (21/40) of the human drug stores reported that they sold 
antimicrobials without a prescription while all veterinary drug stores sold 
antimicrobials without a prescription. Multivariable logistic regression analysis 
revealed prescribing practices did not vary significantly by clinical training, store 
type, range of antimicrobials sold and/or education level (P>0.05) (Table E5 in 
Appendix E).  
Across both human and veterinary drug stores, the most important factor for 
prescribing antimicrobials was indication of use – based on symptoms – (in 
>75% of the stores) , followed by price of the antimicrobial (in >50% of the 
stores). Of note, 28% and 31% of human and veterinary pharmacists respectively 
considered customer preference as an important factor when prescribing an 
antimicrobial. 





In this study I aimed to investigate the patterns of antimicrobial sales in humans 
and animals in a large and rapidly developing city in a LMIC: Nairobi, Kenya. I 
also evaluated the level of awareness and common behaviours related to 
antimicrobial use and AMR amongst human and veterinary pharmacists. This 
study was based on gathering data on antimicrobials stocked in human and 
veterinary drug stores across the city, where antimicrobial sales were interpreted 
as representing antimicrobial usage.  
This study shows considerable overlap in the antimicrobial classes (10/15) sold for 
human and animal use in urban Nairobi, with marked variations in the sale of 
some antimicrobial classes such as cephalosporins and fluoroquinolones – mostly 
found in human drug stores. This overlap in antimicrobial classes, including of 
critically important antimicrobials (WHO, 2017a), highlights the need for 
prudent use of all antimicrobials and continued monitoring and surveillance of 
antimicrobial usage in LMIC urban settings (Morgan et al., 2011)  
The most common symptoms prompting antimicrobial purchase in humans were 
similar to those reported in other studies, respiratory tract infections and 
diarrhoeal disease (Okeke et al., 2005; Feikin et al., 2011; Omulo et al., 2017). Broad 
spectrum β-lactams, fluoroquinolones, first and second generation 
cephalosporins and metronidazole were the most commonly sold/bought 
antimicrobials in human drug stores. This finding is consistent with antimicrobial 
prescription in the community in previous Kenyan studies (Omulo et al., 2017; 
Mukokinya et al., 2018), in other low income countries such as Uganda (Mbonye 
et al., 2016), Tanzania (Horumpende et al., 2018a), India (Gandra et al., 2017) and 
in high income countries such as United Kingdom (Smith et al., 2018) and the 
USA (Durkin et al., 2018). The finding that WHO-classified highest priority 
critically important antimicrobial classes such as carbapenems, third and fourth 
generation cephalosporins, and glycopeptides were sold over the counter and 




potentially without prescription in human drugs stores is of public health 
concern.  
In the current study, tetracyclines, sulphonamides, penicillins, and macrolides 
were the most commonly purchased veterinary antimicrobials and poultry 
farmers were the major consumers of antimicrobials. Further, my findings 
indicate that colistin – a drug considered of last resort in human medicine (Liu et 
al., 2015) – was the antimicrobial of choice amongst poultry farmers in 16% of 
veterinary drug stores, as has been found in previous studies in other parts of the 
world (Carrique‐Mas et al., 2015; Gondam Kamini et al., 2016; Wongsuvan et al., 
2018). Urban livestock are increasingly important, particularly among the low and 
middle income population bracket in most low resource urban settings 
(Satterthwaite et al., 2010; McCarron et al., 2015), and antimicrobial usage is a low-
cost alternative for comprehensive hygiene and biosafety measures (Robinson et 
al., 2016b).  
Knowledge about antimicrobial resistance among pharmacists has only been 
studied to a limited extent in LMICs (Wilkinson et al., 2018). Consistent with a 
recent multi-country survey by the World Health Organization (WHO, 2015a) 
this survey found that, whilst the majority of the pharmacists have an 
understanding of the problem of antimicrobial resistance and the effect(s) on 
public health, they do not fully understand how AMR develops and spreads. 
Encouragingly, the majority of respondents (>80%) identified several behaviours 
that can help reduce AMR burden; such as handwashing, antimicrobial 
stewardship by both doctors and the public, and ensuring children’s vaccinations 
are up-to-date. However, considering their key role in antimicrobial stewardship, 
the finding that 38% and 26% of human and veterinary pharmacists agreed there 
was little they could do to stop AMR highlights the need for enhanced 
involvement of pharmacists in antimicrobial stewardship programs.  




Whilst the majority of the pharmacists interviewed have an understanding of the 
threat posed by AMR to public health, these data highlight the poor quality of 
community pharmacy practice, most notably the dispensing of antimicrobials 
without prescriptions and the inclusion of customer preference as an important 
factor when selling antimicrobials. Antimicrobials were dispensed without 
prescription in 53% and 100% of the human and veterinary drug stores 
respectively; a finding consistent with similar studies in Tanzania (92.3%) 
(Horumpende et al., 2018b), Serbia (47.2%) (Horvat et al., 2017), Ghana (70%) 
(Donkor et al., 2012), and broadly across the developing world (19-100%) (Morgan 
et al., 2011). By contrast, a recent study conducted in community pharmacies in 
Nairobi reported low sale of antimicrobials without prescription (Mukokinya et 
al., 2018). Part of this difference, however, may be related to the fact that in that 
study, information was based on just three pharmacies hence not generalizable 
across the city. In this study, whilst clinical training significantly influenced 
knowledge on issues related to antimicrobial use and AMR, prescribing practices 
did not change with levels of clinical training. Considering the complexity of 
factors contributing to antimicrobial prescribing, including the public’s demand 
for antimicrobials, behavioural and policy interventions could be explored 
(Meeker et al., 2016). Because many members of the public in most LMICs bypass 
healthcare facilities and veterinarians in favour of seeking medication at 
pharmacies, policy makers could consider expanding the role of pharmacists in 
antimicrobial stewardship initiatives (Wickens et al., 2013; Ministry of Health, 
2017).  
Restating the particular relevance of training to antimicrobial stewardship 
measures, the role of enhanced training in antimicrobial prescribing and AMR 
has been identified in surveys of both medical personnel and the public, both in 
Kenya and globally (Goff et al., 2017). Results from a recent survey indicate that 
only 14.1% of clinicians in a national referral and teaching hospital in Kenya had 
received more than four lectures on antimicrobial stewardship and AMR as part 




of their medical training (Genga et al., 2017). To address this challenge, 
antimicrobial stewardship needs to be integrated in the undergraduate 
veterinary/medical curriculums and continuing medical/veterinary education 
programs.  
Similar to other studies (WHO, 2015; Sadiq et al., 2018), this findings indicate 
greater familiarity amongst human and veterinary pharmacists with ‘antibiotic 
resistance’ and ‘drug resistance’ terminologies, and minimal familiarity with 
‘AMR’ and ‘superbugs’. This indicates that public health initiatives on 
antimicrobial stewardship and/or antimicrobial resistance initiatives need to take 
an evidence-based approach in designing effective communication strategies 
(Wellcome Trust, 2015; WHO, 2015b).  
This is the first study designed to capture the overlapping patterns of 
antimicrobial sales in humans and livestock in a developing city via an 
epidemiologically-structured approach. A variety of approaches are available for 
assessing patterns of antimicrobial use in humans and animals (Queenan et al., 
2017). Considering that pharmacies are the primary level of outpatient/veterinary 
care (consultation, diagnosis, and prescription of antimicrobials) for many urban 
dwellers in Nairobi, focusing on them provides important insights into the 
probable antimicrobial usage patterns at the consumer level. Future research 
would benefit from conducting longitudinal surveys of antimicrobial use in 
healthcare facilities and the community to better assess trends over time. While, 
I acknowledge that this study used a relatively small sample size (19 and 40 
veterinary and human drug stores respectively), there was minimal heterogeneity 
in the results obtained. It is important to highlight that although extrapolating 
antimicrobial consumption from sales data is not ideal, and care will be required 
when interpreting these results, various other studies have shown that relying on 
sales data is of direct relevance for initiatives aimed at monitoring global and 
national antimicrobial patterns (Moulin et al., 2008; Nga et al., 2014). Although 




this study focused on pharmacists in urban Nairobi, these results are likely to be 
relevant to many other developing cities across the world with large income 
disparity and where livestock are commonly kept in close contact with humans. 
7.6 Conclusions 
Monitoring and surveillance of antimicrobial use in LMICs is challenging, but 
vital, as it provides valuable information for public health policy. This study 
shows that at the retail level in urban Nairobi, there is a considerable overlap 
between antimicrobial classes available for use in both human and veterinary 
medicine. Whilst the majority of human and veterinary pharmacists showed high 
knowledge about antimicrobial use and antimicrobial resistance, inappropriate 
prescribing practices were noted, highlighting the need for continued education 
to the pharmacists and the public, about prudent antimicrobial prescribing and 
use. Although further research is necessary to understand the drivers of 
antimicrobial consumption in both populations, it is clear that interventions are 
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Everything is connected to everything else – There is one ecosphere 
for all living organisms and what affects one, affects all.  
Barry Commoner, 1971 
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Chapter 8 Co-occurrence patterns of antimicrobial 
resistance genes and distribution of plasmids in E. 
coli isolates 
8.1 Abstract  
HGT of AMR determinants, often located on plasmids, is considered to be the 
main reason for the rapid proliferation and spread of AMR. Here, I investigate the 
co-occurrence patterns of acquired AMR genes and the role of conjugative 
plasmids on the epidemiology of AMR spread in E. coli isolates from sympatric 
humans (n=315) and livestock (n=594) from 99 households across Nairobi. 
These results indicate that in both human and livestock isolates AMR genes were 
frequently co-located, potentially enabling the acquisition and spread of multi-
drug resistance in a single step. The most commonly co-occurring AMR genes 
were those encoding resistance against aminoglycosides (strA, strB) and 
sulfonamides (sul2), and were dispersed across the bacteria phylogeny suggesting 
they are potentially exchanged across both human and animal populations 
independent of bacterial transmission. Screening all isolates for plasmid replicon 
types revealed 31 different plasmid types present in similar proportions in human 
and livestock isolates with the exception of colBS512, IncB/O/K/Z and p0111, 
IncHI1B, more common in humans and livestock respectively. ColRNAI, IncFII, 
and IncFIB, plasmids were the most common (>40%) plasmid replicons 
identified, and the carriage of plasmid replicons did not differ by host group. AMR 
genes were significantly associated with plasmid replicons, specifically the strA, 
strB, sul2 AMR gene cluster and the ColRNAI, IncQ1 and p0111 plasmid types.  
Taken together, by integrating genomic analyses on a large collection of bacterial 
isolates, I show evidence of AMR gene connections that are potentially co-
transferred on conjugative plasmids. These findings provide insights into the co-
distribution of plasmid types and AMR genes transmission in E. coli in cohabiting 
human and livestock living community settings in a developing city landscape.  
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8.2 Introduction  
HGT in bacteria leads to acquisition of AMR genes from the ‘mobile gene pool’, 
which can then be vertically propagated (Baker et al., 2018a). This aids a rapid 
evolutionary adaptation of bacterial pathogens to novel ecological niches, such 
as new hosts, without the reliance upon rare beneficial mutations arising from 
spontaneous mutation in bacterial populations (Jain et al., 2003).  
The importance of HGT in the current global AMR crisis is exemplified by the 
rapid global dissemination of AMR genes in both clinical and community setting. 
Studies suggest that this has happened for extended spectrum β-lactamase 
encoding blaCTX-M genes, carbapenemase-encoding blaNDM-1 gene and colistin 
encoding mcr-1 gene (Cantón et al., 2012; Johnson and Woodford, 2013; Wang et 
al., 2018).  Crucially, horizontal spread of AMR genes among bacteria by 
conjugative plasmids shape the evolution and spread of resistant ‘superbugs’ – a 
serious public health threat (San Millan, 2018). Evidence of HGT of AMR genes 
(such as identical plasmids in bacterial species within and between different host 
groups) would be enhanced by strong epidemiological data, however these 
datasets are lacking.  
E. coli is an ideal model for studying the role of HGT owing to its open pan-
genome (Lukjancenko et al., 2010) and that it is a commensal in both animals and 
humans. Urban Nairobi, a rapidly developing city, is an ideal place to analyse 
understand the impact of HGT in the emergence of antimicrobial resistant 
bacteria in cohabiting human and livestock populations. Improved genomic 
analysis based on whole genome sequencing provides an unprecedented level of 
resolution useful in understanding how and where AMR genes spread across 
different host populations or niches.  
Using WGS, here, I investigate; (i) the co-occurrence of resistance genes, allowing 
me to identify combinations of genes, and (ii) the role of conjugative plasmids on 
the epidemiology of AMR spread in E. coli isolates obtained from sympatric 
humans and livestock from 99 households across Nairobi. I investigate the 
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hypothesis that the constant exchange of AMR genes within and between human 
and livestock populations is aided by HGT.  
Tracking the genetic context of AMR using targeted sampling and the power of 
WGS will contribute substantially to the understanding of the mechanistic basis 
of resistance and its dissemination, and by extension the epidemiology of AMR 
across developing urban landscapes.  
8.3 Material and methods 
Details on study design, sample collection, bacterial isolation, whole genome 
sequencing and bioinformatic analysis are presented in chapter 2.  
8.3.1 Co-occurrence network of acquired resistance genes 
Two approaches were taken to assess relationships among pairs of acquired AMR 
genes. First, co-occurrence patterns among pairs of acquired AMR genes based 
on presence/absence data were assessed with the probabilistic approach of Veech 
(Veech, 2013) with the ‘cooccur’ package (Griffith et al., 2016). When the 
probability that two AMR genes would co-occur more or less frequently than 
observed, if distributed randomly, was < 0.05, that AMR gene pair was considered 
to have significant positive or negative co-occurrence, respectively. The model 
calculates the expected frequency of co‐occurrence between each pair of AMR 
genes based on the distribution of one AMR gene being independent of the 
second one. It then compares the expected frequency to the observed frequency 
and returns the probability that a lower or higher value of co‐occurrence could 
have been obtained by chance.  
Second, for a subset of AMR gene pairs found to have significant positive co-
occurrence a network analysis of co-occurring AMR genes was visualized using 
igraph package in R (Csardi and Nepusz, 2006). Attributable fractions were used 
to quantify the relationship between the strA, strB, sul2 gene cluster and the 
proportion of tetA gene using the package epiR (Stevenson et al., 2013).  
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8.3.2 Role of mobile genetic elements in transmission of AMR genes 
Considering the high prevalence of MDR carriage in the isolates (chapter 4), I 
hypothesised that that this was due to the co-transfer of groups of AMR genes via 
mobile elements, in particular plasmids. However, determining the genetic 
context of resistance genes from de novo assemblies from short-read sequencing 
technologies, such as those offered by the Illumina is difficult, because plasmids 
often contain repeat sequences thus introducing assembly ambiguity (Orlek et 
al., 2017). Instead, I used plasmid replicon typing as an indicator of plasmid load 
and diversity. Plasmid replicons as defined in the PlasmidFinder database were 
identified from read data via the Center for Genomic Epidemiology batch upload 
platform (identity ≥90%, coverage ≥60%) (Carattoli et al., 2014).  
Additionally, I investigated the potential role of previously identified plasmids 
associated with the most frequent AMR gene cluster (strA, strB and sul2) in 
carriage and dispersal of AMR genes in these isolates. Following recent evidence 
of two plasmids (pCERC1 and pCERC2 (Anantham and Hall, 2012)) associated 
with MDR in E. coli obtained from human samples in sub-Saharan Africa (Ingle 
et al., 2018), including Kenya, I investigated the E. coli genomes to evaluate 
whether the plasmids and AMR genes were mobilised together. The genetic 
contexts of the AMR genes (strA, strB and sul2) were explored in detail via manual 
inspection of the SPAdes assembly graphs using Bandage’s (Wick et al., 2015) 
integrated BLAST search (McGinnis and Madden, 2004). For isolates that had the 
plasmid and the AMR genes located on the same contig I inferred that those genes 
were moving together on a plasmid. Associations between AMR gene clusters and 
the two plasmids (pCERC1 and pCERC2) were calculated using Chi Squared tests 
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8.3.3 Plasmid carriage by host types 
The Mann–Whitney U test was used to compare the carriage of plasmid replicons 
between humans and livestock. For comparisons of more than two groups, the 
Kruskal–Wallis test was applied, and statistical differences were corrected for a 
multiple comparison test using the Bonferroni correction. P values of <0.05 were 
considered significant. 
8.3.4 Procrustes analyses  
To investigate the effect of plasmid replicon types on the distribution of acquired 
AMR genes, I used Procrustes analysis (Jackson, 1995). The AMR genes matrix 
and plasmid replicon matrix were Hellinger transformed and Jaccard 
dissimilarities were calculated in R package Vegan (Oksanen et al., 2015). Each 
dissimilarity matrix was ordinated using Principal Coordinates Analysis (PCoA) 
using the vegan function ‘betadisper’ in Vegan (Oksanen et al., 2015). The 
symmetric Procrustes correlation coefficients between the plasmid replicon and 
the acquired AMR gene ordinations, were obtained using the ‘protest’ function in 
Vegan.  
8.3.5  Visualization of AMR gene clusters and plasmid genotypes 
against a core gene tree 
The presence of AMR gene clusters, pCERC-like plasmids and plasmid replicons 
was plotted as a heatmap against the core genome SNP phylogeny generated in 
chapter 6 using the plotTree function https://github.com/katholt/plotTree#r-
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8.4 Results 
A total of 909 isolates composed of 315 human and 594 livestock isolates (Table 
5.1) were whole genome sequenced and screened for known acquired AMR genes.  
8.4.1 Antimicrobial resistance genes characterisation  
As reported in chapter five, 60 acquired genes known to confer resistance to 9 
antimicrobial classes were detected across all isolates at varying abundances. The 
most common AMR genes were, sul2 (46%), strA (41.1%), strB (41.1%), tetA 
(38.3%), and blaTEM-1B (25%) conferring resistance to sulphonamides, 
aminoglycosides, tetracyclines and β-lactams respectively.  
8.4.2 AMR gene co-occurrence analysis  
Probabilistic modelling of acquired AMR genes co‐occurrence revealed instances 
of positive (AMR genes co‐occur significantly more frequently than expected), 
negative (AMR genes co‐occur significantly less frequently than expected), and 
random AMR genes associations (observed frequency of co‐occurrence does not 
significantly depart from expected) (Figure 8.1). Just 264 (14.9%) of the 1770 total 
AMR gene pair comparisons yielded statistically significant co-occurrence, 
comprising 243 (13.7%) positive, and 21 (1.2%) negative. 1506 (85.1%) AMR gene 


















8.4.3 Network analysis 
Next, using a co-occurrence network analysis, the most common gene network 
comprised of strA, strB and sul2 AMR genes. This cluster co-occurred in 366 
isolates (40.2%): 155 (49.2%) humans, and 211 (35.5%) livestock – 138 (43.9%) 
poultry, 16 (26.2%) bovines, 25 (50%) pigs, 27 (21.1%) goats and 5 (12.2%) rabbits. 
The strA, strB and sul2 cluster was significantly more likely to be found in human 
than livestock isolates (X2 = 8.5, p= 0.003, Chi-squared test). Further, the AMR 
gene combination significantly co-occurred with tetA in 255 (28.1%) isolates (X2 
= 259.51, p<0.001, Chi-squared test), with blaTEM-1B in 190 isolates (21.1%), and with 
the combination of tetA and blaTEM-1B in 144 (15.8%) isolates (Figure 8.2).  
Figure 8.1. Heatmap visualisation showing pairwise associations calculated 
according to the probability co‐occurrence model for 60 acquired AMR genes. 
Significant positive (negative) associations are displayed where AMR genes co‐
occurred more (less) frequently than by chance, with an alpha threshold of 0.05. 
Each tick on the x- and y-axes refers to an AMR gene.   
                 Chapter 8. Co-occurrence patterns of resistance genes 
152 
AMR genes making up cluster 1 (strA, strB, sul2) and cluster 2a (strA, strB, sul2, 
tetA) were more likely to be found in their respective clusters than outside of it. 
Conversely, all genes involved in clusters 2b and 3, except blaTEM-1B, were more 
likely to be found outside the cluster than in it (Table 8.2). Next, I investigated 
how the presence of strA, strB, sul2 genes accounted for the presence of tetA 
(cluster 2a) and blaTEM-1B (cluster 2b). I found that 76% and 86.7% of tetA and 
blaTEM-1B occurrences respectively were attributable to strA, strB, sul2 genes.  
Table 8.1. Proportion of the AMR genes occurring as part of the three clusters. 
                          *strA and strB co-occur always 
 
 






Cluster 2b ( 
strA, strB, sul2, 
blaTEM-1B ) 
Cluster 3 
(strA, strB, sul2, 
tetA, blaTEM-1B ) 
strA* 96.3 % 67.1% 50% 37.9% 
strB* 96.3% 67.1% 50% 37.9% 
sul2 86.5% 60.3% 44.9% 34% 
tetA - 73.9% - 41.7% 
blaTEM-1B - - 83.7% 63.4% 
Figure 8.2. The network analysis revealing the statistically significant AMR co-
occurrence patterns among human and livestock E.coli isolates.  
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8.4.4 Investigation of mobile genetic elements associated with transfer 
of AMR genes 
As reconstructing the genetic context of acquired AMR genes is generally not 
possible using short-read sequence data, I analysed the distribution of two 
plasmids (pCERC1 and pCERC2) previously found to mobilize the strA, strB, sul2 
gene cluster (Ingle et al., 2018). The combination of genes in cluster 1 and the 
pCERC1 plasmid was found in 62 (6.8%) isolates (p<0.001, Fisher’s Exact Test) – 
21 (6.7%) human and 41 (6.9%) livestock isolates:  35 (11%) poultry, 3 (4.9%) 
bovines, 1 (0.8%) goat, 1 (2.4%) rabbit and 1 (2%) pig respectively. The 
combination of the cluster 1 genes and the pCERC2 plasmid was found in 27 
(2.9%) isolates (p<0.001, Fisher’s Exact Test) – 14 (4.4%) human and 13 (2.2%) 
livestock isolates: 8 (2.5%) poultry, 2 (3.3%) bovines and 3 (6%) pigs. The 
combination of cluster 1 and both plasmids (pCERC1 and pCERC2) was found in 
just 6 isolates – 3 (1%) human and 3 (0.5%) livestock. The occurrence of the 
pCERC-like plasmids together with AMR genes in either cluster 2 (a and b) or 
cluster 3 was infrequent (less than 2%). Next, I tested the hypothesis that the strA, 
strB, sul2 gene cluster could occur independently of the two plasmids. This 
analysis indicated that the 3 gene cluster remained significant in the absence of 
the two plasmids (p<0.01, Fisher Exact Test). 
I further examined the distribution of the AMR gene clusters and the pCERC 
plasmids on the bacterial core genome phylogeny. Overall, my results revealed 
that the AMR gene clusters and the pCERC plasmids were interspersed across the 

























Figure 8.3. Maximum likelihood tree based on SNPs in the core genes of  E. coli 
isolates cultured from humans and livestock annotated with host (red, human; 
blue, livestock), AMR gene clusters (cluster 1 - strA, strB, sul2; cluster 2a - strA, 
strB, sul2, tetA; cluster 2b - strA, strB, sul2, blaTEM-1B ; cluster 3 - strA, strB, sul2, 
tetA, blaTEM-1B ), pCERC1 plasmid and pCERC2 plasmid.  
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In some genomes, the plasmid sequences could be fully resolved, indicating the 
location of the AMR gene clusters (Figure 8.4). For example, E. coli isolates 
TMP021231 carried a dfrA14 gene within a strA, strB, sul2 cluster on a pCERC1 










Figure 8.4. Assembly graph for two E. coli isolates, TMP021231 and TMP018919, 
indicating the AMR gene arrangement in (a) pCERC1 and (b) pCERC2 plasmids 
previously found in E. coli isolates. Colour blocks indicate BLAST hits to AMR genes 
as labelled. Assembly graphs were visualised in Bandage. 
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8.4.5 Distribution of plasmid replicons 
Screening against PlasmidFinder revealed 31 plasmid replicon types in 831/909 
(91.4%) E. coli isolates. The most common plasmid type across all isolates were 
ColRNAI (59.8%), IncFII (44.5%) and IncFIB (43.6%) (Figure 8.5). The remaining 
replicon types were found in ≤15% of the genomes. The distribution of 26/31 
(83.4%) replicons did not differ by host, with the exceptions being ColBS512, 
IncB/O/K/Z and IncQ1, which were significantly more common in humans than 
in livestock and p0111 and IncHI1B more common in livestock than in humans 
(p<0.01,Fisher Exact Test).  
Figure 8.5. Distribution of plasmid replicons in 315 humans and 594 
livestock E. coli isolates. 
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8.4.6 Carriage of plasmid replicons by host 
Overall, the mean plasmid carriage was three unique matching plasmid replicons 
identified per isolate, however, carriage did not significantly differ between 
human (mean 3.08) and livestock (mean 2.81) isolates (p>0.05, Man-Whitney U 
test) (Figure 8.6a). Similarly, when compared to the different livestock groups, 
human carriage of replicon types was not significantly different from poultry, 
pigs, bovines and goats (p>0.05, Kruskal Wallis, Bonferroni correction). 
Conversely, human isolates had a higher carriage when compared to rabbit 
isolates (p=0.008, Kruskal Wallis, Bonferroni correction) (Figure 8.6b).  
More than one replicon type was found in 698 (76.7%) isolates, and in 289 of 
these isolates a combination of replicon types IncFIB and IncFII was detected – 










Figure 8.6. Number of plasmid replicons per isolate in a) humans and 
livestock, b) humans and the different livestock groups. P values were 
calculated using the Wilcoxon test and Kruskal Wallis. Numbers indicate 
plasmid replicon diversity within each group. 
a) b) 
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8.4.7 Association of plasmid replicons with AMR genes and sequence 
types 
Procrustes analysis was used to investigate whether plasmid replicons correlated 
with the AMR gene composition based on the PCoA of both the AMR genes and 
plasmid replicons. The analysis revealed that the AMR gene distribution 
correlated significantly with the plasmid replicon composition, (P = 0.001, 999 
permutations, although with low correlation coefficients (correlation: 0.33)). 
Hence, isolates with similar plasmid replicon compositions tended to have 
similar AMR gene compositions. Procrustes analyses, however, cannot illustrate 
the detailed relations between the specific AMR genes and plasmid replicons. 
Analysis of the distribution of AMR among plasmid replicon types indicated that 
the majority of the AMR genes co-occurred with ColRNAI, IncFII, IncFIB, IncQ1 
and p0111 plasmids (Figure 8.7, Table F1 in Appendix F), and that IncFII and IncFIB 
replicons were associated with the same AMR genes, suggesting that these two 
replicons were potentially on one plasmid. The strA, strB, sul2 AMR gene cluster 
(and with tetA) was significantly associated with ColRNAI, IncQ1 and p0111 


















Figure 8.7. A heatmap illustration of associations between plasmid replicon 
and acquired AMR genes. Different colours represents the strength of the 
relationship: blue/green - strong, yellow - weak, grey - no association. The 
scale bar at the right indicates the strength of the associations. 
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Analysing the association between sequence types and the most common 
plasmids replicons (present in at least 10 isolates), my results suggest that, overall, 
plasmid backbones were associated with a variety of sequence types. The three 
most common replicon types (ColRNAI, IncFII and IncFIB) appeared to be 
strongly associated with the most common sequence types (ST48, ST155, and 
ST10) (Figure F1 in Appendix F). Mapping plasmid replicons on the core genome 
phylogeny revealed that plasmid types were intermixed and widely distributed 















Figure 8.8. Maximum likelihood tree based on SNPs in the core genes of 
E. coli isolates cultured from humans and livestock annotated with host 
(red, human; blue, livestock), and plasmid replicon types (plasmid 
replicon columns: green, present; white, absent).  
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8.5 Discussion 
In this study, I investigated the patterns of AMR gene co-occurrence and the 
distribution of conjugative plasmids. The results provide insight into the role of 
HGT on the dissemination of acquired AMR genes across host populations.  
In agreement with my data relating to a tetracycline-sulfonamide-trimethoprim 
cluster in the AMR phenotypes (chapter 4), the AMR gene co-occurrence analysis 
revealed clusters conferring resistance to the three antimicrobial classes, and in 
addition to β-lactams and aminoglycosides. The AMR gene clusters were 
ubiquitous across both human and animal isolates highlighting widespread 
dispersal across both populations. The strA, strB, sul2 gene cluster (and in 
combination with other genes) has been identified in previous studies (Yau et al., 
2010; Wang et al., 2015; Ingle et al., 2018), and its distribution is likely to be 
attributed to, (i) co-selection for resistance to the commonly used 
aminoglycosides and sulfonamides in both human and animal medicine in 
Nairobi (chapter 7), (ii) maintenance of the gene cluster in the E. coli population 
by a conjugative element. I could not distinguish between hypotheses using this 
data. Further, the AMR gene clusters were distributed across phylogenetically 
diverse isolates and involved multiple sequence types indicating that they have 
become widely established and persistent within E. coli populations favoured by 
selective pressures. 
In this study, determining the genetic context of resistance genes and the linked 
mobile genetic elements from the short-read sequence data was not possible. 
However, there was evidence of pCERC-like plasmids (pCERC1 and pCERC2) 
which encode resistance genes mainly to aminoglycosides, sulphonamides, 
trimethoprim, and infrequently to other antimicrobial classes. The pCERC-like 
plasmids, have been reported in E. coli and Salmonella spp. in many countries 
including Kenya (Anantham and Hall, 2012; Ingle et al., 2018), indicating a global 
distribution. The strA, strB, sul2 gene cluster was significantly associated with the 
pCERC-like plasmids, however, the gene cluster remained significant even in the 
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absence of the two plasmids. This suggests that the two plasmids did not fully 
account for the AMR gene clustering, but instead, other mobile genetics elements 
such as integrons and transposons could be playing an additional role in the 
occurrence of the gene cluster. In particular, the transposon Tn6029 has been 
identified in previous studies to be playing an important role in the dissemination 
of the sul2, strA, strB gene cluster (Chowdhury et al., 2015; Ingle et al., 2018). This 
finding is a proof of principle for the association between gene clusters and 
specific plasmids. However, it does not provide a comprehensive explanation for 
the clustering observed, most of which seems unrelated to those two plasmids. 
In agreement with a previous study in Tanzania (Madoshi et al., 2016), in this 
study, ColRNAI and IncF (IncFII, IncFIB) replicons were the most abundant 
plasmid types in both human and livestock E. coli isolates. ColRNAI, IncF (IncFII, 
IncFIB) replicons encoding multiple antimicrobial resistance genes have been 
reported widely in E. coli and other Enterobacteriaceae from human and animal 
samples (Carattoli, 2009; Carattoli et al., 2014; Carroll et al., 2017; Mohsin et al., 
2017). Further, the association between AMR genes and plasmid replicons 
reported in this study, specifically the strA, strB, sul2 AMR gene cluster and 
ColRNAI, IncQ1 and p0111, does suggest that plasmids may have a key role in 
harbouring and disseminating AMR genes. The occurrence of these ubiquitous 
AMR-plasmids may be linked to positive selection exerted by the high 
antimicrobial use in both human and animal populations across the urban 
landscape and are potentially frequent disseminated across both host groups.  
Despite the common use of replicon typing in characterising plasmids, a major 
shortcoming of replicon typing is that individual plasmids can contain multiple 
replicons, complicating classification, and that it inherently misses new plasmid 
types (Orlek et al., 2017). To fully characterise the genetic context of AMR genes, 
further research using long-read sequencing could resolve plasmid structures 
(George et al., 2017).  
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In this study I investigated the potential role of horizontal gene transfer in E. coli 
isolates from epidemiologically linked human and livestock populations. 
Screening of all bacterial genomes revealed clinically relevant connections 
between resistance genes, widespread in both human and animal populations. 
The AMR gene connections detected here were associated with previously 
described plasmids (pCERC1 and pCERC2) and plasmid replicons (proxy for 
conjugative plasmids) suggesting the existence of a reservoir of resistance genes 
that is highly mobile. Co-located AMR genes, pCERC-like plasmids and plasmid 
replicons were ubiquitous and dispersed across the bacterial phylogeny 
suggesting they are potentially exchanged across both human and animal 
populations independent of bacterial transmission. Future studies investigating 
the driving factors associated with accessory gene cassettes transfer and plasmid 
spreading will contribute substantially to the understanding of the mechanistic 
basis of resistance and its dissemination. 








Chapter 9  












Antoine Magnan, a French zoologist, in 1934 made some very 
careful studies of bumblebee flight and came to the conclusion 
that bumblebees cannot fly at all! Fortunately, the bumblebees 
never heard this bit of news and so went on flying as usual 
Ross E. Hutchins, 1968 




Chapter 9   Thesis summary and discussion 
Increasing levels of antimicrobial resistance represent a public health and 
economic threat on a global scale (WHO, 2015b), and the role of livestock in the 
rising levels of AMR bacteria has been the subject of much speculation. The 
interplay of AMR transmission between people and livestock is likely to be most 
evident in LMICs where humans and livestock are linked in many ways including 
direct contact due to close proximity, and shared environments receiving human 
and animal waste. The links between human and livestock populations provide 
an opportunity for either population to act as a reservoir from which AMR 
bacteria and/or their AMR determinants could be transmitted in either direction 
(Woolhouse et al., 2015; Robinson et al., 2016a). Livestock have been implicated 
as a reservoir for AMR bacteria and AMR genes that may spread to humans, with 
the keeping of livestock posited as a risk factor for AMR in humans. However, the 
relative contribution of livestock to AMR carriage among humans remains to be 
elucidated (Muloi et al., 2018).  
Previous understanding of transmission of AMR bacteria and/or AMR 
determinants relied on low resolution typing tools and most studies have been 
limited by opportunistic sampling with little spatiotemporal overlap between 
humans and livestock. High-resolution analysis of bacterial genomes obtained 
from co-habiting humans and livestock using phylogenetic and ecological 
methods can help to shed light on important questions on direction and 
frequency of AMR transmission between humans and livestock. In this thesis, I 
used the ubiquitous E. coli as a marker to investigate the role of livestock keeping 
as a potentially high-risk urban interface for AMR transmission between humans 
and livestock in Nairobi, Kenya. The main hypothesis was that there is an 
epidemiologically significant spillover of AMR bacteria and AMR determinants 
from livestock to human populations.  




In the following paragraphs, I will provide a summary of the key results of this 
thesis and discuss how they contribute to answering the main questions of this 
thesis. Further, I will discuss how such findings relate with current knowledge of 
AMR transmission and the broader implications of these results to epidemiology, 
animal, public and ecosystem health. Lastly, I will highlight the questions raised 
by this thesis and provide suggestions for the direction of future work before 
drawing the thesis to a conclusion.  
9.1 Review of evidence supporting/refuting transmission of AMR 
bacteria from livestock to humans 
In chapter three, I analysed the available evidence on the role of livestock as a 
source of resistant E. coli and their AMR determinants in humans and 
systematically reviewed the kinds of evidence used to support, or refute, the 
transfer of AMR bacteria to humans. I demonstrated that whilst eight (18%, n=45) 
studies describe transmission of AMR from livestock to humans, robust 
conclusions on the directionality of transmission are limited by study 
methodologies. The eight studies suggesting to provide evidence of directional 
transmission of AMR were broadly similar to 25 studies that suggested only 
overlap of resistance between the two populations. This finding provide evidence 
that demonstration of similarity of AMR bacteria or AMR determinants does not, 
by itself, provide evidence of directionality of transfer. Further, this analysis 
demonstrated that current understanding of AMR transmission is complicated 
by that fact that AMR studies have used different approaches, varying in the (i) 
resolution of phenotypic/molecular methods used to characterise strains, (ii) 
antimicrobials tested, and (iii) sampling frames and data collection approaches. 
In the discussion section, I highlighted major recommendations for future studies 
investigating the direction and frequency of AMR between human and livestock 
populations. Importantly, and in line with the rest of my thesis, I recommended 
the use of high resolution genomics methods on human and livestock bacterial 




isolates collected in time and space in an epidemiologically-structured 
framework.  
9.2 Antimicrobial resistance carriage at a community level 
In chapters 4 and 5, utilising AMR phenotypes and genotypes respectively, I 
explored the variation in carriage of AMR E. coli between human and livestock 
populations, and investigated the role of livestock ownership as a risk factor for 
AMR carriage in humans. Chapter 4 focused on the epidemiology of clinically 
relevant AMR phenotypes in humans and urban livestock. 633 livestock and 321 
human E. coli isolates were tested for susceptibility to 13 antimicrobial drugs 
representing 9 antimicrobial classes. Prevalence of resistance to sulfonamides, 
trimethoprim, tetracyclines, and aminoglycoside was consistently higher (>40% 
of resistant isolates) than that to other tested antimicrobials across both human 
and livestock isolates, and 47.6% and 21.1% of isolates displayed resistance to ≥ 3 
and ≥5 antimicrobial classes respectively. Human, poultry and pigs had the 
highest prevalence of AMR E. coli carriage compared to goats, rabbits and cattle. 
At household interfaces, exchange of AMR between humans was influenced by 
human density, and the presence of livestock manure, but not livestock keeping 
by itself. I found evidence of a co-occurring phenotype (conferring resistance to 
tetracycline, sulfonamide and trimethoprim antimicrobial classes) common in 
both human and livestock isolates, suggestive of a conjugative plasmid 
disseminating MDR within the E. coli population in the host groups.  
In chapter 5, I genomically characterized the carriage, diversity and assemblages 
of AMR genes within commensal E. coli populations from humans and livestock. 
By screening AMR genes, I detected 60 different acquired genes and 14 point 
mutations associated with reduced antimicrobial susceptibility present in 
variable proportions in human and livestock isolates. sul2, strA, strB, tetA, and 
blaTEM-1B AMR genes, conferring resistance to sulphonamides, aminoglycosides, 
tetracyclines and β-lactams respectively, were the most common AMR genes 




across both host groups. Most (64/74, 86.5%) of the genes were found in similar 
proportions in both humans and livestock while the remainder (10/74, 13.5%) 
were significantly more common in human than in livestock isolates. Highest 
AMR gene carriage was observed in humans, pigs and poultry compared to 
rabbits, goats and bovines. However, AMR gene assemblages did not differ by 
host type or household location. Analysing the potential drivers of variation in 
AMR gene carriage in humans, I demonstrate that presence of livestock in the 
household did not influence AMR gene carriage in humans, but human AMR 
gene carriage was instead influenced by presence of animal manure in the 
household. 
9.3 Tracking bacterial sharing in co-habiting humans and livestock  
In chapter 6, I used high resolution genetic data to characterise E. coli 
populations, and to elucidate patterns of strain sharing as a proxy for 
transmission potential. Phylogenetic analysis of core genome demonstrated that 
livestock and patient isolates were genetically heterogeneous, with minimal 
evidence of clustering by host group, and as such my results suggest that E. coli 
is circulated widely between human and livestock populations. Genomic 
comparison of isolates revealed 91 sharing events differing by less than ten base 
pairs (59 involving livestock isolates only (mostly in poultry), 23 human isolates 
only, and 9 between humans and livestock). As a likely point of contact, hence an 
opportunity for bacterial transmission, I found evidence that, most of the sharing 
events were confined within households with instances of spread between 
households. By comparing the population structure of the human E. coli genomes 
with respect to livestock keeping status this thesis demonstrated that E. coli core 
genomes in humans did not segregate according to livestock ownership. Further, 
I demonstrated that high-resolution sequence-based analysis of SNPs is more 
discriminatory than MLST in typing of bacteria, in particular between commensal 
strains which have a high genetic diversity.  




9.4 Antimicrobial usage patterns  
Chapter 7 describes a survey I undertook to investigate the patterns of 
antimicrobials available for sale in urban Nairobi, as a proxy for antimicrobial 
usage in human and livestock populations. I found evidence of overlap in 
antimicrobial classes, including of critically important antimicrobials, available 
for use in human and veterinary medicine, with noticeable variations in the sale 
of some antimicrobial classes. Broad spectrum β-lactams, fluoroquinolones, first 
and second generation cephalosporins, and metronidazole were the most 
commonly purchased human antimicrobials while tetracyclines, sulphonamides, 
penicillins, and macrolides were the most commonly purchased veterinary 
antimicrobials. Colistin – a drug considered of last resort in human medicine – 
was an antimicrobial of choice amongst poultry farmers in 16% of veterinary drug 
stores. Analysing the level of awareness and common behaviours related to 
antimicrobial prescribing amongst human and veterinary pharmacists, I found 
that whilst most pharmacists showed high knowledge about antimicrobial use 
and AMR, inappropriate prescribing practices were common. In addition, over 
the counter sale of antimicrobials, without a prescription, was a common 
occurrence in both human veterinary drug stores.  
9.5 Co-occurrence patterns of antimicrobial resistance genes 
In chapter 8, I analysed the patterns of AMR gene co-occurrence and the 
distribution of conjugative plasmids in E. coli isolates from humans and livestock. 
I found evidence of a co-occurring AMR gene cluster comprised of strA, strB, and 
sul2 genes frequently co-located with tetA, blaTEM-1B and dfrA1 genes conferring 
resistance to aminoglycoside, sulfonamide, tetracycline, β-lactams and 
trimethoprim antimicrobial classes respectively.  This co-location of multiple 
AMR genes, often on dispersive elements such as plasmids and transposons, 
enables acquisition and dissemination of multi-drug resistance phenotypes in a 
single step. I demonstrate evidence that two previously described plasmids 
(pCERC1 and pCERC2) were significantly associated with the co-located AMR 




genes. Screening of plasmid replicons, I found 31 plasmid replicons distributed in 
similar proportions in human and livestock isolates, with the exception of 
colBS512 and IncB/O/K/Z significantly more common in humans, and p0111 and 
IncHI1B plasmids more common in livestock. Plasmid replicon carriage per 
isolate did not differ between human and livestock populations. I found evidence 
that AMR gene distribution was significantly correlated with the plasmid replicon 
composition, in particular, the ColRNAI, IncQ1 and p0111 plasmid backbones were 
significantly associated with carriage of the strA, strB, sul2 AMR gene cluster.  
9.6 Implications of this thesis 
Results of this thesis have implication on the epidemiology of bacteria and AMR 
transmission between human and livestock populations and practical relevance 
to public and animal health. In the following section, I will discuss the how the 
results presented in this thesis fits with current literature and how the 
conclusions and limitations of the thesis highlight important areas for future 
work.  
9.6.1 Expanded genomic approaches to further understand bacterial 
transmission  
Previous studies have investigated the transmission epidemiology of AMR E. coli 
between human and livestock, but very few use high-resolution genetic data and 
samples col-located in time and space (Muloi et al., 2018). A smaller number have 
focused on developing countries, with none considering the role of the 
ubiquitous urban livestock in the maintenance of zoonotic bacteria and AMR in 
humans. By utilizing tools with the finest resolution available to investigate the 
associations of E. coli and AMR between and within co-located human and urban 
livestock populations, the approach used in this thesis is novel, and has enabled 
me to address some important epidemiological questions. First, the findings 
presented in chapter 4 and 5 demonstrate overlapping patterns of AMR 
phenotype and gene carriage in human and livestock populations, and most 
importantly, that livestock ownership, in and of itself, does not add to the risk of 




acquisition or carriage of AMR bacteria in humans.  Further, supporting this, 
findings in chapter 6 demonstrate that E. coli strains are largely shared within 
livestock and human populations separately with limited transmission in either 
direction and that human E. coli population is not differentiated by livestock 
ownership. The finding that most bacterial sharing was limited within the same 
host group may partly be attributed to the fact that for most livestock species, as 
well as most humans, most of direct contact is confined within members of the 
same species. Taken together, these findings relate directly to the findings in 
(Muloi et al., 2018), and support a small, but growing, body of evidence suggesting 
that livestock plays a minimal role in acquisition and infection of AMR bacteria 
in humans (Mather et al., 2013; Gouliouris et al., 2018; Ludden et al., 2019a; Ludden 
et al., 2019b). 
Second, understanding how pathogen communities are structured is a 
fundamental step towards developing a predictive framework for pathogen 
emergence at urban livestock-human interfaces including AMR bacteria. In this 
study, the dispersal of bacteria and AMR determinants (AMR phenotypes, AMR 
genes and plasmids) and lack of structure in microbial community by host or 
wealth categories exemplifies the Baas Becking tenet ‘everything is everywhere, 
but the environment selects’ (Becking, 1934), suggesting that the hypothesis also 
applies to genes, besides microbes for which it was originally formulated. 
‘Everything is everywhere’ alludes to the dispersal potential of E. coli, whereas 
‘the environment selects’ denotes the specifically adapted bacterial clones that 
have the ability to thrive and proliferate in a particular environment, for example 
the closely related lineage of goat E. coli isolates observed in chapter 6. By doing 
so, these analyses demonstrates that, across the fragmented urban landscapes, 
AMR genes act as ‘public goods’ and are available for bacteria in different 
ecological niches to integrate into their genomes. Besides describing the 
pathways for the distribution of bacteria and AMR gene pools, this analysis 




provides important biological insights into the dispersal of AMR determinants 
across multiple hosts and habitats.  
 
Finally, this study highlights the added value of integrated epidemiological and 
genomic approaches in tracking transmission of AMR bacterial clones and in 
surveillance of AMR genetic determinants in complex multi-host-pathogen 
interfaces (Baker et al., 2018b). Analysis of fine-scale genetic variation in this 
thesis has demonstrated evidence of bacterial sharing within and between host 
groups and revealed evidence that commensal E. coli population is diverse. 
Further, this thesis exploits WGS to investigate the epidemiology of AMR genes 
and plasmids – important genomic resistance markers. Given the epidemiological 
significance of horizontal genetic transfer mechanisms in rapid dissemination of 
AMR genes (Sheppard et al., 2016; Baker et al., 2018a) detailed genetic analysis in 
this thesis highlights the added value of focusing on these dispersive elements 
when tracking transmission of AMR.  
9.6.2 Implications for surveillance and public health  
The widespread carriage of clinically relevant AMR phenotypes and AMR genes 
in both human isolates reported in this thesis support previous findings (Kalter 
et al., 2010; Nguyen et al., 2015; Caudell et al., 2018; Ingle et al., 2018; Williams et 
al., 2018) that AMR is increasingly common across LMICs. This thesis provides 
data regarding AMR frequencies for a range of antimicrobials in human and 
livestock populations – a significant contribution to the information gap of AMR 
in LMICs. My results reiterate the need for routine surveillance activities of AMR 
in low income settings and for public health policy to adopt effective strategies 
targeting a reduction in the emergence and spread of such resistance in the 
future. Global platforms such as World Health Organization’s Global AMR 
Surveillance System (GLASS) could offer a cost-effective model to conduct 
surveillance for AMR bacteria in LMICs (Seale et al., 2017), and could be 
integrated with existing systems for reporting of zoonoses in human and animal 




health. The cost-effectiveness of the surveillance programs could be enhanced by 
focusing on particular resistance phenotypic or genetic markers deemed of more 
clinical relevance (DANMAP, 2018).  The use of WGS in this thesis in a low income 
settings is important given the concerted effort to implement WGS in public 
health settings as the cost of sequencing declines. In clinical and public health 
settings, genomics would aid the characterising and tracking of bacterial spread 
and provide critical surveillance data on genomic mechanisms of resistance.  
Phenotypic resistance profiles and genotypes detected in the E. coli isolates 
(chapter 4 and 5) correlated with the most commonly used antimicrobial in the 
study (chapter 7).  Further, over the counter dispensing of non-prescribed human 
and veterinary antimicrobials was common across Nairobi (chapter 7). 
Antimicrobial use is singlehandedly the most important driver of AMR in both 
humans and livestock (Holmes et al., 2016) and recent studies suggest that 
antimicrobial consumption rates in LMICs have surpassed those observed in high 
income countries (Klein et al., 2018). As the urban population in most low and 
middle-income countries grows (UNPD, 2014b), disease burden and consequent 
increase in antimicrobial usage is projected to rise (Sosa et al., 2010). As such, 
findings of this research could be adopted into policy recommendations aimed at 
selectively reducing inappropriate use of antimicrobials, increasing appropriate 
use of antimicrobials to treat and prevent disease, and reducing the need for 
antimicrobials (Laxminarayan and Heymann, 2012). Programmes on rational 
antimicrobial use or antimicrobial stewardship in the community and the clinic 
should be initiated. While this thesis reports high AMR carriage in the 
community, public health policy should balance the need to reduce overall 
antimicrobial use with expanding essential access as lack of access to 
antimicrobial still results in more deaths in low income settings than does AMR 
(Das and Horton, 2016).  
To reduce the carriage of AMR in humans across household interfaces this thesis 
highlights some interventions that could be implemented at local and policy 




level. For example, in chapter 4 and 5, disposal of animal manure in the household 
was identified as a risk factor for carriage of AMR in humans.  Strategies that limit 
AMR gene flow to and from manure (to humans) could be adopted. Such 
interventions include educating people on safe disposal of manure from 
households, and manure pre-treatment prior to application onto crop farms 
where possible.  
9.7 Future directions 
In chapter 6, I demonstrate evidence of bacterial sharing within and between 
human and livestock population, in either direction. Directionality of bacterial 
and AMR sharing between human and livestock populations has been subject of 
much debate with recent studies suggesting that some MRSA clones infecting 
humans may have originated from livestock (Lowder et al., 2009; Ward et al., 
2014; Richardson et al., 2018). This thesis does not provide insights on the 
direction of bacterial and/or AMR transmission as datasets used here were cross 
sectional snapshots, but the use of  longitudinal sampling of human and animal 
populations (over time and space) combined with phylogeographic inferences 
(De Maio et al., 2015) will provide robust insights into transmission history in the 
near future.  
In chapter 4, I used disc diffusion for antimicrobial susceptibility testing and 
Clinical and Laboratory Standards Institute (CLSI, 2016) guidelines for 
interpretation of inhibition zone diameters. Breakpoint setting and use has, and 
still is, a controversial subject and the focus of much debate in microbiology and 
clinical infectious disease research (MacGowan and Wise, 2001; Turnidge and 
Paterson, 2007). Evidently, the pre-established clinical cut offs did not accurately 
reflect the distribution of inhibition zone diameters in the bacterial population 
in this study. Despite this limitation, breakpoints are an integral part of modern 
microbiology laboratory practice globally, and most importantly in low resource 
settings such as Nairobi. In the recent past, a small number of studies have 
assessed the feasibility of using WGS to predict antimicrobial susceptibility 




phenotype (genotype-to-phenotype),  in Staphylococcus aureus (Gordon et al., 
2014), E. coli (Stoesser et al., 2013; Ingle et al., 2018) and Mycobacterium 
tuberculosis (Bradley et al., 2015). However, none of these studies have focused 
on commensal bacteria or isolates of livestock origin. Such research questions 
represent the next step towards understating whether genetic predictions could 
also be used to guide clinical decision making and for surveillance purposes.  
In chapter 6 and 8, I hypothesised that the widespread carriage of acquired AMR 
and co-occurrences between clinically relevant resistance genes was mediated by 
conjugative plasmids that are shared between human and livestock populations.  
However, owing to shortcomings in reconstructing plasmids and other mobile 
elements encoding resistance genes from short read data, I was unable to 
determine the precise location of AMR genes and associated mobile genetic 
elements. It would be beneficial for additional studies to characterise plasmids 
using long-read sequencing to accurately reconstruct all plasmids in order to 
understand mechanisms by which AMR determinants may be acquired and 
dispersed (Conlan et al., 2014; Rozwandowicz et al., 2018). 
By only sequencing a single E. coli isolate from each host, this study may have 
underestimated both within-host strain and AMR mechanism diversity and 
potential sharing of strains between hosts (Stoesser et al., 2015). The decision to 
sequence a single isolates from each host was made as a cost-based trade-off 
between the depth of sampling E. coli genetic diversity within each individual and 
the number of unique individuals from which samples could be included. Recent 
advances in metagenomics permit sequencing of bacterial microbiomes, which, 
when used in combination with structured epidemiological data could be used to 
explore the variation in the structure of bacterial and AMR communities within 
and between human and livestock populations (Pehrsson et al., 2016; Hendriksen 
et al., 2019).  




Chapter 7 used a relatively small sample size (19 and 40 veterinary and human 
drug stores respectively) to analyse antimicrobial sales in human and veterinary 
drug stores in Nairobi, as proxy for antimicrobial usage in animal and human 
populations. By doing do this, this thesis may not have reliably captured the real 
antimicrobial usage patterns in either population. Also, considering the many 
sources of sales of antimicrobials across the city, including informal sources, it is 
possible that I missed some of these during data collection hence 
underestimating use. It would be interesting for future studies to extend this 
work to longitudinal surveys of antimicrobial use in healthcare facilities and the 
community.  
9.8 Concluding remarks 
The emergence and transmission of AMR bacteria poses an immediate threat to 
global health, and the role of livestock in transmission of AMR bacteria to 
humans is unclear. This thesis has demonstrated how fine-scale analysis of 
bacterial genomes explicitly embedded within an epidemiologically structured 
sampling framework can be utilized; (i) in the surveillance of AMR prevalence, 
(ii) to identify risk factors for carriage of AMR strains and AMR genes, (iii) to 
track bacterial strain sharing in a low-income urban setting. I provide evidence 
that human and livestock bacterial and AMR communities overlap, but livestock 
ownership in and of itself does not add to the risk of acquisition or carriage of 
AMR bacteria in humans. At the SNP level, bacterial sharing is largely confined 
within livestock and human populations with limited evidence of transmission in 
either direction. The work presented herein offers insights into the epidemiology 
of AMR in commensal bacteria in humans and their livestock in a low income 
developing city and reaffirms the need for enhanced surveillance of resistant 
bacteria as well as antimicrobial sales and usage in both populations.  
 
 








































































If I have seen further, it is by standing on the shoulders of Giants 
Isaac Newton, 1676 
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“Messieurs, c'est les microbes qui auront le dernier mot." 
Gentlemen, it is the microbes who will have the last word. 
Louis Pasteur, 1822-1895 
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11.1 Appendix A. Are Food Animals Responsible for Transfer of 
Antimicrobial-Resistant Escherichia coli or Their Resistance 
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Appendix Table A2. Data search strategies  
 
Search strategy for PubMed 
 
((((((((((((((antibiotic resistan*) OR antimicrobial resistan*) OR drug 
resistan*) AND Escherichia coli) OR E. coli) OR Enterobacteria*) AND 
human*) AND livestock) OR food animal*) OR pig*) OR swine) OR poultry) 
OR bovine*) OR cattle) OR cow*) 
 
Search strategy for Web of Science and SCOPUS 
 
(antibiotic resistan*) OR (antimicrobial resistan*) OR (drug resistan*) AND 
(Escherichia coli) OR (E. coli) OR (Enterobacteria*) AND (human*) AND 
(livestock) OR (food animal*) OR (pig*) OR (swine) OR (poultry) OR (bovine) 
OR (cattle) OR (cow*) 
 
Search strategy for EMBASE  
 
1. antibiotic resistance/exp  
2. antibiotic resistance/ exp  
3. drug resistance/ exp  
4. Escherichia coli/ exp  
5. Enterobacteria/ exp 
6. human/ exp 
7. livestock/ exp  
8. food animal/ exp 
9. pig/ exp 
10. swine/ exp 
11. poultry/ exp  
12. bovine/ exp  
13. cattle/ exp  
14. cow/ exp  
15 1 or 2 or 3  
17. 4 or 5  
18. 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14   

































                        Chapter 11. Appendices  
 
221 









                        Chapter 11. Appendices  
 
222 
Appendix Figure A3. Counts of antimicrobials reported. Note that some 
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Appendix B for: Epidemiology of antimicrobial 
resistant Escherichia coli carriage in sympatric 
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Appendix Table B1. Antimicrobials tested (and the respective antimicrobial 
classes) and interpretation of zone of inhibition (mm). * Custom breakpoints 
based on examination of the distributions of the zones of inhibition.  




Antimicrobial  Disc Content 
µg    





10 ≥18 <13 
Penicillin  Ampicillin 10 ≥17 <13 
Cephalosporin  Cefepime 30 ≥25 <18 
 Cefotaxime 30 ≥26 <22 
 Ceftazidime 30 ≥21 <17 
Fluoroquinolone Ciprofloxacin 10 ≥21 <15 
 Nalidixic acid  30 ≥19 <13 
Aminoglycoside  Streptomycin 25 ≥15 <11 
 Gentamycin 10 ≥15 <12 
Phenicol Chloramphenicol 30 ≥18 <12 




Trimethoprim  2.5 ≥16 <10 
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Appendix Table B2. Percentages of E. coli isolates resistant to a panel of 13 
antimicrobials classified by host type. Numbers show percentages of isolates 
classified as resistant based on the zone of inhibition. Definition of resistance 
















β-lactam Co-amoxiclav 2.5 0.6 3.9 1.6 0 2.4 
Penicillins Ampicillin 40.8 27 41.2 21.9 16.7 17.1 
Phenicols Chloramphenicol 6.5 3.5 0 3.1 1.5 2.4 
Cephalosporins Ceftazidime 1.6 1.4 2 0 1.5 0 
Cefotaxime 2.2 4.3 2 4.7 3.8 0 
Cefepime 2.2 0.9 2 0 0.8 0 
Fluoroquinolones Ciprofloxacin 2.2 2.6 0 0 1.5 4.9 
Nalidixic acid 9.7 6.7 3.9 0 3 9.8 
Sulfonamides Sulfamethoxazole 66 66.7 54.9 37.5 34.1 39 
Tetracyclines Tetracycline 45.5 57.4 56.9 28.1 25.8 26.8 
Aminoglycosides Streptomycin 47 35.4 39.2 25 22 26.8 
Gentamicin 2.5 2.6 0 1.6 1.5 4.9 
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Appendix Figure B1. Percentages of E. coli isolates resistant to five 
antimicrobial classes by source type: human (n=321), poultry (n=345), pig 
(n=51), bovine (n=64), goat (n=132), and rabbit (n=41). P values are from a post-
hoc Tukey’s test. Only antimicrobial classes (5/9) with statistically significant 
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Appendix Table B3: Results of separate Poisson generalised linear mixed 
models investigating household risk factors for individual resistances by class in 
humans at the household level. Households not keeping livestock and having 
no manure in the household were used as the reference level in all models. Given 
the low prevalence of resistance (<5%) to co-amoxiclav, phenicols, 






P value  
Model 1: AMR carriage, humans in all 
households 
   
Tetracyclines 
Human density  0.6432 0.2069 0.00188 
Large livestock (with or without small 
livestock) 0.1249 0.3068 0.68405 
Small livestock only 0.4232 0.2849 0.13737 
Aminoglycosides 
Human density  0.6329 0.2213 0.00424 
Large livestock (with or without small 
livestock) -0.1438 0.324 0.65711 
Small livestock only -0.2107 0.3011 0.48398 
Sulfonamides 
Human density  0.61873 0.22858 0.00679 
Large livestock (with or without small 
livestock) 0.07985 0.31112 0.79745 
Small livestock only 0.55916 0.29782 0.06045 
Penicillins 
Human density  0.7688 0.2304 0.000847 
Large livestock (with or without small 
livestock) -0.639 0.3371 0.058015 
Small livestock only -0.1738 0.3048 0.568543 
Trimethoprim 
Human density  0.3728 0.2054 0.0695 
Large livestock (with or without small 
livestock) -0.2668 0.3013 0.3759 
Small livestock only 0.1893 0.2819 0.5019 
Model 2: AMR carriage, humans in 
livestock keeping household only    
Tetracyclines 
Human density  0.7179 0.2599 0.005733 
Manure in household 0.3683 0.313 0.239321 




Human density  0.5369 0.2866 0.061 
Manure in household 0.3933 0.3142 0.211 
Aminoglycosides 
Human density  0.6915 0.2926 0.01812 
Manure in household 0.1996 0.3507 0.56919 
Penicillins 
Human density  0.6728 0.2571 0.00886 
Manure in household 0.566 0.3384 0.09435 
Trimethoprim 
Human density  0.2467 0.2508 0.325 



























Appendix Table B4. Profile composition and number of E. coli isolates from 
human and animal in Nairobi, Kenya. Abbreviations:  Cephalosporins (Ceph), 
Aminoglycosides (Amg), Phenicols (Phn), Tetracyclines (Tet), Penicillins 
(Pcn), Penicillin lactams (Amc), Folate inhibitors (Tmp), Sulfonamides (Sul) 
and Fluoroquinolones (Fq). 
Profile composition Human Poultry Bovine Goat Pig Rabbit 
Pansusceptible 67 76 33 72 17 19 
Amc 0 0 1 0 1 0 
AmcTmp 0 0 0 0 1 0 
Amg 9 9 2 5 0 2 
AmgAmc 1 0 0 0 0 0 
AmgFqPhnSulTmp 0 2 0 0 0 0 
AmgFqSul 0 0 0 0 0 1 
AmgFqTetSulTmp 2 4 0 1 0 1 
AmgPcn 0 1 2 0 0 1 
AmgPcnAmcFqTetSulTmp 1 0 0 0 0 0 
AmgPcnAmcTetSul 0 1 0 0 0 0 
AmgPcnAmcTetSulTmp 2 1 0 0 0 0 
AmgPcnFqPhnTetSulTmp 1 0 0 0 0 0 
AmgPcnFqTet 1 0 0 0 0 0 
AmgPcnFqTetSulTmp 9 6 0 1 1 0 
AmgPcnPhnSulTmp 6 0 0 0 0 0 
AmgPcnPhnTet 1 0 0 0 0 0 
AmgPcnPhnTetSulTmp 6 1 2 0 0 0 
AmgPcnSul 5 3 0 0 0 0 
AmgPcnSulTmp 11 1 1 1 0 1 
AmgPcnTet 2 4 0 1 1 0 
AmgPcnTetSul 3 3 1 0 0 1 
AmgPcnTetSulTmp 47 40 4 10 13 2 
AmgPhnTetSulTmp 2 1 0 0 0 0 
AmgPhnTmp 1 0 0 0 0 0 
AmgSul 6 2 0 1 0 0 
AmgSulTmp 5 2 0 2 0 0 
AmgTet 3 3 1 0 0 0 
AmgTetSul 7 6 1 3 3 0 
AmgTetSulTmp 13 20 0 2 1 1 
AmgTetTmp 0 1 0 0 0 0 
AmgTmp 3 0 0 0 0 1 
Ceph 0 1 0 1 0 0 
CephAmg 0 1 0 0 0 0 
CephAmgFqPhnSulTmp 0 1 0 0 0 0 
CephAmgFqPhnTetSulTmp 0 1 0 0 0 0 
CephAmgFqTetSul 0 0 0 1 0 0 
CephAmgPcn 0 0 1 0 0 0 
CephAmgPcnAmcTetSulTmp 1 0 0 0 0 0 
CephAmgPcnFqPhnTetSulTmp 0 1 0 0 0 0 
CephAmgPcnFqSulTmp 1 0 0 0 0 0 
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CephAmgPcnFqTetSulTmp 2 1 0 0 0 0 
CephAmgPcnPhnTetSul 0 1 0 0 0 0 
 
Antibiogram Human Poultry Bovine Goat Pig Rabbit 
CephAmgPcnTetSul 0 1 0 0 0 0 
CephAmgPcnTetSulTmp 2 4 1 0 1 0 
CephAmgTet 0 0 0 1 0 0 
CephAmgTetSulTmp 0 3 0 0 0 0 
CephPcnAmcFqTetTmp 1 0 0 0 0 0 
CephPcnFqPhnSulTmp 1 0 0 0 0 0 
CephPcnFqTetSulTmp 1 0 0 0 0 0 
CephPcnSulTmp 0 0 0 1 0 0 
CephPcnTetSulTmp 0 0 0 1 0 0 
CephSul 0 1 0 0 0 0 
CephTetSulTmp 0 2 1 0 0 0 
Fq 3 1 0 0 0 0 
FqSul 0 1 0 0 0 0 
FqSulTmp 1 2 0 1 0 0 
FqTet 0 0 0 0 1 0 
FqTetSul 1 0 0 0 0 0 
FqTetSulTmp 2 4 0 0 0 1 
FqTmp 1 0 0 0 0 0 
Pcn 2 1 0 2 2 0 
PcnAmc 1 0 0 0 0 0 
PcnAmcFqTetSulTmp 0 0 0 0 0 1 
PcnAmcTetSulTmp 1 0 0 0 0 0 
PcnFq 1 0 0 0 0 0 
PcnFqTetSulTmp 2 0 0 0 0 0 
PcnPhnTet 1 0 0 1 0 0 
PcnPhnTetSulTmp 1 3 0 0 0 0 
PcnSul 0 1 0 0 0 0 
PcnSulTmp 6 3 0 0 0 0 
PcnTet 0 2 0 2 0 0 
PcnTetSul 2 1 0 0 0 0 
PcnTetSulTmp 9 13 2 2 3 1 
PcnTetTmp 1 0 0 0 0 0 
Phn 0 0 0 0 0 1 
PhnSul 0 1 0 0 0 0 
PhnSulTmp 1 0 0 1 0 0 
Sul 18 18 3 11 1 4 
SulTmp 23 17 3 0 0 0 
Tet 7 12 0 2 0 0 
TetSul 0 6 1 1 0 0 
TetSulTmp 11 51 4 5 5 2 
TetTmp 1 1 0 0 0 1 
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Profile composition and number of E. coli isolates from human and animal in 
Nairobi, Kenya. Abbreviations:  Cephalosporins (Ceph), Aminoglycosides (Amg), 
Phenicols (Phn), Tetracyclines (Tet), Penicillins (Pcn), Penicillin lactams (Amc), 








Appendix C for: One Health genomic 
epidemiology of antimicrobial resistant 
Escherichia coli carriage in sympatric humans 
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Appendix Table C1. Distribution of AMR gene by host type.  
Antimicrobial 





























(23.4) 7 (17.1) <0.001 <0.001 






(45.9) 27 (54) 
17 





(46.5) 26 (52) 
17 
(27.9) 27 (21.1) 5 (12.2) <0.001 <0.001 
aadA1 41 (13) 37 (11.8) 5 (10) 4 (6.6) 8 (6.2) 5 (12.2) 0.33 1 
aadA2 7 (2.2) 15 (4.8) 0 1 (1.6) 3 (2.3) 0 0.17 1 
aadA24 1 (0.3) 1 (0.3) 0 0 0 0 0.97 1 
aadA4 1 (0.3) 0 0 0 0 0 0.86 1 
aadA5 19 (6) 24 (7.6) 1 (2) 3 (4.9) 3 (2.3) 1 (2.4) 0.21 1 
aac3_IIa 1 (0.3) 0 0 0 0 0 0.86 1 
aac3_IId 3 (1) 2 (0.6) 0 0 0 0 0.77 1 
aph3_Ia 1 (0.3) 2 (0.6) 1 (2) 0 1 (0.8) 1 (2.4) 0.5 1 
aph3_Ic 0 2 (0.6) 0 0 0 0 0.58 1 












(24.4) <0.001 <0.001 
tetB 31 (9.8) 17 (5.4) 6 (12) 2 (3.3) 9 (7) 1 (2.4) 0.1 1 
tetD 0 0 0 0 0 1 (2.4) 0.0008 0.06  
β-lactams blaCARB_2 1 (0.3) 0 0 0 0 0 0.86 1 
blaCMY_48 1 (0.3) 0 0 0 0 0 0.86 1 
blaCMY_60 1 (0.3) 0 0 0 0 0 0.86 1 
blaCMY_68 1 (0.3) 0 0 0 0 0 0.86 1 
blaTEM_1B 
108 
(34.3) 67 (21.3) 21 (42) 11 (18) 
16 
(12.5) 4 (9.8) <0.001 <0.001 
blaCTX_M_15 7 (2.2) 2 (0.6) 1 (2) 0 0 0 0.2 1 
blaTEM_33 1 (0.3) 0 0 0 0 0 0.86 1 
blaCMY_79 1 (0.3) 0 0 0 0 0 0.86 1 
blaCTX_M_14 1 (0.3) 1 (0.3) 0 0 0 0 0.97 1 
blaOXA_1 7 (2.2) 1 (0.3) 0 0 3 (2.3) 0 0.16 1 
blaTEM_1C 6 (1.9) 9 (2.9) 0 0 1 (0.8) 1 (2.4) 0.45 1 
blaOXA_10 1 (0.3) 0 0 0 1 (0.8) 0 0.7 1 
blaSHV_1 1 (0.3) 0 0 0 0 0 0.86 1 
blaTEM_176 0 2 (0.6) 0 0 0 0 0.58 1 
blaTEM_207 0 0 1 (2) 0 0 0 0.004 0.3  
blaTEM_30 2 (0.6) 0 0 0 0 0 0.58 1 
ampC 1 (0.3) 0 0 0 0 0 0.86 1 






(46.5) 16 (32) 
15 
(24.6) 15 (11.7) 7 (17.1) <0.001 <0.001 
dfrA12 5 (1.6) 13 (4.1) 0 1 (1.6) 3 (2.3) 0 0.2 1 
dfrA14 54 (17.1) 
87 
(27.7) 15 (30) 8 (13.1) 7 (5.5) 2 (4.9) <0.001 <0.001 
dfrA7 
46 
(14.6) 16 (5.1) 4 (8) 3 (4.9) 5 (3.9) 1 (2.4) 0.0001 0.005  
dfrA8 17 (5.4) 4 (1.3) 1 (2) 0 1 (0.8) 0 0.005 0.36 
dfrA15 3 (1) 0 0 0 0 0 0.34 1 
dfrA16 1 (0.3) 0 0 0 0 0 0.86 1 
dfrA17 19 (6) 24 (7.6) 1 (2) 3 (4.9) 3 (2.3) 1 (2.4) 0.21 1 
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dfrA21 1 (0.3) 0 0 0 0 0 0.86 1 
dfrA5 14 (4.4) 9 (2.9) 4 (8) 0 4 (3.1) 2 (4.9) 0.27 1 
dfrB4 1 (0.3) 0 0 0 0 0 0.86 1 
Fluoroquinolones qepA 2 (0.6) 1 (0.3) 0 0 1 (0.8) 0 0.93 1 
qnrB19 1 (0.3) 1 (0.3) 0 0 0 0 0.97 1 
qnrB2 0 1 (0.3) 0 0 1 (0.8) 0 0.7 1 
qnrB60 1 (0.3) 0 0 0 0 0 0.86 1 
qnrB7 0 1 (0.3) 0 0 0 0 0.86 1 
qnrS1 15 (4.8) 10 (3.2) 4 (8) 1 (1.6) 2 (1.6) 0 0.15 1 
qnrS2 0 1 (0.3) 0 0 0 0 0.86 1 
aac6Ib_cr 2 (0.6) 0 0 0 0 0 0.58 1 
gyrA_D87Y 1 (0.3) 0 0 0 0 0 0.86 1 
gyrA_S83L 28 (8.9) 14 (4.5) 2 (4) 0 1 (0.8) 1 (2.4) 0.002 0.16  
gyrA_S83A 2 (0.6) 0 0 0 0 0 0.58 1 
gyrA_D87N 7 (2.2) 4 (1.3) 0 0 1 (0.8) 1 (2.4) 0.59 1 
parC_E84A 1 (0.3) 0 0 0 0 0 0.86 1 
parC_E84V 2 (0.6) 0 0 0 0 0 0.58 1 
parC_A56T 2 (0.6) 9 (2.9) 3 (6) 1 (1.6) 1 (0.8) 0 0.05 1 
parC_S57T 2 (0.6) 2 (0.6) 0 0 0 0 0.88 1 
parC_A108V 0 1 (0.3) 0 0 0 0 0.86 1 
parC_S80I 9 (2.9) 6 (1.9) 0 0 1 (0.8) 1 (2.4) 0.46 1 
parC_E84G 1 (0.3) 1 (0.3) 0 0 0 0 0.97 1 
parE_I529L 4 (1.3) 0 0 0 0 0 0.18 1 
parE_D475E 4 (1.3) 3 (1) 0 0 1 (0.8) 0 0.86 1 
Phenicols catA1 32 (10.2) 5 (1.6) 1 (2) 1 (1.6) 2 (1.6) 0 <0.001 0.0001  
catA2 2 (0.6) 2 (0.6) 0 1 (1.6) 0 0 0.76 1 
catB3 2 (0.6) 0 0 0 0 0 0.58 1 
cmlA1 2 (0.6) 7 (2.2) 0 0 1 (0.8) 0 0.3 1 
floR 0 1 (0.3) 0 0 0 0 0.86 1 
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Table C2: Results of separate Poisson generalised linear mixed models 
investigating household risk factors for individual AMR genes in humans at the 
household level. Households not keeping livestock and having no manure in the 
household were used as the reference level in all models. Only included gene 
having a prevalence of greater or equal to 15%.   
Model 1: AMR gene length, humans in all 
households Estimate SE P value  
sul2    
Human density  0.5827 0.22279 0.00891 
Large livestock (+/- small livestock) -0.03187 0.32072 0.92083 
Small livestock only 0.48931 0.30248 0.10573 
strA    
Human density  0.58846 0.21411 0.00599 
Large livestock (+/- small livestock) 0.07125 0.31414 0.82057 
Small livestock only 0.30505 0.29455 0.30037 
strB    
Human density  0.62736 0.20997 0.00281 
Large livestock (+/- small livestock) 0.07983 0.30766 0.79526 
Small livestock only 0.27992 0.28873 0.3323 
dfrA1    
Human density  0.0944 0.19973 0.6365 
Large livestock (+/- small livestock) -0.04276 0.31329 0.8914 
Small livestock only 0.22329 0.28873 0.4393 
tetA    
Human density  0.0944 0.19973 0.6365 
Large livestock (+/- small livestock) -0.04276 0.31329 0.8914 
Small livestock only 0.22329 0.28873 0.4393 
blaTEM-1B    
Human density  0.7257 0.235 0.002015 
Large livestock (+/- small livestock) -0.5728 0.3577 0.109273 
Small livestock only -0.1068 0.3241 0.741799 
dfrA14    
Human density  -0.04071 0.3246 0.9 
Large livestock (+/- small livestock) 1.16133 0.53196 0.029 
Small livestock only 1.13879 0.50792 0.025 
Model 1: humans in livestock keeping household 
only    
tetA    
Human density  0.5412 0.2511 0.03112 
Manure in household 0.0596 0.3346 0.85863 
sul2    
Human density  0.5772 0.2675 0.0309 
Manure in household 0.5573 0.3329 0.0941 
strA    
Human density  0.6237 0.2592 0.01613 
Manure in household 0.5017 0.3198 0.11667 
strB    
Human density  0.6237 0.2592 0.01613 
Manure in household 0.5017 0.3198 0.11667 
dfrA1    
Human density  0.1275 0.2472 0.606 
Manure in household 0.1288 0.329 0.695 
dfrA14    
Human density  -0.12502 0.3936 0.7508 
Manure in household -0.03976 0.4653 0.9319 
blaTEM-1B    
Human density  0.5857 0.2849 0.0398 
Manure in household 0.9288 0.421 0.0274 




11.2 Appendix D for: Escherichia coli genetic diversity and sharing in 
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Appendix Figure D1. Histogram of SNP pairwise distances between isolates with differences of 0-100 core genome SNPs 
coloured by type of sharing (A) All isolates (B) isolates involved in between-household sharing only, and (C) isolates involved in 
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Appendix Figure D2. Histogram of SNP pairwise distances between isolates 
belonging to sequence type 10. The distributions represent 2628 pairwise 
comparisons. Red line represents the median of the pairwise distance.  
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Appendix Table D1. Summary of metadata associated with isolates involved in human-livestock sharing  












ALQ020141 Human  
3 
23 UTH30 6 
blaTEM-
1B,dfrA8,mph(A),strA,strB,sul2 Male  No  
ALQ020449 
Poultry 
(Chicken) 23 UTH29 6 
blaTEM-




48 LOR099 1 blaTEM-1C Male - head - no livestock contact - bachelor’s degree No 




NVL SPV064 2  
Male - Farmhand - handling - manure -  milking - 
collecting eggs - slaughter- primary school Yes 




NVL SPV064 2  
Male - Farmhand - handling - manure -  milking - 
collecting eggs - slaughter- primary school Yes 
INT006147 
Poultry 
(Turkey) NVL SPV064 2   Yes 
5 
INT004723 Human  
3 
6178 KRR037 2  
Male - head - handling -  milking -collecting eggs - 
bachelor’s degree Yes 




58 MWK056 6  Male - head - handling - manure -diploma Yes 
INT007394 
Poultry 




10 NGN080 5  
Male - Farmhand - handling - manure -  milking - 
collecting eggs - slaughter-primary school Yes 
INT008356 
Poultry 




538 KTS088 1  
Male - Farmhand - handling - manure -  milking - 
collecting eggs - slaughter-primary school Yes 
PLQ2296 
Poultry 




206 KHW049 6 
aadA1,aph(3')-
Ia,dfrA14,mph(A),strA,strB,sul2,t
et(A) Male.  Yes 
TMP021678 Poultry 206 KHW049 6 
aadA1,aph(3')-Ia,dfrA14, tet(A), 
mph(A),strA,strB,sul2  Yes 
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Appendix Table D2. Summary of metadata of isolates involved in sharing. *BOV – Bovine, HUM – Human, RAB – Rabbit and 







combination* Wealth ST 
Keeping 
livestock ARGs 
INT005621-TMP019524 7 KHW049-KIG020 BOV-BOV 6 ST906 Yes  
INT005621-TMP021809 6 KHW049 BOV-BOV 6 ST906 Yes  
TMP016878-TMP016889 5 KAN007 BOV-BOV 1 ST187 Yes  
INT004696-INT004723 3 KRR037 BOV-HUM 2 ST6178 Yes  
TMP016016-TMP019096 8 MSA004-MAK017 BOV-RAB 6 ST155 Yes 
aadA1,blaTEM1B,dfrA1,sul1,sul2,tetA -- 
dfrA5,strA,strB,sul2,tetA 
ALQ017189-INT005029 4 KIL042 GOAT 2 ST297 Yes  
ALQ019065-ALQ019380 9 KIG019 GOAT 6 ST223 Yes PanSuc -- dfrA5,strA,strB,sul1,sul2 
ALQ019365-TMP019339 9 KIG019 GOAT 6 NVL Yes  
ALQ020209-ALQ020457 0 UTH029 GOAT 6 ST1079 Yes  
INT004567-INT007541 9 UMJ036-MWK057 GOAT 4-6 ST297 Yes  
INT004567-INT007592 8 UMJ036-MWK057 GOAT 4-6 ST297 Yes  
INT005034-INT005045 3 KIL042 GOAT 2 ST3884 Yes  
INT007541-INT007592 1 MWK057 GOAT 6 ST297 Yes  
PLQ000563-PLQ000593 7 NGN079 GOAT 5 ST4088 Yes  
TMP014928-TWAG1869 9 VIW002-BOM092 GOAT 7-3 ST297 Yes aadA1,blaTEM1B,dfrA1,strA,strB,sul1,sul2,tetA -- PanSuc 
TMP014928-TWAG1878 8 VIW002-BOM092 GOAT 7-3 ST297 Yes aadA1,blaTEM1B,dfrA1,strA,strB,sul1,sul2,tetA -- PanSuc 
TMP019846-TMP019851 8 MLK023 GOAT 7 ST223 Yes  
TMP020486-TMP020499 6 KWG070 GOAT 6 ST56 Yes PanSuc -- strA,strB,sul2 
TMP020486-TMP020669 2 KWG070 GOAT 6 ST56 Yes  
TMP020499-TMP020669 6 KWG070 GOAT 6 ST56 Yes strA,strB,sul2 -- PanSuc 
TWAG1869-TWAG1878 3 BOM092 GOAT 3 ST297 Yes  
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Appendix Table D2. Summary of metadata of isolates involved in sharing. *BOV – Bovine, HUM – Human, RAB – Rabbit and 







combination* Wealth ST 
Keeping 
livestock ARGs 
INT005621-TMP019524 7 KHW049-KIG020 BOV-BOV 6 ST906 Yes  
INT005621-TMP021809 6 KHW049 BOV-BOV 6 ST906 Yes  
TMP016878-TMP016889 5 KAN007 BOV-BOV 1 ST187 Yes  
INT004696-INT004723 3 KRR037 BOV-HUM 2 ST6178 Yes  
TMP016016-TMP019096 8 MSA004-MAK017 BOV-RAB 6 ST155 Yes 
aadA1,blaTEM1B,dfrA1,sul1,sul2,tetA -- 
dfrA5,strA,strB,sul2,tetA 
ALQ017189-INT005029 4 KIL042 GOAT 2 ST297 Yes  
ALQ019065-ALQ019380 9 KIG019 GOAT 6 ST223 Yes PanSuc -- dfrA5,strA,strB,sul1,sul2 
ALQ019365-TMP019339 9 KIG019 GOAT 6 NVL Yes  
ALQ020209-ALQ020457 0 UTH029 GOAT 6 ST1079 Yes  
INT004567-INT007541 9 UMJ036-MWK057 GOAT 4-6 ST297 Yes  
INT004567-INT007592 8 UMJ036-MWK057 GOAT 4-6 ST297 Yes  
INT005034-INT005045 3 KIL042 GOAT 2 ST3884 Yes  
INT007541-INT007592 1 MWK057 GOAT 6 ST297 Yes  
PLQ000563-PLQ000593 7 NGN079 GOAT 5 ST4088 Yes  
TMP014928-TWAG1869 9 VIW002-BOM092 GOAT 7-3 ST297 Yes aadA1,blaTEM1B,dfrA1,strA,strB,sul1,sul2,tetA -- PanSuc 
TMP014928-TWAG1878 8 VIW002-BOM092 GOAT 7-3 ST297 Yes aadA1,blaTEM1B,dfrA1,strA,strB,sul1,sul2,tetA -- PanSuc 
TMP019846-TMP019851 8 MLK023 GOAT 7 ST223 Yes  
TMP020486-TMP020499 6 KWG070 GOAT 6 ST56 Yes PanSuc -- strA,strB,sul2 
TMP020486-TMP020669 2 KWG070 GOAT 6 ST56 Yes  
TMP020499-TMP020669 6 KWG070 GOAT 6 ST56 Yes strA,strB,sul2 -- PanSuc 
TWAG1869-TWAG1878 3 BOM092 GOAT 3 ST297 Yes  
ALQ023279-TMP024272 7 SPV064-LOR099 GOAT-HUM 2-1 ST48 Yes-No blaTEM1C,tetA -- blaTEM1C 
ALQ020462-INT010077 1 UTH029-SPV100 GOAT-RAB 6-2 ST7324 Yes  
ALQ019547-ALQ019550 1 MLK024 HUM 7 ST678 Yes blaTEM1B,catA1,dfrA7,dfrA8,mphA,strA,strB,sul2,tetA 
ALQ019547-ALQ019554 6 MLK024 HUM 7 ST678 Yes blaTEM1B,catA1,dfrA7,dfrA8,mphA,strA,strB,sul2,tetA 
        









combination* Wealth ST 
Keeping 
livestock ARGs 
ALQ019547-TMP018942 9 MLK024 HUM 7 ST678 Yes blaTEM1B,catA1,dfrA7,dfrA8,mphA,strA,strB,sul2,tetA 
ALQ019550-ALQ019554 7 MLK024 HUM 7 ST678 Yes blaTEM1B,catA1,dfrA7,dfrA8,mphA,strA,strB,sul2,tetA 
ALQ019550-TMP018942 8 MLK024 HUM 7 ST678 Yes blaTEM1B,catA1,dfrA7,dfrA8,mphA,strA,strB,sul2,tetA 
ALQ019554-TMP018942 3 MLK024 HUM 7 ST678 Yes blaTEM1B,catA1,dfrA7,dfrA8,mphA,strA,strB,sul2,tetA 
ALQ019662-ALQ019663 0 KYL025 HUM 6 ST155 Yes blaTEM1B,dfrA14,strA,strB,sul2,tetA -- PanSuc 
ALQ019705-ALQ019713 8 KYL027 HUM 6 ST2351 No  
ALQ019705-ALQ019749 7 KYL027 HUM 6 ST2351 No  
ALQ019705-ALQ019784 8 KYL027 HUM 6 ST2351 No  
ALQ019713-ALQ019784 0 KYL027 HUM 6 ST2351 No  
ALQ019911-ALQ019980 7 KYL026-UTH028 HUM 6 ST10 Yes catA1,dfrA7,strA,strB,sul1,sul2,tetA 
ALQ032869-ALQ034796 5 MUT084-EMB086 HUM 2-4 ST69 Yes-No aac3-IIa,dfrA14,QnrS1,strA,strB,sul2 -- blaTEM1B 
ALQ034735-PLQ2415 4 EMB086-KTS089 HUM 4-1 ST10 No-Yes strA,strB,sul2,tetA 
INT003900-INT004245 1 DAN032 HUM 6 ST10 Yes blaTEM1B,dfrA7,strA,strB,sul1,sul2 
INT004422-INT004425 0 UMJ034 HUM 4 ST131 No 
aadA5,blaTEM1B,dfrA17,mphA,strA,strB,sul1,sul2 -- 
PanSuc 
INT004642-INT004645 7 KRR037 HUM 2 ST1611 Yes  
INT005269-PLQ2349 9 EAS045-KTS089 HUM 5-1 ST1136 No-Yes aadA1,dfrA1,strA,strB,sul2,tetA 
INT008624-INT008641 4 EMB086 HUM 4 ST216 No PanSuc -- blaTEM1B,dfrA8,strA,strB,sul2 
PLQ2481-TMP016360 2 KTS089-HAR010 HUM 1-3 ST210 Yes dfrA5,mphA,sul1 
TMP018696-TMP019915 2 MLK023 HUM 7 NVL Yes  
TMP019182-TMP019284 7 KIG019 HUM 6 ST10 Yes aadA1,blaTEM1B,catA1,dfrA1,strA,strB,sul1,sul2 
TMP019273-TMP019279 1 KIG019 HUM 6 ST131 Yes blaTEM-30,mphA,strA,strB,sul2 
ALQ020141-ALQ020449 3 UTH030-UTH029 HUM-POL 6 ST23 No-Yes blaTEM1B,dfrA8,mphA,strA,strB,sul2 
ALQ023299-INT006147 4 SPV064 HUM-POL 2 NVL Yes  
PLQ2189-PLQ2296 6 KTS088 HUM-POL 1 ST538 Yes  
ALQ023299-INT006051 2 SPV064 HUM-RAB 2 NVL Yes  
ALQ028389-INT007544 10 KOR059-MWK057 PIG 7-6 ST48 Yes blaTEM1B,dfrA5,strA,strB,sul2,tetA 
TMP018094-TMP018438 3 KYL026 PIG 6 ST1302 Yes  
ALQ017153-ECL000675 5 KIL042 POL 2 ST6635 Yes  
ALQ017241-ALQ017368 5 HAR011 POL 3 ST1196 Yes aadA1,aadA2,cmlA1,dfrA12,sul3 
ALQ017241-TMP016254 6 HAR011 POL 3 ST1196 Yes aadA1,aadA2,cmlA1,dfrA12,sul3 
ALQ017241-TMP016275 4 HAR011 POL 3 ST1196 Yes aadA1,aadA2,cmlA1,dfrA12,sul3 
        









combination* Wealth ST 
Keeping 
livestock ARGs 
ALQ017368-TMP016254 5 HAR011 POL 3 ST1196 Yes aadA1,aadA2,cmlA1,dfrA12,sul3 
ALQ017368-TMP016275 5 HAR011 POL 3 ST1196 Yes aadA1,aadA2,cmlA1,dfrA12,sul3 
ALQ018881-ALQ019005 9 MAK017 POL 6 ST2309 Yes dfrA14,strA,strB,sul2 
ALQ018914-ALQ019107 8 MAK017 POL 6 ST3333 Yes dfrA14,strA,strB,sul2,tetA -- PanSuc 
ALQ034646-TMP023415 4 EMB085 POL 4 ST223 Yes  
ALQ034661-TMP023356 1 EMB085 POL 4 ST2622 Yes  
ALQ034843-ALQ034865 1 EMB087 POL 4 ST1638 Yes dfrA14,strA,strB,sul2,tetA 
INT003119-INT003176 3 KRR037 POL 2 ST1302 Yes PanSuc -- sul2 
INT003875-INT003892 2 DAN032 POL 6 ST4162 Yes blaTEM1B,dfrA8,strA,strB,sul2,tetB 
INT004680-INT004683 1 KRR037 POL 2 ST5273 Yes strA,strB,sul2,tetA 
INT005129-INT005135 3 EAS043 POL 5 ST48 Yes dfrA14,QnrS1,strA,strB,sul2,tetA 
PLQ000871-PLQ000881 4 MUT082 POL 2 ST746 Yes dfrA14,strA,strB,sul2,tetA 
PLQ2453-PLQ2462 1 KTS089 POL 1 ST162 Yes  
PLQ2453-PLQ2468 2 KTS089 POL 1 ST162 Yes  
PLQ2462-PLQ2468 3 KTS089 POL 1 ST162 Yes  
TMP016254-TMP016275 4 HAR011 POL 3 ST1196 Yes aadA1,aadA2,cmlA1,dfrA12,sul3 
TMP023349-TMP023446 0 EMB085 POL 4 ST189 Yes dfrA14,strA,strB,sul2,tetA 
TWAG1723-TWAG1772 4 BOM091 POL 3 ST2351 Yes  
PLQ000667-TMP022768 6 NGN080 POL-GOAT 5 ST2614 Yes aadA5,dfrA17,sul2,tetA 
TMP015782-TMP021071 3 VIW001-GTN074 POL-GOAT 7-6 ST155 Yes blaTEM1B,dfrA5,strA,strB,sul2,tetA 
INT007394-INT007533 2 MWK056 POL-HUM 6 ST58 Yes strA,strB,sul2,tetA -- PanSuc 
INT008356-TMP022790 8 GTN074-NGN080 POL-HUM 6-5 ST10 Yes  
TMP021678-TMP021689 0 KHW049 POL-HUM 6 ST206 Yes aadA1,aph3'-Ia,dfrA14,mphA,strA,strB,sul2,tetA 
ALQ034833-INT008582 6 EMB087 POL-RAB 4 ST1125 Yes  
ALQ017321-ALQ017332 6 HAR011 RAB 3 ST4568 Yes  
ALQ017321-TMP016046 6 HAR011 RAB 3 ST4568 Yes  
ALQ017321-TMP016335 5 HAR011 RAB 3 ST4568 Yes  
ALQ017332-TMP016046 0 HAR011 RAB 3 ST4568 Yes  
ALQ017332-TMP016335 5 HAR011 RAB 3 ST4568 Yes PanSuc -- aadA1,dfrA1,sul1,tetA 
TMP016046-TMP016335 5 HAR011 RAB 3 ST4568 Yes PanSuc -- aadA1,dfrA1,sul1,tetA 
TWAG00324-TWAG00337 1 MIH068 RAB 5 ST1304 Yes  
TWAG00324-TWAG00343 2 MIH068 RAB 5 ST1304 Yes  









combination* Wealth ST 
Keeping 
livestock ARGs 
TWAG00337-TWAG00343 1 MIH068 RAB 5 ST1304 Yes  
INT006051-INT006147 4 SPV064 RAB-POL 2 NVL Yes  



















11.3 Appendix E for: A cross-sectional survey of practices and 
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Appendix Table E1: Summary of variables  
Theme  Data collected  Data description  
Socio-demographic 
variables  
Type of drug store   Human  
 Veterinary 
Age  Years   
Gender   Male  
 Female 
Educational level High  
 Doctorate degree 
 Master’s degree 
 Bachelor’s degree 
 College (Certificate/Diploma/Higher Diploma) 
Low  
 No formal Education 
 Primary Education 
 Secondary Education 
Number of 
workers in the 
drug store  
Number 
Type of business  Sole proprietorship 
 Joint ownership 
 Chain store 
Respondents role 
in the drug store   
 Owner  
 Full time employee  
 Part time employee 
Duration of 
working in the 
drug store  
 More than 5 years 
 2-4 years 




 Bachelor’s degree (Medicine, pharmacy, vet medicine nursing etc.) 
 Diploma (clinical medicine, pharmacy, animal health etc.) 




appropriate use of 
antimicrobials 
Categorical (yes/no) 
Source of training   Degree/diploma training more than 3 years ago  
 Degree/diploma training less than 3 years ago  
 Continuous development program/workshop (> 3 years ago) 
 Continuous development program/workshop (< 3 years ago) 
Antimicrobials sold 
and sale dynamics  
Antimicrobials 
available in the 
store for sale 




classes (top 4) 
Participants were asked to subjectively describe which 4 antimicrobial classes 
were most commonly sold 
Antimicrobial sale 
changes compared 
to similar period 
in the previous 
year 
 Increased  
 Decreased 
 No change  
Reasons for 
change in 
antimicrobial sales  
 More/less demand from customers 
 More/less institutional procurement procedures   





 Neighbouring wholesaler  
 Wholesaler in a another location in Nairobi county   
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 Wholesaler in a another location outside Nairobi county   
 Drug distribution company   
 Drug manufacturing company 





 Service (i.e. reliability) 











































 Correct dosage 
 Directions for use 
 Storage instructions 
 Potential side effects 
 Expiry date 
 Contra-indications 




antimicrobial to a 
customer 
 Price of antimicrobial 
 Type of antimicrobial 
 Availability of antimicrobial 
 Indications of use 
 Efficacy 
 Adverse reactions/effects 
 Recommended antimicrobial choice 








 Antimicrobial resistance occurs when your body becomes resistant to 
antimicrobials and they no longer work as well 
 Many infections are becoming increasingly resistant to treatment by 
antimicrobials 
 If bacteria are resistant to antimicrobials, it can be very difficult or 
impossible to treat the infections they cause 
 Antimicrobial resistance is an issue that could affect me or my family 
 Antimicrobial resistance is only a problem for people who take 
antimicrobials regularly 
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 Bacteria which are resistant to antimicrobials can be spread from person to 
person 
 Antimicrobial-resistant infections could make medical procedures like 
surgery, organ transplants and cancer treatment much more dangerous 
 Antimicrobial resistance is one of the biggest problems the world faces 
 Antimicrobial resistance is one of the biggest problems Kenya faces 
 I am not at risk of getting an antimicrobial resistant infection, as long as I 




 There is not much people like me can do to stop antimicrobial resistance 
 People should use antimicrobials only when they are prescribed by a doctor 
or nurse 
 Farmers should give fewer antimicrobials to food-producing animals 
 People should not keep antimicrobials and use them later for other illnesses 
 The governments should reward the development of new antimicrobials 
 Pharmaceutical companies should develop new antimicrobials 
 Doctors should only prescribe antimicrobials when they are needed 
 Medical experts will solve the problem of antimicrobial resistance before it 
becomes too serious 
 Everyone needs to take responsibility for using antimicrobials responsibly 
 Parents should make sure all of their children’s vaccinations are up-to-date 
 People should wash their hands regularly 
 
Appendix Table E2. Cronbach’s alpha for responses to ten statements about 
knowledge on antimicrobial resistance 






R S/N alpha se 
Antimicrobial resistance occurs when your 
body becomes resistant to antimicrobials and 
they no longer work as well 0.74 0.75 0.81 0.25 3 0.05 
Many infections are becoming increasingly 
resistant to treatment by antimicrobials 0.72 0.74 0.79 0.24 2.8 0.056 
If bacteria are resistant to antimicrobials, it can 
be very difficult or impossible to treat the 
infections they cause 0.7 0.71 0.78 0.22 2.5 0.059 
Antimicrobial resistance is an issue that could 
affect me or my family 0.69 0.7 0.74 0.2 2.3 0.061 
Antimicrobial resistance is only a problem for 
people who take antimicrobials regularly 0.69 0.72 0.78 0.22 2.5 0.06 
Bacteria which are resistant to antimicrobials 
can be spread from person to person 0.69 0.71 0.78 0.22 2.5 0.061 
Antimicrobial-resistant infections could make 
medical procedures like surgery, organ 
transplants and cancer treatment much more 
dangerous 0.69 0.71 0.78 0.22 2.5 0.06 
Antimicrobial resistance is one of the biggest 
problems the world faces 0.69 0.7 0.76 0.2 2.3 0.06 
Antimicrobial resistance is one of the biggest 
problems Kenya faces 0.67 0.68 0.75 0.19 2.1 0.063 
I am not at risk of getting an antimicrobial 
resistant infection, as long as I take my 
antimicrobials correctly 0.73 0.75 0.8 0.25 3 0.053 
 * G6: Guttman’s lambda 6 - calculated from the squared multiple correlation. 
Average R: average inter-item correlation. 




Appendix Figure E1. Principal component analysis of attitudes and perceptions 
related to antimicrobial resistance, from a sample of 40 human pharmacists and 















Antimicrobial resistance occurs when your body becomes resistant to antimicrobials and they no longer 
work as well 
knowledge_treatment Many infections are becoming increasingly resistant to treatment by antimicrobials 
knowledge_infections 
If bacteria are resistant to antimicrobials, it can be very difficult or impossible to treat the infections 
they cause 
knowledge_family Antimicrobial resistance is an issue that could affect me or my family 
knowledge_ABusepatterns Antimicrobial resistance is only a problem for people who take antimicrobials regularly 
knowledge_AMRspread Bacteria which are resistant to antimicrobials can be spread from person to person 
knowledge_medicalprocedures 
Antimicrobial-resistant infections could make medical procedures like surgery, organ transplants and 
cancer treatment much more dangerous 
knowledge_world Antimicrobial resistance is one of the biggest problems the world faces 
knowledge_kenya Antimicrobial resistance is one of the biggest problems Kenya faces 
knowledge_AMRnorisk 
I am not at risk of getting an antimicrobial resistant infection, as long as I take my antimicrobials 
correctly 





Appendix Table E3. Percentage of responses (strongly agree/agree, strongly 
disagree/disagree and neutral) from 40 human and 19 veterinary pharmacists 
to nine statements about knowledge on antimicrobial resistance.  
 



















       
1. Antimicrobial resistance occurs when your 
body becomes resistant to antimicrobials 
and they no longer work as well 
80% (32) 89.5% (17) 5% (2) 5.3% (1) 15% (6) 10.6% (2) 
2. Many infections are becoming increasingly 
resistant to treatment by antimicrobials 
87.5% (35) 89.5% (17) 5% (2) 5.3% (1) 7.5% (3) 5.3% (1) 
3. If bacteria are resistant to antimicrobials, it 
can be very difficult or impossible to treat 
the infections they cause 
80% (32) 79% (15) 5% (2) 5.3% (1) 15% (6) 15.8% (3) 
4. Bacteria which are resistant to 
antimicrobials can be spread from person to 
person 
52.5% (21) 52.7% (10) 5% (2) 
26.4% 
(5) 
42.5% (17) 21.1% (4) 
5. Antimicrobial-resistant infections could 
make medical procedures like surgery, 
organ transplants and cancer treatment 
much more dangerous 
77.5% (31) 73.7% (14) 15% (6) 15.8% (3) 7.5% (3) 10.6% (2) 
6. Antimicrobial resistance is one of the 
biggest problems the world faces 
87.5% (35) 79% (15) 7.5% (3) 5.3% (1) 5% (2) 15.8% (3) 
7. Antimicrobial resistance is one of the 
biggest problems Kenya faces 
85% (34) 79% (15) 7.5% (3) 5.3% (1) 7.5% (3) 15.8% (3) 
8. Antimicrobial resistance is an issue that 
could affect me or my family 
92.5% (37) 89.5% (17) 0 0 7.5% (3) 5.3% (1) 
9. Antimicrobial resistance is only a problem 
for people who take antimicrobials 
regularly 
40% (16) 52.7% (10) 5% (2) 5.3% (1) 55% (22) 42.2% (8) 
10. I am not at risk of getting an antimicrobial 
resistant infection, as long as I take my 
antimicrobials correctly 
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Appendix Figure E2. Percentage of responses on ten statements about knowledge on antimicrobial resistance from a) 40 human 
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Appendix Table E4. Percentage of responses (agree, disagree and neutral) 
from 40 human and 19 veterinary pharmacists to ten statements on potential 


























1. There is not much people like me 
can do to stop antimicrobial 
resistance 
37.5% (15) 26.4% (5) 10% (4) 
10.6% 
(2) 
52.5% (21) 63.2% (12) 
2. People should use antimicrobials 
only when they are prescribed by a 
doctor or nurse 
82.5% (33) 94.8% (18) 2.5% (1) 5.3% (1) 15% (6) 0 
3. Farmers should give fewer 
antimicrobials to food-producing 
animals 
67.5% (27) 79% (15) 17.5% (7) 0 15% (6) 21.1% (4) 
4. People should not keep 
antimicrobials and use them later 
for other illnesses 
80% (32) 84.3% (16) 7.5% (3) 0 12.5% (5) 15.8% (3) 
5. The governments should reward the 
development of new antimicrobials 
82.5% (33) 73.7% (14) 10% (4) 21.1% (4) 7.5% (3) 5.3% (1) 
6. Pharmaceutical companies should 
develop new antimicrobials 
67.5% (27) 79% (15) 12.5% (5) 21% (4) 20% (8) 0 
7. Doctors should only prescribe 
antimicrobials when they are 
needed 
95% (38) 94.8% (18) 5% (2) 0 0 5.3% (1) 
8. Medical experts will solve the 
problem of antimicrobial resistance 
before it becomes too serious 
77.5% (31) 73.7% (14) 7.5% (3) 21.1% (4) 15% (6) 5.3% (1) 
9. Everyone needs to take 
responsibility for using 
antimicrobials responsibly 
90% (36) 84.3% (16) 2.5% (1) 5.3% (1) 7.5% (3) 10.6% (2) 
10. Parents should make sure all of 
their children’s vaccinations are up-
to-date 
95% (38) 94.7% (18) 0 0 5% (2) 5.3% (1) 
11. People should wash their hands 
regularly 
97.5% (39) 94.7% (18) 0 0 2.5% (1) 5.3% (1) 
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Appendix Figure E3. Percentage of responses on 11 statements about potential solutions to AMR from a) 40 human b) 19 veterinary 
pharmacists 
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Appendix Table E5. Results of a multivariable regression examining the 
influence of sociodemographic factors on prescribing practices in a sample of 40 
and 19 human and veterinary drug stores respectively. 
 
Variable  Estimate Standard 
error  
X2 df p-value 
Veterinary drug store -0.11 0.5 0.2 1 0.66 
Range of antimicrobials -0.1 0.24 0.2 1 0.62 
Medical/vet training  0.38 0.25 2.4 1 0.12 

























11.4 Appendix F for: Co-occurrence patterns of antimicrobial 

















Appendix Table F1. Distribution of AMR genes among plasmid replicon types. 
Columns designate: number of isolates in which the replicon was identified; 
range (median number) of AMR genes detected in isolates with this plasmid 
replicon; number (%) of these isolates in which acquired AMR genes were also 
detected.  
Replicon #isolates #AMR  genes ARGS (%) 
ColRNAI 544 0-15 (5) 347 (63.8) 
IncFII 405 0-15 (4) 245 (60.5) 
IncFIB 396 0-15 (4) 237 (59.8) 
IncQ1 142 0-13 (7) 141 (99.3) 
p0111 142 0-15 (6) 125 (88) 
Col156 130 0-13 (3) 72 (55.4) 
IncHI1B 116 1-15 (5) 88 (75.9) 
ColMG828 111 0-15 (2) 65 (58.6) 
Not detected 78 0-10 (0) 13 (16.7) 
IncFIA 77 0-13 (0) 36 (46.8) 
IncY 77 0-10 (4) 45 (58.4) 
IncI1 75 0-11 (2) 45 (60) 
IncB_O_K_Z 75 0-13 (3) 48 (64) 
Col8282 53 0-15 (6) 42 (79.2) 
IncX1 45 0-10 (5) 36 (80) 
ColpVC 40 0-13 (6) 31 (77.5) 
ColBS512 34 0-13 (6) 28 (82.4) 
IncFIC 31 0-10 (1) 17 (54.8) 
ColMGD2 27 0-13 (6) 21 (77.8) 
ColMP18 27 0-8 (4) 17 (63) 
IncI2 19 0-11 (3) 11 (57.9) 
IncR 19 0-8 (6) 16 (84.2) 
IncX4 18 0-10 (1) 9 (50) 
IncX3 7 1-8 (8) 7 (100) 
IncN 6 7-12 (7.5) 6 (100) 
IncHI2 6 8-15 (11) 6 (100) 
IncHI2A 5 8-15 (10) 5 (100) 
pSL483 5 0-7 (0) 2 (40) 
IncX2 4 0-7 (6) 3 (75) 
pEC4115 3 - - 
ColKP3 1 - 1 








Appendix Figure F1. A heatmap illustration of associations between plasmids 



















































Appendix Table G1. Household 
questionnaire, formatted for use 
with ODK Open Data Kit (ODK) 
Collect software. 
label 
S0Q1: Start time 
S0Q2: End time 
S0Q3: Date 
S0Q4: Device ID 
S0Q5: Simcard serial number 
S0Q6: Device phone number 
S0Q7: Recorder Name 
S0Q8: This questionnaire is being conducted in…? 
S0Q9: Scan household unique barcode on 
Household Master Sheet 
S0Q91: The barcode has not scanned correctly. 
Please go back and try again or enter manually 
S1Q11: Select the first letter of the current 
Sublocation 
S1Q12: Select the current sublocation 
S1Q2: Is this a livestock-owning household? 
S1Q3: Select a household member to start the 
livestock questionnaire 
S2Q1: What is the first name of the household 
head? 
S2Q2: Which gender is ${s2q1_hh_head_id}? 
S2Q3: What is the total number of family members 
in this household? 
S2Q41: How many adult (18 and over) family 
members live in this household? 
S2Q42: How many of the adult family members of 
this household are present today? 
S2Q51: Is the household head present today? 
S2Q52: Did ${s2q1_hh_head_id} provide a faecal 
sample? 
S2Q53: Did ${s2q1_hh_head_id} complete a 
consent form? 
S2Q53B: Unfortunately we cannot accept a faecal 
sample without a completed consent form 
S2Q54: How old is ${s2q1_hh_head_id}? 
S2Q55: What education has ${s2q1_hh_head_id} 
had? 
S2Q56: What ethnicity is ${s2q1_hh_head_id}? 
S2Q57: Which tribe is  ${s2q1_hh_head_id}? 
S2Q58: What is ${s2q1_hh_head_id}'s occupation? 
S2Q59: Does ${s2q1_hh_head_id} work with any of 
the following outside the household? 
S2Q6: Number of adult family members absent 
today  
S2Q60: Adult family members absent today 
S2Q61: What is the first name of the absent family 
member 
S2Q62: Which gender is ${s2q61_adlt_abs_id}? 
S2Q63: What relation is ${s2q61_adlt_abs_id} to 
${s2q1_hh_head_id}? 
S2Q64: What relation is ${s2q61_adlt_abs_id} to 
${s2q1_hh_head_id}? 
S2Q65: Did ${s2q61_adlt_abs_id} provide a faecal 
sample? 
S2Q66: Did ${s2q61_adlt_abs_id} complete a 
consent form? 
S2Q66B: Unfortunately we cannot accept a faecal 
sample without a completed consent form 
S2Q67: How old is ${s2q61_adlt_abs_id}? 
S2Q68: What education has ${s2q61_adlt_abs_id} 
had? 
S2Q69: What ethnicity is ${s2q61_adlt_abs_id}? 
S2Q610: Which tribe is ${s2q61_adlt_abs_id}? 
S2Q611: What is ${s2q61_adlt_abs_id}'s 
occupation? 
S2Q612: Does ${s2q61_adlt_abs_id} work with any 
of the following outside the household? 
S2Q7: How many children (under 18) live in this 
household? 
S2Q612: How many of the children in this 
household are present today? 
S2Q8: Number of children present today 
S2Q81: Number of children absent today  
S2Q82: Children absent today 
S2Q90: What is the first name of the absent child 
S2Q91: Which gender is ${s2q91_chl_abs_id}? 
S2Q92: What relation is ${s2q91_chl_abs_id} to 
${s2q1_hh_head_id}? 
S2Q93: What relation is ${s2q91_chl_abs_id} to 
${s2q1_hh_head_id}? 
S2Q99: Did ${s2q91_chl_abs_id} provide a faecal 
sample? 
S2Q96: Did ${s2q91_chl_abs_id} complete an 
assent form? 
S2Q96B: Unfortunately we cannot accept a faecal 
sample without a completed consent form 
S2Q94: How old is ${s2q91_chl_abs_id}? 
S2Q97: What education has ${s2q91_chl_abs_id} 
had? 
S2Q98: What ethnicity is ${s2q91_chl_abs_id}? 
S2Q910: Which tribe is ${s2q91_chl_abs_id}? 
S2Q911: Does ${s2q91_chl_abs_id} attend school? 
S2Q912: Does ${s2q91_chl_abs_id} eat food 
provided at school? 
S2Q913: Does ${s2q91_chl_abs_id} eat any of these 
from the school? 
S2: Do you employ any staff? 
S2Q10: Staff employed 
S2Q111: How many indoor staff (maids / cleaning 
staff / housekeepers / cook/nanny, etc) do you 
employ? 
S2Q112: Number of indoor staff 
S2Q113: How many guards do you employ? 
S2Q114: Number of guards 
S2Q115: How many farmhands / gardeners do you 
employ? 
S2Q116: Number of farmhands 
S2Q12: Number of staff employed 
S2Q121: How many staff are present today? 
S2Q122: Number of staff present 
S2Q13: Do any other non-family members (eg. 
friends, tenants) live in the household? 
S2Q131: How many non-family members live in the 
house? 
S2Q132: How many of them are present today? 
S2Q133: Number of other adults present today 
S2Q14: Total number of people present in the 
household today 




S2Q15: The total number of people present in the 
household today is ${s2q14_sum_pres}. Is this 
correct? 
S3Q0: The next section of the questionnaire relates 
to your house and land 
S3Q1: Which of these best describes the housing 
type? 
S3Q2: Do you own the house / apartment? 
S3Q3: Do you own the land on which the house is 
built? 
S3Q4: Was the house…? 
S3Q5: How many hectares of land do you have at 
this location? 
S3Q4: Which of these best describes your 
situation? 
S3Q5: How much rent do you pay per month? 
S3Q6: Do you own and/or rent any land 
elsewhere? 
S3Q7: Land owned or rented 
S3Q8: Current land status 
S3Q9: Where is the land that you 
${s3q91_land_curr}? 
S3Q91: Location of land 
S3Q10: Current land location 
S3Q11: Location of land 
S3Q91: What is the name of sublocation / region 
where your land is located? 
S3Q7: How many hectares of land do you 
${s3q91_land_curr} ${s3q111_land_loc_curr} 
Nairobi? 
S3Q8: How many hectares of the land that you 
${s3q91_land_curr} ${s3q111_land_loc_curr} Nairobi 
is used for agriculture? 
S3Q9: Do you keep any livestock on the land that 
you ${s3q91_land_curr} ${s3q111_land_loc_curr} 
Nairobi? 
  
S3Q10: Which of these livestock do you keep on 
the land that you ${s3q91_land_curr} 
${s3q111_land_loc_curr} Nairobi? 
S3Q8: How many rooms in your house? 
S3Q114: How many bedrooms in your house? 
S3Q10: How many rooms do you rent out? 
S3Q11: What is the floor made from? 
S3Q12: What are the walls made from? 
S3Q13: What is the roof made from? 
S3Q15: Transport 
S3Q15: Does anyone in the household own a car or 
truck? 
S3Q16: Does anyone in the household own a 
motorbike or scooter? 
S3Q171: Does anyone in the household own a 
bicycle? 
S3Q172: Does anyone in the household own an 
animal-drawn cart? 
S3Q17: Electrical items 
S3Q171: Does the household have electricity? 
S3Q172: Does the household have a solar panel? 
S3Q172: Do you own a refrigerator? 
S3Q173: Do you own a television? 
S3Q183: Do you own a radio? 
S3Q183: Personal belongings 
S3Q184: Does anyone in the household own a 
watch? 
S3Q185: Does anyone in the household own a 
mobile phone? 
S3Q191: Where does your household do most of its 
cooking? 
S3Q192: Which sources of cooking fuel do you use? 
S3Q25: What is your main source of lighting? 
S3Q26: What is your main source of drinking 
water? 
S3Q27: What is your main source of non-drinking 
water? 
S3Q27: Do you have a water tank? 
S3Q28: Do you use any water treatments for 
drinking water? 
S3Q29: How would you rate the water quality? 
S3Q30: Is the water supply always regular? 
S3Q31: What type of toilet facility does your family 
use? 
S3Q32: Where is the facility located? 
S3Q33: Do you share this facility with other 
families? 
S3Q34: What happens to waste water? 
S3Q35: How do you dispose of household waste? 
S3Q36: What do you do with animal waste? 
S4Q11: Do you see any of the following types of 
wild animal around your property? 
S4Q12: Which of the following carnivores have you 
seen around your property? 
S4Q13: Which of the following primates have you 
seen around your property? 
S4Q20: Wildlife encounters 
S4Q21: Current wildlife type 
S4Q22: Where do you see ${s4q21_curr_wl}s? 
S4Q23: Do you ever see ${s4q21_curr_wl}s inside 
the house? 
S4Q24: Do you ever see ${s4q21_curr_wl}s inside 
the kitchen? 
S4Q25: Approximately how many 
${s4q21_curr_wl}s do you see inside the house 
and/or kitchen? 
S4Q26: per… 
S4Q27: Do you ever see ${s4q21_curr_wl}s inside 
the animal housing? 
S4Q28: Approximately how many 
${s4q21_curr_wl}s do you see in the animal 
housing? 
S4Q29: per… 
S4Q210: Approximately how many 
${s4q21_curr_wl}s do you see outside? 
S4Q211: per… 
S4Q30: How often do you see ${s4q21_curr_wl}s? 
S4Q31: Do you think ${s4q21_curr_wl}s cause your 
family any of the following problems? 
S4Q32: Do you think ${s4q21_curr_wl}s cause your 
family any of the following problems? 
S4Q33: Are there any measures you use to try and 
control ${s4q21_curr_wl}s? 
S4Q34: What type of poison do you use? 
S4Q35: How many ${s4q21_curr_wl}s do you trap? 
S4Q36: Number of ${s4q21_curr_wl}s trapped... 
S4Q37: per… 
S4Q9: Has anyone in the household ever been 
bitten by a ${s4q21_curr_wl}? 
S5Q1: You have finished the questionnaire! Thank 
you very much.  




S5Q2: If any absent family members have provided 
consent and faecal samples, collect them now 
S5Q20: Household head absent - faecal sample left 
S5Q21: You now need to make one swab from 
${s2q1_hh_head_id}'s stool sample and place in 
Amies transport media. Make a second swab and 
place in Trizol 
S5Q22: Label and scan the faecal sample pot for 
${s2q1_hh_head_id} 
S5Q22B: The barcode has not scanned correctly. 
Please go back and try again or enter manually 
S5Q23: Label and scan the Amies faecal swab 
${s2q1_hh_head_id} 
S5Q23B: The barcode has not scanned correctly. 
Please go back and try again or enter manually 
S5Q24: Label and scan the Trizol faecal swab for 
${s2q1_hh_head_id} 
S5Q24B: The barcode has not scanned correctly. 
Please go back and try again or enter manually 
S5Q30: Adult family members absent today 
S5Q31: Current adult family member absent today  
S5Q32: Current adult family member sample 
provided?  
S5Q33: Current adult family member consent 
provided?  
S5Q34: You now need to make one swab from 
${s5q31_adlt_abst_no}'s stool sample and place in 
Amies transport media. Make a second swab and 
place in Trizol 
S5Q35: Label and scan the faecal sample pot for 
${s5q31_adlt_abst_no} 
S5Q35B: The barcode has not scanned correctly. 
Please go back and try again or enter manually 
S5Q36: Label and scan the faecal swab for 
${s5q31_adlt_abst_no} 
S5Q36B: The barcode has not scanned correctly. 
Please go back and try again or enter manually 
S5Q37: Label and scan the Trizol faecal swab for 
${s5q31_adlt_abst_no} 
S5Q37B: The barcode has not scanned correctly. 
Please go back and try again or enter manually 
S5Q40: Child family members absent today 
S5Q41: Current child family member absent today  
S5Q42: Current child family member sample 
provided?  
S5Q43: Current child family member consent 
provided?  
S5Q44: You now need to make one swab from 
${s5q41_child_abst_no}'s stool sample and place in 
Amies transport media. Make a second swab and 
place in Trizol 
S5Q45: Label and scan the faecal sample pot for 
${s5q41_child_abst_no} 
S5Q45B: The barcode has not scanned correctly. 
Please go back and try again or enter manually 
S5Q46: Label and scan the faecal swab for 
${s5q41_child_abst_no} 
S5Q46B: The barcode has not scanned correctly. 
Please go back and try again or enter manually 
S5Q47: Label and scan the Trizol faecal swab for 
${s5q41_child_abst_no} 
S5Q47B: The barcode has not scanned correctly. 
Please go back and try again or enter manually 
S5Q51: Capture the GPS of the current location. 

























Appendix Table G2. Livestock-
keeping questionnaire formatted 
for use with ODK Open Data Kit 
(ODK) Collect 
label 
S0Q1: Start time 
S0Q3: Date 
S0Q4: Device ID 
S0Q5: Simcard serial number 
S0Q6: Device phone number 
S0Q7: Recorder Name 
S0Q8: Scan household unique barcode on 
Household Master Sheet 
S0Q8.1: The barcode has not scanned correctly. 
Please go back and try again or enter manually 
S1Q1.0: Which types of animals are present in the 
households today? 
S4Q1.1: Which of the following ruminant species 
are present in this household today? 
S4Q1.2: Which of the following monogastric 
species are present in this household today? 
S4Q1.4: Which of the following types of bird are 
present in this household today? 
S4Q1.5: Which of the following types of bird are 
present in this household today? 
S4Q1.6: Which of the following other species are 
present in this household today? 
S4Q1.61: Specify other type(s) of poultry 
S4Q1.3: Which of the following other species are 
present in this household today? 
S41.31: Specify other type(s) of animals 
S1Q2.0: Use a combination of the farmer's 
knowledge and your own observations when 
completing this section 
S1Q2.1: Which breed(s) of beef cattle do you own? 
S1Q2.2: Number of beef cattle owned 
S1Q2.3: How many breeding beef bulls do you 
own? 
S1Q2.4: How many breeding beef cows do you 
own? 
S1Q2.5: How many beef bullocks / steers / heifers 
do you own? 
S1Q2.6: How many beef calves (<6 months old) do 
you own? 
S1Q2.7: Total number of beef animals 
S1Q3.1: Which breed(s) of dairy cattle do you own? 
S1Q3.2: Number of dairy cattle owned 
S1Q3.3: How many breeding dairy bulls do you 
own? 
S1Q3.4: How many lactating dairy cows do you 
own? 
S1Q3.5: How many dry cows do you own? 
S1Q3.6: How many heifers do you own? 
S1Q3.7: How many dairy calves (<6 months old) do 
you own? 
  
S1Q3.8: Total number of dairy animals 
S1Q4.1: Do you have any dairy breed bullocks / 
steers that you are rearing for meat? 
S1Q4.2: How many dairy bullocks / steers do you 
own? 
S1Q4.3: Total number of dairybeef animals 
S1Q4.4: Total number of cattle 
S1Q4.5: The total number of cattle present on the 
premises today is ${s1q4.4_ctl_total} 
S1Q4.6: How many separate groups are these 
animals kept in? 
S1Q5.1: Specify breed of meat goat, if known 
S1Q5.2: Number of meat goats owned 
S1Q5.3: How many breeding bucks do you own? 
S1Q5.4: How many breeding does do you own? 
S1Q5.5: How many rearing stock ( approx 4-12 
months old) do you own? 
S1Q5.6: How many kids (≤ 3 months old) do you 
own? 
S1:  
S1Q5.7: Total number of meat goats 
S1Q6.1: Which breed(s) of dairy goats do you own? 
S1Q6.2: Number of dairy goats owned 
S1Q6.3: How many breeding dairy bucks do you 
own? 
S1Q6.4: How many lactating dairy goats do you 
own? 
S1Q6.5: How many dry/ pregnant goats do you 
own? 
S1Q6.6: How many doelings (not yet kidded) do 
you own? 
S1Q6.7: How many dairy kids(≤ 3 months old) do 
you own? 
S1:  
S1Q6.8: Total number of dairy goats 
S1Q7.1: Do you have any dairy breed 
bucks/wethers that you are rearing for meat? 
S1Q7.2: How many dairy goats being reared for 
meat do you own? 
S1Q7.3: Total number of dairymeat goats 
S1Q7.4: Total number of goats 
S1Q7.5: The total number of goats present on the 
premises today is ${s1q7.4_gt_total} 
S1Q7.6: How many separate groups are these 
animals kept in? 
S1Q8.1: Which breed(s) of sheep do you own? 
S1Q8.2: Number of sheep owned 
S1Q8.3: How many breeding rams do you own? 
S1Q8.4: How many breeding ewes do you own? 
S1Q8.5: How many fattening lambs (4-12 months 
old) do you own? 
S1Q8.6: How many lambs(≤ 3 months old) do you 
own? 
S1:  
S1Q8.7: Total number of sheep 
S1Q8.8: The total number of sheep present on the 
premises today is ${s1q8.7_shp_total} 
S1Q8.9: How many separate groups are these 
animals kept in? 
S1Q9.1: Which breed(s) of pig do you own? 
S1Q9.2: Number of pigs owned 
S1Q9.3: How many breeding boars do you own? 
S1Q9.4: How many breeding sows do you own? 
S1Q9.5: How many weaners / rearers / finishers do 
you own (5 weeks old and over) ? 
S1Q9.6: How many piglets(<5 weeks old) do you 
own? 
S1:  




S1Q9.7: Total number of pigs 
S1Q9.8: The total number of pigs present on the 
premises today is ${s1q9.7_pig_total} 
S1Q9.9: How many separate groups are these 
animals kept in? 
S1Q10.1: Which breed(s) of rabbit do you own? 
S1Q10.2: Number of rabbits owned 
S1Q10.3: How many breeding bucks do you own? 
S1Q10.4: How many breeding does do you own? 
S1Q10.5: How many rabbit kittens / young stock do 
you own? 
S1:  
S1Q10.6: Total number of rabbits 
S1Q10.7: The total number of rabbits present on 
the premises today is ${s1q10.6_rbt_total} 
S1Q10.8: How many separate groups are these 
animals kept in? 
S1Q11.0: Chicken Type 
S1Q11.1: Current Chicken Type 
S1Q11.2: Number of ${s1q11.1_curr_chkn} chickens 
owned 
S1Q11.3: How many adult cocks do you own? 
S1Q11.4: How many laying / breeding hens do you 
own? 
S1Q11.5: How many pullets do you own (6 weeks to 
point of lay) ? 
S1Q11.6: How many broiler chickens do you own? 
S1Q11.7: How many chicks or other immature birds 
do you own? 
S1Q11.8: How many separate groups are chickens 
kept in? 
S1Q12.0: Other poultry Type 
S1Q12.1: Current  Type (Other poultry species) 
S1Q12.11: Current livestock type 
S1Q12.2: Number of ${s1q12.11_curr_sp} owned 
S1Q12.3: How many adult males do you own? 
S1Q12.4: How many laying / breeding females do 
you own? 
S1Q12.5: How many immature birds do you own? 
S1:  
S1Q12.6: How many separate groups are 
${s1q12.11_curr_sp} kept in? 
S1:  
S1Q13: How many horses / donkeys / mules do you 
own? 
S1Q14: How many camels do you own? 
S1Q15: How many cats do you own? 
S1Q16: How many dogs do you own? 
S1Q17: How many ${s41.31_other_spp_own} do you 
own? 
S2Q10.2: Livestock management 
S2Q10.3: Current ruminant type 
S2Q10.4: Is there purpose-built housing for the 
${s2q1.1_curr_rum}? 
S2Q10.5: Cleaning practices 
S2: How often do you clean the housing? 
S2Q10.6: Do you use disinfectant to clean the 
housing? 
S2Q13: Are the ${s2q1.1_curr_rum} allowed to graze 
/ scavenge? 
S2Q13: Which of the following do you feed the 
${s2q1.1_curr_rum}? 
S2Q14: Ruminant access to house 
S2Q1.2: Do your ${s2q1.1_curr_rum} share or have 
access to your general living areas? 
S2Q1.4: Do your ${s2q1.1_curr_rum} have access to 
food preparation areas? 
S2Q11.3: Livestock management 
S2Q11.4: Current monogastric type 
S2Q11.5: Is there purpose-built housing for the 
${s2q2.1_curr_mono}? 
S2Q11.6: Cleaning practices 
S2Q11.7: How often do you clean the housing? 
S2: Do you use disinfectant to clean the housing? 
S2Q1.7: Are the ${s2q2.1_curr_mono} allowed to 
graze / scavenge? 
S2Q1.7: Which of the following do you feed the 
${s2q2.1_curr_mono}? 
S2Q1.8: Monogastrics access to house 
S2Q2.2: Do your ${s2q2.1_curr_mono} share or 
have access to your general living areas? 
S2Q2.4: Do your ${s2q2.1_curr_mono} have access 
to food preparation areas? 
  
  
S2Q1.1: Chicken management 
S2Q1.2: Current chicken type 
S2Q1.3: Is there purpose-built housing for the 
${s2q3.1_curr_chkn} chickens? 
S2Q1.4: Chicken cleaning practices 
S2Q1.5: How often do you clean the housing? 
S2Q1.6: Do you use disinfectant to clean the 
housing? 
S2Q1.7: Are the ${s2q3.1_curr_chkn} chickens 
allowed to scavenge? 
S2: Which of the following do you feed the 
${s2q3.1_curr_chkn} chickens? 
S2Q2.8: Chickens access to house 
S2Q3.1: Do your ${s2q3.1_curr_chkn} chickens 
share or have access to your general living areas? 
S2Q3.3: Do your ${s2q3.1_curr_chkn} have access 
to food preparation areas? 
S2: Poultry management 
S2Q4.1: Current poultry type 
S2Q2.0: Current poultry type 
S2Q2.1: Is there purpose-built housing for the 
${s2q4.11_curr_pltry}? 
S2Q2.2: Poultry cleaning practices 
S2Q2.3: How often do you clean the housing? 
S2Q2.4: Do you use disinfectant to clean the 
housing? 
S2Q2.6: Are the ${s2q4.11_curr_pltry}  allowed to 
scavenge? 
S2Q2.10: Which of the following do you feed the 
${s2q4.11_curr_pltry}? 
S2Q2.8: Poultry access to house 
S2Q4.11: Do your ${s2q4.11_curr_pltry} share or 
have access to your general living areas? 
S2Q4.3: Do your ${s2q4.11_curr_pltry} have access 
to food preparation areas? 
S3Q3.5: Ruminant value chains 
S3: Current ruminant type 
S3Q3.6: How many different sources do your 
${s3q1.1_curr_rum} come from? 
S3Q3.7: Which is the main source of your 
${s3q1.1_curr_rum}? 
S3Q3.8: Can you tell us the location of the 
${s3q1.3_source}? 
S3Q3.9: Secondary sources 




S3: What is the next source of your 
${s3q1.1_curr_rum}? 
S3Q4.0: Can you tell us the location of the 
${s3q1.6_source}? 
  
S3Q1.8: What do you use your ${s3q1.1_curr_rum} 
for? 
S3Q1.9: What happens to breeding / milking 
animals at the end of their productive life? 
S3Q2.4: Approximately how many 
${s3q1.1_curr_rum} have you sold in the past year? 
S3Q2.5: Where do you sell your 
${s3q1.1_curr_rum}? 
S3Q2.6: Which market / abbattoir do you use? 
S3: Where do you sell milk from your 
${s3q1.1_curr_rum} 
S3Q4.3: Monogastric value chains 
S3Q4.4: Current monogastric type 
S3Q4.5: How many different sources do your 
${s3q2.1_curr_mono} come from? 
S3: Which is the main source of your 
${s3q2.1_curr_mono}? 
S3Q4.7: Can you tell us the location of the 
${s3q2.3_source}? 
S3Q2.8: Secondary sources 
S3Q4.8: What is the next source of your 
${s3q2.1_curr_mono}? 
S3: Can you tell us the location of the 
${s3q2.6_source}? 
S3Q2.8: What do you use your 
${s3q2.1_curr_mono} for? 
S3Q2.9: What happens to breeding animals at the 
end of their productive life? 
S3Q2.10: Approximately how many 
${s3q2.1_curr_mono} have you sold in the past 
year? 
S3Q2.11: Where do you sell your 
${s3q2.1_curr_mono}? 
S3Q2.12: Which market / abbattoir do you use? 
S3Q2.13: In which subloaction is the community 
slab that you sell to? 
S3Q3.0: Chicken value chains 
S3Q3.1: Current chicken type 
S3Q3.2: How many different sources do your 
${s3q3.1_curr_chkn} chickens come from? 
S3Q3.3: Which is the main source of your 
${s3q3.1_curr_chkn} chickens? 
S3Q3.4: Can you tell us the location of the 
${s3q3.3_source}? 
S3Q3.5: Which commercial hatchery do your 
chickens come from? 
S3Q3.6: Secondary sources 
S3Q3.7: What is the next source of your 
${s3q3.1_curr_chkn} chickens? 
S3Q3.8: Can you tell us the location of the 
${s3q3.7_source}? 
S3Q3.9: Which commercial hatchery do your 
chickens come from? 
S3Q3.10: What do you use your 
${s3q3.1_curr_chkn} chickens for? 
S3Q3.11: What happens to laying birds at the end 
of their productive life? 
S3Q3.12: Approximately how many 
${s3q3.1_curr_chkn} chickens have you sold in the 
past year? 
S3Q3.13: How do you sell your ${s3q3.1_curr_chkn} 
chickens? 
S3Q3.14: Where do you sell your 
${s3q3.1_curr_chkn} chickens? 
S3Q3.15: Where do you sell carcasses from your 
${s3q3.1_curr_chkn} chickens? 
S3Q3.16: Where do you sell heads and feet from 
your ${s3q3.1_curr_chkn} chickens? 
S3Q3.17: Where do you sell intestines from your 
${s3q3.1_curr_chkn} chickens? 
S3Q3.18: If selling to a broker: 
S3Q3.19: Do you know where the broker/trader 
sells your ${s3q3.1_curr_chkn} chickens? 
S3Q3.20: Specify: 
S3Q3.15: Where do you sell eggs from your 
${s3q3.1_curr_chkn} chickens 
S3Q4.0: Poultry value chains 
S3Q4.1: Current poultry type 
S3Q4.11: Current poultry type 
S3Q4.2: How many different sources do your 
${s3q4.11_curr_pltry} come from? 
S3Q4.3: Which is the main source of your 
${s3q4.11_curr_pltry}? 
S3Q4.4: Can you tell us the location of the 
${s3q4.3_source}? 
S3Q4.5: Secondary sources 
S3Q4.6: What is the next source of your 
${s3q4.11_curr_pltry}? 
S3Q4.7: Can you tell us the location of the 
${s3q4.6_source}? 
S3Q4.8: What do you use your 
${s3q4.11_curr_pltry} for? 
S3Q4.9: What happens to laying birds at the end 
of their productive life? 
S3Q4.10: Approximately how many 
${s3q4.11_curr_pltry} have you sold in the past 
year? 
S3Q4.11: Where do you sell your 
${s3q4.11_curr_pltry} ? 
S3Q4.13: Where do you sell eggs from your 
${s3q4.11_curr_pltry} 
:  
S3Q16: Are there any other reasons that you keep 
livestock? 
S4Q1: Have any of your animals had any health 
problems in the last six months? 
S4Q2.0: Animals with health problems 
S4Q2.1: Current livestock type 
S4Q2.2: Have your ${s4q2.1_curr_sp} had any 
health problems in the last 6 months? 
S4Q2.3: Did you use any antibiotics to treat the 
${s4q2.1_curr_sp}? 
S4Q2.4: What drug formulation(s) did you use? 
S4Q2.41: Please specify "other" formulation 
S4Q2.5: Antibiotic use 
S4Q2.6: Current formulation 
S4Q2.71: Which ${s4q2.6_curr_form} antibiotics 
did you use? 
S4Q2.72: Which ${s4q2.6_curr_form} antibiotics 
did you use? 
S4Q2.73: Which ${s4q2.6_curr_form} antibiotics 
did you use? 
S4Q2.74: Which ${s4q2.6_curr_form} antibiotics 
did you use? 




S4Q2.75: Which ${s4q2.6_curr_form} antibiotics 
did you use? 
S4Q2.8: What was the name of the drug? 
S4Q2.9: Was the ${s4q2.6_curr_form} antibiotic 
a...? 
S4Q2.10: Do you know the dose (mg) or volume 
(ml) of the ${s4q2.6_curr_form} antibiotic given? 
S4Q2.11: What was the amount of 
${s4q2.6_curr_form} antibiotic given (per dose)? 
S4Q2.12: Select whether dosage reported is in mg 
or ml. 
S4Q2.12B: In what volume of water (litres) was this 
given? 
S4Q2.13: How many ${s4q2.1_curr_sp} were 
treated? 
S4Q2.14: How often was the ${s4q2.6_curr_form} 
antibiotic given? 
S4Q2.15: For how many days was the 
${s4q2.6_curr_form} antibiotic used? 
S4Q2.16: Were any doses missed? 
S4Q2.17: Do you know when the last dose of drug 
was given ? 
S4Q2.18: Any other relevant information 
S4Q2.19: Do you give your ${s4q2.1_curr_sp} any 
drugs routinely to prevent disease? 
S4Q2.20: Which type(s) of drugs do you routinely 
use in your ${s4q2.1_curr_sp}? 
S4Q2.21: Prophylactic drug use 
S4Q2.22: Current drug type 
S4Q2.23: Can you tell us the name of the 
${s4q2.22_curr_drug} that you normally use in 
your  ${s4q2.1_curr_sp}? 
S4:  
S4:  
S4Q3.0: Animals with health problems 
S4Q3.1: Current livestock type 
S4Q3.2: Have your ${s4q3.1_curr_sp} had any 
health problems in the last 6 months? 
S4Q3.3: Did you use any antibiotics to treat the 
${s4q3.1_curr_sp}? 
S4Q3.4: What drug formulation(s) did you use? 
S4Q3.41: Please specify "other" formulation 
S4Q3.5: Antibiotic use 
S4Q3.6: Current formulation 
S4Q3.71: Which ${s4q3.6_curr_form} antibiotics 
did you use? 
S4Q3.73: Which ${s4q3.6_curr_form} antibiotics 
did you use? 
S4Q3.74: Which ${s4q3.6_curr_form} antibiotics 
did you use? 
S4Q3.75: Which ${s4q3.6_curr_form} antibiotics 
did you use? 
S4Q3.8: What was the name of the drug? 
S4Q3.9: Was the ${s4q3.6_curr_form} antibiotic 
a...? 
S4Q3.10: Do you know the dose (mg) or volume 
(ml) of the ${s4q3.6_curr_form} antibiotic given? 
S4Q3.11: What was the amount of 
${s4q3.6_curr_form} antibiotic given (per dose)? 
S4Q3.12: Select whether dosage reported is in mg 
or ml. 
S4Q3.12B: In what volume of water (litres) was this 
given? 
S4Q3.13: How many ${s4q3.1_curr_sp} were 
treated? 
S4Q3.14: How often was the ${s4q3.6_curr_form} 
antibiotic given? 
S4Q3.15: For how many days was the 
${s4q3.6_curr_form} antibiotic used? 
S4Q3.16: Were any doses missed? 
S4Q3.17: Do you know when the last dose of drug 
was given ? 
S4Q3.18: Any other relevant information 
S4Q3.19: Do you give your ${s4q3.1_curr_sp} any 
drugs routinely to prevent disease? 
S4Q3.20: Which type(s) of drugs do you routinely 
use in your ${s4q3.1_curr_sp}? 
S4Q3.21: Prophylactic drug use 
S4Q3.22: Current drug type 
S4Q3.23: What ${s4q3.22_curr_drug} 
formulation(s) do you use? 
S4Q3.24: Antibiotic use 
S4Q3.25: Which in-feed antibiotic do you use? 
S4Q3.26: Which in-feed anticoccidial do you use? 
S4Q3.27: What is the name of the drug? 
S4Q3.28: How is the in-feed ${s4q3.22_curr_drug} 
delivered? 
S4Q3.29: Is the in-feed ${s4q3.22_curr_drug} 
given...? 
S4Q3.30: Any other relevant information 
S4Q3.31: Antibiotic use 
S4Q3.32: Which in-water antibiotic do you use? 
S4Q3.33: Which in-water anticoccidial do you use? 
S4Q3.34: What is the name of the drug? 
S4Q3.35: Is the in-water ${s4q3.22_curr_drug} 
given...? 
S4Q3.36: How often do you replace the in-water 
${s4q3.22_curr_drug}? 
S4Q3.37: Any other relevant information 
S4Q3.38: Can you tell us the name of the 
${s4q3.22_curr_drug} that you normally use in 
your  ${s4q3.1_curr_sp}? 
S4Q4.0: Animals with health problems 
S4Q4.1: Current livestock type 
S4Q4.2: Have your ${s4q4.1_curr_sp} chickens had 
any health problems in the last 6 months? 
S4Q4.3: Did you use any antibiotics to treat the 
${s4q4.1_curr_sp} chickens? 
S4Q4.4: What drug formulation(s) did you use? 
S4Q4.41: Please specify "other" formulation 
S4Q4.5: Antibiotic use 
S4Q4.6: Current formulation 
S4Q4.71: Which ${s4q4.6_curr_form} antibiotics 
did you use? 
S4Q4.73: Which ${s4q4.6_curr_form} antibiotics 
did you use? 
S4Q4.74: Which ${s4q4.6_curr_form} antibiotics 
did you use? 
S4Q4.75: Which ${s4q4.6_curr_form} antibiotics 
did you use? 
S4Q4.8: What was the name of the drug? 
S4Q4.9: Was the ${s4q4.6_curr_form} antibiotic 
a...? 
S4Q4.10: Do you know the dose (mg) or volume 
(ml) of the ${s4q4.6_curr_form} antibiotic given? 
S4Q4.11: What was the amount of 
${s4q4.6_curr_form} antibiotic given (per dose)? 
S4Q4.12: Select whether dosage reported is in mg 
or ml. 




S4Q4.12B: In what volume of water (litres) was this 
given? 
S4Q4.13: How many ${s4q4.1_curr_sp} were 
treated? 
S4Q4.14: How often was the ${s4q4.6_curr_form} 
antibiotic given? 
S4Q4.15: For how many days was the 
${s4q4.6_curr_form} antibiotic used? 
S4Q4.16: Were any doses missed? 
S4Q4.17: Do you know when the last dose of drug 
was given ? 
S4Q4.18: Any other relevant information 
S4Q4.19: Do you give your ${s4q4.1_curr_sp} 
chickens any drugs routinely to prevent disease? 
S4Q4.20: Which type(s) of drugs do you routinely 
use in your ${s4q4.1_curr_sp} chickens? 
S4Q4.21: Prophylactic drug use 
S4Q4.22: Current drug type 
S4Q4.23: What ${s4q4.22_curr_drug} 
formulation(s) do you use? 
S4Q4.24: Antibiotic use 
S4Q4.26: Which in-feed antibiotic do you use? 
S4Q4.27: Which in-feed anticoccidial do you use? 
S4Q4.28: What is the name of the drug? 
S4Q4.29: How is the in-feed ${s4q4.22_curr_drug} 
delivered? 
S4Q4.30: Is the in-feed ${s4q4.22_curr_drug} 
given...? 
S4Q4.32: Any other relevant information 
S4Q4.33: Antibiotic use 
S4Q4.34: Which in-water antibiotic do you use? 
S4Q4.35: Which in-water anticoccidial do you use? 
S4Q4.36: What is the name of the drug? 
S4Q4.37: Is the in-water ${s4q4.22_curr_drug} 
given...? 
S4Q4.38: How often do you replace the in-water 
${s4q4.22_curr_drug}? 
S4Q4.39: Any other relevant information 
S4Q4.40: Can you tell us the name of the 
${s4q4.22_curr_drug} that you normally use in 
your  ${s4q4.1_curr_sp} chickens? 
S4Q5.0: Animals with health problems 
S4Q5.1: Current livestock type 
S4Q5.11: Current livestock type 
S4Q5.2: Have your ${s4q5.11_curr_sp} had any 
health problems in the last 6 months? 
S4Q5.3: Did you use any antibiotics to treat the 
${s4q5.11_curr_sp}? 
S4Q5.4: What drug formulation(s) did you use? 
S4Q5.41: Please specify "other" formulation 
S4Q5.5: Antibiotic use 
S4Q5.6: Current formulation 
S4Q5.71: Which ${s4q5.6_curr_form} antibiotics 
did you use? 
S4Q5.73: Which ${s4q5.6_curr_form} antibiotics 
did you use? 
S4Q5.74: Which ${s4q5.6_curr_form} antibiotics 
did you use? 
S4Q5.75: Which ${s4q5.6_curr_form} antibiotics 
did you use? 
S4Q5.8: What was the name of the drug? 
S4Q5.9: Was the ${s4q5.6_curr_form} antibiotic 
a...? 
S4Q5.10: Do you know the dose (mg) or volume 
(ml) of the ${s4q5.6_curr_form} antibiotic given? 
S4Q5.11: What was the amount of 
${s4q5.6_curr_form} antibiotic given (per dose)? 
S4Q5.12: Select whether dosage reported is in mg 
or ml. 
S4Q5.12B: In what volume of water (litres) was this 
given? 
S4Q5.13: How many ${s4q5.11_curr_sp} were 
treated? 
S4Q5.14: How often was the ${s4q5.6_curr_form} 
antibiotic given? 
S4Q5.15: For how many days was the 
${s4q5.6_curr_form} antibiotic used? 
S4Q5.16: Were any doses missed? 
S4Q5.17: Do you know when the last dose of drug 
was given ? 
S4Q5.18: Any other relevant information 
S4Q5.19: Do you give your ${s4q5.11_curr_sp} any 
drugs routinely to prevent disease? 
S4Q5.20: Which type(s) of drugs do you routinely 
use in your ${s4q5.11_curr_sp}? 
S4Q5.21: Prophylactic drug use 
S4Q5.22: Current drug type 
S4Q5.23: What ${s4q5.22_curr_drug} 
formulation(s) do you use? 
S4Q5.24: Antibiotic use 
S4Q5.25: Which in-feed antibiotic do you use? 
S4Q5.26: Which in-feed anticoccidial do you use? 
S4Q5.27: What is the name of the drug? 
S4Q5.28: How is the in-feed ${s4q5.22_curr_drug} 
delivered? 
S4Q5.29: Is the in-feed ${s4q5.22_curr_drug} 
given...? 
S4Q5.30: Any other relevant information 
S4Q5.31: Antibiotic use 
S4Q5.32: Which in-water antibiotic do you use? 
S4Q5.33: Which in-water anticoccidial do you use? 
S4Q5.34: What is the name of the drug? 
S4Q5.35: Is the in-water ${s4q5.22_curr_drug} 
given...? 
S4Q5.36: How often do you replace the in-water 
${s4q5.22_curr_drug}? 
S4Q5.37: Any other relevant information 
S4Q5.38: Can you tell us the name of the 
${s4q5.22_curr_drug} that you normally use in 
your  ${s4q5.11_curr_sp}? 
S4Q6.0: Animals with health problems 
S4Q6.1: Current livestock type 
S4Q6.11: Current livestock type 
S4Q6.2: Have your ${s4q6.11_curr_sp} had any 
health problems in the last 6 months? 
S4Q6.3: Did you use any antibiotics to treat the 
${s4q6.11_curr_sp}? 
S4Q6.4: What drug formulation(s) did you use? 
S4Q6.41: Please specify "other" formulation 
S4Q6.5: Antibiotic use 
S4Q6.6: Current formulation 
S4Q6.71: Which ${s4q6.6_curr_form} antibiotics 
did you use? 
S4Q6.73: Which ${s4q6.6_curr_form} antibiotics 
did you use? 
S4Q6.74: Which ${s4q6.6_curr_form} antibiotics 
did you use? 
S4Q6.75: Which ${s4q6.6_curr_form} antibiotics 
did you use? 
S4Q6.8: What was the name of the drug? 




S4Q6.9: Was the ${s4q6.6_curr_form} antibiotic 
a...? 
S4Q6.10: Do you know the dose (mg) or volume 
(ml) of the ${s4q6.6_curr_form} antibiotic given? 
S4Q6.11: What was the amount of 
${s4q6.6_curr_form} antibiotic given (per dose)? 
S4Q6.12: Select whether dosage reported is in mg 
or ml. 
S4Q6.12B: In what volume of water (litres) was this 
given? 
S4Q6.13: How many ${s4q6.1_curr_sp} were 
treated? 
S4Q6.14: How often was the ${s4q6.6_curr_form} 
antibiotic given? 
S4Q6.15: For how many days was the 
${s4q6.6_curr_form} antibiotic used? 
S4Q6.16: Were any doses missed? 
S4Q6.17: Do you know when the last dose of drug 
was given ? 
S4Q6.18: Any other relevant information 
S4Q6.19: Do you give your ${s4q6.11_curr_sp} any 
drugs routinely to prevent disease? 
S4Q6.20: Which type(s) of drugs do you routinely 
use in your ${s4q6.11_curr_sp}? 
S4Q6.21: Prophylactic drug use 
S4Q6.22: Current drug type 
S4Q6.23: What ${s4q6.22_curr_drug} 
formulation(s) do you use? 
S4Q6.24: Antibiotic use 
S4Q6.25: Which in-feed antibiotic do you use? 
S4Q6.26: Which in-feed anticoccidial do you use? 
S4Q6.27: What is the name of the drug? 
S4Q6.28: How is the in-feed ${s4q6.22_curr_drug} 
delivered? 
S4Q6.29: Is the in-feed ${s4q6.22_curr_drug} 
given...? 
S4Q6.30: Any other relevant information 
  
S4Q6.31: Antibiotic use 
S4Q6.32: Which in-water antibiotic do you use? 
S4Q6.33: Which in-water anticoccidial do you use? 
S4Q6.34: What is the name of the drug? 
S4Q6.35: Is the in-water ${s4q6.22_curr_drug} 
given...? 
S4Q6.36: How often do you replace the in-water 
${s4q6.22_curr_drug}? 
S4Q6.37: Any other relevant information 
S4Q6.38: Can you tell us the name of the 
${s4q6.22_curr_drug} that you normally use in 
your  ${s4q6.1_curr_sp}? 
S5Q2.19: You have finished the survey! Thank you 
very much for your time. 





























Appendix Table G3. Individual 
human questionnaire formatted for 
use with ODK Open Data Kit 
(ODK) Collect 
label 
S1Q1: Start time 
S1Q3: Date 
S1Q4: Device ID 
S1Q5: Simcard serial number 
S1Q6: Device phone number 
S1Q7: Recorder Name 
S1Q8: Scan household unique barcode on 
Household Master Sheet 
S1Q81: The barcode has not scanned correctly. 
Please go back and try again or enter manually 
S1Q9: Does the respondent live on site? 
S1Q10: Label and scan barcode for respondent's 
consent form 
S1Q101: The barcode has not scanned correctly. 
Please go back and try again or enter manually 
S2Q1: Does the respondent know their date of 
birth? 
S2Q2: Date of birth 
S2Q21: What is the respondent's date of birth? 
S2Q22: Respondent's age 
S2Q23: Respondent's age category 
S2Q24: The respondent's age is ${s2q22_resp_age}. 
Is this correct? 
S2Q25: Respondent's age 
S2Q26: What is the respondent's age?  
S2Q27: Select: 
S2Q28: Respondent's age category 
S2Q31: Confirm that the respondent is over 18 
S2Q32: If the respondent is under 18, confirm you 
have the consent of a parent or guardian before 
proceding 
S2Q4: Is the respondent: 
S1Q5: Is this respondent the head of the 
household? 
S2Q6: What is the first name of the household 
head? 
S2Q61: Confirm the first name of the household 
head with the household Master Sheet 
S2Q7: Which gender is the respondent? 
S2Q80: Relationship to household head 
S2Q81: Respondent's gender 
S2Q82: Respondent's gender 
S2Q83: Relationship category 
S2Q84: What relation is the respondent to 
${s2q6_hh_head_id}? 
  
S2Q9: What position does the respondent hold in 
the household? 
S2Q10: What education has the respondent had? 
S2Q11: Has the respondent attended school in the 
last 6 months? 
S2Q12: What is the respondent's occupation? 
S2Q13: Does the respondent work with any of the 
following OUTSIDE the household? 
S2Q14: Which of these activities does the 
respondent perform with the livestock in this 
household?  
S2Q151: What ethnicity is the respondent? 
S2Q152: Which tribe is the respondent? 
S3Q11: Is the respondent the main person 
responsible for buying food in this household? 
S3Q12: Does the respondent regularly help to 
prepare food in this household? 
S3Q2: In a normal week, on how many days do you 
BUY meat to cook or eat at home? 
S3Q3: Which of these meats do you buy? 
S3Q4: Where and how do you buy meat? 
S3Q41: Current meat type 
S3Q42: Which of these forms of 
${s3q41_curr_meat} do you buy? 
S3Q43: Which of these forms of 
${s3q41_curr_meat} do you buy? 
S3Q44: Which of these forms of 
${s3q41_curr_meat} do you buy? 
S3Q51: Do you normally buy… 
S3Q52: Do you normally buy… 
S3Q6: How much ${s3q41_curr_meat} (kg) in any 
form do you buy in a typical week? 
S3Q71: Where do you buy ${s3q41_curr_meat} ? 
S3Q72: Do you buy any particular brand of 
${s3q41_curr_meat} ? 
S3Q73: Do you buy any particular brand of 
${s3q41_curr_meat} ? 
S3Q74: Where do you buy ${s3q41_curr_meat} ? 
S3Q75: Where do you buy ${s3q41_curr_meat} ? 
S3Q81: Where do you buy ${s3q52_chckn_liv} 
chicken ? 
S3Q82: Please specify where you buy 
${s3q52_chckn_liv} chicken ? 
S3Q83: Do you buy any particular brand of 
${s3q52_chckn_liv} chicken ? 
S3Q10: Have you bought any more meat than 
normal in the last two weeks (eg for festive 
periods) 
S3Q11: Which of these meats did you additionally 
buy? 
S3Q12: In a normal week, on how many days do 
you BUY milk to consume at home? 
S3Q13: What type of milk do you buy? 
S3Q140: Milk purchasing 
S3Q141: Milk species 
S3Q142: What form of ${s3q141_milk_sp_curr} milk 
do you buy? 
S3Q143: What form of ${s3q141_milk_sp_curr} milk 
do you buy? 
S3Q144: Where do you buy ${s3q141_milk_sp_curr} 
milk? 
S3Q145: Do you buy any particular brand of 
${s3q141_milk_sp_curr} milk? 
S3Q146: Do you boil ${s3q141_milk_sp_curr} milk 
before it is consumed by the family? 
S3Q147: Is the mala you buy made from…? 
 
S3Q15: How often do you BUY eggs to consume at 
home? 
S4Q16: Where do you buy eggs? 
S5Q17: What type of eggs do you buy? 
S6Q18: Do you usually buy any particular brand of 
eggs? 




S7Q19: Which brand(s)? 
S3Q20: Do you ever eat any livestock or livestock 
products that you produce yourself? 
S3Q21: Which products do you consume from your 
own livestock? 
S3Q220: Home-produced dairy 
S3Q221: How do you prepare milk you produce 
yourself? 
S3Q222: Do you make mala? 
S3Q223: Do you make yoghurt? 
S3Q23: Production of mala/yoghurt 
S3Q231: What do you prepare mala from? 
S3Q232: What do you prepare yoghurt from? 
S3Q24: Which of these meats do you eat from the 
livestock that you produce? 
S3Q250: Consumption of own meat products 
S3Q251: Current meat type 
S3Q252: Are the chickens that you  eat yourself...? 
S3Q253: Which types of poultry that you produce 
do you eat yourself...? 
S3Q254: Where are the animals that you use to 
produce your own ${s3q251_curr_meat} meat 
normally kept?  
S3Q255: Do the animals enter this household prior 
to slaughter? 
S3Q256: Where are animals slaughtered? 
S3Q257: Where are animals slaughtered? 
S3Q258: Where are animals slaughtered? 
S4Q0: This next section is about foods that you 
have consumed IN THE LAST 7 DAYS 
S4Q11: Which of these food types have you 
consumed IN THE LAST 7 DAYS? 
S4Q12: Which of these food types have you 
consumed IN THE LAST 7 DAYS? 
S4Q2: Food frequency 
S4Q3: Current food type 
S4Q31: On how many days out of the last 7  did 
you eat ${s4q3_curr_food}? 
S4Q32: Where did you eat the eggs? 
S4Q2: Which of these types of meat have you 
consumed IN THE LAST 7 DAYS? 
S4Q3: Where and how did you eat meat in the last 
7 days? 
S4Q31: Current meat type 
S4Q32: Which of these forms of 
${s4q31_curr_meat} did you eat? 
S4Q33: Which of these forms of 
${s4q31_curr_meat} did you eat? 
S4Q34: Which of these forms of 
${s4q31_curr_meat} did you eat? 
S4Q35: On how many days out of the last 7 did 
you eat ${s4q31_curr_meat} (In any form)? 
S4Q36: In which of these places did you eat 
${s4q31_curr_meat} (In any form)? 
S4Q37: In which of these places did you eat 
${s4q31_curr_meat} (In any form)? 
S4Q38: Do you know what kind of of 
${s4q31_curr_meat} you ate? 
  
S4Q4: Which of these types of dairy product have 
you consumed IN THE LAST 7 DAYS? 
S4Q5: Where and how did you consume dairy 
products in the last 7 days? 
S4Q61: Current dairy product type 
S4Q62: On how many days out of the last 7 did 
you consume ${s4q61_curr_dairy}? 
S4Q63: In which of these places did you consume 
${s4q61_curr_dairy}? 
S4Q64: How was the ${s4q61_curr_dairy} you 
drank prepared? 
  
S4Q7: Which of these types of fish have you 
consumed IN THE LAST 7 DAYS? 
S4Q8: How often did you consume fish products 
in the last 7 days? 
S4Q81: Current fish type 
S4Q82: On how many days out of the last 7 did 
you consume ${s4q81_curr_fish}? 
  
S4Q9: Do you ever eat meat? 
S4Q90: Meats eaten more rarely 
S4Q91: How often do you eat beef? 
S4Q92: How often do you eat mutton or lamb? 
S4Q93: How often do you eat goat? 
S4Q94: How often do you eat pork (any form)? 
S4Q95: How often do you eat rabbit? 
S4Q96: How often do you eat chicken? 
S4Q97: How often do you eat any other kind of 
poultry (duck, turkey, quail, etc)? 
  
S5Q0: We are now going to ask you some 
questions about your health, and perform an 
examination 
S5Q1: Has the respondent had any of the following 
in the last 7 days? 
S5Q2: What was the appearance of the 
diarrhoearic stools? 
S5Q21: Did the stool smell different? 
S5Q22: When was the first episode of diarrhoea? 
S5Q23: When was the first episode of diarrhoea? 
S5Q3: Has the respondent used any of the 
following in the past two weeks? 
S5Q31: Medicine used 
S5Q32: Current medication type 
S5Q33: Select which antibiotic has been used 
S5Q34: What is the name of the 
${s5q32_curr_med_type} medication used? 
S5Q35: Do you know the dosage (mg)? 
S5Q36: Do you know the frequency? 
S5Q37: Has the patient missed any doses, or had 
any problems with compliance? 
S5Q38: Any other relevant information 
  
S5Q4: How long did the diarrhoea take to respond 
to medication? (days) 
S5Q40: Medication failure 
S5Q41: Did you have to change medication at any 
point due to failure of the first one? 
S5Q42: Drug changed from…? 
S5Q43: Drug changed to…? 
  
S5Q5: Has the participant had any conditions 
requiring antibiotic treatment in the last 6 
months? 
S5Q50: Antibiotic use 
S5Q51: What was the antibiotic prescription 
related to? 
S5Q52: Select which antibiotic has been used 
S5Q53: What is the name of the antibiotic used? 




S4Q54: Do you know when the last dose of drug 
was given ? 
S4Q55: Do you know the dose (mg) antibiotic 
given? 
S4Q56: What was the amount of antibiotic given 
(per dose)? 
S4Q57: How often was the  antibiotic given? 
S4Q58: For how many days was the antibiotic 
used? 
S4Q59: Were any doses missed? 
S5Q6: Any other relevant information 
  
S6Q1: Appearance 
S6Q2: Hydration status 
S6Q3: Capillary refill 
S6Q4: Pulse rate 
S6Q5: Respiratory rate 
S6Q6: Temperature (⁰C) 
S6Q7: Blood pressure 
S6Q71: Blood pressure (systolic) 
S6Q72: Blood pressure (diastolic) 
S6Q73: blood pressure is ${s6q71_bp_sys} over 
${s6q72_bp_dias} 
  
S6Q8: Mid upper arm circumference (cm) 
S6Q9: Weight (kg) 
S6Q10: Height (cm) 
S7Q1: Has the participant provided a stool sample? 
S7Q2: Is the participant willing to have three 
faecal swabs taken? 
S7Q21: Take three faecal swabs and place in Amies 
transport media 
S7Q22: Is the participant willing to have two nasal 
swabs taken? 
S7Q23: Take two nasal swabs and place one in 
Trizol and one in TSB transport media 
S7Q3: You have finished the questionnaire! Thank 
you very much for your participation 
S7Q40: Nasal swabs 
S7Q41: Label and scan the barcode of the 
partcipant's TSB nasal swab 
S7Q42: The barcode has not scanned correctly. 
Please go back and try again or enter manually 
S7Q43: Label and scan the barcode of the 
participant's Trizol nasal swab 
S7Q44: The barcode has not scanned correctly. 
Please go back and try again or enter manually 
S7Q45: Send the nasal swab in TSB to KEMRI. 
Send the swab in Trizol to ILRI 
  
S7Q5: Faecal samples (pot) 
S7Q50: You now need to make one swab from the 
stool sample and place in Amies transport media. 
S7Q51: Label and scan the barcode of the patient's 
stool sample pot 
S7Q52: The barcode has not scanned correctly. 
Please go back and try again or enter manually 
S7Q53: Label and scan the barcode of the patient's 
faecal swab 
S7Q54: The barcode has not scanned correctly. 
Please go back and try again or enter manually 
S7Q55: Send the faecal pot to KEMRI and the swab 
to UoN 
  
S7Q5B: Faecal samples (no pot) 
S7Q51B: Label and scan the barcode of the 
patient's first faecal swab 
S7Q52B: The barcode has not scanned correctly. 
Please go back and try again or enter manually 
S7Q53B: Label and scan the barcode of the 
patient's second faecal swab 
S7Q54B: The barcode has not scanned correctly. 
Please go back and try again or enter manually 
S7Q55B: Label and scan the barcode of the 
patient's third faecal swab 
S7Q56B: The barcode has not scanned correctly. 
Please go back and try again or enter manually 
S7Q57B: Send two faecal swabs to KEMRI and one 
swab to UoN 
  
S7Q6: Faecal samples (pot) 
S7Q60: You now need to make one swab from the 
stool sample and place in Trizol 
S7Q61: Label and scan the barcode of the patient's 
Trizol pot 
S7Q62: The barcode has not scanned correctly. 
Please go back and try again or enter manually 
  

















Appendix Table G4. Human drug 
store questionnaire formatted for 









What is the respondent's age? 
What is the respondent's gender? 
What is the respondent's highest educational 
level?  
How many people work in this shop?  
What type of business is this? 
What is your role in this pharmacy?  
  
Respondent education  
For how long have you worked in this premise? 
Do you have specific training in medical sciences? 
Have you received specific training on appropriate 
use of antibiotics?  
  
Products sold 
What kind of products do you sell in your shop?  




What formulations are tetracylines available in?  
What formulations are Sulfonamides available in?  
What formulation is Sulfonamide+Trime available 
in?  
What formulations are Penicillins available in?  
What formulation is Penicillin+Streptomycin 
available in?  
What formulation are Aminoglycosides available 
in?  
What formulation are 1st Cephalosporins available 
in?  
What formulation are 2nd Cephalosporins 
available in?  
What formulation are 3rd Cephalosporins 
available in?  
What formulation are 4th Cephalosporins 
available in?  
What formulations are Amphenicols available in?  
What formulations are Macrolides available in?  
What formulations are Quinolones available in?  
What formulations are Floroquinolones available 
in?  
What formulation is Fosfomycin available in?  
What formulation are Polypeptides (colistin) 
available in?  
What formulations are Glycopeptides (avopracin) 
available in?  
What formulations are lincosamides available in?  
What formulation is Nitroimidazole available in?  
What formulations are carbapenems available in?  
  
Sales estimate dynamics 
Of these antibiotic classes ${antibiotics_sold} 
please indicate the four most commonly 
prescribed/sold antibiotic class?  
  
Sales estimate dynamics cont.. 
Of these antibiotic classes ${antibiotics_sold} 
please indicate the four least commonly 
commonly prescribed/sold antibiotic class?  
  
Sales estimate 
Have your antibiotic sales during the last one year 
increased, decreased or stayed the same compared 
to the previous year?  
  
Reasons for sales change 




What factors do you take into account when 
choosing a supplier?  
Where do you acquire your antibiotics from?  
  
Reasons for source choice 
Of these sources ${antibiotics_purchase} what is 
the most important source?  
Do you get regular supplies? 
  
Reasons for sales irregular supply  
What are the reasons for irregular supply?  
Are there certain antibiotic classes you would like 
to purchase from your suppliers but you are 
unable? 
  
Abtibiotics unable to buy  
Which of these antibiotic classes are you not able 
to buy from your suppliers? 




On estimate how many customers have you had in 
the last one week?  
On estimate how many customers have you sold 
antibiotics to in the last one week?  
On average how many customers without a 
prescription do you serve in a week? 
On average how many customers with a 
prescriptions do you serve in a week? 
For customers with a written prescription do you 
change/substitute the antibiotics indicated ? 
  
Prescription change  
What are the reasons for the change/substitution?  
What antibiotic classes are only sold to customer 
with a written prescription? 
  
Customer characteristics cont.. 
For the antibiotic customers, what is the most 
common gender? 




What are the common presented complaints for 
purchasing antibiotics? 
Where do most of your customers come from?  
  
Purchase process 
Which of the following information do you give 
customers when buying antibiotics ?  
What factors do you take into account when 
recommending a certain antibiotic to a customer?  
How do you store your antibiotics?  
  
Antimicrobial resistance 
Have you heard of any of the following terms? 
  
Please indicate whether you agree with the 
following statements  
Antibiotic resistance occurs when your body 
becomes resistant to antibiotics and they no 
longer work as well 
Many infections are becoming increasingly 
resistant to treatment by antibiotics 
If bacteria are resistant to antibiotics, it can be 
very difficult or impossible to treat the infections 
they cause 
Antibiotic resistance is an issue that could affect 
me or my family 
  
Please indicate whether you agree with the 
following statements  
Antibiotic resistance is an issue in other countries 
but not here 
Antibiotic resistance is only a problem for people 
who take antibiotics regularly 
Bacteria which are resistant to antibiotics can be 
spread from person to person 
Antibiotic-resistant infections could make medical 
procedures like surgery, organ transplants and 
cancer treatment much more dangerous 
  
Do you agree the following actions would help 
address the problem of antibiotic resistance?  
People should use antibiotics only when they are 
prescribed by a doctor or nurse 
Farmers should give fewer antibiotics to food-
producing animals 
People should not keep antibiotics and use them 
later for other illnesses 
Parents should make sure all of their children’s 
vaccinations are up-to-date 
  
Do you agree the following actions would help 
address the problem of antibiotic resistance?  
People should wash their hands regularly 
Doctors should only prescribe antibiotics when 
they are needed 
The governments should reward the development 
of new antibiotics 
Pharmaceutical companies should develop new 
antibiotics 
  
Do you agree with following statements? 
Antibiotic resistance is one of the biggest 
problems the world faces  
Antibiotic resistance is one of the biggest 
problems Kenya faces 
Medical experts will solve the problem of 
antibiotic resistance before it becomes too serious 
  
Do you agree with following statements? 
Everyone needs to take responsibility for using 
antibiotics responsibly  
There is not much people like me can do to stop 
antibiotic resistance  
I am worried about the impact that antibiotic 
resistance will have on my health, and that of my 
family 
I am not at risk of getting an antibiotic resistant 
infection, as long as I take my antibiotics correctly 
  
Licence 
What proportion of the antibiotics sold are 
generic brands?  
Do you require a licence to operate your business?  
  
You have finished the questionnaire! Thank you 
very much.  
Kindly tick where possible  
Shop is well stocked  
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What is the respondent's age? 
What is the respondent's gender? 
What is the respondent's highest educational level?  
What type of business is this? 
How many people work in this shop?  
What is your role in this pharmacy?  
  
Respondent education  
For how long have you worked in this premise? 
Do you have specific training in veterinary sciences? 
Have you received specific training on appropriate use 
of antibiotics?  
  
Products sold 
What kind of products do you sell in your shop?  
What antibiotic classes do you have in your shop now? 
  
Formulations  
What formulations are tetracylines available in?  
What formulations are Sulfonamides available in?  
What formulation is Sulfonamide+Trime available in?  
What formulations are Penicillins available in?  
What formulation is Penicillin+Streptomycin available 
in?  
What formulation are Aminoglycosides available in?  
What formulation are 1st Cephalosporins available in?  
What formulation are 2nd Cephalosporins available in?  
What formulation are 3rd Cephalosporins available in?  
What formulation are 4th Cephalosporins available in?  
What formulations are Amphenicols available in?  
What formulations are Macrolides available in?  
What formulations are Quinolones available in?  
What formulations are Floroquinolones available in?  
What formulation is Fosfomycin available in?  
What formulations are Polypeptides (colistin) available 
in?  
What formulations are Glycopeptides (avopracin) 
available in?  
What formulations are lincosamides available in?  
What formulation is Nitroimidazole available in?  
What formulations are carbapenems available in?  
  
Sales estimate dynamics 
Of these antibiotic classes ${antibiotics_sold} please 
indicate the four most commonly prescribed/sold 
antibiotic class?  
  
Sales estimate dynamics cont.. 
Of these antibiotic classes ${antibiotics_sold} please 
indicate the four least commonly commonly 
prescribed/sold antibiotic class?  
  
Sales estimate 
Have your antibiotic sales during the last one year 
increased, decreased or stayed the same compared to 
the previous year?  
  
Reasons for sales change  
What are the most important reasons for this change? 
  
Antibiotic sources 
What factors do you take into account when choosing a 
supplier?  
Where do you acquire your antibiotics from?  
  
Reasons for source choice 
Of these sources ${antibiotics_purchase} what is the 
most important source?  
Do you get regular supplies? 
  
Reasons for sales irregular supply  
What are the reasons for irregular supply?  
Are there certain antibiotic classes you would like to 
purchase from your suppliers but you are unable? 
  
Abtibiotics unable to buy  
Which of these antibiotic classes are you not able to 
buy from your suppliers? 




On estimate how many customers have you had in the 
last one week?  
On estimate how many customers have you sold 
antibiotics to in the last one week?  
  
Customer characteristics cont.. 
Of the following who are your customers of antibiotics?  
  
Customer characteristics cont.. 
On average, how many veterinarians do you serve in a 
week? 
On average, how many para veterinarians do you serve 
in a week? 
On average, how many dairy farmers do you serve in a 
week? 
On average, how many pig farmers do you serve in a 
week? 
On average, how many poultry farmers do you serve in 
a week? 
On average, how many beef farmers do you serve in a 
week? 
On average, how many rabbit farmers do you serve in a 
week? 
  
Antibiotic sales by category 
Which of these antibiotic classes are most commonly 
sold to pig farmers? 
  
Antibiotic sales by category 
Which of these antibiotic classes are most commonly 
sold to dairy farmers? 





Antibiotic sales by category cont.. 
Which of these antibiotic classes are most commonly 
sold to beef farmers? 
  
Antibiotic sales by category cont.. 
Which of these antibiotic classes are most commonly 
sold to poultry farmers? 
  
Antibiotic sales by category cont.. 
Which of these antibiotic classes are most commonly 
sold to rabbit farmers? 
  
Purchase process 
How often do farmers make a request/demand 
(without advice) for a specific antibiotic?  
How often do farmers visit your shop with an antibiotic 
prescription?  
How often do animal health professionals make a 
request/demand (without advice) for a specific 
antibiotic?  
Where do most of your customers come from?  
  
Purchase process cont… 
Which of the following information do you give 
customers when buying antibiotics ?  
What factors do you take into account when 
recommending a certain antibiotic to a customer?  
How do you store your antibiotics?  
  
Antimicrobial resistance 
Have you heard of any of the following terms? 
  
Please indicate whether you agree with the following 
statements  
Antibiotic resistance occurs when your body becomes 
resistant to antibiotics and they no longer work as well 
Many infections are becoming increasingly resistant to 
treatment by antibiotics 
If bacteria are resistant to antibiotics, it can be very 
difficult or impossible to treat the infections they cause 
Antibiotic resistance is an issue that could affect me or 
my family 
  
Please indicate whether you agree with the following 
statements  
Antibiotic resistance is an issue in other countries but 
not here 
Antibiotic resistance is only a problem for people who 
take antibiotics regularly 
Bacteria which are resistant to antibiotics can be 
spread from person to person 
Antibiotic-resistant infections could make medical 
procedures like surgery, organ transplants and cancer 
treatment much more dangerous 
  
Do you agree the following actions would help address 
the problem of antibiotic resistance?  
People should use antibiotics only when they are 
prescribed by a doctor or nurse 
Farmers should give fewer antibiotics to food-
producing animals 
People should not keep antibiotics and use them later 
for other illnesses 
Parents should make sure all of their children’s 
vaccinations are up-to-date 
  
Do you agree the following actions would help address 
the problem of antibiotic resistance?  
People should wash their hands regularly 
Doctors should only prescribe antibiotics when they 
are needed 
The governments should reward the development of 
new antibiotics 
Pharmaceutical companies should develop new 
antibiotics 
  
Do you agree with following statements? 
Antibiotic resistance is one of the biggest problems the 
world faces  
Antibiotic resistance is one of the biggest problems 
Kenya faces 
Medical experts will solve the problem of antibiotic 
resistance before it becomes too serious 
  
Do you agree with following statements? 
Everyone needs to take responsibility for using 
antibiotics responsibly  
There is not much people like me can do to stop 
antibiotic resistance  
I am worried about the impact that antibiotic 
resistance will have on my health, and that of my 
family 
I am not at risk of getting an antibiotic resistant 
infection, as long as I take my antibiotics correctly 
  
Licence 
What proportion of the antibiotics sold are generic 
brands?  
Do you require a licence to operate your business?  
  
You have finished the questionnaire! Thank you very 
much.  
Kindly tick where possible  
Shop is well stocked  










Chapter 11. Appendices 
 
 
11.6 Appendix H: Contributions and affiliations of people involved in 
the UrbanZoo project.  
 
Funding acquisition and study design:  
Prof. Eric Fèvre1, 2  
Prof. Mark Woolhouse3  
Prof. Jonathon Rushton1  
Dr. Tim Robinson4  
Prof. Sam Kariuki5  
Prof. Julio Davila6  
Prof. Erastus Kangethe7  
Prof. Cecila Tacoli8  
Dr. Catherine Kyobutungi9  
Fieldwork – data collection:  
Dr. Judy Bettridge1,2 Affiliations  
Dr James Hassell1,2  
Titus Imboma10 1. Institute of Infection and Global Health, University of Liverpool, UK 
2. International Livestock Research Institute, Nairobi, Kenya 
3. Usher Institute of Population Health Sciences & Informatics, University 
of Edinburgh, Edinburgh, UK 
4. Food and Agriculture Organization of the United Nations, Rome, Italy 
5. Kenya Medical Research Institute, Nairobi, Kenya 
6. The Bartlett Development Planning Unit, Faculty of the Built 
Environment, UCL, London, UK 
7. University of Nairobi, Nairobi, Kenya 
8. International Institute for Environment and Development, London, UK 
9. African Population Health Research Centre, Nairobi, Kenya 
10. National Museums of Kenya, Nairobi, Kenya 
11. Faculty of Veterinary Medicine, Hokkaido University, Japan 
12. Department of Epidemiology, Columbia University, New York, US 
13. Veterinary Services Department, Kenya Wildlife Service, Kenya 
14. Uppsala University, Uppsala, Sweden 
15. Centre for Immunity, Infection and Evolution, University of Edinburgh, 
Edinburgh, UK 















Logistic and administrative support: 
Victoria Kyallo2 
Laboratory work – supervision: 
Dr. John Kiiru5 
Dr. Judy Bettridge1,2 
Laboratory work – bacteriology:  
Tom Ouko and the Kenya Medical Research 
Institute (KEMRI) laboratory team5 
 
Nduhiu Gitahi and the University of Nairobi 
(UoN) laboratory team7 
 
Laboratory work – DNA extraction:  
Velma Kivali2  
Alice Kiyonga2  
Christine Ndinda2  
Database Management:  
Dr. Judy Bettridge1,2  
Absolomon Kihara2  
Jason Rogena2  
Bioinformatics and phylogenetics   
Dr. Melissa Ward15,16  
Dr. Hang Phan16  
Dr. Al Ivens15  
Dr. Bryan Wee3  
No one can whistle a symphony. It takes a whole orchestra to play it.  
Halford E. Luccock, 1885 – 1960 



































Are Food Animals Responsible for Transfer
of Antimicrobial-Resistant Escherichia coli
or Their Resistance Determinants to Human Populations?
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Abstract
The role of farm animals in the emergence and dissemination of both AMR bacteria and their resistance
determinants to humans is poorly understood and controversial. Here, we systematically reviewed the current
evidence that food animals are responsible for transfer of AMR to humans. We searched PubMed, Web of
Science, and EMBASE for literature published between 1940 and 2016. Our results show that eight studies
(18%) suggested evidence of transmission of AMR from food animals to humans, 25 studies (56%) suggested
transmission between animals and humans with no direction specified and 12 studies (26%) did not support
transmission. Quality of evidence was variable among the included studies; one study (2%) used high resolution
typing tools, 36 (80%) used intermediate resolution typing tools, six (13%) relied on low resolution typing tools,
and two (5%) based conclusions on co-occurrence of resistance. While some studies suggested to provide
evidence that transmission of AMR from food animals to humans may occur, robust conclusions on the
directionality of transmission cannot be drawn due to limitations in study methodologies. Our findings highlight
the need to combine high resolution genomic data analysis with systematically collected epidemiological
evidence to reconstruct patterns of AMR transmission between food animals and humans.
Keywords: antimicrobial resistance, Escherichia coli, food animals, humans, systematic review
Introduction
The evolution of microbial pathogens that enablesthem to evade antimicrobial treatment has been regarded
as a serious public health threat (Davies, 2011; WHO, 2015;
O’Neill, 2016).
At present, the role of farm animals in the emergence and
dissemination of both antimicrobial resistance (AMR) bacteria
and their resistance determinants to humans is poorly under-
stood and controversial (Marshall and Levy, 2011; Woolhouse
et al., 2015). Various studies have suggested that AMR bac-
teria and their AMR determinants can be transmitted from
food animals to humans via direct contact and/or through an-
imal products (Howells and Joynson, 1975; Aminov and
Mackie, 2007; Jakobsen et al., 2010; Overdevest et al., 2011;
Kluytmans et al., 2013; Voets et al., 2013). However, most of
these studies have relied heavily on traditional microbiology
and molecular tools, such as pulsed-field gel electrophoresis
(PFGE) and multilocus sequence typing (MLST). These tools
may not have sufficient discriminatory power to provide
evidence of the transmission (or not) of resistant bacteria and
their AMR determinants and, importantly, to infer the di-
rection of the transmission (de Been et al., 2014; Woolhouse
et al., 2015). Two key pathways of transfer of resistant bacteria
1Usher Institute of Population Health Sciences & Informatics, University of Edinburgh, Edinburgh, United Kingdom.
2Centre for Immunity, Infection and Evolution, School of Biological Sciences, University of Edinburgh, Edinburgh, United Kingdom.
3Nuffield Department of Clinical Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom.
4Institute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom.
5International Livestock Research Institute, Nairobi, Kenya.
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and their AMR determinants from food animals to humans
have been hypothesized: (i) horizontal transmission of AMR
genes of food animal origin and (ii) clonal transfer of resistant
bacteria of food animal origin to humans (Lipsitch et al., 2002;
Chang et al., 2015). Evidence from a recent systematic review
suggests that a proportion of human cephalosporin-resistant
Escherichia coli (E. coli) clones, often associated with human
disease, originate from food animals through food products
(Lazarus et al., 2015), though these products could have been
contaminated elsewhere in the production chain (Wooldridge,
2012).
Evidence either supporting or refuting the claim that dis-
semination of AMR bacteria or their resistance determinants
from food animals to humans is occurring will be key to the
development of effective policies on antibiotic stewardship
and infection control for both human and animal health. To
address this knowledge gap, we performed a systematic re-
view to (i) explore the current evidence that food animals are
of the source of resistant E. coli and their AMR determinants
in humans, (ii) examine and summarize the kinds of evidence
used to support, or not support, transfer of resistant E. coli and
their AMR determinants to humans, and (iii) make recom-
mendations for future studies to address this question. E. coli
is found in both human and food animal populations (Neid-
hardt et al., 1996), and it has recently been categorized as one
of the priority pathogens that pose the greatest threat to hu-
man health due to widespread AMR (WHO, 2017). It is for
these reasons that, when considering transmission between
hosts, we chose to focus on E. coli.
Methods
Data sources and search strategy
A systematic literature search according to the PRISMA
(Preferred Reporting Items for Systematic reviews and Meta-
Analyses) guidelines (Liberati et al., 2009) was performed.
Searches were carried out in multiple electronic databases:
PubMed, Web of Science, and EMBASE for research articles
published between 1940 and 2016; and Scopus for research
articles published between 1960 and 2016 without geo-
graphical and language restriction. We did initial and sub-
sequent keyword searches with various combinations of
search terms: E. coli, AMR terminologies, human, and food
animal descriptors (Supplementary Data; Supplementary
Data are available online at www.liebertpub.com/fpd).
Selection criteria and data extraction
Articles were included if they comprised an original re-
search published in a peer reviewed journal, and investigated
transmission of resistant E. coli and/or AMR determinants
between humans and food animals. Articles were excluded
if (i) they reported only agents other than E. coli; (ii) they
studied nonfood animals; (iii) they focused exclusively on
food animals or humans without any overlap between the
two populations and/or (iv) they focused exclusively on food
of animal origin. Article searches and screening were per-
formed by considering article titles and abstracts for inclu-
sion according to the search criteria. Data extraction from
studies was performed by one author (D.M.M.) and inde-
pendently checked by another author (B.v.B.) using a cus-
tomized checklist.
Data analysis
For all included studies we categorized the direction of
AMR transmission according to the authors’ conclusions: (i)
studies suggesting to provide evidence of transmission from
food animals to humans with direction specified; (ii) studies
suggesting to provide evidence of transmission from humans
to food animals with direction specified; (iii) studies suggest-
ing overlap indicating the possibility of between-host AMR
transmission, with no direction specified; and (iv) studies
suggesting no evidence of transmission in either direction.
The quality of evidence was assessed using a customized
Grading of Recommendations Assessment, Development and
Evaluation (GRADE) system (Godfray et al., 2013). Each ar-
ticle was matched to the following categories: (i) high resolu-
tion typing: studies using whole genome sequencing (WGS) and
phylogenetic analysis; (ii) intermediate resolution typing:
studies carrying out genetic characterisation through molecular
tools such as MLST; (iii) low resolution typing: studies using
tools such as PFGE; or (iv) co-occurrence of resistances: studies
comparing AMR phenotypes between the two populations.
Additionally, we assessed the methodological quality of
the articles included in the review by adapting a standardized
quality assessment (Centre for Reviews Dissemination,
2009). Each article was evaluated based on two items aimed
at assessing potential biases including study design (a ctive,
passive) and spatiotemporal matching (no matching, tempo-
ral matching only, spatial matching only, and both temporal
and spatial matching).
Because of heterogeneity of the studies (regarding typing
tools, antibiotics investigated and quality of evidence) we did
not perform a meta-analysis. However, we used Fisher’s
exact tests using R package ‘‘stats’’ (R Core Team, 2017) to
describe associations between direction of transmission, se-
lection bias variables and nature of transmission (clonal,
determinant or both). We considered p < 0.05 to be statisti-
cally significant.
Results
Description of included studies
Of the 5662 distinct articles retrieved, 256 studies were
reviewed (Fig. 1); and 45 studies met all inclusion criteria
(Supplementary Table S1 in the Supplementary Data). The 45
studies were geographically diverse and included 20 countries,
with 26 from Europe, 11 from Asia, five from North America,
two from Africa, and one from the Middle East (Fig. 2).
Although the studies span five decades, there has been an
increasing number of studies on this subject in recent years;
with 56% of the studies published since 2010 (Supplementary
Fig. S1 in the Supplementary Data). Twenty two studies
(49%) had both temporal and spatial matching for human and
food animal sampling, while seven (16%) had temporal
matching only, and 16 (35%) were not temporally or spatially
matched. We found no statistical associations between
whether direction of transmission was inferred and study
design or spatiotemporal matching.
Studies in our review reported different livestock species,
either alone or in combination with other species. Of the eight
studies that suggested transfer of AMR from food animals
to humans, seven studies were based on poultry isolates
and one study on pig isolates (Supplementary Fig. S2 in the
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Supplementary Data). Among the studies, 13 antibiotic classes
were reported, either alone or in combination with other
classes (Supplementary Fig. S3 in the Supplementary Data).
Overall, eight studies (18%) suggested to have data to
support transfer of AMR bacteria and/or their AMR determi-
nants from food animals to humans (Levy, 1978; Al-Ghamdi
et al., 1999; van den Bogaard et al., 2001; Hammerum et al.,
2006; Johnson et al., 2006; Leverstein-van Hall et al., 2011;
Giufre et al., 2012; Dierikx et al., 2013), while 25 studies
(56%) presented data showing overlap of AMR bacteria and
AMR determinants between food animals and humans, in-
dicating the possibility of between-host AMR transmission
but with no direction specified ( Jorgensen, 1983; Oppegaard
et al., 2001; Winokur et al., 2001; Ho et al., 2009, 2010;
FIG. 1. Flow diagram showing the selection of studies for inclusion.
FIG. 2. Geographic distribution of included studies. Different colors show the number of articles from each country. The map
was created using several R packages [ggplot2 (Wickham et al., 2013), mapdata (Becker and Wilks, 2016), maps (Becker and
Wilks, 2017), and ggmap (Kahle and Wickham, 2013)] in R version 3.4.1. The shapefile with borders of countries is freely
available from the Natural Earth data set (www.naturalearthdata.com). Color images available online at www.liebertpub.com/fpd
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Moodley and Guardabassi, 2009; Mulvey et al., 2009; Smet
et al., 2009; Zhang et al., 2009; Jakobsen et al., 2010, 2011;
Zhao et al., 2010; Deng et al., 2011; Vieira et al., 2011;
Stokes et al., 2012; Ciccozzi et al., 2013; Hu et al., 2013; de
Been et al., 2014; Hammerum et al., 2014; Valentin et al.,
2014; Dahms et al., 2015; Dohmen et al., 2015; Huijbers
et al., 2015; Lupindu et al., 2015; Tseng et al., 2015), and 12
studies (26%) did not suggest to find evidence supporting
transmission between food animals and humans (Kariuki
et al., 1997, 1999; Maynard et al., 2004; Kang et al., 2005;
Phongpaichit et al., 2007; Graziani et al., 2009; Schwaiger
et al., 2010; Xia et al., 2010; Johnson et al., 2012; Riccobono
et al., 2012; Jakobsen et al., 2015; Ueda et al., 2015). No
study in our review suggested to provide evidence for AMR
transmission from humans to food animals (Fig. 3).
Only one study (2%) based its conclusion regarding
transmission on high resolution typing tools, 36 studies
(80%) on intermediate resolution typing tools, six (13%) on
low resolution typing tools, and two (5%) on co-occurrence
of resistances (Fig. 3). Overall, 18 (40%) studies based their
conclusion on transmission of AMR determinants, nine
(20%) on transmission of AMR bacteria, and 18 (40%)
transmission of AMR bacteria together with AMR determi-
nants (Supplementary Fig. S4 in the Supplementary Data).
We found no statistical association between whether direc-
tion of transmission was inferred and the nature of trans-
mission ( p = 0.33).
Studies suggesting to provide evidence
of transmission of AMR from food animals
to humans with direction specified
Three studies suggested to find evidence for transfer of
AMR bacteria from food animals to humans, two of which
concluded there is transfer of resistant clones from poultry to
humans (Al-Ghamdi et al., 1999; van den Bogaard et al.,
2001). In addition to overlapping clonal patterns, one study
reported that human and chicken isolates were resistant to
spectinomycin, an antibiotic mostly used in veterinary
medicine (Al-Ghamdi et al., 1999). Similarly, one study (van
den Bogaard et al., 2001) reported a higher prevalence of
ciprofloxacin resistance among food animal isolates com-
pared to human isolates.
One study found identical ciprofloxacin-resistant isolates
in chicken and humans, which they concluded was suggestive
of food animal to human AMR transmission ( Johnson et al.,
2006). Two studies suggested to find evidence for horizontal
transfer of AMR determinants from food animals to humans
(Hammerum et al., 2006; Dierikx et al., 2013). One study
found that clonally unrelated poultry and human isolates
shared ESBL/AmpC genes located on identical plasmid
families (Dierikx et al., 2013). Another study found that
sulfonamide-resistant isolates from pigs and healthy humans
shared sul1 and sul2 genes (Hammerum et al., 2006).
Three studies suggested to support transmission of both
AMR bacteria and their AMR determinants from food ani-
mals to humans. Two studies found similar sequence types,
plasmid families and ESBL genes in E. coli isolates sourced
from poultry and human patients (Leverstein-van Hall et al.,
2011; Giufre et al., 2012). A further study reported an in-
crease in tetracycline-resistant E. coli in humans in contact
with tetracycline fed chicken and, therefore, suggested that
chicken were a reservoir of AMR bacteria and plasmids for
humans (Levy, 1978).
We found that studies suggesting to provide evidence of
transmission of AMR from food animals to humans did not
have distinct features compared to those suggesting overlap
of resistance, with regard to study methodologies, food ani-
mal species, typing tools, or antibiotics tested. For most of
these it is unclear why they suggested evidence of directional
transmission when 25 broadly similar studies suggested only
overlap of resistance.
Studies suggesting overlap indicating the possibility
of between-host AMR transmission, with no
direction specified
Four studies suggested there was evidence of overlap of
resistant E. coli between humans and food animals. One of
these studies found human and avian sequence types asso-
ciated with multidrug resistance clustered together in a
Bayesian phylogenetic tree (Ciccozzi et al., 2013). Another
study found indistinguishable PFGE patterns of ampicil-
lin and tetracycline-resistant isolates in cattle and humans
(Lupindu et al., 2015). A cluster analysis of E. coli phy-
logroups found that human, pig, and chicken isolates clustered
together ( Jakobsen et al., 2010). One extensive ecological
study reported a significant correlation between the prevalence
of resistance in human and livestock isolates, for both cepha-
losporins and fluoroquinolones (Vieira et al., 2011).
Thirteen studies suggested there was evidence of overlap
of AMR determinants in human and food animal isolates. Of
the 13 studies, one study based on WGS and plasmid re-
construction found that clonally unrelated human and poultry
isolates carried ESBL genes encoded on genetically identical
plasmids (de Been et al., 2014). Eleven studies found that
unrelated human and food animal isolates shared identical
AMR genes, integrons and plasmids (Oppegaard et al., 2001;
Winokur et al., 2001; Ho et al., 2009, 2010; Moodley and
FIG. 3. Nature of evidence used to infer direction of
transmission in each study. Color images available online at
www.liebertpub.com/fpd
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Guardabassi, 2009; Mulvey et al., 2009; Smet et al., 2009;
Zhang et al., 2009; Stokes et al., 2012; Huijbers et al., 2015;
Tseng et al., 2015). One study identified identical plasmids
encoding chloramphenicol resistance in unrelated human and
food animal isolates ( Jorgensen, 1983).
Eight studies suggested there was evidence of overlap of
resistant E. coli and AMR determinants, with five of these
finding that clonally related human and food animal isolates
harbored similar ESBL gene types and plasmid types (Hu et al.,
2013; Hammerum et al., 2014; Valentin et al., 2014; Dahms
et al., 2015; Dohmen et al., 2015). Likewise, two studies found
that clonally related human and food animal isolates carried
similar fluoroquinolone AMR genes (Zhao et al., 2010; Deng
et al., 2011). In one study, cluster analysis of AMR gene pro-
files and E. coli pathotypes showed that human and food animal
isolates clustered together (Jakobsen et al., 2011).
Studies suggesting no evidence of transmission
of AMR between humans and food animals
Two studies found no evidence for transfer of resistant
clones, with one of these studies finding that human and avian
ciprofloxacin-resistant E. coli strains had distinct phyloge-
netic compositions (Graziani et al., 2009). Likewise, a PFGE
analysis of multidrug-resistant E. coli isolates from sympatric
children and chicken found that the isolates were source
specific (Kariuki et al., 1999).
Three studies reported no evidence for transfer of AMR
determinants between food animals and humans with one of
these studies reporting that human and porcine isolates had
different distribution patterns of sulfonamide and tetracy-
cline resistance genes (Schwaiger et al., 2010). Two studies
(Kariuki et al., 1997; Phongpaichit et al., 2007) reported that
human and food animal multidrug-resistant isolates had
distinct plasmids and integrons.
Seven studies reported no evidence for transmission of
bacterial clones together with AMR determinants between
food animals and humans. These studies showed that human
and food animal isolates belonged to different phylogenetic
groups, and had different AMR genes and plasmid profiles
(Maynard et al., 2004; Kang et al., 2005; Xia et al., 2010;
Johnson et al., 2012; Riccobono et al., 2012; Jakobsen et al.,
2015; Ueda et al., 2015).
Discussion
We performed a systematic review to explore the evidence
that food animals are responsible for the transfer of AMR
E. coli and their AMR determinants to humans. Some studies
in our review suggested to provide evidence for the transfer
of AMR from and between food animals and humans, while a
larger number did not suggest to provide evidence of trans-
mission in either direction. In addition to the differing nature
of methods used to infer direction, studies in our review
differed in sampling methodologies and antibiotics tested.
These differences may have affected the conclusions made
regarding the epidemiological connection between food an-
imals and humans.
Much of the evidence regarding transfer of AMR was based
on the demonstration that AMR E. coli clones and AMR de-
terminants were indistinguishable in both food animal and
human isolates. However, the demonstration of overlapping
patterns should be interpreted with care as the direction of
transmission is difficult to infer, and co-colonization from a
shared source is also possible. Demonstrating the direction of
transmission and thus the epidemiological history of patho-
gens and their determinants requires a quantitative description
of relatedness, including phylogenetic analysis (Grad and
Lipsitch, 2014).
Molecular techniques, such as MLST and PCR, used in
most studies in our review, are limited in resolution (Didelot
et al., 2014). In one study, E. coli isolates were considered
genetically indistinguishable based on MLST suggesting
clonal transfer (Leverstein-van Hall et al., 2011); however,
subsequent WGS revealed that the isolates were genetically
distinct (de Been et al., 2014), highlighting the need for se-
quencing the entire genome, rather than only a few loci. WGS
provides the current ‘‘gold standard’’ resolution for studying
genetic relatedness, but as it is a technology that has only
recently become routinely available it was used in just one
study in our review. Future studies in this area could benefit
from combining phylogeographic methods with WGS, which
yields the potential for quantitative hypothesis testing for
inferring pathogen movement between host populations (De
Maio et al., 2015; Woolhouse et al., 2015).
Just over half of the studies in our review did not consider
spatiotemporal relationships between human and food animal
isolates, a fundamental requirement for investigating trans-
mission (Singer et al., 2006). Future research on the direc-
tionality of transmission will benefit from designing studies
in which epidemiologically linked human and food animal
populations are systematically sampled, preferably longitu-
dinally (Woolhouse et al., 2015). Moreover, there is con-
siderable diversity within both human populations (i.e.,
healthy individuals vs. hospitalized patients) and food ani-
mals (i.e., free range vs. intensive farming) and the specific
population considered may impact their exposure to diverse
groups of bacteria; thus we recommend that future studies
investigating transmission of AMR between humans and
food animals clearly clarify the subpopulations studied. In
addition, inclusion of detailed data on antibiotic usage in
these populations should be considered.
None of the included studies provided a detailed overview
of antibiotic usage in either human or food animal popula-
tions, or association between antibiotic usage and subsequent
development of AMR. A recent systematic review has indi-
cated that interventions that limit antibiotic use in food ani-
mals are associated with a reduction of AMR development in
humans (Tang et al., 2017), and therefore further research is
warranted to explore this complex association.
Although transfer of AMR from humans to food animals is
likely (Barber, 2001; Wooldridge, 2012), none of the studies
in our review suggested to find evidence to support trans-
mission from humans to animals. In many instances, re-
sponsibility for the burden of AMR has been placed on food
animals (Barber, 2001; Woolhouse et al., 2015; Mendelson
et al., 2017), and thus study bias may exist in terms of source
attribution. Therefore, more research is needed to provide
evidence for this potential route of transfer and, importantly,
the relative magnitude of that spread.
Akin to the studies in our review, most AMR studies focus
on a single bacterial type; however, rapid dissemination of
AMR determinants frequently occurs between bacterial
species, making it hard to track infection source (Sheppard
et al., 2016). Tracking these determinants, frequently located
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on plasmids, using traditional molecular techniques may be
limited. Using long read sequencing technologies such as
Pacbio can overcome this by accurately generating plasmid
structures (Orlek et al., 2017).
Our systematic review excluded studies focusing on
transmission of resistant bacteria and/or their AMR deter-
minants through food animal-sourced food products. How-
ever, we acknowledge the potentially significant role played
by food products of food animal origin in dissemination of
AMR as reported in a recent systematic review (Lazarus
et al., 2015).
We have highlighted studies that suggest to provide evi-
dence for transfer of resistant E. coli and their AMR deter-
minants from food animals to humans. However, differences
in study methodologies, such as lack of spatiotemporal
overlap in sample collection, and the quality of typing tools
used, suggest that transmission may occur, the evidence used
to support the hypothesis is rarely compelling. The underly-
ing problem is that demonstrating similarity or identity of
AMR bacteria and/or AMR resistance determinants does not,
by itself, provide information on directionality of transfer;
this could be in either direction, or both, or neither but from a
different source. Information on differential prevalence of
resistance, and consumption of antibiotics, in the two popu-
lations may make stronger inference possible, but these data
are rarely available.
Taken together, by combining genomic data analysis and
epidemiological approaches it may be possible to reconstruct
the complex transmission dynamics of resistant bacteria and
their AMR determinants between human and food animal
populations. Although we still have some way to go before a
truly comprehensive integration of data—differential antibiotic
usage data, detailed denominator data, information about the
origin of the samples, human-food animal contact data, and
pathogen sequence data—is available, disentangling and
quantifying transmission of resistant bacteria and their AMR
determinants between humans and food animals may still be an
attainable goal.
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There are substantial limitations in our understanding of the distribution of antibiotic resistance 
(AMR) in humans and livestock in developing countries. Here, we present the results of an 
epidemiological study examining patterns of AMR in Escherichia coli isolates circulating in 
sympatric human (n=321) and livestock (n=633) samples from 99 households across Nairobi, 
Kenya. E. coli isolates were tested for susceptibility to 13 antimicrobial drugs representing 9 
antibiotic classes.  
We detected high rates of AMR, with 47.6% and 21.1% of isolates displaying resistance to ≥ 3 
and ≥5 antibiotic classes respectively. Human isolates showed higher levels of resistance to 
sulfonamides, trimethoprim, aminoglycosides and penicillins compared to livestock (p<0.01), 
while poultry isolates were more resistant to tetracyclines (p=0.01) compared to humans. The 
most common co-resistant phenotype observed was to tetracyclines, streptomycin and 
trimethoprim (30.5%). At the household level, AMR carriage in humans was associated with 
human density (p<0.01) and the presence of livestock manure (p=0.03), but livestock keeping 
on its own had no influence on human AMR carriage (p>0.05).  
Our findings revealed a high prevalence of AMR E. coli circulating in healthy humans and 
livestock in Nairobi, with no evidence to suggest that keeping livestock, when treated as a 
single risk factor significantly contributed to the burden of AMR in humans, although the 
presence of livestock waste was significant. These results provide an understanding of the 
broader epidemiology of AMR in complex, and interconnected urban environments.   
 





1. Introduction  
Antimicrobial resistance (AMR) in bacteria is regarded as one of the most serious public health 
threats of this century [1-3]. Over the last decade, increasing levels of resistance to clinically 
relevant antibiotics – including carbapenems [4]  and colistin [5], which are considered 
antibiotics of last resort – has been reported in both human and animal populations.  
Although E. coli can be a harmless gut commensal, some pathogenic strains can cause life-
threatening bloodstream infections, and other common illnesses, such as urinary tract 
infections [6]. E. coli can also cause disease in animals, leading to severe economic losses due to 
mortality and morbidity [7]. Recently, E. coli was categorised by the World Health Organization 
as a priority pathogen due to its widespread antibiotic resistance [8].  
Livestock have been implicated as a reservoir for AMR bacteria that may spread to humans, 
with the keeping of livestock widely believed to be a risk factor for AMR in humans [9, 10]. 
However, quantitative evidence describing the role of livestock in the emergence and 
transmission of AMR bacteria to human populations is lacking [11], particularly in low- and 
middle-income countries (LMICs) [12]. In the absence of routine surveillance of AMR in most 
LMICs, understanding the epidemiology of AMR is key to developing effective strategies 
targeting a reduction in the emergence and spread of resistance in the future. 
To date, studies investigating the epidemiology of AMR have tended to focus on either human 
or livestock populations without making comparisons of resistances between the two 
populations. A recent systematic review [11] of studies investigating the link of AMR E. coli 
between humans and livestock found only 22 studies of spatiotemporally-related isolates from 
human and livestock populations, just six of which were conducted in LMICs. Notably, none of 
these studies considered urban livestock, which are increasingly important, particularly in LMIC 
settings [13] and may contribute to the maintenance of zoonotic bacteria and AMR in the 
complex urban environment [14].   
This study focuses on the role of livestock keeping as a potentially high-risk urban interface for 
AMR transmission between humans and livestock in urban Nairobi. Nairobi is a rapidly growing 
city where livestock are commonly kept within household compounds, bringing them into close 
contact with people. E. coli is an ideal organism to study the spread of AMR in this complex 
environment since it is a ubiquitous commensal in both livestock and humans, but with a wide 
range of resistance phenotypes.   
Here, we report the first study characterising the patterns and epidemiology of antibiotic 
resistant E. coli from co-habiting human and livestock populations in a low resource urban 
setting.  At the scale of individual households, we explore the role of livestock as risk factors for 
AMR carriage in humans, hence providing insight into the pathways of AMR transfer. 
2. Methods 
2.1. Study design  
A cross-sectional study targeting sympatric human and livestock populations in Nairobi, Kenya 
was carried out from August 2015 to October 2016 as part of the Urban Zoo Project [15]. 
Briefly, Nairobi city was stratified into administrative sublocations according to socioeconomic 
status, identifying 70 possible sub-locations. Thirty three sub-locations were chosen with the 
aim of maximising spatial distribution, socio-economic diversity, and attempting to capture the 
diversity of livestock keeping practices across the city [15]. For each sub-location, three 
households – two livestock keeping (small livestock only (poultry, rabbits and goats), and large 
livestock (cattle and pigs) with or without small livestock) and one non-livestock-keeping – were 
selected at random within the dominant housing type.  
A total of 99 households were involved in the study (Figure 1). Study design is explained in 
detail in the electronic supplementary material.  
2.2. Sample collection and antimicrobial susceptibility testing (AST) 
In each household, a questionnaire was used to collect data on household composition, socio-
economic variables, livestock ownership, food consumption and medical history. Human and 
animal faecal samples were collected and transported on ice to one of two laboratories 
(University of Nairobi or Kenya Medical Research Institute) within 5 hours of collection. Samples 
were enriched in buffered peptone water for 24 hours, and thereafter plated onto eosin 
methylene blue agar (EMBA) and incubated for 24 hours at 37°C. One colony from each plate 
was selected and sub-cultured for a further 24 hours on a second round of EMBA. 
Subsequently, one purified colony from each plate was selected at random (hereafter referred 
to as an ‘isolate’), and confirmed as E. coli by biochemical testing, using triple sugar iron agar, 
Simmon’s citrate agar, and motility-indole-lysine media.  
Antimicrobial susceptibility testing for 13 antibiotics – ampicillin  (10 g/ml), amoxicillin-
clavulanic acid (30 g/ml), cefepime (30 g/ml), cefotaxime (30 g/ml), ceftazidime (30g/ml), 
chloramphenicol (30 g/ml), ciprofloxacin (5 g/ml), gentamicin (10 g/ml), nalidixic acid (30 
g/ml), streptomycin (25 g/ml), sulfamethoxazole (30 g/ml), tetracycline (30 g/ml), and 
trimethoprim (2.5 g/ml) – that are frequently used in either/both veterinary and/or human 
medicine in Kenya was carried out using the Kirby-Bauer disc diffusion method (Oxoid Ltd., 
Basingstoke, United Kingdom). Standardised protocols were used, in which antibiotic discs were 
dispensed onto bacteria-containing agar plates and incubated for a maximum of 18 hours at 
35oC. E. coli ATCC 25922 was used as a quality control of the susceptibility tests.  
Clinical and Laboratory Standards Institute (CLSI) interpretive criteria for Enterobacteriaceae 
[16] were used to determine breakpoints for classifying isolates as either susceptible 
(‘susceptible’ or ‘intermediate’) or non-susceptible (‘resistant’) for eleven of the 13 drugs. For 
tetracycline and trimethoprim, we classified isolates into resistant or susceptible because 
examination of the distributions of the zones of inhibition showed populations of isolates with 
distinct phenotypic resistance patterns (see electronic supplementary material, table S1). To 
describe multidrug patterns, the overall resistance profile was calculated by combining the 
resistance phenotype to each individual class, and thus antibiogram length (hereafter also 
referred to as AMR carriage) is the total number of antibiotic classes to which an isolate was 
phenotypically resistant.  
2.3. Statistical analysis  
The distribution of resistance phenotypes between hosts was calculated using Chi-squared tests 
(humans and livestock), and an one way ANOVA (human vs different livestock groups). Tukey's 
multiple-comparison test was performed post-hoc for pairwise comparisons between groups, 
and P values of <0.05 were considered significant. 
Generalized linear mixed models (GLMMs), implemented in R package ‘lme4’ [17], with 
antibiogram length as the dependent variable were used to test whether AMR carriage differed 
between host groups. To investigate the co-occurrence of AMR phenotypes, a pairwise co-
occurrence matrix (presence and absence) of the phenotypes was constructed using polycor 
package [18] in R and the co-occurrence relationships visualized using corrplot [19]. A 
correlation between two AMR phenotypes was considered statistically significant if the P-value 
(adjusted for multiple testing using Bonferroni correction) was <0.05.  
To investigate finer scale household-level risk factors for AMR carriage in humans, we fitted a 
Poisson-distributed GLMM, with the counts of resistance phenotypes (antibiogram length) as 
the response variable. Model explanatory variables were human density (count of people in a 
household as a function of household area) and types of livestock kept in the household (small 
livestock only, large livestock with or without small livestock, and no livestock).  Additionally, 
for households that kept livestock, a separate Poisson-distributed GLMM was fitted to 
investigate the effect of human density and manure disposal practises (manure disposed in the 
household compound or outside) on human antibiogram length. Separate models were fitted 
for the most prevalent AMR phenotypes (tetracyclines, aminoglycosides, sulfonamides, 
penicillins, and trimethoprim).  
To account for the nested (or hierarchical) nature of our sampling design household site (n=99), 
sublocation (n=33) and wealth category (n=7) were included as random factors.  Further details 
of data exploration and statistical models are given in the electronic supplementary material. 
3. Results  
A total of 954 isolates composed of 321 human and 633 livestock E. coli isolates in Nairobi, 
Kenya, were analysed. The number of isolates obtained from each source is presented in Table 
1. 
3.1. Patterns of antimicrobial resistance in humans and livestock 
The most common resistance phenotypes (>40% of resistant isolates) were to sulfonamides, 
trimethoprim, tetracyclines, and aminoglycosides. A smaller percentage of isolates (<10%) were 
resistant to amoxicillin/clavulanic acid, cephalosporins, phenicols, and fluoroquinolones (Table 
2 and Figure 2). The distribution of resistance to the individual drugs tested is given in Table s2. 
When analysed by host, human isolates were more commonly resistant to each of the 
individual antibiotic classes, than those of animal origin. Of 321 human isolates, >40% were 
resistant to sulfonamides, trimethoprim, aminoglycosides, and tetracyclines. Of 633 livestock 
isolates, >40% of isolates were resistant to sulfonamides, tetracyclines and trimethoprim. For 
both human and livestock isolates, <10% of isolates were resistant to phenicols, 
fluoroquinolones, cephalosporins and beta-lactams. Resistance to penicillins, aminoglycosides, 
sulfonamides and trimethoprim was significantly more common in humans than in livestock 
(p<0.01, Chi-squared test; Table 2, Figure 2a). 
The prevalence of resistance to penicillins, tetracycline, aminoglycoside, sulfonamides and 
trimethoprim varied significantly between humans and livestock stratified by taxonomic groups 
(poultry, pigs, rabbits, bovines and goats; Tukey’s post hoc test). Humans were more likely to 
carry E. coli resistant to penicillins, aminoglycoside, sulfonamides and trimethoprim than all 
species of livestock (p<0.05, one-way ANOVA with Tukey's multiple-comparison test). 
Conversely, poultry were more likely to carry isolates resistant to tetracyclines than humans 
(Figure 2b, Supplementary Figure s1).   
Overall, 284 (29.7%) isolates were susceptible to all 13 antibiotics tested (nine antibiotic 
classes). The proportion of pan-susceptible isolates was significantly higher among livestock 
isolates (n=217/633, 34.3%) than in human isolates (n=67/321, 20.9%) (X2=17.6, p<0.01, Chi-
squared test). Of the 217 pan-susceptible livestock isolates, 22% of poultry isolates (n=76), 
51.6% of bovine isolates (n=33), 33.3% of pig isolates (n=17), 54.6% of goat isolates (n=72), and 
46.3% of rabbit isolates (n=19) were pan-susceptible. Across both human and livestock isolates, 
404 (47.6%) and 201 (21.1%) isolates were resistant to ≥ three and five antibiotic classes 
respectively. Eight isolates (0.8%) showed resistance to ≥7 antibiotic classes tested; five (1.6%) 
from humans and three (0.9%) from poultry (Figure 3). 
Antibiogram length (i.e. the total number of antibiotic classes an isolate is resistant to) was 
significantly higher in humans than in livestock (OR=1.14, 95% CI 0·68 to 0·81, p<0.01, marginal 
R2 0·041, GLMM). However when studied in more detail, antibiogram lengths in human isolates 
were similar to those from pigs and poultry (p>0.05, marginal R2 0.151, GLMM) but significantly 
higher than those from bovines, goats and rabbits (p<0.05, marginal R2 0.151, GLMM) (Table 3, 
Figure 3).  
Examination of the similarity of E. coli antibiograms from human and livestock isolates revealed 
84 distinct profiles: 30 in livestock, 19 in humans and 35 common to both (Table s4). Using a co-
occurrence analysis based on a statistically significant (p<0.05) correlation coefficient (ρ>0.5) 
we identified a tetracycline-sulfonamide-trimethoprim cluster (Figure 4). This co-resistance was 
identified in 340 isolates (30.5%): 115 (35.8%) humans and 225 (35.5%) livestock – 156 (45.2%) 
poultry, 24 (47.1%) pigs, 9 (22.0%) rabbits, 14 (21.9%) bovines, and 22 (16.7%) goats. There 
were no significant differences in the distribution of this profile between human and the other 
host groups (X2<0.01, p > 0.98, Chi-squared test). Further, denoting multi-resistance, this cluster 
was commonly associated with resistance to aminoglycoside and penicillins.  
3.2 Antimicrobial resistance exchange between humans and livestock at the household level 
In any given household, we found no evidence that the presence of livestock increased risk of 
human AMR carriage (large livestock OR=0.94 p=0.24, 95%CI 0.72 to 1.22; small livestock OR=1.04, 
p=0.94, 95% 0.82 to 1.30, marginal R2 0.3, GLMM) (Table 4). However, human antibiogram length 
increased with human density (OR=1.26, p=0.003, 95% CI 1.08 to 1.47, marginal R2 0.3, GLMM) 
(Figure 5). The impact of livestock keeping on human AMR carriage was potentially influenced by 
disposal practices of animal manure: keeping manure inside the household perimeter, compared 
to disposing of it externally, was associated with greater human antibiogram length (OR=1.29, 
p=0.03, 95%CI 1.02 to 1.63, marginal R2 0.5, GLMM) (Table 4). Our results were consistent when 
we performed separate analyses for the individual resistances (Table s3).   
4. Discussion  
In this study we applied ecological and epidemiological approaches to characterise the 
epidemiology of AMR E. coli isolates systematically collected from sympatric human and 
livestock populations in the rapidly developing urban landscape of Nairobi, Kenya.  
Resistance to aminoglycosides, sulfonamides, tetracyclines, trimethoprim and penicillins was 
high in both humans and livestock, while resistance to cephalosporins and fluoroquinolones 
was low. These results are consistent with previous studies [20-23] and may in part be a 
reflection of the patterns of antibiotic use in human and animal health. However, background 
data on antimicrobial use in these populations is limited. Our results indicating a high 
prevalence of AMR carriage are based on non-clinical isolates from humans and livestock.  
When analysed by host, human isolates appeared to have a higher prevalence of AMR carriage 
when compared to livestock isolates, with the exception of tetracyclines. In particular, the 
observed prevalence was significantly higher in four clinically relevant antibiotic classes 
(penicillins, sulfonamides and trimethoprim and aminoglycosides). A possible explanation for 
this variation in AMR carriage is that it relates to variation in antibiotic use between these 
populations. Although antibiotics are used extensively in both human and livestock populations, 
previous studies have shown that frequency of  use of antibiotics is higher in human medicine 
than in livestock, especially in resource-poor settings [24, 25]. Similarly, in community settings 
where over-the-counter access to drugs is common, it is likely that humans have access to a 
broader range of antibiotics, either through self-medication or inappropriate prescribing; 
common practices in many low and middle-income countries (LMICs) [26, 27]. Likewise, in such 
settings, infections are commonly treated empirically (often using antibiotics) with limited 
microbiological investigations to ascertain the causal organism(s).  
Although chloramphenicol use in food animals has been banned in Kenya [28], we noted 3% 
resistance to this antibiotic in livestock. This may be explained by the use of florfenicol, a 
fluorinated derivative of chloramphenicol, which shows some cross-resistance with 
chloramphenicol [29]. Similarly, the observed levels of resistance against ciprofloxacin (a 
quinolone antimicrobial not licensed for veterinary use) among livestock isolates is probably 
explained by cross-resistance with other quinolones used in veterinary medicine, such as 
enrofloxacin and norfloxacin.  
At the household level, there is evidence of an intricate interplay between humans and 
livestock in relation to the development and transmission of AMR. Our analysis revealed that 
human AMR carriage increased with number of occupants in a household, and that keeping 
manure inside the household compound was also significantly associated with AMR carriage in 
humans. In urban Nairobi, people live in a continuum of urban spaces with varying human and 
animal population densities, with the majority (>60%) of people living in slums [30, 31], 
environments characterised by small household areas and high population densities. Population 
density is an important factor in the population prevalence of AMR in populations [32], and 
may in part be due to the significant correlation between overcrowding and high infectious 
diseases burden more broadly[33]; an important driver of antibiotic use in resource poor 
settings such as Nairobi. Similarly, high human populations within a household result in a 
greater epidemiological connectivity; thus facilitating exchange of AMR bacteria and their AMR 
determinants. The number of urban dwellers in the majority of LMIC cities, including Nairobi, is 
projected to grow significantly in the near future [34]. While this urban demographic change is 
unfolding, disease burden is expected to burgeon, precipitating high antibiotic use. For this 
reason, measures to curb infectious diseases burden by the public health policy makers, in part 
to reduce drug pressure on micro-organisms, are needed.  
Our results suggest that at the household level, livestock ownership in and of itself does not 
add to the risk of acquisition or carriage of AMR bacteria in humans. However, given the 
multiple pathways of AMR exchange between humans and livestock [35], via the food chain or 
due to environmental pollution, it is possible that the direct effect of livestock keeping on levels 
of AMR in humans could be confounded by other factors not captured in this study. Our study 
does, however, suggest that, whilst AMR carriage (antibiogram length) was not directly 
associated with the presence of livestock in the household, the impact of keeping livestock on 
human AMR carriage was mediated by some practices associated with livestock keeping, 
namely the presence or absence of animal manure in the household. These results support 
other studies that have identified animal manure as a reservoir of AMR bacteria and AMR 
determinants [36, 37]. Importantly, amplification and persistence of AMR determinants such as 
AMR plasmids can take place in manure and be further disseminated to humans via cross-
contamination pathways such as through exposed water and food [38], or via peri-domestic 
wildlife. Although there is still a lack of knowledge concerning the exact mechanism, particularly 
the genetic basis of transmission [39], strategies that limit AMR gene flow to and from manure 
(to humans) should be adopted. Such measures include safe disposal of manure from 
households, and manure pre-treatment prior to application onto crop farms where possible.  
It is important to note that, while our analysis was not designed to address transmission of 
AMR bacteria and their AMR determinants, it is also plausible that clonal expansion could have 
played a role in the observed AMR patterns. Our finding of 35 common AMR profiles in both 
human and livestock bacterial populations may, in part, reflect overlapping antibiotic usage 
patterns, acquisition of AMR from a shared source or clonal expansion. We hypothesise that 
our finding that 30.5% (340/954) of all isolates contain a tetracycline-sulfonamide-trimethoprim 
cluster phenotype and that the pairwise correlations between these three antibiotic classes 
were very high is suggestive of a conjugative MDR plasmid circulating within the E. coli 
population in both human and livestock populations. AMR genes conferring resistance to 
tetracycline, sulfonamide and trimethoprim antibiotic classes are commonly associated with 
mobile genetic elements [40], and these elements play a pivotal role in dissemination of 
multidrug resistance in E. coli isolates. Genetic data is required to validate the existence of 
mobile genetic elements, and determine whether AMR genes are being transferred across 
them.  
Distinguishing molecular transmission of AMR, from selection for AMR due to antibiotic use, is 
challenging [11]. In particular, in an urban environment such as Nairobi, where human 
habitation, livestock keeping, and food supply chains are interconnected [41] the relative 
contributions of the aforementioned drivers are difficult to quantify. At a finer scale, any study 
investigating the transmission of AMR between humans and livestock in these low resource 
settings needs to consider indirect transmission, rather than just direct animal to human and/or 
human to animal transmission. Whilst direct host-to-host transmission of AMR bacteria and 
AMR determinants may occur, in these intricate ecosystems, the role played by the wider 
environment (e.g. wildlife, soil and, in particular, hospital and farm effluents) in relation to 
acquisition of AMR from a common source may be vital.  
 
5. Conclusion  
Taken together, using a rigorously-structured epidemiological study design, we report a high 
prevalence of AMR E. coli carriage in livestock and humans outside the clinical setting across a 
developing-country urban landscape, with no evidence that direct contact with livestock 
contributes to the burden of human AMR, but that indirect contact between livestock and 
humans does play a role. In LMIC urban ecosystems, the elevated prevalence of AMR in both 
human and livestock populations could be attributed to unregulated access to antibiotics, poor 
hygiene and sanitation, and waste management, which encourage the evolution and spread of 
AMR bacteria. These findings highlight a need for targeted surveillance strategies across various 
sectors, and for actors to address and design effective measures to curb AMR in these 
populations, both in Nairobi and in other similar urban landscapes. Further work is required to 
understand the ecology of genetic determinants of resistance, in particular the extent of the 
role plasmids play in the dissemination and evolution of resistance traits in these human and 
livestock populations.  
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Figure Legends  
 
Figure 1. Map of Nairobi city, Kenya indicating the location of the sampled households (black 
dots) and 33 sublocations (coloured by wealth category; 1 – wealthy, 7 – poor).  
  
 
Figure 2. Radar charts showing percentages of E. coli isolates resistant to 9 antibiotic classes. a) 
human (n=321) and livestock (n=633), and b) human and the different livestock species’ 
(poultry, pig, bovine, goat, rabbit). (Asterisks denote significant differences between carriage of 
this particular resistance phenotype in livestock and humans). 
  
 
Figure 3. Distribution of multidrug resistance patterns among E.coli isolates obtained from 
humans (n=321), poultry (n=345), pigs (n=51), bovines (n=64), goats (n=132), and rabbits 
(n=41), in Nairobi, Kenya.  
  
 
Figure 4. Heat map representing correlations among AMR phenotypes across human (n=321) 
and livestock (n=633) E. coli isolates. The boldness of the colour represents the strength of the 
relationship between phenotypes, with stronger correlations having bolder colours. Numbers 
within boxes represent correlation coefficient (r) values. * indicates statistically significant 
correlations (p<0.05). The scale bar at the bottom indicates whether the correlation between 
phenotypes is positive (closer to 1, dark blue) or negative (closer to −1, dark red).  
  
 
Figure 5. Fit of a Poisson generalised linear mixed effects model showing how increasing human 
density in a household influences the antibiogram length in humans.  All other covariates in the 
models are kept constant. Shading on either side of each line represents 95% confidence 
intervals. Points have been jittered for clarity.  
  
Table 1. Number of human and livestock isolates collected from the 99 households from 






Table 2. Percentages of E. coli isolates resistant to different antibiotic classes classified by host 
type (human or livestock). Numbers show percentages of isolates classified as resistant based 
on the zone of inhibition. Categorical interpretation is based on breakpoints used as described 







(n=633) Adj. p value 
Sulfonamides 58.2 66 54.2 0.005 
Aminoglycosides 37.1 47.7 31.8 <0.001 
Trimethoprim 47.3 56.1 42.8 0.001 
Tetracyclines 45.7 45.5 45.8 NS 
Penicillins 30.2 40.8 24.8 <0.001 
β-lactam (co-amoxiclav) 1.5 2.5 0.95 NS 
Phenicols 4.0 6.5 2.69 NS 
Cephalosporins 3.8 2.8 4.27 NS 
Fluoroquinolones 6.8 9.7 5.37 NS 
 
Table 3. Results of a Poisson generalise linear mixed model examining the likelihood of AMR 
carriage within different host groups. Human is used as the reference level. NS =Not significant 
 No of isolates Estimate Standard error P value 
Human  321 Reference Reference Reference 
Livestock  633 -0.13 0.16 <0.01 
    Bovine 64 -0.28 0.14 0.03 
    Poultry 345 -0.08 0.05 NS 
    Pigs 51 0.08 0.11 NS 
    Rabbits 41 -0.37 0.16 0.02 
    Goats 132 -0.48 0.11 <0.01 
   
Source  Number of isolates  % of isolates  
Human 321 33.7 
Livestock:   
Poultry 345 36.2 
Bovine 64 6.7 
Goat 132 13.8 
Pig 51 5.3 
Rabbit 41 4.3 
Table 4. Results of two generalized Poisson Mixed Models investigating household risk factors 
for AMR carriage (antibiogram length) in humans at the household level. Households not 
keeping livestock used as the reference level in Model 1.  
Model 1: Antibiogram length, humans in all 
households 
Estimate Standard error P value 
Human density 0.23 0.08 0.003 
Large livestock (with or without small livestock) -0.14 0.12 0.24 
Small livestock only 0.0075 0.11 0.94 
Model 2: Antibiogram length, humans in livestock 
keeping household only 
   Human density 0.24 0.09 0.009 
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A cross-sectional survey of practices and 
knowledge among antibiotic retailers in Nairobi, 
Kenya
Background Antimicrobial resistance (AMR) driven by antibiotic con-
sumption is a growing global health threat. However, data on anti-
microbial consumption patterns in low- and middle-income countries 
(LMICs) is sparse. Here, we investigate the patterns of antibiotic sales 
in humans and livestock in urban Nairobi, Kenya, and evaluate the lev-
el of awareness and common behaviours related to antibiotic use and 
AMR amongst human and veterinary pharmacists.
Methods A total of 40 human and 19 veterinary drug store pharmacists 
were interviewed in Nairobi in 2018 using a standard questionnaire. 
Data recorded included demographic variables, types of antibiotics sold, 
antibiotic customers, antibiotic prescribing practices and knowledge of 
antibiotic use and AMR.
Results Our study shows that at the retail level, there is a considerable 
overlap between antibiotic classes (10/15) sold for use in both human 
and veterinary medicine. Whilst in our study, clinical training signifi-
cantly influenced knowledge on issues related to antibiotic use and AMR 
and respondents had a relatively adequate level of knowledge about 
AMR, several inappropriate prescribing practices were identified. For 
example, we found that most veterinary and human drug stores (100% 
and 52% respectively) sold antibiotics without a prescription and not-
ed that customer preference was an important factor when prescribing 
antibiotics in half of the drug stores.
Conclusion Although more research is needed to understand the driv-
ers of antibiotic consumption in both human and animal populations, 
these findings highlight the need for immediate strategies to improve 
prescribing practices across the pharmacists in Nairobi and by exten-
sion other low- and middle-income country settings.
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Antibiotic resistance (AMR) has been described as one of the most serious 
public health threats of this century [1-3]. Antimicrobial use, misuse and 
overuse in human and animal medicine exerts an important selective pres-
sure for AMR. Global antimicrobial use in human and food animals is in-
creasing, mainly due to increased disease burdens and expanded intensive 
livestock production respectively [4].
As in most cities in low and middle income countries (LMICs), in urban 
Nairobi the high incidence of bacterial diseases and antimicrobial resis-
tance in clinical medicine is a major public health challenge [5]. In both 
human and animal populations, antibiotics are used for both prophylaxis 
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and treatment of infectious diseases and many of the antibiotics used to treat these infectious diseases are 
pharmacologically similar. It is estimated that more than half of all antibiotics (for use in both humans 
and animals) are purchased without a prescription and used over-the-counter [6]. There is a paucity of 
data in Kenya regarding antibiotic usage at both the national and the regional level, but there have been 
attempts to assess the consumption of antibiotics in food producing animals and human health using 
sales data [7]. These studies, based on antibiotic import data, estimate that, from 1997-2001, consump-
tion of antibiotics in clinical medicine increased by 4%, with penicillins and fluoroquinolones being the 
most widely used antibiotics. Collecting data on antibiotic use simultaneously in both animals and hu-
mans could provide essential data to help disentangle the primary drivers for the development of antibi-
otic resistance. Here, we carried out a survey to investigate the patterns of antibiotic sales in humans and 
animals in urban Nairobi.
Pharmacists (both human and veterinary) play a pivotal role in enhancing antimicrobial stewardship ini-
tiatives, not just by highlighting the AMR problem, but also by influencing crucial prescribing decisions 
[8,9]. To further improve antibiotic use and antibiotic stewardship programmes it is important to have 
an understanding of the knowledge and attitudes towards antibiotics within different populations such 
as pharmacists. At present, there has been limited research in understanding pharmacists’ knowledge of 
antibiotic resistance. Here, we aimed to assess the level of awareness and common behaviours related to 
antibiotic prescribing amongst human and veterinary pharmacists.
MATERIALS AND METHODS
Study design and setting
A cross-sectional study targeting human and veterinary drug stores in urban Nairobi, Kenya was carried 
out in January 2018 as part of the UrbanZoo project [10]. Briefly, Nairobi County was classified into sev-
en wealth categories according to average income, identifying 70 possible sub-locations. Thirty-three 
sub-locations were chosen for sampling with the aim of maximising spatial distribution, socio-econom-
ic diversity, and attempting to capture the diversity of livestock keeping practices across the city [10]. 
Within each of the pre-selected 33 sub-locations we randomly selected and visited two community drug 
stores – one veterinary drug store and one human drug store. The final distribution of sampled human 
and veterinary drug stores is shown in Figure 1. Community human drug stores are mostly operated by 
pharmaceutical technicians who are responsible for dispensing antibiotics, while only a few, mostly large, 
drug stores have a registered pharmacist (holding a bachelor’s degree in pharmacy). Both pharmaceutical 
technicians and pharmacists are able to sell, but not prescribe antibiotics in Kenya [11]. Veterinary drugs 
stores are mostly operated by animal health technicians (also referred to as para-veterinarians) with just 
a few operated by veterinarians. Animal health technicians are also not allowed to prescribe antibiotics. 
All of the above-mentioned groups will 
have obtained clinical/veterinary train-
ing at varying levels. In this study, we 
define ‘pharmacist’ as someone selling 
antibiotics in a veterinary or a human 
drug store irrespective of the level of 
clinical training.
A draft of the questionnaire was pre-test-
ed with five drug stores (three human 
and two veterinary), and refined on ba-
sis of the feedback from the pre-testing 
sessions before final dissemination. In 
each drug store a detailed questionnaire 
was used to collect data on socio-de-
mographic variables, training on anti-
biotic use, types of antibiotics sold (by 
class), the four antibiotic classes most 
commonly sold, variation in antibiot-
ic sales, antibiotic sources, antibiotic 
customer characteristics, and antibiotic Figure 1. Map of Nairobi county indicating locations of study sites.
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prescribing practices. A summary of the collected data are presented in Table S1 in Online Supplemen-
tary Document. To assess the knowledge of antibiotic use and AMR amongst the human and veterinary 
pharmacists we adapted a standard questionnaire prepared and used by the World Health Organization 
[12]. First, we assessed respondents’ knowledge on a number of terms routinely used to describe the 
problem of antimicrobial resistance. These terms included: antibiotic resistance, superbugs, antimicrobi-
al resistance, AMR, drug resistance and antibiotic-resistant bacteria. Next, respondents were asked about 
their level of agreement with ten statements describing their knowledge on AMR and potential solutions 
to antimicrobial resistance. The statements were written on a 5-point Likert scale [13].
Data analysis
Descriptive statistics were prepared for all data including frequencies and percentages for categorical 
variables (eg, gender and education level) and means, medians, standard deviations (SDs), quartiles, and 
ranges for quantitative variables (eg, number of customers) depending on the distribution of the data. 
We used a χ2 or Fisher exact test using R package stats [14] to describe differences between proportions 
of clinical training (present or absent) by type of drug store (human or veterinary) and Mann-Whitney U 
test to compare range of antibiotics (number of different antibiotic classes) in the two types of drug stores.
Prescribing practices
Next, we aimed to describe practices and evaluate the factors associated with drug prescribing amongst 
human and veterinary pharmacists. To achieve this, we collected data on information provided to cus-
tomers after purchasing antibiotics as an indicator of good prescribing practices. This included: whether 
pharmacists provided customers with information on dosage, directions for use (ie, completing the pre-
scribed dose), storage instructions, side effects, expiry date and contra-indications [15]. The data were then 
assessed for multicollinearity using the corrplot package [16] in R to determine if answers to any two or 
more questions were correlated. There did not appear to be a sufficiently strong correlation between any 
two questions for any of them to be excluded. To derive a measure of prescribing practices amongst the 
respondents we developed a composite score (sum of the binary variables, 0/1) from individual indica-
tors of good prescribing practices. We fitted a generalized linear model (GLM) using R package lme4 [17] 
to assess possible influence of type of drug store (human/veterinary), clinical/veterinary training (pres-
ent or absent), education level (high or low) and range of antibiotics sold (number of different antibiotic 
classes) in the drug store (proxy for store size) on the composite prescribing practices score. We analysed 
clinical/vet training (defined as having a degree or diploma in clinical or veterinary medicine) and educa-
tion level separately as some pharmacists had received training in disciplines not related to medicine or 
veterinary studies. We considered P < 0.05 to be statistically significant.
Knowledge on antimicrobial resistance
In order to assess the internal consistency of the ten statements evaluating the level of knowledge on 
AMR, Cronbach’s alpha coefficients were calculated for each statement. Internal consistency is a measure 
of item-total correlations and reliability of the scale, thus describing the extent to which all items in a test 
measure the same concept or construct [18]. An unstandardized Cronbach’s alpha coefficient of 0.7 or 
above was considered to demonstrate adequate reliability.
Principal Component Analysis (PCA) using polychoric correlation [19] was used to generate a composite 
index for knowledge score and to investigate clustering of the knowledge statements [20]. Analyses were 
performed using the psych package [21] to conduct PCA (using the principal function) without rotation 
of axes. Scree plot inspection [22] and parallel analysis [23] were used to choose the optimal model in 
terms of number of components to retain.
The scores of the first PCA component were used as measure of knowledge of AMR, and the higher the 
knowledge score, the higher the implied knowledge of AMR of that respondent. A generalised linear 
model was used to investigate the possible influence of type of drug store (human or veterinary), clinical 
training (present or absent), education level (high or low), and range of antibiotics sold in the drug store 
(proxy for store size) on the level of knowledge of AMR.
Ethical approval
Ethical approval for this study was obtained from the International Livestock Research Institute (ILRI) In-
stitutional Research Ethics Committee (ILRI IREC) (project reference: ILRI-IREC2017-35).
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Demographic data about the respondents
A total of 59 participants were interviewed – 40 from hu-
man drug stores and 19 from veterinary drug stores (Table 
1). Some sub-locations did not have a veterinary drug store 
as these tend to be located in zones of the city where animals 
are kept. The median age of participants in both human and 
veterinary stores was 30 years (range; human, 21-51; live-
stock, 19-67 years). More than two thirds of participants in-
terviewed in both stores were employees (human, 73% and 
veterinary, 74%), and the remainder were store owners. Sig-
nificantly more human pharmacists (90%) than veterinary 
pharmacists (57%) had undergone some form of clinical 
training (P = 0.01, Fisher exact test). Additionally, for partici-
pants who underwent clinical training, professional develop-
ment programmes/trainings aimed at continuing education 
in AMR were an important source of information on antibi-
otic stewardship (human pharmacists, 50%; and veterinary 
pharmacists, 41%).
Antibiotics sold and sale dynamics
A total of 15 antibiotic classes were available in either or both 
human and veterinary drug stores (Figure 2). Two thirds of 
the antibiotic classes (10/15) were found in both human and 
veterinary drug stores while five classes (metronidazole, am-
phenicols, lincosamides, glycopeptides and carbapenems) 
were only found in human drug stores. Of the ten overlap-
ping antibiotic classes, beta lactam/penicillin, tetracycline, 
sulfonamide, and macrolide antibiotic classes were found in 
more than 78% of both types of drug stores. Of note, car-
bapenems, third and fourth generation-cephalosporins and 
glycopeptides – antibiotics restricted to clinical use – were 
found in 15%, 4% and 3% of human drug stores respective-
ly. Overall, human drug stores had a broader range of anti-
biotics available for sale when compared to veterinary stores 
(P < 0.01, Mann-Whitney U test) (Figure 2).
Penicillins, metronidazole, fluoroquinolones, and first and 
second-generation cephalosporins were reported as being 
amongst the four most commonly sold antibiotic classes by 
the human drug stores in 93%, 65%, 63%, and 43% of the 
stores respectively. However, among the veterinary drug stores, 
tetracyclines, sulfonamides, penicillins and macrolides were 
reported to be amongst the four most commonly sold anti-
biotic classes in 79%, 74%, 58%, and 47% of the stores re-
spectively. Tetracyclines and sulfonamides were reported to be 
amongst the four most commonly purchased antibiotic class-
es by poultry farmers in 79% and 90% of the veterinary drug 
stores respectively. The antibiotic colistin was described as be-
ing commonly purchased by poultry farmers in 16% of the 
drugs stores. Sulfonamides, tetracyclines and penicillins were reported to be amongst the four most com-
monly purchased antibiotic classes by dairy farmers in 63%, 47% and 52% of drug stores respectively. In 
11% of the veterinary drug stores, dairy farmers reportedly purchased first and second-generation cepha-
losporin intra-mammary tubes to treat mastitis cases. The antibiotics reported to be amongst the four most 
commonly purchased antibiotic classes by pig farmers were penicillins, macrolides and sulphonamides in 
37%, 16% and 11% of the veterinary drug stores respectively (Figure 3).
Table 1. Participant demographics and baseline clinical charac-
teristics
CharaCteristiC human drug stores Veterinary drug stores
Number of individuals 40 (67%) 19 (33%)
Gender:
Female 21 (52.5%) 9 (47.4%)
Male 19 (47.5%) 10 (52.6%)
Highest education level:
Primary 0 1 (5.2%)
Secondary 4 (10%) 5 (26.3%)
Certificate 4 (10%) 5 (26.3%)
Diploma 24 (60%) 7 (36.8%)
Degree 8 (20%) 1 (5.3%)
Role:
Owner 11 (27.5%) 5 (26.3%)
Worker 29 (72.5%) 14 (73.7)
Age (median) 30 30
Clinical/veterinary training:
Present 36 (90%) 11 (57%)
None 4 (10%) 8 (42.1%)
Source of training on antibiotic stewardship and AMR:
Clinical training only 16 (40%) 3 (15.8%)
CPD 20 (50%) 8 (41.1%)
None 4 (10%) 8 (42.1%)
AMR – antimicrobial resistance, CPD – continuing professional de-
velopment
Figure 2. Proportion of the 15 antibiotic classes reported in 
human (n = 40) and/or veterinary drug stores (n = 19). Data ar-
ranged in order of the average proportion of antibiotic classes.
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Fifty eight percent of human and 42% of veterinary drug 
stores reported a rise in antibiotic sales compared to the 
same period a year earlier. Increased customer demand 
for antibiotics was believed to be the main driver by 80% 
and 60% of human and veterinary pharmacists respective-
ly. Wholesale operations (defined as companies that buy 
drugs in bulk and sell them in smaller quantities to drug 
stores) were reported as the main provider of antibiotics to 
human drug stores (78%). On the other hand, distribution 
companies (defined as corporations that purchase drugs 
from pharmaceutical companies, store and subsequently 
distribute to drug stores) were reported as the main pro-
vider of antibiotics to veterinary drug stores (58%).
Antibiotic customer characteristics
The average daily number of customers purchasing antibi-
otics was not significantly different (P = 0.20; Mann-Whit-
ney U test) between human drug stores (25 customers, 
range 2-130) and veterinary drug stores (14 customers, 
range 2-113).
Antibiotics were reportedly prescribed frequently for re-
spiratory tract infections, gastro-intestinal infections, and 
sore throat in 83%, 65% and 58% of human drug stores 
respectively. Additional prescriptions were linked to fever, 
body aches, and skin wounds in 38%, 35% and 13% of 
human drug stores respectively.
Poultry farmers and veterinary para-professionals were 
the most frequent customers of antibiotics, being report-
ed as customers in 95% and 74% of the veterinary drug 
stores respectively. Other customers for antibiotics includ-
ed: dairy farmers, veterinarians, pig farmers, rabbit fam-
ers, and beef farmers in 63%, 58%, 47%, 37%, and 11% 
of stores.
Knowledge of antimicrobial resistance
More than two-thirds of the respondents in both stores 
types were aware of the terms “antibiotic resistance” and 
“drug resistance”. By contrast, fewer than half of respon-
dents had heard of the terms “AMR” and “super bugs” 
(Figure 4).
More than three quarters of the respondents in both store 
types agreed that the prevalence of drug resistant infec-
tions was increasing, and if left unchecked routine med-
ical and surgical procedures would become a much risk-
ier proposition. Likewise, more than 79% in both types of stores recognised that AMR is a problem, and 
has the potential to affect any country and anyone, including them and/or their families. However, most 
respondents (>80%) believed that AMR occurs when their body becomes resistant to antibiotics rather 
than the bacteria themselves that develop resistance. Similarly, 40% and 53% of human and veterinary 
respondents respectively suggested that AMR is only a problem for regular consumers of antibiotics. More 
than half (52%) of the respondents interviewed responded neutrally or disagreed with the statement that 
antibiotic resistant bacteria could be spread from person to person (Table S3 and Figure S2 in Online 
Supplementary Document).
Association between sociodemographic factors and knowledge on AMR
Cronbach’s alpha coefficient for the ten “knowledge statements” was 0.74, suggesting an acceptable lev-
el of internal consistency and a potential underlying latent construct (Table S2 and Figure S1 in Online 
Figure 3. Proportion of drug stores reporting the most common-
ly purchased antibiotics by different types of farmers based on the 
primary animal on the farm.
Figure 4. Terms used to describe antimicrobial resistance.
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Supplementary Document). The knowledge score (knowledge about AMR) of the respondents had sig-
nificant positive association with medical/veterinary training (P = 0.02), meaning respondents with clin-
ical training had a higher knowledge about AMR than those who had not undergone such training. The 
level of knowledge about AMR did not differ by store type, education level or range of antibiotics avail-
able in the store (P > 0.05) (Table 2).
Table 2. Results of a multivariable regression examining the influence of sociodemographic factors on knowledge 
about AMR in a sample of 40 and 19 human and veterinary drug stores respectively.
Variable estimate standard error χ2 df P-Value
Veterinary drug store 0.07 0.02 0.3 1 0.59
Range of antibiotics -0.01 0.02 0.31 1 0.58
Clinical/veterinary training 0.3 0.14 4.86 1 0.02
High education level 0.04 0.12 0.13 1 0.72
Knowledge and views on potential solutions to AMR
More than 80% of respondents in both store types agreed that people should use antibiotics only when 
prescribed by a medical practitioner. Also, more than two thirds of respondents in both store types agreed 
that reducing antibiotic use in food animals could help address the problem of antibiotic resistance. In 
both store types, respondents agreed on the need for governments and pharmaceutical companies to in-
vest in research and development of new antibiotics. More than 84% of all respondents agreed that ev-
eryone should use antibiotics prudently, but more than 73% of respondents thought that medical experts 
would solve the problem of antibiotic resistance. Hand washing and vaccination of children against infec-
tions were supported by more than 94% of respondents in both store types. However, 38% and 26% of 
respondents in human and veterinary drug stores agreed that there was not much they could do to stop 
antibiotic resistance (Table S4 and Figure S3 in Online Supplementary Document).
Antibiotic prescribing practices
Fifty-two per-cent (21/40) of the human drug stores reported that they sold antibiotics without a prescrip-
tion while all veterinary drug stores sold antibiotics without a prescription. Multivariable logistic regres-
sion analysis revealed prescribing practices did not vary significantly by clinical training, store type, range 
of antibiotics sold and/or education level (P > 0.05) (Table S5 in the Online Supplementary Document).
Across both human and veterinary drug stores, the most important factor for prescribing antibiotics was 
indication of use – based on symptoms – (in >75% of the stores), followed by price of the antibiotic (in 
>50% of the stores). Of note, 28% and 31% of human and veterinary pharmacists respectively consid-
ered customer preference as an important factor when prescribing an antibiotic.
DISCUSSION
In this study, we aimed to investigate the patterns of antibiotic sales in humans and animals in a large and 
rapidly developing city in a LMIC: Nairobi, Kenya. We also evaluated the level of awareness and common 
behaviours related to antibiotic use and AMR amongst human and veterinary pharmacists. Our study was 
based on gathering antibiotic sales data from human and veterinary drug stores across the city, where sales 
data were interpreted as representing antibiotic usage.
Our study shows considerable overlap in the antibiotic classes (10/15) sold for human and animal use in 
urban Nairobi, with marked variations in the sale of some antibiotic classes such as cephalosporins and 
fluoroquinolones – mostly found in human drug stores. This overlap in antibiotic classes, including of 
critically important antimicrobials [24], highlights the need for prudent use of all antimicrobials and con-
tinued monitoring and surveillance of antimicrobial usage in LMIC urban settings [25].
The most common symptoms prompting antibiotic purchase in humans were similar to those reported in 
other studies, respiratory tract infections and diarrhoeal disease [7,26,27]. Broad-spectrum beta lactams, 
fluoroquinolones, first and second-generation cephalosporins and metronidazole were the most common-
ly sold/bought antibiotics in human drug stores. This finding is consistent with antibiotic prescription in 
the community in previous Kenyan studies [27,28], in other low income countries such as Uganda [29], 
Tanzania [30], India [31] and in high income countries such as United Kingdom [32] and the USA [33]. 
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Our finding that WHO-classified highest priority critically important antibiotic classes such as carbapen-
ems, third and fourth generation cephalosporins, and glycopeptides were sold over the counter and po-
tentially without prescription in human drugs stores is of public health concern.
In the current study, tetracyclines, sulphonamides, penicillins, and macrolides were the most commonly 
purchased veterinary antibiotics and poultry farmers were the major consumers of antibiotics. Further, 
our findings indicate that colistin – a drug considered of last resort in human medicine [34] – was an an-
tibiotic of choice amongst poultry farmers in 16% of veterinary drug stores, as has been found in previ-
ous studies in other parts of the world [35-37]. Urban livestock are increasingly important, particularly 
among the low and middle income population bracket in most low resource urban settings [38,39], and 
antibiotic usage is a low-cost alternative for comprehensive hygiene and biosafety measures [40].
Knowledge about antimicrobial resistance among pharmacists has only been studied to a limited extent 
in LMICs [41]. Consistent with a recent multi-country survey by the World Health Organization [12] 
our survey found that, whilst the majority of the pharmacists have an understanding of the problem of 
antibiotic resistance and the effect(s) on public health, they do not fully understand how AMR develops 
and spreads. Encouragingly, the majority of respondents (>80%) identified several behaviours that can 
help reduce AMR burden; such as handwashing, antibiotic stewardship by both doctors and the pub-
lic, and ensuring children’s vaccinations are up-to-date. However, considering their key role in antibiotic 
stewardship, the finding that 38% and 26% of human and veterinary pharmacists agreed there was little 
they could do to stop AMR highlights the need for enhanced involvement of pharmacists in antibiotic 
stewardship programs.
Whilst the majority of the pharmacists we interviewed have an understanding of the threat posed by AMR 
to public health, our data highlight the poor quality of community pharmacy practice, most notably the 
dispensing of antibiotics without prescriptions and the inclusion of customer preference as an import-
ant factor when selling antibiotics. Antibiotics were dispensed without prescription in 53% and 100% of 
the human and veterinary drug stores respectively; a finding consistent with similar studies in Tanzania 
(92.3%) [42], Serbia (47.2%) [43], Ghana (70%) [44], and broadly across the developing world (19%-
100%) [25]. By contrast, a recent study conducted in community pharmacies in Nairobi reported low sale 
of antibiotics without prescription [45]. Part of this difference, however, may be related to the fact that in 
that study, information was based on just three pharmacies hence not generalizable across the city. In our 
study, whilst clinical training significantly influenced knowledge on issues related to antibiotic use and 
AMR, prescribing practices did not change with levels of clinical training. Considering the complexity of 
factors contributing to antibiotic prescribing, including the public’s demand for antibiotics, behavioural 
and policy interventions could be explored [46]. Because many members of the public in most LMICs 
bypass health care facilities and veterinarians in favour of seeking medication at pharmacies, policy mak-
ers could consider expanding the role of pharmacists in antibiotic stewardship initiatives [47,48].
Restating the particular relevance of training to antibiotic stewardship measures, the role of enhanced 
training in antimicrobial prescribing and AMR has been identified in surveys of both medical personnel 
and the public, both in Kenya and globally [49]. Results from a recent survey indicate that only 14.1% 
of clinicians in a national referral and teaching hospital in Kenya had received more than four lectures 
on antimicrobial stewardship and AMR as part of their medical training [50]. To address this challenge, 
antibiotic stewardship needs to be integrated in the undergraduate veterinary/medical curriculums and 
continuing medical/veterinary education programs.
Similar to other studies [51,52], our findings indicate greater familiarity amongst human and veterinary 
pharmacists with ‘antibiotic resistance’ and ‘drug resistance’ terminologies, and minimal familiarity with 
‘AMR’ and ‘superbugs’. This indicates that public health initiatives on antibiotic stewardship and/or an-
timicrobial resistance initiatives need to take an evidence-based approach in designing effective commu-
nication strategies [51,53].
This is the first study designed to capture the overlapping patterns of antibiotic sales in humans and live-
stock in a developing city via an epidemiologically-structured approach. A variety of approaches are avail-
able for assessing patterns of antibiotic use in humans and animals [54]. Considering that pharmacies are 
the primary level of outpatient/veterinary care (consultation, diagnosis, and prescription of antibiotics) 
for many urban dwellers in Nairobi, focusing on them provides important insights into the probable an-
tibiotic usage patterns at the consumer level. Future research would benefit from conducting longitudinal 
surveys of antimicrobial use in health care facilities and the community to better assess trends over time. 
While, we acknowledge that our study used a relatively small sample size (19 and 40 veterinary and hu-
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Articles
Clinically relevant antimicrobial resistance at the 
wildlife–livestock–human interface in Nairobi: 
an epidemiological study
James M Hassell*, Melissa J Ward*, Dishon Muloi, Judy M Bettridge, Timothy P Robinson, Sam Kariuki, Allan Ogendo, John Kiiru, Titus Imboma, 
Erastus K Kang’ethe, Elin M Öghren, Nicola J Williams, Michael Begon, Mark E J Woolhouse, Eric M Fèvre
Summary
Background Antimicrobial resistance is one of the great challenges facing global health security in the modern era. 
Wildlife, particularly those that use urban environments, are an important but understudied component of 
epidemiology of antimicrobial resistance. We investigated antimicrobial resistance overlap between sympatric 
wildlife, humans, livestock, and their shared environment across the developing city of Nairobi, Kenya. We use these 
data to examine the role of urban wildlife in the spread of clinically relevant antimicrobial resistance.
Methods 99 households across Nairobi were randomly selected on the basis of socioeconomic stratification. A detailed 
survey was administered to household occupants, and samples (n=2102) were collected from the faeces of 75 wildlife 
species inhabiting household compounds (ie, the household and its perimeter; n=849), 13 livestock species (n=656), 
and humans (n=333), and from the external environment (n=288). Escherichia coli, our sentinel organism, was 
cultured and a single isolate from each sample tested for sensitivity to 13 antibiotics. Diversity of antimicrobial 
resistant phenotypes was compared between urban wildlife, humans, livestock, and the environment, to investigate 
whether wildlife are a net source for antimicrobial resistance in Nairobi. Generalised linear mixed models were used 
to determine whether the prevalence of antimicrobial resistant phenotypes and multidrug-resistant E coli carriage in 
urban wildlife is linked to variation in ecological traits, such as foraging behaviour, and to determine household-level 
risk factors for sharing of antimicrobial resistance between humans, wildlife, and livestock.
Findings E coli were isolated from 485 samples collected from wildlife between Sept 6,2015, and Sept 28, 2016. Wildlife 
carried a low prevalence of E coli isolates susceptible to all antibiotics tested (45 [9%] of 485 samples) and a high 
prevalence of clinically relevant multidrug resistance (252 [52%] of 485 samples), which varied between taxa and by 
foraging traits. Multiple isolates were resistant to one agent from at least seven antimicrobial classes tested for, and a 
single isolate was resistant to all antibiotics tested for in the study. The phenotypic diversity of antimicrobial-resistant 
E coli in wildlife was lower than in livestock, humans, and the environment. Within household compounds, statistical 
models identified two interfaces for exchange of antimicrobial resistance: between both rodents, humans and their 
rubbish, and seed-eating birds, humans and their rubbish; and between seed-eating birds, cattle, and bovine manure.
Interpretation Urban wildlife carry a high burden of clinically relevant antimicrobial-resistant E coli in Nairobi, 
exhibiting resistance to drugs considered crucial for human medicine by WHO. Identifiable traits of the wildlife 
contribute to this exposure; however, compared with humans, livestock, and the environment, low phenotypic 
diversity in wildlife is consistent with the hypothesis that wildlife are a net sink rather than source of clinically relevant 
resistance. Wildlife that interact closely with humans, livestock, and both human and livestock waste within 
households, are exposed to more antimicrobial resistant phenotypes, and could therefore act as conduits for the 
dissemination of clinically relevant antimicrobial resistance to the wider environment. These results provide novel 
insight into the broader epidemiology of antimicrobial resistance in complex urban environments, characteristic of 
lower-middle-income countries.
Funding UK Medical Research Council and CGIAR Research Program on Agriculture for Nutrition and Health.
Copyright © 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.
Introduction
Antimicrobial resistance in bacteria is one of the great 
challenges facing global health security in the modern 
era, and will ultimately limit our capacity to treat 
microbial infections. The repercussions for human and 
domestic animal health are severe; as infections become 
more difficult and costly to treat, morbidity and mortality 
will increase, and the extra burden placed on health 
services and livestock production will have considerable 
economic consequences.1
The two most probable sources of clinically relevant 
antimicrobial resistance are the exposure of pathogens to 
antibiotic use in humans and in livestock.2 Little is 
known about the ecology of antimicrobial resistance 
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outside human and livestock hosts, but it is increasingly 
clear that focusing only on these compartments of the 
transmission system will result in an incomplete 
epidemiological picture of resistance.3 Bacterial popu- 
lations in aquatic and soil habitats are enormously 
diverse, and have crucial roles in nitrogen cycling, carbon 
sequestration, and the stability of aquatic ecosystems.4 
These bacteria also act as reservoirs of naturally occurring 
bacterial resistance, the burden of which is exacerbated 
by flows of resistance elements and other chemicals 
(such as heavy metals) from livestock and human waste, 
which can coselect for drug resistance.5 Resulting 
changes to microbial diversity could lead to damaging 
effects on terrestrial and aquatic ecosystems, such as 
nitrification and mobilisation of heavy metals.6,7
Wildlife exist across multiple trophic levels, and are 
therefore well placed to accumulate and disperse 
resistance determinants within ecosystems. Ecological 
traits, such as habitat, feeding preferences, and ranging 
behaviour could determine the exposure of wildlife 
species to antimicrobial resistance, and how widely it is 
dispersed in the environment.8,9 The presence of diverse 
bacterial resistance profiles in wildlife inhabiting pristine 
environments also shows the complexity of naturally 
occurring antimicrobial-resistant communities in the 
gut of free-ranging vertebrates, for which environmental 
acquisition probably has an important role.10,11 As land-
use changes reduce the availability of natural habitats, 
wildlife species are forced to seek alternative sources of 
food and shelter, bringing them into closer association 
with humans, livestock, and their waste, and increasing 
the potential for transfer of antimicrobial resistance 
between them.3,12
In lower-middle-income countries, urban environments 
act as hotspots for interactions between humans, 
animals, and their shared environment. The focus of this 
study is on the informal keeping of livestock by 
households in Nairobi, Kenya, as a potentially high-risk 
urban interface for antimicrobial-resistant transmission 
between wildlife, humans, livestock, and the environ-
ment. Livestock are frequently kept within household 
perimeters in low-income country urban centres, where 
differing levels of waste management could cause 
variation in environmental dispersal of determinants of, 
and exposure of wildlife to, antimicrobial resistance.12 
Being ubiquitous in vertebrates and the environment, 
Escherichia coli is frequently targeted in studies of 
antimicrobial resistance, and is an ideal sentinel bacteria 
Research in context
Evidence before this study
We searched PubMed for the terms “wildlife”, “antimicrobial 
resistance”, and “urban”, with no date limits set and language 
limited to English. Earlier studies described antimicrobial 
resistance in select species of urban wildlife, and a single study 
compared differences in prevalence between wildlife and 
livestock (cattle, on UK dairy farms). No published studies 
examined the presence of antimicrobial resistance across diverse 
urban wildlife taxa inhabiting the same urban environment, 
and no studies compared antimicrobial resistance in sympatric 
wildlife, livestock, and human populations.
Added value of this study
Ecological and epidemiological approaches were applied to 
provide, to our knowledge, the first epidemiologically 
structured comparative analysis of phenotypic antimicrobial 
resistance characterisation in sympatric wildlife, livestock, 
humans, and the environment in an urban setting, and the 
most comprehensive analysis of urban wildlife-borne 
antimicrobial-resistant phenotypes so far. Because this study 
was done on a city-wide scale, it allowed us to evaluate carriage 
of clinically relevant antimicrobial resistance in urban wildlife 
across Nairobi, and relate this to antimicrobial resistance in the 
broader urban epidemiological system. We present several 
important findings, showing that, although urban wildlife carry 
high burdens of clinically relevant antimicrobial resistance, 
phenotypic diversity is lower than in humans, livestock, or the 
external environment. Wildlife that associate closely with 
livestock, humans, and both livestock and human waste are 
exposed to higher levels of antimicrobial-resistant phenotypes 
than wildlife that do not associate as closely with livestock and 
human waste, and could thus act as conduits for dissemination 
to the wider environment. Our findings emphasise the 
importance of understanding ecological flows of antimicrobial 
resistance within complex urban systems, to inform strategies 
aimed at limiting human exposure to multidrug-resistant 
bacteria.
Implications of all the available evidence
The results of this study and previous studies suggest that 
through anthropogenic exposure, wildlife have a taxa-specific 
role in the acquisition and dissemination of clinically relevant 
antimicrobial resistance across urban landscapes, and have the 
potential to disseminate antimicrobial resistance from urban 
areas to broader ecosystems. Similarly scaled future studies 
done in a variety of urban settings would permit examination 
of context-specific differences in wildlife antimicrobial 
resistance carriage and exposure. More broadly, 
contamination of urban environments with antimicrobial 
resistance is a serious issue, and future studies should focus on 
identifying antimicrobial resistant flow through urban 
ecological systems, and relating this to coresistance and 
crossresistance to other environmental pollutants (such as 
heavy metals). Such evidence could be used to develop 
cost-effective surveillance for urban ecological systems, and to 
inform interventions that are aimed at limiting environmental 
contamination with pollutants of public health significance. 
Ultimately, this work forms part of a broader strategy to 
understand the epidemiology of antimicrobial resistance 
across developing urban landscapes.
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for the study of the dispersal of antimicrobial resistance 
across diverse vertebrate host species and the 
environment.8
Using E coli antimicrobial-resistance phenotypes 
collected from households across Nairobi, we explored the 
role of urban wildlife in the epidemiology of antimicrobial 
resistance. In considering antimicrobial resistance as 
defined by clinically significant human treatment break-
points and to antibiotics of importance in human 
medicine, the true clinical relevance of antimicrobial 
resistance in urban wildlife is examined.13 Wildlife, which 
are not treated with antibiotics, might be a net recipient (or 
sink) of antimicrobial resistance in urban environments, 
while acting as an effective conduit of antimicrobial 
resistance between other parts of the system. These 
hypotheses are tested by using statistical models to 
compare the carriage of clinically relevant antimicrobial 
resistance between epidemiological compartments 
(ie, wildlife, humans, livestock, and the environment). To 
further understand the determinants of exposure of 
wildlife to antimicrobial resistance, variation in host taxon 
and functional ecology (eg, foraging traits) are related to 
carriage of multidrug-resistant E coli, and antibiogram 
length in wildlife across the city. At a finer scale, epidemio- 
logical models are used to investigate risk factors for 
exchange of antimicrobial resistance between sympatric 
wildlife, humans, and livestock, thus shedding light on 




Faecal samples (n=2081) from 75 wildlife species (birds 
and mammals [n=794], appendix), 13 livestock species 
(n=677), humans (n=333), and samples from the external 
environmental (n=277) were collected from households 
across Nairobi that were participating in the UrbanZoo 
99-household project between Sept 6, 2015, and 
Sept 28, 2016.14 An additional 24 faecal samples were 
collected from birds and rodents in abattoirs across the 
city. Our study design is explained in detail in the 
appendix; briefly, Nairobi was split into administrative 
units, and 33 were chosen on the basis of a socioeconomic 
stratification. Three households were randomly selected 
in each sublocation to obtain two livestock-keeping 
and one non-livestock-keeping household (a total of 
99 households), with the aim of maximising the spatial 
distribution and diversity of livestock-keeping practices 
captured within the sampling frame. Wildlife samples 
were also obtained from an additional household, where 
the occupants declined to submit human samples or 
questionnaire data. As such, 100 households were 
included in analyses in which isolates from wildlife were 
considered alone. Households in each sublocation had to 
meet strict inclusion criteria of keeping small ruminants 
or poultry, large ruminants or pigs, or no livestock within 
the household perimeter. Abattoirs in Nairobi were 
selected and sampled in a separate value chain study done 
as part of the wider UrbanZoo project.15 Wildlife samples 
were obtained by a range of taxon-specific trapping 
methods, which are described in the appendix, along 
with protocols for collection of human, livestock, and 
environmental samples. Questionnaires detailing house-
hold composition and socioeconomic data, and live stock 
ownership and management, were administered at each 
household (appendix). Household occupants who 
provided samples and answered questionnaires provided 
written consent.
The collection of data adhered to the legal requirements 
of the country in which the research was conducted. 
Wildlife were trapped under approval of an International 
Livestock Research Institute (ILRI) Institutional Animal 
Care and Use Protocol (IACUC; 2015.12), and permits 
obtained from the National Museums of Kenya and 
Kenya Wildlife Service. Livestock samples were obtained 
under approval of ILRI IACUC (2015.18). Human 
samples and questionnaire data were collected under 
approval of ILRI Institutional Research Ethics Committee 
approval (2015-09).
Microbiological testing
All rectal swabs and fresh faecal samples were placed in 
Amies transport media, and transported on ice to one of 
two laboratories (Kenya Medical Research Institute or 
University of Nairobi [UoN]). Boot socks (on which 
surface material from livestock pens and the external 
environment were collected) and modified Moore swabs 
were transported in saline-filled polythene bags, and 
water samples were transported in conical tubes, all on 
ice. Samples were enriched in buffered peptone water for 
24 h, and then plated onto eosin methylene blue agar 
(EMBA) and incubated for 24 h at 37°C. Subsequently, 
five colonies were selected and subcultured on EMBA, 
before being further subcultured on Müller-Hinton agar 
and stored at –20°C in cryovials. A single colony was 
picked at random from the plate for each original sample 
(ie, an isolate) and biochemical tests (triple sugar iron 
agar, Simmon’s citrate agar, and motility-indole-lysine 
media) were used for presumptive identification of E coli. 
A single colony was picked from each avian or bat pooled 
faecal sample.
All isolates were revived and inoculated onto 
Müller-Hinton plates before antimicrobial susceptibility 
testing. Isolates were tested for susceptibility to 
ampicillin (10 µg), amoxicillin–clavulanic acid (30 µg), 
cefepime (30 µg), cefotaxime (30 µg), ceftazidime (30 µg), 
chloramphenicol (30 µg), nalidixic acid (30 µg), cipro-
floxacin (5 µg), gentamicin (10 µg), streptomycin (25 µg), 
sulfamethoxazole (30 µg), tetracycline (30 µg), and 
trimethoprim (2·5 µg) using the disc diffusion method 
according to the Clinical and Laboratory Standards 
Institute guidelines.13 Antibiotics included those freq-
uently used in both veterinary and human medicine in 
Kenya.16 Clinical and Laboratory Standards Institute 
See Online for appendix
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guidelines were also used to determine human 
breakpoints for classifying isolates as sensitive, inter-
mediate, or resistant to the drug.13 Following previous 
studies, intermediate strains were deemed to be moving 
towards resistance, and thus considered resistant on an 
evolutionary basis.17,18 All protocols were standardised 
between laboratories, and between-laboratory quality 
control was done at regular intervals. Multidrug-resistant 
E coli was defined as “non-susceptibility to at least one 
agent in three or more antimicrobial classes”17 (appendix). 
Wildlife isolates were also assessed for high levels of 
multidrug resistance (non-susceptibility to at least seven 
antimicrobial classes tested) and resistance to all 
antibiotics tested for in this study. An antibiogram was 
defined as the combination of antibiotics to which an 
isolate was resistant, and thus antibiogram length was 
defined as the number of antibiotics to which an isolate 
was phenotypically resistant.
Statistical analysis
All statistical analyses were done using R, version 3.3.2. 
Spatial structure in the dataset was represented using 
distance-based Moran’s eigenvector maps—a powerful 
multivariate approach to model spatial structure in a 
response variable, which can be partitioned at broad, 
medium, and fine spatial scales.19,20 Further details of how 
we dealt with missing data, data exploration, and 
statistical models (distributions, choice of fixed and 
random effects, implementation, and model selection 
procedures) are given in the appendix.
To test the hypothesis that urban wildlife are a net 
source or sink of antimicrobial resistance in Nairobi 
when compared with humans, livestock, and the 
environment, epidemiological and ecological statistical 
modelling approaches were applied. Prevalence of 
resistance to 13 antibiotics was compared between all 
four epidemiological compartments (ie, wildlife, human, 
livestock, environment) in a Bayesian analysis frame-
work, using Markov Chain Monte Carlo methods.21,22 
Generalised linear mixed effects models (GLMMs) with 
binomial (log-link function) and Poisson distributions 
were used to test whether multidrug-resistant E coli 
carriage and antibiogram length differed between 
compartments, and how this varied spatially across the 
city. To assess how antibiogram diversity was distributed 
across compartments, antibiogram diversity was com-
pared using four ecological measures of diversity related 
to Rényi’s measures of generalised entropy.23 Methods 
adapted from community ecology were used to extend 
the comparison of phenotypic diversity between com-
partments by estimating the number of undetected 
antibiograms. Chao2, ICE, and Jack-knife incidence-
based statistical methods were used to estimate the 
minimum total antibiogram richness in each com part-
ment from the data, by looking at frequencies of 
phenotype occurrence in collections of individuals. To 
consider the implications for surveillance, methods 
from Chao and colleagues24 were followed to estimate 
the sampling effort required to detect a given proportion 
of the total antibiograms estimated for each 
compartment. Our approach is described in full in the 
appendix.
A Bayesian analysis framework, as described earlier, 
was used to estimate and compare prevalence of 
resistance to 13 antibiotics between wildlife taxa. 
Ecological traits considered potentially important factors 
for exposure of wildlife to antimicrobial resistance were 
modelled against multidrug-resistant E coli carriage and 
antibiogram length in wildlife in binomial and Poisson 
GLMMs, respectively. Separate binomial GLMMs were 
developed to investigate fine-scale household-level risk 
factors for the likelihood of multidrug-resistant E coli 
carriage in select urban wildlife with synanthropic traits 
(ie, rodents and seed-eating birds). Risk factors were 
sourced from a set of anthropogenic and ecological 
covariates capturing antimicrobial-resistant E coli 
carriage in humans and livestock, livestock-keeping 
practices, land use within households, and ranging 
behaviour of wildlife. All anthropogenic and ecological 
variables were derived from metadata collected within 
households, and published sources (appendix). The 
laboratory in which samples were tested was included as 
a confounding factor in these models.
Role of the funding source
The funders of the study had no role in the study design, 
data collection, data analysis, or interpretation. JMH and 
EMF always had full access to the data in the study, and 
had final responsibility for the decision to submit for 
publication.
Results
Samples were collected from 547 individual birds, 
nine avian populations (31 pooled samples across nine 
populations), 167 rodents, 44 individual bats, five bat 
populations (20 pooled samples across nine populations), 
five carnivores, and four primates across 100 house holds, 
as well as from 11 abattoirs in Nairobi, between 
Sept 6, 2015, and Sept 28, 2016. Antimicrobial sus-
ceptibility tests were done on a single E coli isolate 
cultured from 282 (52%) of 547 birds, 20 (65%) of 31 avian 
populations, 155 (93%) of 167 rodents, 22 (50%) of 
44 bats, six (22%) of 27 bat populations, three (60%) of 
five carnivores, and four (100%) of four primates. 
Because of low sample numbers, primates and carnivores 
were not included in further statistical analysis, and each 
pooled population sample was considered as coming 
from an individual bird or bat for the purposes of 
all further analysis. E coli was isolated from, and 
antimicrobial susceptibility tests done on, 638 livestock, 
321 human, and 256 environmental samples. 252 (52%) 
of 485 samples from wildlife sampled in Nairobi carried 
multidrug-resistant E coli; eight (2%) of 485 wildlife 
isolates (all originating from birds) carried E coli resistant 
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to agents belonging to at least seven of the antimicrobial 
classes tested; and E coli isolated from a single avian 
sample was resistant to all antimicrobials tested.
Prevalence of antimicrobial-resistant E coli in wildlife 
was significantly lower than at least one epidemiological 
compartment for six of the antibiotics tested (ampicillin 
[human], cefepime [livestock], cefotaxime [livestock], 
streptomycin [human], tetracycline [human, livestock, 
environment], and trimethoprim [human]), and not 
significantly higher than other compartments for any of 
the 13 antibiotics tested (appendix). Wildlife were less 
likely to carry multidrug-resistant E coli than humans 
and livestock (β=0·662, 95% CI 0·36 to 0·97, p<0·0001; 
β=0·284, 95% CI 0·03 to 0·53, p=0·026), and had shorter 
antibiogram lengths than all other compartments 
(marginal R² 0·028; table 1). Five distance-based Moran’s 
eigenvector maps were associated with multidrug-
resistant E coli carriage and antibiogram length of 
isolates, and were thus included as covariates in the 
GLMMs. Both models showed broad-scale spatial 
relationships for antimicrobial resistance carriage across 
the city; the probability of multidrug-resistant E coli 
carriage in all epidemiological compart ments increased 
along a west to east gradient (MEM1; β=0·15, 95% CI 
0·02 to 0·28, p=0·026; marginal R² 0·028; figure 1), 
whereas antibiogram lengths decreased from eastern to 
western Nairobi (MEM1) and increased from northern to 
southern Nairobi (MEM2; β=0·07, 95% CI 0·03 to 0·11, 
p=0·00093; β=–0·04, 95% CI –0·08 to 0, p=0·041; 
marginal R² 0·028, 0·043; figure 1).
Population-diversity measures of resistance indicated 
that wildlife had less diverse antibiograms than other 
compartments. E coli isolated from wildlife had a lower 
expected antibiogram diversity than all other compart- 
ments as measured by three of the four Dα diversity 
indices calculated (Shannon entropy , Simpson diversity, 
and Berger-Parker; appendix). When compared across all 
compartments, the range of median α values was 
significantly lower in wildlife than all other compartments 
(wildlife:environmental p=0·0079; wildlife:livestock 
p=0·002; wildlife:human p=0·00021). Asymptotic 
estimates of minimum total antibiogram richness in 
wildlife were 273 (95% CI 245–300) unique antibiograms, 
most of which could be detected if an additional 
8848 samples were collected (figure 2; appendix). This 
richness estimate is lower than estimates for the 
environment (350, 95% CI 305–395) and livestock 
(416, 378–454), but higher than the estimate for humans 
(185, 165–205). Unlike the human compartment, where 
an asymptote was reached at 270 samples, wildlife and 
livestock estimates were only beginning to reach an 
asymptote at the sampling extremes achieved in this 
study. None of the statistical estimators reached an 
asymptote for environment, suggesting that the rate of 
discovery of new antibiograms in this compartment was 
Estimate SE Z score p value
Model: MDR carriage in all isolates
Intercept 0·030 0·102 0·296 0·77
Environment 0·322 0·165 1·954 0·051
Human 0·662 0·155 4·273 <0·0001
Livestock 0·284 0·128 2·222 0·026
MEM1 0·148 0·067 2·225 0·026
MEM2 –0·118 0·066 –1·781 0·075
MEM5 –0·130 0·063 –2·072 0·038
Model: antibiogram length of all isolates
Intercept 1·095 0·031 35·8 <0·0001
Environment 0·107 0·044 2·42 0·015
Human 0·199 0·040 4·94 <0·0001
Livestock 0·070 0·036 1·96 0·049
MEM1 0·070 0·021 3·31 0·00093
MEM2 –0·042 0·020 –2·04 0·041
MEM5 –0·049 0·019 –2·60 0·0095
SE=standard error. MDR=multidrug resistance. MEM1, MEM2, and MEM5 indicate 
the spatial scales across which variation in MDR carriage or antibiogram length 
occurs.
Table 1: Estimated regression parameters, SEs, Z scores, and p values for 
generalised linear mixed models
Figure 1: Variation in probability of multidrug resistant Escherichia coli carriage (A) and antibiogram 
length (B) in different epidemiological compartments along a west to east gradient across Nairobi
Coloured shading represent 95% CI.
























West to east gradient
–3 –2 –1 0 1 2 3
West to east gradient
–3 –2 –1 0 1 2 3
West to east gradient
–3 –2 –1 0 1 2 3





























Wildlife Environmental Human Livestock
Epidemiological compartment
Articles
e264 www.thelancet.com/planetary-health   Vol 3   June 2019
still high, and minimum richness estimates could 
therefore be considerably higher than 350.
When split into taxonomic groups, prevalence of E coli 
isolates susceptible to all antibiotics tested was 45 (9%) of 
485 samples across all wildlife, 26 (9%) of 282 birds, 
two (10%) of 20 avian populations, 13 (8%) of 155 rodents, 
and four (14%) of 28 bats. Bayesian models showed that 
prevalence of resistance to streptomycin, tetracycline and 
trimethoprim varied significantly between wildlife when 
stratified by taxonomic or functional groups (appendix). 
Birds belonging to the orders Pelecaniformes and 
Ciconiiformes were more likely to carry E coli resistant to 
ceftazidime (odds ratio 7·9, 95% CI 1·7–28·5; p=0·0033), 
and had significantly longer antibiograms than other 
species of wildlife (p=0·04).
Multidrug-resistant E coli carriage varied by taxonomic 
functional groups, and along an east to west gradient 
across Nairobi (marginal R² 0·08; figure 3). Frugivorous 
bats and seed-eating, omnivorous, and scavenging birds 
were significantly more likely to carry multidrug-resistant 
E coli than frugivorous birds, and the probability of 
carrying multidrug-resistant E coli increased significantly 
from west to east Nairobi (appendix). E coli antimicrobial 
resistant antibiograms were longer in birds than 
rodents (β=–0·16, 95% CI –0·29 to –0·03, p=0·016), and 
antibiogram length showed spatial correlation across 
multiple scales of the city (broad-scale [east to west; 
MEM1], medium-scale [MEM8, 10, 19], and fine-scale 
[MEM25, MEM27] resolutions; marginal R² 0·13; 
appendix). Wildlife-borne E coli processed at UoN 
laboratories had significantly longer antibiograms. The 
effects of laboratory were only present in a single model, 
and all reasonable efforts were taken to ensure that 
Figure 2: Asymptotic antibiogram richness estimates for each epidemiological compartment
Dotted curves indicate Chao2 estimators at every sample point (95% CIs indicated by bars at asymptote). 
Horizontal lines indicate asymptotic estimate of antibiogram richness for each compartment. Shaded curves 
indicate species accumulation curves (line represents model fitted values, shaded areas represent 95% CIs). Vertical 
dotted lines indicate number of samples collected from each compartment. Vertical dashed lines indicate sampling 
effort required to detect 80% and 85% of the asymptotic estimate for antibiogram richness in each compartment.
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protocols were standardised between laboratories; 
specifically, a postdoctoral researcher was responsible for 
ensuring that these standards were maintained 
throughout the project. As such, although this variation 
could have arisen through operator bias, it is likely to 
have had a limited effect, if any, on our results.
Seed-eating birds and rodents, which are ubiquitous in 
households across Nairobi and frequently display 
anthropophilic (human-associated) feeding behaviour, 
were used as the basis of efforts to understand 
antimicrobial resistance overlap within households. In 
any given household, the likelihood of carriage of 
multidrug resistance in seed-eating birds was best 
described by increasing numbers of cattle in the 
household perimeter, and antibiogram length of the 
human inhabitants (β=3·41, 95% CI 1·42–5·4, 
p=0·00078; β=1·22, 95% CI 0·16–2·29, p=0·025; R² 0·3; 
table 2). The relationship between human antibiogram 
length and avian carriage of multidrug resistance was 
affected by whether rubbish was kept within the 
household perimeter or not (β=4.76, 95% CI 0·76–8·76, 
p=0·02); keeping rubbish within the perimeter resulted 
in a stronger relationship between human antibiogram 
length and avian carriage of multidrug resistance 
(figure 4A). When manure was kept inside the household 
perimeter, the probability of carriage of multidrug 
resistance in seed-eating birds increased with longer 
antibiogram lengths in livestock, whereas the opposite 
was true when manure was disposed of externally 
(figure 4B). The likelihood of multidrug resistance 
carriage in rodents increased with increasing antibiogram 
length of human and livestock inhabitants in the 
household (β=1·31, 95% CI 0·25–2·37, p=0·015; β=0·41, 
95% CI 0·03–0·79, p=0·035; R² 0·42; figure 4C; table 2). 
Although not statistically significant within the model, 
keeping both rubbish and manure outside the household 
perimeter reduced the likelihood of rodents carrying 
multidrug resistance as human antibiogram length 
increased.
Discussion
We show that urban wildlife species are important 
components of the environmental pool of resistance to 
clinically relevant antimicrobials, and through exposure 
mediated by resource provisioning, could be involved in 
disseminating clinically relevant resistance across 
landscapes (appendix). Unlike most previous studies on 
antimicrobial resistance in wildlife, in which wild 
animals have been opportunistically sampled,11 we used 
an epidemiological study design to compile a large 
bacterial dataset for investigation burdens of anti-
microbial resistance in sympatric wildlife, humans, and 
livestock, and their shared environment.
High numbers of E coli resistant to clinically relevant 
antibiotics were detected in urban wildlife, including 
resistance to the more newly developed drugs such 
as third-generation cephalosporins, and synthetic 
fluoroquinolones, which WHO considers crucial for 
human medicine.25 E coli that produce extended-spectrum 
β-lactamase enzymes, which generally confer resistance 
to cephalosporins, are a major concern to human and 
veterinary medicine worldwide, and have been frequently 
reported in wildlife.26 However, livestock and environ-
mental compartments (both of which had higher 
ecological diversity of antimicrobial resistance, higher 
prevalence of multidrug resistance, longer antibiogram 
length, and with which humans have more direct contact) 
yield more potential as routes of human exposure to 
novel antimicrobial resistance genes in Nairobi. As such, 
our results are consistent with the hypothesis that wildlife 
are not a net source of antimicrobial resistance diversity 
in Nairobi, and probably pose little direct threat to human 
health in the urban areas. The estimate of total 
antimicrobial resistance richness in humans was 
considerably lower than that of all other compartments. 
This difference, which was robustly supported by 
statistical estimators, might indicate that, compared with 
humans, wildlife and livestock are exposed to greater 
antimicrobial resistance diversity through their closer 
interaction with the environment.
The vertebrate gastrointestinal microbiome plays a key 
role in the population structure for genes conferring 
resistance to antimicrobials, and microbiome composition 
is directed by an array of factors linked to host genotype, 
Estimate SE Z score p value
Model: MDR carriage in seed-eating birds
Intercept –5·4935 2·3398 –2·348 0·019
Total cattle 3·4136 1·0158 3·361 0·00078
Human ABG 1·2222 0·5443 2·245 0·025
Livestock ABG 0·1056 0·2893 0·365 0·72
Manure (outside house) 2·5294 1·4222 1·779 0·075
Garbage (outside house) 4·7585 2·0421 2·320 0·02
Garbage (outside house), 
human ABG
–1·0513 0·5332 –1·972 0·049
Manure (outside house), 
livestock ABG
–0·9655 0·4708 –2·051 0·04
Model: MDR carriage in rodents
Intercept –4·3039 1·7504 –2·459 0·014
Human ABG 1·3059 0·5383 2·426 0·015
Livestock ABG 0·4085 0·1942 2·104 0·035
Manure (outside house) 2·9078 1·2650 2·299 0·022
Garbage (outside house) 1·4198 1·6627 0·854 0·39
Laboratory (University of 
Nairobi)
–2·0261 1·1738 –1·726 0·084
Garbage (outside house), 
human ABG
–1·0043 0·5821 –1·725 0·085
Manure (outside house), 
human ABG
–0·5909 0·3290 –1·796 0·073
SE=standard error. MDR=multi-drug resistant Escherichia coli. ABG=antibiogram 
length.
Table 2: Estimated regression parameters, SEs, Z scores, and p values for 
generalised linear mixed models
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age, and diet.27 Although the direct effects of diet and 
physiological factors on selection for faecal antimicrobial 
resistance genes could not be assessed, our results are 
broadly supportive of previous studies that report that 
anthropophilic omnivores and carnivores have a higher 
risk of carrying, and potentially spreading, antimicrobial-
resistant bacteria.8 In this study, scavenging birds and 
water birds had longer antibiograms than all other wildlife 
species. Antimicrobial resistance-carriage in high 
proportions of water birds is a common finding in other 
parts of the world,28 where, in the absence of natural 
habitats such as wetlands, these species forage on sewage 
treatment plants, rubbish dumps, and abattoir viscera 
ponds. Artificial habitats such as these are considered 
important routes for the dispersal of human-excreted and 
livestock-excreted antimicrobial resistance into the 
environment.11,29
Within households, increasing likelihood of multidrug-
resistant E coli carriage in synanthropic wildlife as 
phenotypic antimicrobial resistance diversity in sympatric 
livestock and humans also increases suggests transfer of 
clinically relevant antimicrobial resistance between 
humans and livestock, and certain wildlife species. These 
associations were more pronounced for seed-eating birds 
in the presence of manure and rubbish, indicating that 
human and livestock waste are conduits for the transfer of 
antimicrobial resistance between humans, livestock, and 
peridomestic birds, with the potential for dissemination of 
antimicrobial resistance phenotypes into the wider 
environment. Manure can be a reservoir for the 
amplification of antimicrobial resistance determinants, 
particularly plasmids.30 These results support those of 
other studies31–33 that have identified the importance of 
provision of urban resources in bringing wildlife into 
closer association with humans and livestock, offering 
new opportunities for disease transmission. However, 
although our results are suggestive of antimicrobial 
resistance exchange, transmission cannot be inferred 
from overlap of phenotypic antimicrobial resistance and, 
as such, genetic data are required to corroborate the 
existence of interfaces for antimicrobial resistance 
exchange, and determine the direction in which bacteria 
or resistance elements are being transferred. We aim to 
address this in forthcoming studies.34 More broadly, 
wildlife–livestock–human interfaces such as these repres-
ent a crucial point for cross-species transmission, and 
emergence of pathogens into new host populations.12 
Removal of manure and rubbish (sources of anthro-
pogenic resource provision) from households reduced the 
magnitude of antimicrobial resistance exposure in seed-
eating birds, either through limiting wildlife–livestock or 
wildlife–human contact or reduced exposure of wildlife to 
sources of antimicrobial resistance.
Complex urban systems such as those of Nairobi are a 
feature of many lower-middle-income countries, and our 
findings are therefore broadly applicable to the urban 
epidemiology of antimicrobial resistance in these 
countries. High proportions of antimicrobial resistance 
and multidrug-resistant E coli carriage in wildlife could be 
indicative of environmental antibiotic contamination, and 
high background levels of antimicrobial resistance in 
Nairobi’s urban environment (supported by our findings 
Figure 4: Fit of the binomial 
generalised linear mixed 
effects models relating 
multidrug-resistant 
Escherichia coli and carriage 
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of high phenotypic diversity in environmental samples). 
Clinically relevant resistance genes were thought to be rare 
in soils in the preantibiotic era and, as such, it is to be 
expected that the urban environmental resistome (the 
collection of resistance determinants present in pathogenic 
and non-pathogenic bacteria in the soil) in rapidly 
developing cities such as Nairobi is heavily influenced by 
human activity.35 However, interactions between naturally 
occurring and anthropogenic-derived antimicrobial 
resistance determinants in bacteria occurring in the 
broader urban environment, outside urban reanimation 
units, are poorly understood. The geospatial, temporal, 
chemical, and biological complexities of urban systems 
make this a particularly challenging topic of study.
If wildlife exposure to antimicrobial resistance is largely 
determined by habitat use, targeted surveillance of 
wildlife that frequent high-risk urban environmental 
interfaces (where the accumulation of antibiotic residues 
or other coselecting agents, such as heavy metals, might 
force the accelerated evolution and fixing of resistance 
determinants) could be an efficient way to detect clinically 
important determinants of resistance. To explore 
the practicality of surveillance in wildlife, the sampling 
effort required to detect different fractions of the total 
estimated antimicrobial resistance richness was 
calculated (figure 2; appendix). To detect all 273 predicted 
antibiograms in the wildlife species sampled would 
require an extra 8848 samples, an impractical and 
expensive task. However, detecting 85% of the total 
diversity would require a disproportionately lower 
sampling effort of 1572 samples. Assuming that the 
diversity of antibiograms in selected wildlife is lower than 
the total diversity represented by all taxonomic classes of 
wildlife included in this study, the required sampling 
effort to achieve an acceptable likelihood of detecting new 
antibiograms in these species would be much lower. 
Extending this approach to livestock and humans reveals 
similar outcomes for surveillance of antibiograms in 
these compartments (figure 2), suggesting that practical 
and economically viable surveillance for antimicrobial 
resistance of public health concern in urban wildlife, 
livestock, and humans could be achieved through targeted 
longitudinal surveillance, designed to capture a high 
proportion of diversity at regular intervals.
Urban ecosystems with high levels of background 
environmental antimicrobial resistance could act as 
pools of antimicrobial resistance dissemination to 
peripheral ecosystems, where the flow of water, and 
movement of humans, livestock, and wildlife act as 
vectors for dispersal.29 Although little is known about 
how resistance genes are carried and shed by wildlife 
species,11 previous studies reporting extended-spectrum 
β-lactamase E coli carriage in migratory wild birds, and 
carriage of bacteria with resistance to more antibiotics 
than non-migratory wild birds,36 indicate that wildlife 
could have an important role in disseminating clinically 
relevant antimicrobial resistance across landscapes. Our 
finding of higher levels of antimicrobial resistance 
carriage in birds (particularly scavenging birds with 
large home ranges) than other species suggest that these 
species could disseminate antimicrobial resistance 
determinants to neighbouring ecosystems—Nairobi is 
surrounded by a complex patchwork of high-density 
human populations, natural areas, forest, and 
rangelands. Mapping the distribution of multidrug-
resistant E coli in wildlife by sublocation shows high 
levels of multidrug resistance carriage extending to 
peripheral areas of Nairobi, which border rich Savannah 
ecosystems to the south and east of the city (figure 3). 
Nairobi National Park, which borders the city to the 
south, is home to a high density of migratory wildlife 
species that could disperse anti microbial resistance 
genes to more distant areas.37 Our models for 
antimicrobial resistance carriage showed a clear east to 
west gradient, indicating that wildlife antimicrobial 
resistance diversity is higher in the east of the city, which 
corresponds to the extreme environmental, ecological, 
and social gradients that split Nairobi in east to west. 
Such extreme differentiation within a single city shows 
the highly complex ecosystem within which the urban 
epidemiology of antimicrobial resistance is set.
This study has several limitations. Although the 
prevalence of resistance to individual antibiotics and 
multidrug-resistant E coli carriage in wildlife was high, 
without comparable datasets from other urban or rural 
settings it is difficult to say how unique these results are to 
Nairobi. Studies done in a variety of urban settings, and 
considering high-risk sites of environmental antimicrobial 
resistance contamination beyond the household scale, 
would permit examination of context-specific differences 
in wildlife antimicrobial resistance carriage and exposure. 
Because of the effort required to sample wildlife of 
different species our sample size was small for cryptic 
taxonomic and functional groups (eg, bats, scavengers, 
and frugivores or nectarivores). In addition, by only 
culturing a single isolate from each host, the within-host 
diversity of antimicrobial-resistant E coli was not 
considered. We made this decision as a necessary, cost-
based trade-off between microbiological resolution and 
sample size. However, the effects of restricted sample size 
would only act to increase type II error in our results 
(ie, conservative statistical inference, or missed signal in 
the data), and are thus unlikely to affect the validity of our 
findings. More broadly, our focus on mammalian and 
avian urban wildlife neglects the role of reptiles, aquatic 
organisms, and invertebrates. Studies investigating the 
effects of antimicrobial resistance on invertebrates, and 
their role in carriage and dispersal of resistance elements 
are warranted given the indispensable role invertebrates 
play as pollinators, biocontrol agents, and in the 
degradation and recycling of organic matter in soils.38,39
To conclude, carriage of clinically relevant anti- 
microbial-resistant phenotypes in urban wildlife collected 
from households in Nairobi is predicted by feeding 
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ecology, and interaction with humans, livestock, and both 
human and livestock waste. Even if clinical use is the 
main driver for the emergence of antimicrobial resistance 
in humans, environmental compartments such as wildlife 
can accumulate clinical residues, be reservoirs for novel 
antimicrobial resistance genes, and have the potential to 
disseminate resistance determinants across urban 
landscapes. This potential means that there is a pressing 
need to consider the ecosystem-wide epidemiology of 
antimicrobial resistance in urban environments. As 
Robinson and colleagues40 speculate, poorly enforced 
environmental legislation and unregulated antibiotic 
use might render these factors more pronounced in 
developing countries. Further studies and targeted 
surveillance, which take a similarly broad approach to 
epidemiological com partments, will be required to 
consider how the genetic determinants of resistance are 
passed between compartments and disseminated into the 
wider environment.
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Deterministic processes structure bacterial genetic
communities across an urban landscape
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T. Imboma8, J. Kiiru9, S. Kariuki9, M. Begon10, E.K. Kang’ethe11, M.E.J. Woolhouse 3,5 & E.M. Fèvre1,2
Land-use change is predicted to act as a driver of zoonotic disease emergence through
human exposure to novel microbial diversity, but evidence for the effects of environmental
change on microbial communities in vertebrates is lacking. We sample wild birds at 99
wildlife-livestock-human interfaces across Nairobi, Kenya, and use whole genome sequencing
to characterise bacterial genes known to be carried on mobile genetic elements (MGEs)
within avian-borne Escherichia coli (n= 241). By modelling the diversity of bacterial genes
encoding virulence and antimicrobial resistance (AMR) against ecological and anthropogenic
forms of urban environmental change, we demonstrate that communities of avian-borne
bacterial genes are shaped by the assemblage of co-existing avian, livestock and human
communities, and the habitat within which they exist. In showing that non-random processes
structure bacterial genetic communities in urban wildlife, these findings suggest that it should
be possible to forecast the effects of urban land-use change on microbial diversity.
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Deterministic (i.e., non-random) processes play a centralrole in shaping how species communities interact withone-another and their environment1. As one such pro-
cess, urbanisation is characterised by extreme habitat fragmen-
tation, which can have profound impacts on the distribution of
host populations and epidemiology of infectious disease. In
developing cities such as Nairobi, where urban livestock-keeping
is commonly practiced as a result of growing demand for animal-
sourced food products2, wildlife frequently co-exist with humans
and livestock, forming interfaces across which infectious diseases
can pass3,4. Changes in the composition and distribution of these
host assemblages likely have important implications for microbial
epidemiology, determining how pathogens are distributed within
their reservoir, and dictating opportunities for spillover into non-
reservoir hosts (such as humans)5–7. However, there is little
empirical evidence that directly links changes in the function of
abiotic and biotic systems to the structure of host communities,
and dynamics of microbes living within them. Detecting the
processes underlying the structure of microbial communities in
wildlife and domestic animal populations would bring us a step
closer to developing a predictive framework for pathogen emer-
gence at urban wildlife-livestock-human interfaces8.
Recent advances in sequencing technology, such as whole-
genome sequencing (WGS), offer the potential to study the
community of genes carried on mobile genetic elements (MGEs)
within prokaryote genomes. MGE-borne genes can be horizon-
tally transferred between organisms via recombination mechan-
isms, and may confer adaptive functional traits such as
antimicrobial resistance (AMR) and virulence9. The distribution
of MGE-borne genes amongst bacteria can therefore provide
insight into the community structure of these micro-organisms,
an approach that has been successfully used in conjunction with
typing tools and time-scaled evolutionary analyses to infer bac-
terial transmission between hosts10–12. The wealth of genetic data
generated by WGS could therefore provide an optimal approach
to identify key drivers (such as land-use change) that influence
the structure of bacterial populations at high risk wildlife-
livestock-human interfaces, and assist in untangling the com-
plexity of epidemiological processes, regardless of the taxonomic
distance between hosts.
In this study, we apply principals from evolutionary ecology
and molecular epidemiology to investigate whether urban eco-
logical processes (e.g., changes in habitat structure and wildlife
communities) and anthropogenic processes (e.g., characteristics
of human populations, such as density and livestock keeping)
occurring across the city of Nairobi, Kenya, are associated with
non-random structuring of wildlife-borne bacterial genetic com-
munities. We consider the diversity of MGE-borne genes as a
proxy for the diversity of microbial communities within hosts,
with the view that the ability of such genes to move relatively
freely between bacterial cells through horizontal gene transfer
mimics, to an extent, the movement of directly transmitted
pathogens between hosts. For commensal bacteria, determinism
would be expected in two classes of MGE-borne genes: those
encoding AMR and virulence traits, each of which would be
expected to respond differently to urban environmental change.
Contamination of the external environment with AMR bacteria
excreted from humans and livestock treated with antimicrobials
(e.g., through sewage effluent or faeces), is considered an
important route of wildlife exposure to AMR13. As such, if
wildlife-borne bacteria are under higher selective pressure to
adopt genes encoding AMR in urban areas where greater volumes
of antibiotics are consumed, and antibiotic use is more wide-
spread14,15, the community structure of MGEs encoding AMR
would be hypothesised to respond to changes in human activity
and the presence of livestock, rather than natural processes
occurring in wildlife communities. In contrast, the diversity of
genes encoding virulence traits (for which wildlife-borne bacteria
are assumed not to be subjected to such strong anthropogenic
selection pressure) would be hypothesised to reflect changes in
wildlife host community structure – following the broadly
accepted principal that host and microbial community diversity
are correlated5,16, as wildlife host species diversity increases, the
pool of virulence-associated MGEs to which they are exposed to
should become more diverse.
Adopting the null hypothesis that communities of wildlife-
borne bacterial genes are structured by random processes, we test
the above expectations by considering variation in the diversity of
MGE-borne virulence and AMR genes in commensal Escherichia
coli, collected from wild birds in household compounds across
Nairobi. As likely points of contact (and thus microbial trans-
mission) between vertebrate wildlife, livestock, and humans,
household interfaces are chosen as sampling units representative
of complex multi-host communities that are widely distributed
across a gradient of urban environmental change, and thus sui-
table for testing our hypotheses. Wild birds are chosen as wildlife
hosts in this urban study system, since diverse avian communities
distribute widely across urban landscapes17, demonstrating epi-
demiological and ecological responses to land-use change17,18,
and interacting closely with livestock and humans19. Aside from
investigating processes underlying determinism in bacterial
genetic diversity, studying the diversity of two sets of genes which
may confer adaptive traits to bacteria will enable us to assess
whether an association exists between urban land use and the
genetic determinants of bacterial selection, with potential impli-
cations for human and animal health9.
Results
Bacterial population structure in avian hosts. Faecal samples
(n= 547) were collected from 57 avian species in 99 households
across Nairobi, that were participating in the UrbanZoo project20.
Households were selected in such a way that they captured var-
iation in urban land use, wildlife assemblages, human demo-
graphics, and livestock-keeping practices across the city
(Supplementary Figure 1). A total of 274 E. coli isolates, each of
which originated from a different individual avian host, were
sequenced. Once sequenced, twenty three isolates were removed
for being non-E. coli, and ten potentially mixed isolates were
removed for having a genome size larger than 6 megabases. As
such, a total of 241 E. coli WGS were considered in further
analyses. Genes carried on MGEs, which were known to encode
virulence (n= 63) or AMR (n= 47), were identified in 98% (n=
236) and 44% (n= 107) of these E. coli respectively. E. coli
population structure across hosts was explored using multi-locus
sequence typing (MLST). 128 unique sequence types (STs) were
identified, representing a high genetic diversity of E. coli in avian
samples across the city (Supplementary Figure 2). No sequence
type was assigned to 18 isolates that carried at least one novel
allele not included in the (MLST) database. The most common
STs (ST10, ST155 and ST48; those appearing in > 5% of isolates)
were randomly distributed across host functional groups, and not
associated with the diversity of MGE-borne AMR and virulence
genes in each isolate (Fisher’s Exact test: p= 0.18; Kruskal–Wallis
test AMR genes: Χ2= 7.17, P= 0.62, df= 9; Kruskal–Wallis test
virulence genes: Χ2= 10.4, P= 0.11, df= 6).
To test whether microbial genetic communities in avian hosts
were deterministically structured in association with the environ-
mental conditions and structure of host communities at house-
hold interfaces within which avian hosts resided, the α-diversity
of each set of genes (counts, thus representing richness of
virulence or AMR genes) was calculated for individual hosts, and
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regressed against ecological and anthropogenic characteristics of
households using generalised linear mixed effects models
(GLMMs). Ecological and anthropogenic factors that were
selected as indicators of variation in household environmental
conditions, and used as fixed effects in the models, included: α-
diversity (richness) of avian species present, biotic habitat
diversity, artificial land-use cover (%), wealth indices, livestock-
keeping status of each household, livestock density, and human
density. Variation in bacterial genetic diversity introduced by
differences in the feeding ecology and ranging behaviour of avian
hosts was accounted for by including membership of avian hosts
to epidemiologically relevant functional groups, and allometri-
cally scaled estimates of each species home range, as fixed effects
in each model. Two isolates for which host identity could not be
confirmed were excluded from the statistical analyses (bringing
the total number of genomes on which analyses were performed
to n= 239).
Virulence gene diversity, avian host communities and habitat.
We found that the diversity of virulence genes present in birds
varied between host functional groups, and increased with
α-diversity of household avian communities (marginal R2: 0.08,
Table 1). However, the relationship between virulence gene and
avian diversity varied between functional groups, with a sig-
nificant positive relationship only being present in invertebrate-
eating birds (Fig. 1). Habitat diversity and livestock density
showed significant inverse relationships with virulence gene
diversity (GLMM: β=−0.65, 95% CI=−1.17–−0.13, P < 0.05;
GLMM: β=−0.69, 95% CI=−1.34–−0.07, P < 0.05). To further
explore determinants of virulence gene diversity in seed-eating
birds (which, as synanthropic species, constituted the largest and
most well-distributed avian functional group), a separate Poisson-
distributed GLMM was built considering only the genetic diver-
sity of sequences derived from this functional group (n= 152).
This also had the effect of removing variation associated
with functional group membership. Once other functional groups
had been excluded, habitat diversity had a significant inverse
relationship with diversity of virulence genes in seed-eating
birds; as habitat diversity decreased, diversity of virulence
genes in seed-eating birds increased (GLMM: β=−0.76, 95%
CI=−1.3–−0.23, P < 0.01; marginal R2: 0.06).
AMR gene diversity and assemblages of livestock and humans.
Determinants for the diversity of genes encoding AMR were
investigated in a similar way, utilising the same set of avian E. coli
isolates and household explanatory variables used for virulence
genes. The best-fitting model was a zero-inflated hurdle model
(with a truncated Poisson error distribution), in which the pre-
sence or absence of AMR genes (the zero-inflated component)
and increasing diversity of AMR genes (the conditional compo-
nent) were modelled separately. The conditional model demon-
strated that α-diversity of AMR genes was significantly associated
with increasing human density, but only in households keeping
livestock (GLMM: β= 0.99, 95% CI= 0.34–1.65, P < 0.01;
Table 1). This was supported by the zero-inflated component,
which showed a significant negative association between the
probability of AMR genes not being detected in avian-borne E.
coli and increasing human density (GLMM: β=−2.11, 95%
CI=−3.83–−0.45, P < 0.05; Table 1). To test whether the
interaction between human density and livestock keeping was
dependent upon avian host functional-group membership, the
same model was fitted independently for isolates derived from
seed-eating (n= 152) and non-seed-eating birds. This indicated
that the relationship between AMR gene diversity, livestock
keeping and human density was only present for seed-eating
birds (GLMM: β= 0.91, 95% CI= 0.17–1.65, P < 0.05; Fig. 2),
and that the likelihood of detecting AMR genes increased with the
presence of livestock, and increasing human density (Table 1). To
explore these relationships further, the fixed covariate livestock
keeping was replaced with livestock density (correlation pre-
vented both from being fitted in the same model). The resulting
model showed a positive, although non-significant, association
between livestock density and diversity of AMR genes in seed-
eating birds (GLMM: β= 0.53, 95% CI=−0.07–1.13, P= 0.08;
Table 1).
Gradients of microbial genetic diversity across Nairobi.
Microbial genetic diversity was framed against city-wide variation
in host community structure at household interfaces, by relating
the outcomes of our models to the results of an unconstrained
principal components analysis (PCA) that was used to decompose
variance attributed to avian diversity, livestock density, and
human density within households across Nairobi. The first
principal component (PC1) accounted for 72.9% of variation,
clearly separating households with high avian diversity from
households with high human and livestock density. Relating city-
wide trends in host community structure to associations between
diversity of virulence genes and avian diversity, and diversity of
AMR genes and livestock and human density, reveals opposing
epidemiological gradients of bacterial genetic diversity across
Nairobi (Fig. 3a).
Discussion
Understanding the influence of environmental change on the
diversity and distribution of microbial communities in wildlife is
of fundamental importance to understanding how zoonotic dis-
eases spillover into humans. Here, spatially explicit data on land
use, the ecology of host populations, and high resolution micro-
bial sequencing in individual hosts, is linked to explore this
question across a developing city. We found that deterministic
forces, both ecological (wildlife species assemblages and biotic
habitat diversity) and anthropogenic (human and livestock den-
sity), operating across the urban landscape of Nairobi are asso-
ciated with variation in the structure of bacterial genetic
communities within avian host communities.
For virulence genes, the species richness of host communities
was positively correlated with the diversity of genes present in E.
coli isolates, with increases in avian diversity being associated
with a higher diversity of virulence genes within their E. coli. This
follows an expected pattern for communities of hosts and their
microbial diversity. Assuming each vertebrate host harbours at
least some E. coli bearing unique virulence genes, increasing
vertebrate species diversity will increase the diversity of virulence
genes circulating in the population21 (reviewed by Ostfeld &
Keesing16). Our results are consistent with the hypothesis that, in
this study system, increased vertebrate diversity results in avian-
borne E. coli acquiring a greater diversity of virulence genes,
because of exposure to a larger pool of available genes in the
vertebrate host community. The composition and size of this pool
of available genes would be hypothesised to vary across a gradient
of urban land use, as the structure of avian communities change
in response to the changes in habitat structure and biotic resource
provision. However, our results also suggest that the relationship
between microbial and host community diversity is subject to
variation in host functional ecology. For frugivorous birds, which
had higher mean diversities of virulence genes, virulence gene
diversity was negatively correlated with avian diversity, perhaps
because their exposure to E. coli harbouring novel virulence genes
is driven by dietary exposure rather than transmission
between hosts.
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The results of this study also indicate that differences in the
response of wildlife species to changes in urban land use could
play a part in determining how microbial genetic diversity is
related to host community diversity. For example, the diversity of
virulence genes in E. coli derived from seed-eating birds, which
show more synanthropic behaviour than other functional groups,
was predicted by changes in biotic habitat diversity rather than
avian community diversity: in seed-eating birds, increasing
virulence gene diversity was linked to decreasing biotic com-
plexity of habitats. Further evidence for the role of host taxa in
shaping the response of microbial genetics to variation in urban
land use was provided by considering MGEs conferring AMR in
E. coli. Increasing human and livestock density were associated
with higher AMR gene diversity in avian-borne E. coli, but this
only applied to isolates recovered from seed-eating birds.
Importantly, the significant relationship between AMR gene
diversity and human density was only found amongst household
which kept livestock, providing evidence to suggest that house-
holds may act as an interface for the exchange of genes encoding
AMR between livestock and wild birds. Livestock and human
density could therefore be responsible for influencing the diver-
sity (or pool) of AMR genes present and/or promoting contact
with synanthropic wildlife, resulting in spillover of bacteria and/
or their genetic elements from livestock to wildlife within
household compounds.
Our findings are important for several reasons. First, they point
towards the presence of opposing epidemiological gradients for
AMR and virulence genes across the urban landscape, in which
communities of mobile microbial genes are correlated with
changes in the richness and density of vertebrate host commu-
nities (which may be confounded by the ecological traits of the
host within which that organism resides) (Fig. 3a). Although the
Table 1 Estimated regression parameters, standard errors, z-values and P values for optimal generalised linear models used in
this study, modelling the diversity of avian-borne E. coli virulence and antimicrobial resistance (AMR) genes against household
environmental variables
Model Terms Estimate Std. Error z value P value
Model 1: Virulence genes, All avian functional groups
Intercept 1.0542 0.4432 2.379 <0.05
Avian Species Richness 0.0447 0.0224 2 <0.05
Fruit/Nectar 2.321 0.831 2.793 <0.01
PlantSeed 0.5413 0.4009 1.35 0.18
Omnivore 0.7884 0.5745 1.373 0.17
Livestock Density −0.6939 0.3202 −2.167 <0.05
Habitat Diversity −0.6465 0.2598 −2.488 <0.05
Avian Species Richness:Fruit/Nectar −0.1202 0.0433 −2.778 <0.01
Avian Species Richness:Seedeater −0.0417 0.0236 −1.768 0.08
Avian Species Richness:Omnivore −0.0478 0.0325 −1.468 0.14
Model 2: Virulence genes, Seed-eating birds only
Intercept 1.8383 0.2152 8.54 <0.001
Habitat Diversity −0.7587 0.2698 −2.812 <0.01
Livestock Density −0.6564 0.3365 −1.95 0.05
Model 3: AMR genes, All avian functional groups (Zero-inflated hurdle, truncated Poisson)
Conditional model
Intercept 1.9068 0.1562 12.204 <0.001
Livestock kept within household −0.3171 0.1704 −1.86 0.063
Human Density −0.41413 0.2601 −1.593 0.111
Livestock-keeping:Human Density 0.9948 0.3332 2.986 <0.01
Zero-inflation model
Intercept 1.3175 0.4637 2.841 <0.01
Livestock kept within household −0.8217 0.5202 −1.58 0.114
Human Density −2.1407 0.8627 −2.481 <0.05
Livestock-keeping:Human Density 0.3796 1.3059 0.291 0.771
Model 4: AMR genes, Seed-eating birds only (1) (Zero-inflated hurdle, truncated Poisson)
Conditional model
Intercept 1.8531 0.2073 8.938 <0.001
Livestock kept within household −0.2788 0.2227 −1.252 0.211
Human Density −0.3355 0.304 −1.104 0.2698
Livestock-keeping:Human Density 0.9107 0.3768 2.417 <0.05
Zero-inflation model
Intercept 1.3989 0.6002 2.323 <0.05
Livestock kept within household −1.4189 0.6706 −2.116 <0.05
Human Density −2.2329 0.9883 −2.259 <0.05
Livestock-keeping:Human Density 1.8476 1.4079 1.312 0.1894
Model 5: AMR genes, Seed-eating birds only (2) (Zero-inflated hurdle, negative Binomial)
Conditional model
Intercept 1.58251 0.0923 17.195 <0.001
Livestock Density 0.53141 0.30462 1.745 0.081
Zero-inflation model
Intercept 0.2055 0.2295 0.895 0.371
Livestock Density −1.1402 0.9043 −1.261 0.207
For two-stage hurdle models (Models 3–5), a positive contrast in the conditional model represents a higher abundance, whilst a positive contrast in the zero-inflated model indicates a higher chance of
absence
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-10595-1
4 NATURE COMMUNICATIONS |         (2019) 10:2643 | https://doi.org/10.1038/s41467-019-10595-1 | www.nature.com/naturecommunications
horizontal exchange mechanisms involved in the transfer of these
genes are unlikely to directly mimic the dynamics of microbial
transmission, such deterministic patterns might also be displayed
by microbial communities subject to the same changes in host
community structure. For example, abundance of hosts has been
linked to parasite species richness in a number of previous stu-
dies22,23, and increasing diversity of helminth parasitism in
Southeast Asian murids has been positively correlated with a
gradient of anthropogenic habitat change24.
Second, our results provide evidence for a mechanism by which
anthropogenic processes tied to variation in urban land use result
in spillover of MGEs (and potentially microbes) between verte-
brate host compartments at wildlife-livestock-human interfaces
(Fig. 3b). And third, considering variation in avian community
assemblage and the form of human and livestock populations as
indicators of differing ecological and anthropogenic processes,
our findings suggest that processes associated with urbanisation
can simultaneously exert very different forms of genetic selection
(e.g., exposure to diverse pools of virulence or AMR genes) on the
same species of bacteria. This could have important implications
for public health. For bacterial organisms such as E. coli, exposure
to larger pools of genetic diversity that promote uptake and fixing
of AMR genes can confer adaptive advantages such as drug
resistance25, whilst acquisition of virulence determinents in the
accessory genome has been frequently implicated in the emer-
gence of pathogenic lineages of E. coli. Divergence associated with
horizontal gene transfer between closely related microbial strains
can lead to the emergence of novel pathogens26,27.
In this study, high resolution genetic data collected as part of a
structured epidemiological study, was used to study bacterial
epidemiology in a multi-host urban system. Whilst the scale of
sampling conducted in this study (representing sympatric wild-
life, livestock and human communities along a gradient of urban
land use) provided the opportunity to explore hypotheses that,
until recently could not have been tested, this dataset is not
without epidemiological limitations, and the results presented in
this study should be interpreted with the following considerations
in mind. To better contextualise the transfer of MGE-borne
genes, in particular those borne on plasmids, longer read
sequencing (e.g., PacBio) would provide an advantage over short-
read Illumina data in making epidemiological inferences28.
However, the focus of this study was on patterns of diversity in
terms of gene presence or absence rather than characterising
individual genes and the genetic context of their transfer. The
sensitivity of commensal E. coli in identifying transmission
pathways for other pathogens should also be considered with
caution. Differences in characteristics (such as shedding rates and
effects on host behaviour) between commensal and pathogenic
organisms may have epidemiological consequences that reduce
their representation of one another. In addition, by only
sequencing a single E. coli isolate from each host, the within-host
genetic diversity of E. coli was not considered. Previous molecular
studies on E. coli (albeit it in different hosts, and using lower
resolution sequencing technology), have demonstrated consider-
able within-host diversity across vertebrate taxa29–31. However,
the decision to sequence a single isolate from each host was made
as a necessary, cost-based trade-off between genetic resolution,
depth of sampling E. coli genetic diversity within each individual,
and the number of unique wildlife individuals from which sam-
ples could be included. Under sampling within-host diversity
would only be likely to lead to a signal being missed, rather than
changes to the positive results that we report in this study.
Species richness (count) of avian community in households
10 20
30
































30 10 20 30 10 20 30 10 20 30
Fig. 1 Virulence gene diversity and avian species richness. Fit of the Poisson GLMM, modelling how diversity (richness) of virulence genes in avian hosts
(n= 239) varies as a function of avian host community richness and functional group membership. Coloured lines represent different avian functional
groups, and shading on either side of each line represents 95% confidence intervals































Fig. 2 Antimicrobial resistance (AMR) gene diversity and human density.
Fit of the zero-inflated hurdle model, modelling how diversity of AMR genes
in seed-eating birds increased with human density, when livestock were
part of the vertebrate host community at household interfaces. Coloured
lines represent the presence or absence of livestock in households, and
shading on either side of each line represents 95% confidence intervals. A
subset (n= 152) of E. coli isolates were included in this analysis
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In demonstrating that it is possible to link epidemiological
processes in wildlife to environmental drivers across urban
landscapes, this study has taken the first step towards forecasting
the effects of urban land-use change on disease emergence within
a developing city. Whilst the focus of this study was on wildlife,
understanding how urban environmental change structures
microbial communities in human and livestock hosts is equally
important, and extending analysis of the diversity of genes carried
on MGEs to humans and livestock would provide valuable insight
into the epidemiological responses of these compartments to
variation in land use. By considering genetic diversity in a single
species of Enterobacteriaceae as a proxy for parasite diversity, this
study has necessarily taken a reductionist approach to address
important hypotheses that otherwise could not have been
answered using this dataset. The limitations in using a model
organism such as E. coli could be addressed through utilising
recent advances in metagenomics, which permit sequencing of
bacterial and viral microbiomes, to characterise the structural
response of microbial communities to the environmental drivers
of urban land-use change. Such methods could be utilised in the
future to understand how changes in microbial diversity, and the
uptake and fixing of genes by pathogens, translate to emergence
and manifestation of clinical disease in wildlife, livestock and
humans.
Methods
Animal care and use. The collection of data adhered to the legal requirements of
the country in which the research was conducted. Wildlife were trapped under
approval of an International Livestock Research Institute (ILRI) Institutional
Animal Care and Use Protocol (2015.12).
Human ethics statement. Questionnaire data was collected under ILRI Institu-
tional Research Ethics Committee approval (2015-09), and prior informed consent
was gained for each individual participating in the project.
Study design. The study focused on household livestock keeping as it represents a
point of largely unmanaged, intense contact between synanthropic wildlife, live-
stock and humans. Faecal samples (n= 547) were collected from 57 avian species
from 99 households across Nairobi, that were participating in the UrbanZoo
project20. The UrbanZoo project, based in Nairobi, Kenya from 2012–2017, aimed
to utilise a landscape genetics approach to understanding the movement and
sharing of pathogens in a major developing city. A key component of this project,
within which this study was nested, was the ’99 household project’, which focused
on informal livestock keeping practices in urban households as a route of zoonotic
disease emergence in humans. As such, households were selected with the aim of
maximising the spatial distribution and diversity of livestock keeping practices
across Nairobi, and were chosen to capture three main criteria: socio-economic
diversity, population distribution and livestock keeping practices. Geospatial
mapping data, generated as part of a technical report produced by Institut Français
de Recherche en Afrique (IFRA), was used to identify 17 classes of residential
neighbourhood in Nairobi based on physical landscape attributes, which were
subsequently verified by 817 household questionnaires32. Each of the 17 classes of
neighbourhood were then ranked by average income and reduced into seven wealth
groups. Administrative sublocations were mapped onto each wealth group, iden-
tifying a total of 70 possible sublocations, for which dominant wealth groups were
calculated by extracting the proportion of population belonging to each neigh-
bourhood class within the sub-location boundaries (Supplementary Table 1). A
total of 33 sublocations were selected to be included in the study, with the number
of sublocations belonging to each wealth group chosen proportionately to the
population density and the variety of neighbourhood classes in each of the seven
wealth groups. Final selection of individual sublocations was aimed at maximising
areas with high livestock densities, whilst ensuring coverage of other neighbour-
hood classes and geographical spread.
For each sublocation, three geographical points were selected at random within
the dominant housing type. The order in which sublocations were visited was
randomised. Local officials assisted in the recruitment of a household closest to
each geographical point, to obtain two livestock keeping and one non-livestock
keeping household per sublocation (a total of 99 households, 66 of which kept
livestock). Households had to meet strict inclusion criteria of keeping either large
ruminants (cattle), large monogastrics (pigs), small ruminants (goats/sheep), small
monogastrics (poultry/rabbits), or no livestock species. To ensure an equal sample
of both cattle and pig-keeping households, the combination of livestock keeping
households represented in each sublocation was randomised, and had to consist of
either large ruminant and small monogastric, or large monogastric and small
ruminant species. For sublocations in which households keeping large ruminant or
large monogastric species were absent, a replacement household keeping either
small monogastic or small ruminant species was recruited. Sampling of households
took place between September 2015 and September 2016.
Wildlife trapping and ecological surveys. A dedicated field team was responsible
for collecting data on humans, livestock and wildlife in each household, consisting
of veterinarians, animal health technicians and clinicians. Mist nets were set at
dawn to trap birds, with nets being positioned outside the house and around
livestock keeping facilities. Once caught, all birds were live-sampled in the field
under manual restraint, before being released unharmed. Morphometric data were
collected for identification purposes, and a suite of biological samples (including



















































Fig. 3 Epidemiological gradients in MGE diversity, and pathways to AMR spillover under urban change. a Diagrammatic representation of how
epidemiological gradients in diversity (richness) of virulence and AMR genes in avian-borne E. coli overlay on broad-scale trends in host community
characteristics at urban household interfaces. The characteristics of host communities are represented in the form of a principal components analysis
(PCA), performed on avian diversity (species richness), human density and livestock density in households. PC1 accounts for most variation, separating
households with high avian diversity from households with high human and livestock density. Associations between the diversity of virulence and AMR
genes, and avian diversity human density and livestock density are indicated by circles overlaid onto the PCA biplot. b Schematic illustrating possible
processes leading to spillover of AMR genetic determinants between livestock and synanthropic birds at household interfaces
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faeces if available, or a cloacal swab) were collected from each animal. Due to large
variation in the size of household compounds, trapping effort (i.e., number of mist
nets placed per trapping session) was maintained such that it was proportional to
the size of the household compound. Ecological surveys were used, alongside
trapping data, to estimate the diversity of avian species present within households.
Avian species counts (presence/absence) were conducted by a trained ornithologist
from the National Museums of Kenya, in which species were identified based on
audio-visual identification over a 20-minute period spent walking transects of each
household compound. Surveys were conducted between 6:30am and 9:30am, over
the course of two months in the dry season, ensuring that bird activity and weather
conditions were constant. The species richness of avian communities (α-diversity:
the total number of avian species recorded in a household) was calculated for each
household. Avian species were also grouped into five functional groups, deemed
relevant for the epidemiology of a directly transmitted gastrointestinal parasite
such as E. coli; plant/seed-eating, omnivorous, fruit/nectar-eating, invertebrate-
eating, vertebrate/fish-eating/scavenger. Allocation of avian species to functional
groups was based upon the EltonTraits database33. Home range estimates for all
avian species were calculated by allometric scaling of body weight34. Scaling factors
published for functionally different birds by Ottoviani et al.35 were used, and
species mean body weights were either collected during sampling, or sourced from
published datasets when unavailable36.
Household questionnaires. A nominated member of each household completed a
questionnaire, detailing i) livestock ownership, management, sourcing, sales and
antimicrobial use, and ii) household composition and socio-economic data.
Abundance (counts) of livestock species and humans were derived from this data
for each household. Dividing livestock and human abundance by household area
(meters2, as measured using ArcGIS) generated an estimate of density of livestock
and humans. Household composition and socio-economic data were used to
generate wealth and ruralness indices for each household sampled20. These indices
were calculated based on methods used to create the Demographic and Health
Surveys (DHS) wealth index, which is derived from a Principal Component
Analysis (PCA) of easily measurable households assets (such as access to water,
construction materials and ownership of livestock)37. A modification was made to
the original set of household assets included in the DHS index to better capture
household variation in Nairobi. All field data was recorded using Open Data Kit
(ODK) Collect software (Hartung et al., 2010), on electronic tablets, and uploaded
to databases held on servers at the International Livestock Research Institute
(ILRI).
Land-use classification. Nairobi is characterised by a large variety of land use.
Land use comprises the biotic and abiotic niches within which hosts exist, and was
classified for each household. The boundary of each household compound was
drawn in ArcMap, and a 30 m buffer created around the perimeter of each com-
pound to represent the landscape surrounding it. A buffer of 30 m was chosen to
reflect home range of common urban rodent species (Mus and rattus spp., esti-
mates of which vary from 1m to 30 m)38,39. Visual classification of land-use types
within the compound and buffer area were conducted at 1:500 scale on a 1 m
resolution ESRI World Imagery satellite-image available in ArcGIS 10.5 (ESRI).
Characterisation of ecological characteristics along a perimeter around the
household compound was considered as important, because the ecological setting
within which the household exists extends beyond the boundaries of the com-
pound. The extent to which this influential area of habitat outside the compound
extends is unknown, and as such it was standardised across study sites. Within the
boundary, the areas of nine different land-use types were visually identified and
sketched as polygons; water-body, wetland, crops, mature trees, shrubs, grassland,
bare ground, artificial ground and rubbish (descriptions for each of these are
summarised in Supplementary Table 2). The total area of classified land-use types
at each site were calculated and expressed as proportions. Ecological land-use types
(all except bare ground, artificial and rubbish) were used to calculate Simpson’s
diversity index, which considers both habitat richness, and an evenness of abun-
dance among the land-use types present at each site. This index was created to
represent the diversity of living (biotic) habitat niches available to wildlife within
households, and ranged from 1 (maximum heterogeneity) to 0 (only a single
category of biotic land use present). All classification was undertaken by J.M.H.
who was familiar with the landscape at each site, and subsequently ground-truthed
by revisiting sites.
Microbiological testing. All swabs and fresh faecal samples were placed in Amies
transport media and transported on ice to one of two laboratories (Kenya Medical
Research Institute (KEMRI) or University of Nairobi (UoN)). Samples were enri-
ched in buffered peptone water for 24 hours, and plated onto eosin methylene blue
agar (EMBA). Plates were incubated for 24 hours at 37 °C, after which five colonies
were selected from each EMBA plate. After a further sub-culture on EMBA to
purify the isolates, the pure isolates were sub-cultured on Müller-Hinton (MH)
agar and archived at −80 °C in cryovials containing Soy broth supplemented with
15% glycerol.
Next-generation sequencing. A single colony was picked from each original
sample (referred to as an isolate) and biochemical tests (triple sugar iron agar,
Simmon’s citrate agar, and motility-indole-lysine media) were run for identifica-
tion as E. coli. DNA was extracted from bacterial isolates using commercial kits
(Purelink® Genomic DNA Mini Kit, Invitrogen, Life Technologies, Carlsbad,
California) and transported under licence to The Wellcome Trust Centre for
Human Genetics, Oxford, UK. Whole genome sequencing (WGS) was carried out
at the Wellcome Trust Centre for Human Genetics on the Illumina HiSeq 2500
platform. 150 base-pair paired-end reads were generated and short-read WGS data
were pre-processed using an automated protocol developed by the Modernising
Medical Microbiology Oxford (MMM) Group to: (i) perform standard quality
control checks using fastQC (https://www.bioinformatics.babraham.ac.uk/projects/
fastqc/) with default settings; (ii) trim reads to remove remnant adaptor sequences
using bbduk40 (parameters: minoverlap= 12, k= 19, mink= 12, hdist= 1,
ktrim= r) and (iii) perform a Kraken41 speciation analysis against with an
in-house database of bacterial reads downloaded from the NCBI sequence read
archive (www.ncbi.nlm.nih.gov/sra/), with an automated step for removal of
contaminant (non-bacterial) reads. De novo assembly was performed using SPAdes
v3.642 (parameters:–careful, -t 1,–phred-offset 33). The assemblies were run
through the batch upload mode of the Centre for Genetic Epidemiology web
interface hosted by the Technical University of Denmark (https://cge.cbs.dtu.dk/
services/cge/) which performs speciation analysis43, multilocus sequence typing
(MLST)44, detection of resistance genes45 and detection of virulence genes46. The
threshold of AMR gene detection was set to 90% identity and 60% coverage, as this
is shown to be the optimal threshold for this method. A 60% coverage threshold
was used to ensure that AMR genes spread over two contigs, and/or located on the
edge of the contig, were not missed45. Virulence genes were identified using Vir-
ulenceFinder with 90% minimum match and 60% minimum length. Samples
deemed as non-E. coli on the basis of the speciation analysis with kmerFinder47 in
the Centre for Genetic Epidemiology pipeline were excluded from further analysis.
Potentially mixed E. coli samples were identified as those with an unusually large
assembly size (greater than 6 megabases (Mb)) and were removed from the dataset.
Supplementary Table 3 details the QC and assembly metrics of the 241 E. coli
isolates included in the study.
Statistical analyses. All statistical analyses were conducted using R v3.3.248. The
response variables diversity of virulence and AMR genes, were regressed against
explanatory variables in generalised linear mixed effects models (GLMMs). Isolates
for which AMR or virulence genes were not detected were included in these
analyses. To address the fact that genes co-mobilised on the same MGE might not
represent independent acquisition events without having access to long-read
sequencing (which would enable identification of the location of genes on plas-
mids), we combined all pairs of genes with 100% co-occurrence (e.g., bfpA and
perA). To account for the dependency structure of the data, the household and
sublocation in which samples were collected were included as nested random
effects. To account for the relationship between bacterial population structure and
MGE diversity, we also included a measure of bacterial population structure as a
random effect in each model. Due to high MLST diversity in the dataset (128
unique STs, and 18 novel STs), sequence type could not be included as a random
effect, and as such, each isolate was assigned to a less stringent cluster using the
BURST algorithm, on the basis of 3 rather than 7 genetic loci. This composite
measure of genetic structure was included as a random effect in each model.
Models of virulence gene diversity were fitted with a Poisson distribution in the R
package lme449. Preliminary data exploration indicated substantial zero-inflation in
the response variable α-diversity of AMR genes (i.e., many samples where no AMR
genes were detected), and as such a zero-inflated Poisson model (ZIP) was initially
fitted to the data (56% of data comprising the response variable were zeros).
However, residuals from the optimal ZIP model obtained through step-wise
selection showed considerable overdispersion (dispersion statistic: 3, a value of 1 is
considered to represent adequate statistical dispersion). Dispersion parameters
were stabilised by fitting zero-inflated mixture and hurdle models available in the R
package glmmTMB50 to the data. These classes of model are frequently used to
model zero-inflated count data in ecological datasets. The fit of these models were
compared using Akaike’s information criteria (AIC).
Optimal models were constructed using stepwise, backwards elimination from
the full model based upon (AIC). Significance of model terms were tested by the
maximum likelihood test, and the fit of each model was reported as marginal
regression coefficients of multiple determination (marginal R2) where possible.
Model assumptions were verified by plotting residuals versus fitted values, and by
assessing models for overdispersion. Non-linear relationships were checked by
fitting a generalized additive model (GAM) between the response and explanatory
variables, featuring a nonlinear smoother, in R package mgcv51. The residuals were
also assessed for spatial dependency by plotting them against geographic
coordinates, and examining the results of a semivariogram.
An unconstrained principal component analysis (PCA), was performed on
avian diversity, livestock density, and human density within households across
Nairobi, in the R package vegan52.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
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Data availability
Data (AMR and virulence gene datasets, and accompanying metadata) are available via
an open access repository held by the University of Liverpool (http://dx.doi.org/
10.17638/datacat.liverpool.ac.uk/738). All sequencing reads are available on the
European Nucleotide Archive, under Project ID: PRJEB32607.
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